Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530758-139563458	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2334	"liver: 233.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;RH-30: 1.9;SiHa: 1.5;U-698: 1.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	11000000000	11000000000										"prognostic favourable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943772-196959226	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1462	"liver: 146.2"	"Cell line enhanced"	"Detected in some"		"HEL: 2.8;TIME: 1.2"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	5700000000	5700000000			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	949	"liver: 528.6"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 20.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB016725	Supported				"Secreted to blood"	230000000000	230000000000			"CAB016725: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	528.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.4	0.0	0.8	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.1	20.8	0.0	2.9	0.0	0.8	0.6	0.1	0.0	0.1	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	1.1	0.0	0.4	0.3	0.2	1.0	0.1	0.3	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
BX248415.1		ENSG00000276911			1	196819745-196959210	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	938	"liver: 93.7"	"Cell line enhanced"	"Detected in single"		"RH-30: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"					"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	93.7	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	879	"liver: 113.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;RH-30: 3.4;RPTEC TERT1: 1.0;U-698: 1.4"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	540000000	540000000										"prognostic favourable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.4	0.0	1.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52771700	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	825	"liver: 82.5"	"Cell line enriched"	"Detected in single"	10	"Hep G2: 6.9"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 0.5"	"Region enriched"	"Detected in single"	35	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	1700000000	1700000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 94.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	170000000000	170000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016776: , HPA051370: AB_2681458, HPA064755: "		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavourable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	94.6	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131202-21239246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	618	"liver: 121.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;A549: 2.1;HeLa: 3.3;NTERA-2: 3.0;RPMI-8226: 4.0"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050892	Supported									"HPA050892: AB_2681265"			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	0.0	0.0	1.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882981-7940474	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	594	"liver: 121.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.6;RH-30: 2.2;U-251 MG: 2.4"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049552	Enhanced					200000	200000			"HPA049552: AB_2680814"					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.8	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719180-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	593	"liver: 324.8"	"Cell line enriched"	"Detected in some"	21	"Hep G2: 76.5"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016780, CAB018650, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	43000000000	43000000000			"CAB016780: , CAB018650: AB_2246689, HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	324.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	76.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C9		ENSG00000113600	"Complement C9"	P02748	5	39284262-39424868	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	577	"liver: 419.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.5;RH-30: 1.6;SiHa: 1.0;U-698: 6.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	97000000000	97000000000			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	550	"liver: 823.7"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 162.9"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	44000000000	44000000000	"Golgi apparatus"	"Golgi apparatus"	"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favourable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavourable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	823.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.7	0.9	1.3	1.0	1.3	0.2	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	162.9	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.3	0.0	0.0	1.3	0.4	1.3	0.5	1.3	0.8	0.8	0.6	0.7	1.4	0.9	0.8	0.9	1.0	0.4	0.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell line enriched"	"Detected in some"	55	"Hep G2: 125.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	68000000000	68000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavourable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	125.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032442-106038738	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	414	"liver: 101.8"	"Cell line enriched"	"Detected in single"	474	"Hep G2: 47.3"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	49000000000	49000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	101.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930726	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	333	"liver: 80.2"	"Cell line enriched"	"Detected in single"	20	"Hep G2: 8.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038270	Uncertain									"HPA038270: AB_10672511"							"prognostic favourable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 10.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		12000000	12000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: "	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	321	"liver: 932.2"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 596.2"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB025885	Supported				"Secreted to blood"	210000000000	210000000000			"CAB025885: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.0	2.9	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	65.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	596.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.8	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"	3400000000	3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815993-68831196	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	277	"liver: 120.4"	"Cell line enriched"	"Detected in single"	39	"Hep G2: 15.8"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain									"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF2	"BMP-9, BMP9"	ENSG00000263761	"Growth differentiation factor 2"	Q9UK05	10	47322490-47326270	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	273	"liver: 27.3"	"Cell line enhanced"	"Detected in single"		"K-562: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB023357	Uncertain				"Secreted to blood"	300000	300000			"CAB023357: AB_2111086"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 210.3"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	140000000000	140000000000	"Golgi apparatus"	"Golgi apparatus"	"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	210.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
APOC4-APOC2		ENSG00000224916	"APOC4-APOC2 readthrough (NMD candidate)"		19	44942238-44949565	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	267	"liver: 178.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 11.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055877	Supported									"HPA055877: AB_2682953"	"unprognostic (1.45e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.68e-2)"	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.1	178.9	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.3	0.2	0.6	0.1	0.1	0.1
INHBC		ENSG00000175189	"Inhibin beta C subunit"	P55103	12	57434760-57450828	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	256	"liver: 121.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 9.6;Karpas-707: 9.8;RH-30: 4.9;U-266/70: 5.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	11000000	11000000				"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.2	0.2	0.1	0.1	1.5	0.1	0.5	0.0	9.6	0.0	0.4	0.1	0.3	0.0	0.0	0.6	0.0	0.1	9.8	0.0	0.2	0.1	0.0	0.0	0.1	0.3	4.9	0.7	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009674	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"liver: 85.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"	1700000000	1700000000			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	233	"liver: 326.9"	"Cell line enriched"	"Detected in single"	24	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	4500000000	4500000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	0.9	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0.0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell line enriched"	"Detected in many"	8	"Hep G2: 20.7"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	5900000000	5900000000	Nucleoplasm	Nucleoplasm	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.0	0.7	0.8	0.7	0.5	0.5	0.6	0.9	0.9	2.5	0.6	2.2	0.3	0.4	0.3	2.4	0.5	1.4	0.9	1.4	2.1	0.7	20.7	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.1	0.5	1.4	1.1	0.3	1.4	1.1	0.9	0.6	0.9	1.1	0.9	0.5	0.7	1.0	0.9	0.5	0.5	0.2	1.5	0.9	0.5	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	209	"liver: 112.2"	"Cell line enriched"	"Detected in single"	65	"Hep G2: 35.8"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	15000000	15000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678240	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"liver: 425.4"	"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HL-60: 5.7;RH-30: 6.8;SiHa: 2.4"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	30000000000	30000000000			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favourable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	425.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	1.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.7	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903804-173917378	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	203	"liver: 450.5"	"Cell line enriched"	"Detected in some"	35	"Hep G2: 41.6"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	210000000000	210000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favourable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	450.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	41.6	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703269-7749520	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"liver: 249.0"	"Cell line enriched"	"Detected in single"	1079	"Hep G2: 151.9"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	22000000000	22000000000	"Golgi apparatus"	"Golgi apparatus"	"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	249.0	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0.0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 75.9"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	120000000000	120000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavourable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	75.9	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196850241-196918972	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	188	"liver: 61.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 4.9;U-266/84: 2.0"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	180000000	180000000									"unprognostic (5.97e-1)"	"prognostic favourable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	2.5	0.0	4.9	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353499	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	180	"liver: 299.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.0;Hep G2: 4.8;REH: 6.4;U-266/70: 4.8"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	49000000000	49000000000			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	299.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.1	0.0	1.0	0.7	0.0	0.7	0.1	1.3	0.0	0.3	0.6	1.9	0.0	0.0	0.0	0.2	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.9	5.0	2.6	0.0	4.8	0.0	1.0	0.4	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.9	1.6	0.3	0.4	6.4	3.1	1.3	0.0	0.0	0.0	0.4	0.7	0.2	0.8	1.0	1.1	0.0	1.8	0.3	0.0	0.0	4.8	2.1	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.4	0.5	0.5	0.6	0.0	0.3	0.0	0.0	0.0	1.6	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819757-196832189	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"liver: 218.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.6;HeLa: 3.1;HL-60: 4.7;U-266/70: 6.2"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	15000000000	15000000000	Vesicles	Vesicles	"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favourable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	218.9	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.3	0.2	2.6	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.6	3.1	0.2	0.2	4.7	0.8	0.1	0.0	0.0	0.0	0.1	0.3	2.3	0.8	0.0	1.4	0.0	0.8	0.0	0.8	2.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.4	0.0	1.4	0.9	0.4	0.2	0.2	6.2	0.0	1.1	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1										
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine-glyoxylate aminotransferase"	P21549	2	240868479-240880502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	172	"liver: 247.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 13.1"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		5200000	5200000	Vesicles	Vesicles	"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favourable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	247.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.8	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774795-196795406	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"liver: 121.9"	"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;T-47d: 6.8;U-266/70: 12.4"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	3800000000	3800000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favourable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.4	0.0	0.6	0.2	0.1	1.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.4	0.5	0.0	1.3	0.0	0.0	0.0	0.7	0.0	6.8	0.0	0.0	0.1	0.3	0.3	0.0	12.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.3	0.4	0.6	0.1	0.5	0.3	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843538-40850447	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	165	"liver: 199.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.2;HL-60: 2.8;K-562: 1.4;RH-30: 4.3;SiHa: 2.2;U-937: 1.0"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046713, HPA047262"	Supported				"Intracellular and membrane"					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favourable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	199.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	165	"liver: 16.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039390	Uncertain									"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favourable (7.04e-4)"							"unprognostic (1.01e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 151.8"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	89000000000	89000000000	"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441887-3449495	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"liver: 128.0"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 10.7"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	11000000000	11000000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	1.2	0.7	0.4	0.1	0.0	0.0	0.6	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.7	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452790	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"liver: 189.6"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 19.1"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	460000000	460000000				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favourable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	189.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"liver: 53.7"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.9"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: "	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231349-18236893	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	132	"liver: 263.3"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 22.1"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB026061, HPA060139"	Supported				"Secreted to blood"	72000000000	72000000000			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	0.7	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	263.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	22.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;HL-60: 2.7;SiHa: 2.9;U-266/70: 2.9;U-266/84: 2.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdTCR: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favourable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	2.9	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.9	2.2	1.1	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981496	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 79.1"	"Cell line enriched"	"Detected in single"	23	"Hep G2: 14.6"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"	20000000	20000000				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2										
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081877	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 76.8"	"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 55.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	22000000000	22000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF21		ENSG00000105550	"Fibroblast growth factor 21"	Q9NSA1	19	48755559-48758333	"Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	113	"liver: 37.8"	"Group enriched"	"Detected in some"	9	"HHSteC: 3.0;U-2 OS: 10.3"	"Cancer enriched"	"Detected in single"	315	"liver cancer: 33.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061286	Supported				"Secreted to blood"					"HPA061286: AB_2684466"				"unprognostic (1.64e-2)"		"unprognostic (3.62e-1)"	"unprognostic (3.21e-2)"			"unprognostic (3.42e-1)"				"unprognostic (1.54e-1)"	"unprognostic (1.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell line enriched"	"Detected in some"	9	"RH-30: 10.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.1"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	880000000	880000000	"Golgi apparatus"	"Golgi apparatus"	"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favourable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.4	0.8	0.0	0.0	0.0	1.3	1.1	2.3	0.6	0.0	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.5	20.1	0.0	2.1	1.6	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.6	0.6	1.1	0.4	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	0.6	1.3	1.1	0.9	0.6	1.0	0.6	0.7	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3
CREB3L3	CREB-H	ENSG00000060566	"CAMP responsive element binding protein 3 like 3"	Q68CJ9	19	4153601-4173054	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	95	"intestine: 117.4;liver: 179.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.8;Hep G2: 9.7;HMC-1: 5.6;U-266/70: 6.7"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 91.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;T-reg: 1.5"	"Group enriched"	"Detected in many"	13	"granulocytes: 1.0;T-cells: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040671, HPA056228"	Enhanced									"HPA040671: AB_2677072, HPA056228: AB_2683072"	"unprognostic (1.86e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.41e-4)"	"unprognostic (1.79e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.53e-6)"	"unprognostic (3.18e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.35e-2)"	0.1	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	38.6	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.5	179.5	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.1	0.1	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	9.7	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.5	0.3	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.7	2.8	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.0
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197039191-197067267	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"liver: 76.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;Hep G2: 2.2"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	3400000000	3400000000			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favourable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777592-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"liver: 321.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 10.7;Hep G2: 3.2;HL-60: 2.5"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	31000000000	31000000000	Vesicles	Vesicles	"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favourable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	321.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTP3	"LTM1, TMEM7, Z3CXXC3"	ENSG00000163825	"Receptor transporter protein 3"	Q9BQQ7	3	46497491-46500949	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	91	"liver: 43.3"	"Cell line enriched"	"Detected in some"	9	"SiHa: 14.8"	"Group enriched"	"Detected in some"	17	"liver cancer: 22.9;testis cancer: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA075932			Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA075932: "		"unprognostic (2.09e-1)"				"unprognostic (1.64e-1)"	"prognostic favourable (3.11e-6)"								"unprognostic (1.08e-1)"	"unprognostic (1.58e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487667	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	90	"kidney: 63.5;liver: 82.6"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 6.4"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057699	Supported									"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favourable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.0	63.5	82.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323337-100330378	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	88	"liver: 127.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.6;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	127.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	5.6	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.4	0.0	0.0	0.1	2.0	0.2	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.6;HL-60: 7.4;HMC-1: 7.9;NB-4: 20.2"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA009128, HPA029564"	Enhanced				"Intracellular and membrane"					"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.6	1.4	3.9	0.0	0.3	0.0	2.3	1.2	0.2	0.4	9.6	0.0	0.2	0.3	0.2	1.3	1.5	0.1	1.1	0.5	7.4	7.9	0.9	0.2	0.0	0.6	0.0	0.4	0.3	0.9	0.6	0.5	20.2	5.5	0.3	0.3	5.4	0.0	1.7	0.0	0.0	0.0	3.7	0.0	0.6	0.2	0.8	0.0	1.2	0.4	2.0	0.9	2.0	0.8	2.7	1.3	6.3	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"intestine: 54.3;liver: 40.9"	"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.4"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	19.5	0.0	0.0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	54.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
AC002094.3		ENSG00000273171			17	28364288-28368012	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	82	"liver: 75.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;NTERA-2: 1.0;RT4: 1.1;U-2197: 1.1;U-266/84: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (2.54e-2)"											0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	75.7	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	1.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053195-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 246.8"	"Cell line enriched"	"Detected in single"	76	"Hep G2: 61.1"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004146	Approved				"Secreted to blood"	14000000000	14000000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	246.8	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	61.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 308.4"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	308.4	0.0	7.9	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	6.8	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.2;SiHa: 2.1"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	76000000000	76000000000			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.7	4.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44945982-44949565	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	78	"liver: 506.5"	"Group enriched"	"Detected in some"	4	"Hep G2: 82.9;THP-1: 153.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"NK-cell: 6.5"	"Lineage enriched"	"Detected in single"	21	"NK-cells: 6.5"					"Not detected"	"Not detected"			HPA055877	Supported				"Secreted to blood"	110000000000	110000000000			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0.0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0.0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0.0	0.2	0.0	0.7	0.3	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	0.2	82.9	0.0	1.7	28.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	13.8	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	153.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"kidney: 36.5;liver: 141.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.4;SiHa: 1.6;U-698: 2.2;U-937: 1.5"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.0	36.5	141.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	0.0	0.4	0.0	0.2	0.1	1.1	0.0	1.4	0.0	0.4	0.0	1.2	0.4	0.0	0.3	0.3	0.0	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.5	1.2	0.6	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	1.5	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.0	0.2	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 102.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.1;SCLC-21H: 4.9;SK-MEL-30: 2.1;U-937: 2.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	7	"gdTCR: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	4900000000	4900000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.3	0.3	0.8	0.3	1.2	0.0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1.0	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0.0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	7.1	0.0	0.1	0.0	0.2	1.3	0.0	4.9	0.4	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell line enriched"	"Detected in some"	154	"Hep G2: 164.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	71000000000	71000000000	"Golgi apparatus"	"Golgi apparatus"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	164.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"liver: 43.4"	"Cell line enriched"	"Detected in single"	6	"RT4: 4.6"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB016072, HPA060604"	Supported				"Secreted to blood"	2900000000	2900000000			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500236	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"liver: 50.4"	"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.4"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favourable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.2	0.5	0.4	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"kidney: 76.1;liver: 93.4"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;Hep G2: 9.8"	"Group enriched"	"Detected in some"	450	"liver cancer: 30.9;renal cancer: 17.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA057699	Supported									"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favourable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	76.1	93.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.9	1.0	0.5	0.2	1.2	0.0	1.0	0.0	5.4	1.5	0.0	0.0	1.3	0.9	0.2	0.0	0.0	1.2	0.9	0.1	2.7	0.0	0.7	0.0	0.0	0.0	1.0	0.7	0.2	1.2	9.8	0.0	1.3	1.3	0.0	0.0	0.0	0.4	0.6	0.8	1.2	0.0	0.7	0.6	1.3	1.2	0.0	0.1	1.1	0.2	0.4	0.2	1.9	1.0	2.6	0.0	1.0	2.0	0.4	0.0	0.0	0.9	0.0	0.7	0.8	0.5	0.7	0.7	3.5	1.9	0.5	0.5	0.2	0.6	0.0	0.6	0.1	0.8	0.2	0.1	0.6	0.7	1.2	1.0	0.2	0.1	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PRAMEF10		ENSG00000187545	"PRAME family member 10"	O60809	1	12892896-12898270	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	67	"liver: 7.5"	"Cell line enriched"	"Detected in single"	26	"SCLC-21H: 2.6"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 1.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (1.20e-1)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	5400000000	5400000000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.3	0.0	0.0	0.0	7.6	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.1	0.9	0.0	12.8	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 65.1;liver: 90.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;BJ hTERT+: 1.2;HL-60: 1.9;SiHa: 1.5;U-698: 1.2"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	65.1	90.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.7	0.3	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.5	0.0	0.6	0.8	1.9	0.4	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.2	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16 (all-trans)"	O75452	12	56951431-56959374	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"liver: 114.6"	"Group enriched"	"Detected in some"	6	"HaCaT: 3.4;hTCEpi: 7.6"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"					"Cell type enhanced"	"Detected in single"		"gdTCR: 1.9"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA038518	Enhanced									"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favourable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	114.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.8	0.0		0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0			0.0		0.1	0.0	0.1	0.2	0.0	0.0	0.8	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.1	0.0	7.6	0.0	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.2										
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782897-25832059	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	56	"kidney: 67.6;liver: 17.9"	"Cell line enriched"	"Detected in single"	379	"RPTEC TERT1: 37.9"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050513			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	67.6	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050276	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"liver: 259.9"	"Cell line enhanced"	"Detected in many"		"A549: 20.1;Hep G2: 21.1"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA029339	Supported				"Secreted to blood"	46000000000	46000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favourable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.1	4.6	8.1	6.0	6.9	0.2	2.4	2.5	0.7	1.4	0.6	1.9	2.9	0.1	1.2	7.9	0.2	0.2	1.1	0.6	0.0	1.2	1.0	21.1	1.1	0.7	0.5	3.1	0.4	1.4	2.7	0.7	0.5	2.8	1.5	3.9	0.3	0.1	1.2	7.8	1.7	2.0	0.3	1.2	0.6	1.2	4.8	1.1	0.0	2.0	1.6	2.6	0.9	2.0	0.1	5.4	2.4	1.6	1.2	1.2	1.6	2.7	4.9	0.0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360569-56362823	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"liver: 114.0"	"Cell line enriched"	"Detected in single"	10	"Hep G2: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted to blood"	4000000000	4000000000				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.9	1.8	0.5	1.1	1.4	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.6	0.9	9.7	0.0	0.9	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.3	0.2	0.1	0.5	0.4	0.3	0.4	0.6	0.5	0.4	0.3	0.1	0.4	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.4	0.2	0.4	0.3	1.8	0.5	0.3	0.5	0.2	0.8	1.6	0.7	0.6	0.1	2.1	1.4	1.1	1.3	1.1	0.4	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929210-56966140	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"liver: 240.9"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.7"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	47	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023694	Supported				"Secreted to blood"	3600000000	3600000000			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favourable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	240.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	5.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.3;RH-30: 2.2"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99563761-99623999	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"intestine: 211.4;liver: 60.8"	"Group enriched"	"Detected in some"	6	"AF22: 12.5;Hep G2: 13.7"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA051170, HPA054862"	Uncertain		Approved	Cytosol	"Intracellular and membrane"	450000	450000	Cytosol	Cytosol	"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.1	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.0	53.2	0.2	0.1	53.4	0.0	0.0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0.0	0.4	0.1	1.1	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.5	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.3	0.1	13.7	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.3	0.3	0.2	1.2	0.0	0.0	0.8	0.9	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20773879-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 170.8"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 62.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	94000000000	94000000000	Vesicles	Vesicles	"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.6	0.9	0.3	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	170.8	0.3	0.0	0.0	0.7	0.3	0.0	3.6	0.1	0.2	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	62.7	0.0	0.2	0.1	0.0	0.0	0.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.3	0.0	0.4	0.0	1.0	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0.0	2.3	0.6	0.9	0.0	0.0	0.0	0.7	2.6	0.5
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;NB-4: 4.4;RPMI-8226: 6.6;SCLC-21H: 2.5;SH-SY5Y: 4.9"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033671, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"CAB033671: AB_782375, HPA072245: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.5	0.0	0.5	0.0	0.1	4.4	0.3	0.0	0.0	2.1	6.6	0.0	0.4	2.5	4.9	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	0.0	0.7	0.0	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nuclear membrane"	"Nuclear membrane"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: "	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.4	0.0	0.2	1.6	0.0	0.4	0.3	0.3	7.4	0.4	0.1	0.1	0.3	0.6	0.4	0.8	0.5	0.4	0.4	0.4	0.0	0.5	0.3	0.1	0.6	0.4	0.1	0.2	0.1	0.8	1.9	0.7	0.5	0.2	0.5	0.5	1.8	0.1	0.9	0.2	0.3	0.1	0.5	0.8	1.1	0.9	0.6	0.3	0.8	0.6	0.3	0.8	0.9	0.2	1.2	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775417-69797289	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 121.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042727	Approved									"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favourable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	2.7	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	4.2	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.6	0.3	0.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.8	0.1	0.1	0.8	0.5	0.0	0.4	0.5	1.1	0.1	0.6	0.0	0.3	0.0	0.1	0.8	0.1	0.6	0.1	0.0	0.3	1.7	0.5	0.3	0.4	0.8	0.5	0.2	0.3	1.0	0.6	0.4	2.7	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577130	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 387.0"	"Group enriched"	"Detected in some"	5	"Daudi: 2.3;Hep G2: 7.1"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	7.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.4	0.1	0.0	0.7	0.9	0.0	0.1	0.3	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.5	0.0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell line enriched"	"Detected in some"	11	"CACO-2: 164.9"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	32000000000	32000000000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389"	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	164.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	15.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1										
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin beta E subunit"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 127.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.8;Karpas-707: 22.3;U-266/70: 75.2"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	1400000	1400000	Vesicles	Vesicles	"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	127.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.0	0.9	3.1	0.6	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.8	2.1	0.0	2.6	0.1	0.0	1.0	0.5	0.2	0.1	0.5	0.0	0.3	4.9	0.0	0.0	0.0	3.2	14.8	0.6	0.6	1.4	1.5	0.3	3.3	0.0	1.3	22.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	2.3	0.0	0.0	5.5	0.2	0.0	0.0	2.1	0.1	2.4	0.0	0.0	1.2	0.0	0.1	75.2	2.3	1.0	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1.0	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;NTERA-2: 3.5;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		9200000	9200000	Cytosol	Cytosol	"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favourable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0
DAO	DAMOX	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"brain: 37.0;kidney: 39.0;liver: 64.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.4;HL-60: 1.7;HMC-1: 1.3;RH-30: 1.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Group enriched"	"Detected in many"	5	"cerebellum: 37.0;pons and medulla: 31.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"cerebellum: 74.4;pons and medulla: 21.1"	"Low region specificity"	"Detected in many"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"					"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favourable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.3	0.2	0.0	0.2	2.7	0.2	0.2	37.0	0.7	0.2	0.9	11.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	39.0	64.2	0.3	0.2	6.4	0.5	0.2	0.3	0.2	0.0	0.2	31.2	0.2	1.1	0.0	0.2	0.2	0.2	0.2	0.2	0.3	35.9	0.2	0.2	0.2	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	37.0	0.5	0.8	0.9	6.4	0.5	31.2	0.4
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.2;Hep G2: 10.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdTCR: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	1500000000	1500000000	Mitochondria	Mitochondria	"HPA004826: "	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.4;Karpas-707: 1.8;SK-MEL-30: 4.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA037723: AB_10672606, HPA037724: AB_2675631"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favourable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.4	0.1	0.0	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.5"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favourable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.5	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"liver: 1156.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 64.7;HSkMC: 37.1"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 20.0;eosinophil: 30.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.9;monocytes: 20.0"									"CAB003787, HPA047750"	Enhanced		Approved	Vesicles	"Secreted to blood"	140000000000	140000000000	Vesicles	Vesicles	"CAB003787: , HPA047750: AB_2680146"	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	9.8	0.0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0.0	0.3	0.5	0.3	1.1	0.3	3.0	0.3	0.0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	1.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.0	3.5	30.9	20.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	64.7	0.1	9.2	1.7	37.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.5	0.1	0.7	0.0	0.3	6.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.1	1.4	0.0	0.2	0.0	0.0	1.2	0.0	4.4	0.0	3.6	0.0	2.6	20.0	30.9	0.0	0.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	5.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
GBP7	"FLJ38822, GBP4L"	ENSG00000213512	"Guanylate binding protein 7"	Q8N8V2	1	89131751-89176040	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 48.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	58	"liver cancer: 10.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA051245	Uncertain									"HPA051245: AB_2681404"	"unprognostic (4.22e-5)"	"unprognostic (7.32e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.35e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.3	1.3	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.0	0.2	0.0	0.2	0.9	0.2	0.1	0.3	0.2	0.1	0.1	0.3	0.2	0.2	1.3	1.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6B		ENSG00000215186	"Golgin A6 family member B"	A6NDN3	15	72654738-72666394	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	34	"liver: 8.4;testis: 10.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;U-266/70: 2.6;U-266/84: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087"	Supported									"HPA044978: AB_2679165, HPA050087: AB_2681010"					"unprognostic (5.47e-3)"		"unprognostic (1.88e-2)"			"unprognostic (2.07e-1)"				"unprognostic (2.01e-1)"	"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.1	1.0	0.0	0.6	0.0	0.3	0.8	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.6	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346356-38377023	"Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"liver: 429.7"	"Group enriched"	"Detected in some"	10	"ASC diff: 12.1;HSkMC: 14.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	910000000	910000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (3.62e-12)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	12.8	0.0	0.1	4.7	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.4	0.1	0.0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	4.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	14.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"kidney: 36.1;liver: 50.8;thyroid gland: 67.7"	"Group enriched"	"Detected in some"	26	"Hep G2: 16.6;SK-BR-3: 40.3"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	36.1	50.8	0.4	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	67.7	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	40.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1
SLC22A10	"hOAT5, OAT5"	ENSG00000184999	"Solute carrier family 22 member 10"	Q63ZE4	11	63137867-63369718	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	32	"liver: 41.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	14	"liver cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.17e-2)"				"unprognostic (9.77e-2)"		"unprognostic (7.07e-3)"	"unprognostic (7.46e-4)"			"unprognostic (7.62e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 187.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.4;HDLM-2: 16.4;U-87 MG: 9.6"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 7.0;hippocampal formation: 5.9"	"Not detected"	"Not detected"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	0.5	0.2	2.5	0.5	0.0	0.1	0.1	2.0	0.1	0.2	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0.0	5.8	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0.0	0.0	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.3	0.4	0.0	2.6	0.0	0.0	9.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.0	1.5	0.2	0.2	0.7	0.1	0.0
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481281-126517773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 50.7"	"Cell line enriched"	"Detected in some"	8	"NB-4: 9.3"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					510000	510000			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609589-100695479	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"intestine: 58.4;liver: 26.9"	"Group enriched"	"Detected in some"	6	"BEWO: 2.8;CACO-2: 4.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"															"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.2	0.1	0.5	0.1	1.2	0.1	0.1	0.1	0.9	17.1	0.1	0.1	25.7	0.3	0.1	0.2	0.9	0.3	0.2	0.1	0.1	0.1	26.9	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	1.7	0.1	0.1	0.1	0.1	0.2	58.4	0.8	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 21.9"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		5300000	5300000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.3	0.0	0.2	0.4	0.2	0.1	0.5	0.8	21.9	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.1	0.4	1.0	0.1	0.3	0.3	0.6	0.3	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.5	0.0	0.4	0.5	0.2	0.4	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748844-74756202	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 143.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 6.0"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced									"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	1.1	4.5	1.2	1.1	0.7	0.3	1.1	1.0	2.7	2.2	0.2	0.0	1.6	0.7	0.0	0.0	0.2	0.6	1.3	2.2	0.5	0.0	1.2	0.1	0.2	0.1	0.6	1.2	2.8	1.6	0.8	0.1	1.9	1.1	0.4	0.3	0.1	0.0	0.2	1.9	4.1	0.0	0.8	2.5	1.3	1.7	0.6	2.6	2.4	0.9	0.0	2.3	2.2	1.1	2.1	6.0	0.4	1.6	1.0	0.4	1.1	1.4	1.1	1.2	1.0	0.7	1.6	1.1	2.4	1.2	3.2	1.2	1.2	0.6	0.6	0.5	0.8	0.7	0.5	0.4	1.7	0.7	0.7	4.5	1.1	0.8	1.1	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135955034	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 100.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043883	Enhanced				"Secreted to blood"	820000	820000			"HPA043883: AB_2678714"							"prognostic favourable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	100.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.5	2.5	1.2	0.1	0.8	0.3	1.0	1.2	1.5	2.5	0.6	2.2	2.3	0.5	0.2	0.0	0.0	0.9	1.4	2.4	1.9	1.0	1.5	0.2	0.7	0.2	0.9	3.2	2.4	3.3	4.1	1.0	3.0	0.5	0.8	0.7	1.1	1.1	1.1	0.9	2.0	2.0	1.5	1.2	1.3	1.7	1.9	1.6	1.4	0.7	1.6	2.7	1.0	1.9	0.0	0.6	0.1	0.3	1.6	2.5	0.9	1.5	1.3	0.4	3.6	1.7	1.0	1.1	2.8	2.4	2.4	1.2	0.4	0.7	0.8	0.5	1.3	0.8	0.8	0.2	1.0	0.7	0.5	2.5	0.1	0.6	0.5	0.7	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333252	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 404.1"	"Cell line enriched"	"Detected in single"	237	"Hep G2: 133.4"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"					"Cell type enriched"	"Detected in single"	35	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 13.2"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	61000000000	61000000000	Vesicles	Vesicles	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	404.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	133.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.1										
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882987	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 62.4;liver: 64.4"	"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.4"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019556	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.4	0.1	21.2	0.0	0.0	24.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	62.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	14.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.0
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.1;NB-4: 13.2;RPMI-8226: 15.2;SH-SY5Y: 13.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA002198, CAB020827"	Enhanced					930000000	930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.3	0.0	2.9	1.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.2	0.2	0.0	0.2	3.1	15.2	0.0	0.0	2.5	13.2	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.3	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942238-44945496	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"liver: 126.0"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2;SK-MEL-30: 6.4"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062671	Approved				"Secreted to blood"	1500000000	1500000000			"HPA062671: AB_2684828"							"unprognostic (1.82e-3)"											0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	126.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	3.1	4.3	1.7	0.8	1.2	0.1	0.8	0.0	0.0	0.8	0.0	0.9	1.6	0.0	0.0	1.1	0.2	0.0	0.2	1.1	0.1	0.0	0.1	0.6	0.4	0.3	0.2	0.4	4.2	0.0	2.6	0.0	0.3	1.2	2.4	0.3	0.0	0.4	0.0	1.2	1.9	0.7	1.0	0.3	0.0	0.0	0.5	0.0	0.5	0.8	0.0	1.4	0.5	0.2	0.7	0.8	6.4	1.3	0.0	3.0	0.6	0.3	0.4	0.0	0.8	0.8	2.0	0.2	1.3	0.0	2.1	0.8	1.9	0.9	1.7	0.4	0.6	0.9	1.2	0.4	1.4	0.6	0.6	4.3	0.8	0.8	3.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	180000000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favourable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.0	5.8	0.0	0.0	0.3	1.5	0.6	0.0	6.9	0.1	5.1	11.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.5	0.0	0.7	0.1	18.7	0.1	0.9	0.6	0.2	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.4	0.2	1.6	0.0	0.0	0.0	0.5	1.2	0.2	0.0	0.2	0.0	0.2	0.5	0.3	0.3	0.5	1.9	0.5	3.1	0.5	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3
GOLGA6A	"GLP, GOLGA6"	ENSG00000159289	"Golgin A6 family member A"	Q9NYA3	15	74069857-74082550	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"liver: 6.2;testis: 15.7"	"Group enriched"	"Detected in some"	4	"NTERA-2: 1.9;U-266/70: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087"	Supported									"HPA044978: AB_2679165, HPA050087: AB_2681010"					"unprognostic (1.68e-1)"		"unprognostic (2.09e-2)"			"unprognostic (9.50e-2)"				"unprognostic (9.67e-2)"	"unprognostic (6.70e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	15.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.0	5.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"kidney: 51.2;liver: 49.3"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 25.9"	"Group enriched"	"Detected in some"	50	"liver cancer: 28.1;renal cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.0	51.2	49.3	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PLGLB2	PLGP1	ENSG00000125551	"Plasminogen-like B2"	Q02325	2	87748087-87758793	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	28	"liver: 105.2"	"Cell line enhanced"	"Detected in many"		"AF22: 4.5;RPTEC TERT1: 4.5;U-266/84: 5.1"	"Cancer enriched"	"Detected in single"	25	"liver cancer: 1.2"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7;T-reg: 3.7"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.7"														"Secreted to blood"						"unprognostic (1.10e-2)"	"unprognostic (8.78e-2)"			"unprognostic (3.42e-2)"	"unprognostic (7.03e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-1)"		"unprognostic (1.82e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.04e-4)"	"unprognostic (6.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.11e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	105.2	0.0	0.1	0.1		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.7	0.2	0.0	1.4	4.5	1.4	0.0	1.4	0.0	3.8	2.3	0.6	2.6	0.0	1.4	2.8	2.7	0.6	1.0	0.5	0.0	0.8	0.0	1.2	1.0	3.3	0.0	0.3	0.6	0.5	0.0	0.0	0.3	0.4	0.5	0.3	0.0	0.9	0.0	2.6	0.0	0.0	0.0	2.5	0.0	0.0	4.5	0.3	0.0	3.3	0.9	1.1	0.1	0.2	1.8	0.0	0.0	2.0	0.9	1.4	2.9	5.1	0.4	1.6	0.0	1.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.7	0.8	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2										
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.6;PC-3: 1.0;THP-1: 2.5;TIME: 1.8;U-2197: 2.8"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	1.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339765-194351328	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 225.5"	"Cell line enriched"	"Detected in some"	25	"Hep G2: 36.3"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004732	Uncertain				"Secreted to blood"	42000000000	42000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavourable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.2	1.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	8.5	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.3	0.2	0.6	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.3	36.3	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.8	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0.0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402140-177409576	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 180.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.6;MCF7: 10.9;PC-3: 8.1;SH-SY5Y: 5.5;U-937: 5.6"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.5;eosinophil: 6.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.9;monocytes: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA003825	Approved				"Secreted to blood"	6600000000	6600000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.0	6.9	2.5	0.7	0.3	1.0	0.8	2.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	1.3	0.0	0.4	0.0	1.4	0.7	0.4	0.0	8.6	1.8	1.3	0.3	0.9	0.2	0.7	3.0	0.2	1.3	0.1	0.4	0.2	0.4	3.2	0.0	10.9	0.1	2.6	0.0	8.1	0.6	0.2	1.8	1.1	0.0	2.5	5.5	0.3	1.0	0.7	0.4	0.0	0.0	0.2	1.1	0.0	0.3	0.5	0.0	0.1	0.1	5.6	0.6	0.0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.9	0.7	0.9	1.0	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.4;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.5;SK-BR-3: 1.8"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019551	Enhanced									"HPA019551: AB_2670187"	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.5	1.5	0.0	0.0	0.1	0.4	0.1	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	24	"liver: 470.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 78.3;THP-1: 65.2;U-266/84: 99.3;U-698: 46.7"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 18.7;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	4.6	6.6	2.1	5.0	2.7	2.9	7.0	1.3	2.2	2.4	2.9	2.4	3.9	4.6	2.3	4.0	3.4	2.6	3.1	4.2	2.1	2.1	3.0	470.7	2.8	5.0	2.2	1.4	2.6	3.8	1.4	1.9	4.4	2.1	2.8	1.6	2.6	3.1	2.5	4.3	2.1	4.2	2.5	2.6	3.3	2.8	5.3	1.9	3.8	20.0	3.3	5.5	5.6	7.1	1.1	18.7	2.2	11.9	1.5	1.3	2.5	9.8	6.9	2.6	1.8	2.8	2.4	2.7	7.2	6.0	7.4	4.6	5.2	5.4	8.8	3.7	4.1	3.6	3.3	2.9	3.5	45.0	3.3	6.0	2.1	3.9	1.9	23.3	17.2	16.6	4.7	5.4	1.3	3.2	5.4	78.3	3.6	9.2	3.3	5.1	1.3	9.3	27.9	2.9	3.6	8.4	13.4	4.3	3.0	16.7	7.2	5.0	5.8	65.2	5.4	14.5	9.2	1.7	7.3	2.1	99.3	46.7	11.3	9.3	5.4	0.3	11.9	0.7	0.7	11.7	1.3	1.1	0.9	0.9	7.5	0.7	0.7	0.9	2.2	1.5	3.0	18.7	0.9	2.5	2.1	2.7	1.3	2.2	2.1	2.1	2.2	1.4	2.1	1.9
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121789-160158718	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"liver: 175.8"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 7.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Not detected"	"Not detected"			HPA029846	Approved									"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favourable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	175.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.3	0.3	0.0	0.5	0.0	0.0	1.0	1.0	1.8	1.6	0.6	0.7	0.4	0.2	0.5	0.5	1.4	0.5	0.5	1.1	0.1	0.3	0.0	1.8	0.8	1.5	1.0	0.6	0.6	2.5	0.0	1.5	1.1	0.0	2.0	0.0	1.1	0.1	0.5	0.3	0.3	0.2	0.1	1.1	0.0	0.7	0.0	1.9	1.6	0.3	0.9	0.7	0.0	2.5	0.0	1.6	0.3	0.1	0.0	0.6	0.7	1.8	1.2	1.5	2.8	0.9	0.2	1.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	7.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"kidney: 63.2;liver: 63.3"	"Cell line enriched"	"Detected in single"	11	"T-47d: 3.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					7300	7300			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favourable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	63.2	63.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.4;RH-30: 1.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	24000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favourable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 897.1"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 151.8"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"classical monocyte: 1.2;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.5;monocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	420000000000	420000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favourable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	39.0	2.0	1.4	2.4	3.1	0.3	27.0	0.0	2.1	0.3	1.8	0.0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1.0	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0.0	0.0	0.3	0.5	0.2	0.6	1.6	0.0	1.5	0.0	1.2	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	36.6	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	151.8	0.0	1.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.2	17.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	3.1	0.0	2.1	1.4	2.2	0.2	1.1	0.4	0.0
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391245-18401218	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"intestine: 28.4;liver: 75.5"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.8;RT4: 4.1;SCLC-21H: 5.7;SK-BR-3: 3.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043704	Uncertain									"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favourable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.2	0.1	0.2	2.3	0.3	0.0	0.3	0.1	0.2	0.3	14.0	0.1	0.1	13.0	0.4	0.4	0.1	0.2	0.3	0.4	0.1	0.1	0.6	75.5	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.3	5.1	0.1	0.1	0.1	0.1	0.1	28.4	0.4	0.2	0.6	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	1.4	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.1	1.0	0.0	0.0	0.9	0.0	2.8	4.1	5.7	0.1	0.1	3.6	0.0	1.0	0.5	1.5	1.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.1	0.2	0.2	0.3	0.1
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323394	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 223.9"	"Cell line enriched"	"Detected in some"	11	"T-47d: 116.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017864	Approved				"Secreted to blood"	59000000000	59000000000			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favourable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	1.0	0.0	2.3	10.3	0.1	0.0	0.0	5.2	223.9	0.1	0.0	0.0	0.0	0.8	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 128.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.6;LHCN-M2: 21.2;RH-30: 7.0;RT4: 41.4"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;NK-cell: 1.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 3.0;NK-cells: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.2	0.1	0.1	1.4	0.0	0.0	0.1	0.1	0.2	0.1	0.9	0.0	0.3	0.0	1.7	0.1	0.6	0.1	0.3	1.1	0.0	0.0	5.9	128.2	0.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	1.0	0.1	0.4	0.2	0.1	0.3	0.0	2.9	0.4	0.1	1.4	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.4	0.2	0.7	0.0	0.1	0.3	3.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	8.6	1.1	1.6	1.0	2.8	0.9	0.8	0.5	2.0	0.0	1.7	3.6	0.5	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	2.1	0.0	0.0	0.6	0.0	0.1	0.0	21.2	0.0	0.0	0.0	0.6	0.0	0.0	7.0	0.0	0.0	41.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838547-134902034	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 44.8;liver: 64.1"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 24.2"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA010533, HPA011179"	Enhanced					11000	11000			"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favourable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	2.5	0.0	0.0	0.0	44.8	64.1	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.4	0.9	0.6	0.2	1.7	0.5	0.3	0.1	0.4	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.2	1.0	0.4	0.1	0.5	0.2	24.2	0.3	0.9	0.3	0.1	0.2	0.4	0.2	0.6	0.8	0.0	0.3	0.2	0.7	0.1	0.1	0.4	0.1	0.2	0.6	0.0	0.6	0.9	0.9	0.5	0.4	1.5	0.9	1.3	0.9	1.1	1.7	0.9	0.4	0.2	0.5	1.4	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Group enriched"	"Detected in some"	5	"BEWO: 1.8;BJ hTERT+: 3.2;Hep G2: 6.2;HHSteC: 3.6;RT4: 1.9"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072245			Uncertain	Cytosol				Cytosol	Cytosol	"HPA072245: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.2	3.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"	P24462	7	99685226-99735093	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 73.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;U-87 MG: 2.6"									"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"											HPA072245			Uncertain	Cytosol				Cytosol	Cytosol	"HPA072245: "																		0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0		1.1	73.9	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.5	0.0	0.3	0.5	1.6	0.5	0.2	4.2	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.9	1.3	1.9	0.0	0.0	0.4	0.3	0.4	0.4	0.0	0.3	0.0	0.4	1.0	0.1	0.2	1.1	0.5	0.2	0.2	0.1	0.4	1.4	0.0	0.0	0.3	0.2	0.0	0.5	0.6	0.0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0										
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Group enriched"	"Detected in some"	8	"Hep G2: 17.6;U-2197: 28.8;U-87 MG: 49.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	22000000	22000000	"Golgi apparatus"	"Golgi apparatus"	"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavourable (6.90e-11)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	17.6	0.1	0.3	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 276.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.4;SK-BR-3: 3.3"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 12.8"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.8"	"Low region specificity"	"Detected in single"							HPA039230	Uncertain		Approved	Mitochondria,Cytosol				Cytosol	Cytosol	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	0.9	0.9	2.2	1.4	5.9	0.5	0.4	0.6	2.1	0.5	0.9	0.8	0.0	0.7	0.4	0.2	0.2	0.2	1.4	0.2	1.7	2.5	0.2	276.9	0.6	0.6	4.2	0.7	0.3	0.4	0.1	0.0	1.0	2.8	0.3	0.8	1.3	0.3	0.2	0.2	0.2	0.7	0.3	1.3	0.5	0.9	0.3	0.8	0.1	0.3	0.0	0.3	0.8	0.0	0.0	12.8	0.6	0.8	0.2	0.0	0.3	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.2	0.4	2.3	0.0	0.4	0.0	0.0	0.0	0.5	0.5	1.3	0.6	0.6	0.1	0.8	5.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.4	0.1	0.4	0.8	0.9	0.0	0.8	0.1	0.2	0.5	0.1	0.1	1.6	3.3	0.7	1.2	1.7	0.6	0.0	0.9	1.1	0.3	0.7	0.4	0.2	1.1	0.8	0.3	0.1	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.6	0.2	0.1	1.3	0.0	0.3	2.2	5.9	0.6	1.6	1.7	2.5	4.2	0.7	2.8	0.8
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755268	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 417.7"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 55.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 19.8"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 19.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	110000000000	110000000000			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	0.9	0.0	0.2	0.6	0.2	0.0	1.8	0.2	0.2	0.6	0.3	0.2	6.6	0.0	0.7	17.2	0.2	2.1	0.2	0.3	0.2	0.0	10.2	417.7	1.3	3.4	0.2	0.2	0.7	0.8	0.0	0.2	0.2	0.8	2.1	0.0	1.8	0.5	9.0	0.2	0.4	1.0	0.2	0.2	0.6	0.2	1.7	0.2	0.2	0.7	0.2	0.5	0.6	0.4	0.2	19.8	0.5	0.7	0.4	0.0	0.4	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	55.8	0.4	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	19.8	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.2
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 88.1"	"Cell line enhanced"	"Detected in some"		"A-431: 35.2;A549: 9.7;CAPAN-2: 7.0;HeLa: 8.0;PC-3: 9.7;U-2 OS: 8.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 33.8;liver: 67.3"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 41.5"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA066060	Uncertain									"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	14.0	0.0	0.0	7.8	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.1	2.3	67.3	0.1	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597487-62606159	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 276.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;HL-60: 2.1"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038097	Approved				"Secreted to blood"	45000000	45000000			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	276.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.1	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.7	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Cell line enriched"	"Detected in some"	9	"EFO-21: 80.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	830000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.7	4.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.7	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4
CYP2A13	"CPAD, CYP2A"	ENSG00000197838	"Cytochrome P450 family 2 subfamily A member 13"	Q16696	19	41088472-41096195	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 30.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;NTERA-2: 1.5"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046713, HPA047262"	Supported				"Intracellular and membrane"					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (9.79e-2)"						"unprognostic (1.00e-1)"	"unprognostic (4.51e-3)"		"unprognostic (4.92e-2)"				"unprognostic (1.99e-1)"	"unprognostic (1.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	30.7	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42876165	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 132.7"	"Group enriched"	"Detected in some"	5	"BEWO: 6.7;HEL: 1.7;Hep G2: 2.5;SK-BR-3: 3.0"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	6.7	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.2	0.1	0.2	0.1	0.3	0.6	0.2	0.2	0.0	0.0	6.7	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.5	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.4	0.0	0.0	0.6	3.0	0.3	0.3	0.1	0.3	0.3	0.6	0.3	0.2	0.4	0.1	0.3	0.3	0.4	0.1	1.4	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322906	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 158.8"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.8"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"			Vesicles	Vesicles	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favourable (2.94e-4)"	"prognostic favourable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	8.0	0.1	0.1	0.2	0.1	0.3	1.8	1.0	0.1	1.3	0.3	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.9	0.1	0.0	0.1	158.8	0.8	0.1	0.1	0.1	0.1	2.4	0.0	0.1	0.3	0.1	2.4	0.1	0.1	0.2	0.1	0.1	1.4	0.1	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.1	0.3	2.7	1.8	0.6	3.7	0.7	0.8	0.8	0.1	0.2	0.3	0.8	0.9	1.1	0.8	0.6	0.1	0.3	0.0	0.1	0.0	1.8	0.6	0.6	0.3	0.4	0.2	0.2	0.2	0.5	0.3	0.9	1.1	1.7	0.8	2.6	1.0	0.4	0.0	0.0	0.1	0.3	0.8	0.9	0.3	0.3	0.4	4.8	0.4	0.5	0.8	1.0	0.3	0.3	0.5	0.5	2.0	0.6	0.4	0.2	0.2	1.6	1.0	0.5	2.7	0.7	0.4	0.5	0.3	0.5	0.2	2.0	1.0	3.7	0.7	1.5	0.4	0.2	0.4	1.8	0.4	0.4	0.1	1.1	0.8	0.7	2.8	0.8	0.3	0.6	0.4	0.1	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain family member 4"	Q14624	3	52812975-52831479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 461.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.4;U-266/70: 6.6"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	53000000000	53000000000	Vesicles	Vesicles	"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	0.5	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.1	1.3	0.2	0.1	0.1	0.6	0.1	0.0	0.2	461.4	0.2	0.1	0.1	0.2	0.2	22.8	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	4.1	0.1	0.1	0.2	0.1	0.5	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.3	0.3	0.6	0.6	2.6	0.8	0.0	0.0	0.4	1.0	2.1	1.1	0.0	0.4	0.1	0.0	0.0	0.2	0.3	0.2	1.3	0.0	0.5	1.1	0.0	0.0	0.5	5.4	0.2	2.2	0.0	2.9	0.9	2.5	0.2	0.3	0.4	0.0	0.1	0.0	0.6	1.8	0.0	0.2	0.5	0.7	1.0	0.0	1.8	1.0	0.0	0.8	0.7	0.1	1.0	0.7	0.0	0.4	1.1	0.7	0.2	0.0	0.9	1.0	0.0	6.6	3.1	0.5	0.1	0.7	1.2	0.0	0.6	0.0	0.1	0.1	0.1	0.3	0.7	0.0	0.0	0.2	0.0	0.8	0.6	2.6	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.1
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;EFO-21: 5.2;Hep G2: 19.5;HMC-1: 5.7;MOLT-4: 4.4;U-2197: 15.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	3200000	3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	6.8	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	19.5	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	4.4	0.6	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Group enriched"	"Detected in some"	11	"HEL: 27.8;HMC-1: 38.6;K-562: 25.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011937, CAB016255"	Enhanced									"CAB016255: AB_628395, HPA011937: AB_1858243"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favourable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	2.8	0.0	0.6	38.6	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TTPA	AVED	ENSG00000137561	"Alpha tocopherol transfer protein"	P49638	8	63048553-63086053	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"liver: 74.1"	"Cell line enhanced"	"Detected in some"		"SK-BR-3: 10.2;T-47d: 3.8;U-2 OS: 5.3;U-2197: 6.3"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 21.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																		"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.30e-7)"	"unprognostic (1.78e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.46e-3)"	"unprognostic (6.16e-3)"	0.9	0.4	2.4	0.4	3.3	0.3	2.5	3.5	2.0	0.3	1.6	2.1	0.0	0.4	0.3	0.3	0.3	0.3	0.4	0.3	3.9	1.1	1.4	74.1	0.6	0.3	2.4	1.8	0.3	0.8	0.4	0.3	1.0	3.8	0.3	2.3	0.0	0.3	0.3	0.3	0.4	0.4	0.4	3.1	0.3	0.4	0.4	2.4	0.0	0.3	0.0	0.3	0.3	0.2	0.9	0.3	2.0	0.5	0.3	0.4	0.0	0.1	1.5	1.0	0.2	0.5	0.0	0.0	0.1	0.0	0.4	0.1	0.2	2.4	0.0	0.1	0.0	0.0	2.7	0.2	0.5	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.4	1.2	0.1	0.2	1.0	0.7	0.1	0.0	0.0	0.0	0.7	0.4	0.1	1.0	10.2	1.0	3.8	0.4	0.3	0.1	5.3	6.3	1.1	0.4	0.0	0.1	2.3	0.1	1.9	2.0	0.5	0.3	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.9	0.3	0.3	1.6	0.3	0.2	0.3	0.2	0.0	2.4	3.3	3.5	2.0	3.9	1.1	2.4	1.8	3.8	2.4
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.6"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Actin filaments"	"Secreted to blood"	230000000	230000000	Nucleoli	Nucleoli	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favourable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.4	3.7	0.9	0.0	9.3	11.2	0.1	1.6	3.2	0.4	1.5	2.2	1.9	0.1	0.4	4.5	1.4	1.0	1.1	0.5	6.2	1.4	0.3	2.0	56.6	2.0	1.4	0.2	9.0	0.9	0.5	1.9	2.1	0.0	10.4	1.3	0.2	0.3	0.4	0.2	4.1	0.2	1.5	4.2	0.9	1.1	0.0	0.1	1.6	0.6	2.5	1.5	0.2	1.8	0.6	1.1	0.5	0.2	2.2	1.7	0.2	1.1	0.7	1.8	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 24.8;ASC TERT1: 18.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced									"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favourable (3.46e-4)"	"prognostic favourable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	18.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 241.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.7;U-266/84: 14.6"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favourable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2.0	2.6	1.1	0.3	0.2	0.0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1.0	6.2	0.8	3.2	0.8	0.0	13.3	0.0	0.3	9.9	2.3	2.0	2.0	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.6	0.3	1.7	1.2	2.0	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.3	5.3	0.9	1.0	6.5	2.0	3.2	1.0	0.5	1.1	1.6	5.3	0.9	0.3	1.0	0.5	0.0	0.9	11.7	0.8	2.1	4.6	1.0	6.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2.0	1.7	3.1	0.8	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.8	0.6	0.0	0.2	0.1	3.0	0.6	3.4	2.0	2.5	2.4	0.6	1.1	3.3	2.2	0.0	0.1	1.3	2.0	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2.0	2.6	0.6	0.8
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238302	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"liver: 63.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 9.2"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051365			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051365: "	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.0	0.2	0.1	1.9	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	3.5	63.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.3	2.3	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.7	0.3	0.0	0.6	0.3	0.3	0.9	1.1	0.6	0.0	0.0	0.9	0.3	0.0	0.0	0.0	9.2	0.3	1.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.9	0.0	0.1	2.2	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.8	0.3	0.6	1.7	1.2	0.9	0.8	0.5	0.0	1.8	2.2	1.4	0.3	2.9	0.4	2.0	1.1	2.2	0.6	0.7	1.4	0.2	1.4	2.1	1.2	0.5	2.8	0.5	0.7	0.2	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.9	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 11.8"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdTCR: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		1800000	1800000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809388-167914215	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"liver: 14.9;testis: 38.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;T-47d: 4.9"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015243, HPA017749"	Approved									"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.1	0.2	0.1	0.3	0.0	1.3	1.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.3	14.9	0.1	0.1	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	38.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.4	0.6	0.0	0.3	0.4	0.3	0.1	0.1	0.2	0.6	0.5	2.6	0.1	1.0	0.3	1.1	1.6	0.1	0.2	0.3	0.0	0.0	1.1	0.1	0.2	0.4	1.6	0.5	0.3	0.7	0.1	0.0	0.0	0.1	1.8	0.8	0.6	0.0	1.2	0.1	0.1	0.0	0.5	0.8	1.0	0.0	0.1	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.5	4.9	0.8	0.1	0.2	0.0	0.2	0.1	1.2	0.6	0.8	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.4	0.2	0.3	1.6	0.3	0.3	0.2	0.2	0.3	0.1	0.1
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088842-207099993	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 156.5"	"Group enriched"	"Detected in some"	18	"CACO-2: 38.3;HeLa: 15.9;Hep G2: 49.8"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.6;T-cells: 2.5"					"Low region specificity"	"Detected in all"			HPA051620	Approved				"Secreted to blood"	1300000000	1300000000			"HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	0.5	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.1	0.5	2.0	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1.0	0.6	0.1	0.0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0.0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0.0	0.0	0.0	2.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	49.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.8	0.0	0.0	0.0	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015066	Supported				"Intracellular and membrane"					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496842-27523684	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	16	"liver: 60.9"	"Cell line enhanced"	"Detected in some"		"HEL: 12.4;Hep G2: 19.0;HUVEC TERT2: 6.1;TIME: 3.7"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA064305"	Enhanced		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB034098: AB_2247323, HPA064305: AB_2685239"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.2	2.0	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.3	0.4	0.0	3.9	0.5	0.1	0.0	0.2	60.9	0.1	0.1	0.1	0.1	2.0	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.5	3.1	0.9	0.2	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.8	2.6	1.2	1.7	0.9	0.7	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.6	0.2	0.2	0.0	0.0	0.1	0.0	12.4	0.5	19.0	0.8	0.1	0.4	0.3	0.9	0.5	0.1	6.1	0.0	0.2	0.2	0.1	0.1	0.7	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.1	3.7	0.1	0.3	0.6	0.2	0.3	0.1	0.2	1.1	0.1	0.2	2.6	1.2	0.3	0.6	1.0	0.6	0.8	0.4	0.4	0.1	2.4	0.9	0.8	2.1	1.7	0.3	0.8	0.1	0.7	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 716.5"	"Cell line enriched"	"Detected in single"	229	"Hep G2: 68.3"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.5;plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 7.6"					"Not detected"	"Not detected"								"Secreted to blood"	3900000	3900000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0.0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10.0	1.8	0.3	716.5	0.4	1.0	4.2	0.0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0.0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4.0	0.0	0.3	0.0	1.0	0.4	0.0	0.5	7.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	68.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	1.8	10.8	0.2	4.4	10.0	1.8	4.2	0.0	6.7	4.0
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 834.6"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 157.9"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"					"Cell type enriched"	"Detected in some"	45	"neutrophil: 53.4"	"Lineage enriched"	"Detected in many"	45	"granulocytes: 53.4"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	120000000000	120000000000	Vesicles	Vesicles	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: , HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	834.6	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	53.4	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	157.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.2	0.0	0.0	0.3										
PZP	CPAMD6	ENSG00000126838	"PZP, alpha-2-macroglobulin like"	P20742	12	9148840-9208370	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 56.9"	"Group enriched"	"Detected in some"	8	"HeLa: 9.7;SiHa: 5.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.5;MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	13000000000	13000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.0	0.9	0.6	0.0	56.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	3.5	0.0	0.7	0.9	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.9	0.6	0.0	0.0	1.4	0.6
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 3314.2"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 318.5"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 139.3;monocytes: 203.0"					"Region enriched"	"Detected in many"	6	"cerebellum: 334.2"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	210000000000	210000000000	Vesicles	Vesicles	"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favourable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favourable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	0.9	0.4	0.7	4.9	1.4	3.0	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1.0	0.4	0.5	74.1	3314.2	13.6	5.3	1.0	0.2	0.6	7.4	0.0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7.0	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203.0	0.2	0.3	100.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	12.6	40.1	0.1	1.1	0.0	0.1	0.0	0.8	0.0	4.9	0.0	0.2	0.1	318.5	0.0	1.1	0.1	0.2	0.4	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.1	1.1	0.1	21.5	0.2	0.0	0.0	0.4	0.1	0.1	18.9	0.1	0.1	0.1	5.0	0.1	0.6	0.2	0.1	0.4	0.3	2.8	0.0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203.0	0.7	0.2	100.0	0.7	1.4	0.2	0.7	0.4	0.5	1.0	0.2	0.8	0.8
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.2;HaCaT: 11.0;PC-3: 5.0;RT4: 26.1"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																				"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.8	0.1	0.2	0.1	0.1	0.5	0.0	0.0	0.0	0.0	4.2	0.3	0.1	2.0	0.0	11.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	1.1	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.2	0.4	5.0	0.1	0.1	0.4	0.0	26.1	0.2	0.3	2.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.6	0.3	0.2	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467053	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 42.2;liver: 103.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0"	"Group enriched"	"Detected in some"	21	"liver cancer: 57.6;renal cancer: 11.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024785	Enhanced					89000	89000			"HPA024785: AB_1847856"	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	2.5	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	2.1	0.1	0.0	0.0	0.0	1.6	0.1	0.2	1.3	0.0	0.0	0.1	42.2	103.6	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.1	0.9	0.0	0.2	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.7	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.1	0.0	0.2	0.0	1.3	1.1	2.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.7	0.1	0.6	1.3	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	1.5	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 alpha subunit"	Q86UW1	3	196211487-196243178	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 53.9;liver: 59.5"	"Cell line enhanced"	"Detected in many"		"REH: 7.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039123	Enhanced									"HPA039123: AB_10672770"	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	0.5	2.3	0.3	3.8	0.3	2.4	0.4	0.3	0.4	0.5	12.3	0.4	0.7	13.6	0.4	2.8	0.5	0.5	0.5	0.5	0.3	0.1	2.2	59.5	0.8	0.3	0.3	0.3	0.6	0.3	1.4	0.5	0.3	0.3	0.5	0.1	0.3	0.6	0.3	0.5	1.0	53.9	0.3	0.3	0.8	0.2	1.8	0.3	0.6	0.8	0.3	0.5	0.3	0.7	0.2	0.0	1.7	0.6	0.4	0.6	0.1	1.0	1.6	1.4	1.7	0.0	1.0	0.1	0.8	0.0	0.1	0.0	0.7	0.4	0.1	1.9	1.1	0.9	0.2	0.0	0.0	0.7	2.8	1.0	0.8	1.7	0.2	1.4	1.4	0.3	0.0	0.2	1.3	0.2	0.2	3.3	0.0	0.6	0.1	1.2	0.1	2.0	7.9	0.1	0.5	0.0	0.9	0.3	0.5	0.5	3.2	0.3	2.3	0.5	0.5	1.6	0.7	1.3	0.9	3.3	4.0	0.6	1.1	0.6	0.6	0.0	0.2	1.7	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.6	1.6	0.4	0.5	0.0	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 40.6"	"Cell line enriched"	"Detected in some"	9	"HaCaT: 16.4"	"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104262-207144972	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 377.2"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 28.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	153	"neutrophil: 21.6"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 21.6"									"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	34000000000	34000000000			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	377.2	26.0	0.1	0.1	0.1	0.3	1.8	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499958-49527047	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 2.0;liver: 5.6"	"Cell line enriched"	"Detected in single"	73	"T-47d: 18.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain									"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 107.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;T-47d: 2.1;U-266/70: 5.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	44000000000	44000000000			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favourable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.8	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.2	7.4	0.1	0.1	0.2	0.2	107.6	0.4	0.1	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.4	0.1	0.0	1.4	0.6	0.1	0.2	0.2	0.1	0.1	0.3	0.1	5.0	0.5	0.1	1.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	5.2	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.9	1.0	0.0	1.2	0.2	0.5	0.2	0.0	1.3	0.5	1.5	0.0	0.0	0.4	0.3	0.3	0.0	0.7	2.1	0.2	0.2	0.4	1.4	0.2	0.2	5.1	1.8	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.4	0.1
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289684	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 178.8"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 44.8"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					530000	530000			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.5	0.1	0.2	0.2	0.1	0.0	0.0	0.3	178.8	0.1	0.1	0.1	0.0	0.7	9.9	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	44.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
ONECUT1	"HNF-6, HNF6, HNF6A"	ENSG00000169856	"One cut homeobox 1"	Q9UBC0	15	52756989-52791078	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"gallbladder: 40.1;liver: 59.9;pancreas: 46.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.0;WM-115: 3.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 2.9;pancreatic cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Low region specificity"	"Detected in all"			HPA003457	Enhanced									"HPA003457: AB_1079525"		"unprognostic (5.12e-2)"		"unprognostic (2.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.05e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.03e-1)"		"unprognostic (1.70e-7)"	"unprognostic (9.76e-3)"	"unprognostic (2.11e-1)"		"unprognostic (1.17e-1)"	0.1	0.1	0.5	0.0	0.1	1.2	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	40.1	0.1	0.2	0.2	0.1	59.9	0.1	0.0	0.1	0.0	0.1	46.3	0.0	0.1	0.0	1.4	0.1	0.0	3.5	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	1.2	3.3	1.4	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.2	2.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.2	0.2	1.4	4.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	5.1	0.0	0.0	2.5	0.3	0.9	0.2	0.0	0.0	4.0	1.7	0.0	0.5	0.1	0.4	1.0	0.2	0.0	2.1	2.7	0.0	0.4	0.3	0.1	0.3	0.4	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.9	0.3	0.2	0.2	0.1	0.0	1.4	0.0
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		1800000	1800000	Mitochondria	Mitochondria	"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain									"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC126283.2		ENSG00000285330			4	109713916-109801999	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	13	"kidney: 61.8;liver: 135.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.0;EFO-21: 5.1;Hep G2: 9.4;RPTEC TERT1: 9.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, HPA024061, HPA035909"	Uncertain									"HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074"																		2.4	2.3	0.4	2.0	0.4	0.0	1.6	0.0	1.3	2.6	2.2	0.1	1.3	3.8	2.2	7.6	2.4	1.8	2.5	2.6	0.5		61.8	135.8	4.3	1.5	0.6	0.0	6.6	6.5	0.7	2.0	2.2	1.1	2.0	0.7	4.0	0.5	0.7	1.4	0.0	3.9	0.8	1.4	4.7	1.3	1.8	0.4	0.0	3.0	0.9	0.4	2.6	1.8	0.2	0.8	0.2	0.3	0.2	0.7	1.2	0.0	0.5	0.0	0.3	0.2	0.1	0.0	0.4	0.9	0.0	0.1	0.1	27.0	0.1	5.1	0.2	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.4	9.4	3.2	0.3	0.0	3.4	0.0	0.0	0.1	1.8	0.3	1.5	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.1	9.5	0.8	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	4.1	0.1	1.2	0.2	0.3	0.0	0.3	0.0	0.4	0.1	0.5	0.3	0.7	0.2	0.7	0.5	0.0	0.2	0.2	0.8	0.5	1.2										
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481683-73504001	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 169.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 5.8"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	5000000000	5000000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favourable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC, vitamin D binding protein"	P02774	4	71741693-71804041	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 552.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.1;RH-30: 6.4;SiHa: 3.1;U-698: 2.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	69000000000	69000000000			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favourable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavourable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.0	0.0	2.6	0.1	0.2	0.1	0.1	43.7	0.1	0.1	0.1	2.0	552.1	0.1	0.0	0.1	0.0	0.1	6.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.1	0.4	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	1.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.8	0.0	2.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717819-75732958	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 90.2;liver: 40.5"	"Group enriched"	"Detected in some"	7	"Hep G2: 8.4;RPMI-8226: 5.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA028834	Uncertain									"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.1	0.0	0.1	4.8	0.1	0.0	2.1	0.1	0.1	0.2	34.0	0.1	1.4	22.3	0.1	0.1	0.2	0.0	2.6	0.1	0.1	0.0	0.2	40.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	7.0	0.1	0.4	2.2	0.4	0.9	90.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Group enriched"	"Detected in some"	6	"MCF7: 10.6;T-47d: 10.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	160000000000	160000000000	"Cell Junctions"	"Cell Junctions"	"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: "	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057220	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 33.5;liver: 114.3"	"Group enriched"	"Detected in some"	6	"AF22: 12.2;Hep G2: 36.7;NTERA-2: 24.3;RH-30: 35.0"	"Group enriched"	"Detected in many"	13	"glioma: 15.5;liver cancer: 73.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									390000	390000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favourable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.2	0.2	2.4	0.2	3.1	0.1	0.2	2.2	2.9	0.2	1.4	3.8	0.0	3.1	0.4	5.8	0.5	2.1	0.8	0.2	3.5	2.5	33.5	114.3	0.3	0.3	3.6	3.1	0.3	0.2	0.3	0.2	1.0	4.0	0.5	0.3	0.2	0.2	0.9	0.1	0.2	2.6	0.6	1.7	0.3	0.2	0.2	0.7	0.0	0.1	0.0	0.2	0.3	0.1	0.7	4.7	3.7	0.7	0.9	1.9	0.7	0.0	0.0	12.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.1	36.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	24.3	0.0	0.1	35.0	0.7	0.0	0.0	3.9	1.2	0.1	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	1.5	0.3	4.1	0.1	0.0	0.2	1.2	1.8	0.7	0.7	0.8	0.5	0.9	0.3	0.5	1.2	4.7	0.7	0.3	1.9	3.7	0.9	0.3	0.4	0.8	0.7	2.4	3.1	2.2	2.9	3.5	2.5	3.6	3.1	4.0	0.7
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 702.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 98.0;HSkMC: 60.7;K-562: 25.5;SK-MEL-30: 45.2"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"myeloid DC: 8.9"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"							HPA051518	Supported				"Secreted to blood"	26000000000	26000000000			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	1.5	58.9	6.6	1.6	30.0	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1.0	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2.0	0.4	1.2	1.4	1.0	0.5	11.7	9.6	1.3	1.0	5.2	1.0	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0.0	0.6	0.2	0.0	0.6	0.4	4.6	2.1	0.8	6.7	7.0	19.8	0.2	0.3	0.8	1.3	9.7	8.7	1.4	1.7	0.1	0.3	2.7	0.3	0.4	0.0	11.2	6.2	0.6	98.0	6.0	4.6	3.2	60.7	0.5	0.8	0.3	0.2	25.5	0.1	0.3	0.6	0.2	0.3	20.0	0.9	1.0	2.8	0.1	1.2	0.3	0.9	0.5	3.3	0.0	45.2	0.4	17.0	0.7	0.0	0.3	0.0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.6	6.6	30.0	0.6	3.1	4.1	7.8	20.2	1.0	6.6	5.2
ARID3C		ENSG00000205143	"AT-rich interaction domain 3C"	A6NKF2	9	34621379-34628107	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	12	"liver: 16.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.5;Karpas-707: 5.9;T-47d: 6.0"	"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;ovarian cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.05e-3)"	"unprognostic (4.42e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.28e-14)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.91e-2)"	"unprognostic (4.26e-3)"	0.0	0.0	0.2	0.0	0.5	0.0	0.2	1.4	0.8	0.0	0.0			0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	16.8	0.0	0.0	0.2		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.1	0.4	2.2	0.3	0.7	0.0	0.6	0.1	0.2	0.5	0.1	0.3	0.1	0.2	0.7	0.0	0.4	0.0	0.0	4.5	0.6	0.1	0.6	0.0	1.5	0.0	0.2	0.3	1.1	0.0	0.1	0.1	0.0	5.9	0.1	0.0	0.1	1.9	0.0	0.2	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.2	1.5	0.4	6.0	0.3	0.0	0.1	0.3	1.2	0.0	1.1	0.9	0.0	0.5	1.8	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0										
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132872322-132875046	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 52.4"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	1300000	1300000				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.68e-4)"	0.1	0.1	0.0	0.2	0.1	0.0	0.2	1.5	0.0	0.2	0.3			1.5	0.1	0.1	0.3	0.2	0.4	0.2	0.1	0.0	1.4	52.4	0.2	0.3	0.1		0.2	0.5	0.5	0.2	0.0		0.7	0.5		0.3	0.1	0.9	0.4	2.6	0.0	0.1	0.7	0.5	0.1			0.6		0.5	1.8	0.4	1.6	0.9	4.2	1.3	0.9	2.0	0.3	0.4	2.3	2.3	4.8	2.6	1.3	1.7	1.0	0.2	0.7	1.6	2.3	2.8	2.0	0.4	0.2	4.1	3.8	1.1	0.5	3.5	1.6	1.6	5.7	1.6	0.7	0.9	1.2	1.1	1.9	0.6	1.3	0.7	1.4	4.8	0.7	1.2	1.6	3.8	1.4	1.1	1.4	1.5	1.5	1.0	2.0	1.6	1.1	1.0	1.0	0.8	1.5	1.2	0.4	2.7	1.5	1.2	0.6	5.7	4.3	1.6	0.7	2.7	1.1	4.2	1.3	0.2	1.3	0.9	1.4	1.5	0.9	0.6	0.9	1.6	1.1	1.2	3.2	0.9	0.5	0.8	2.0	0.3										
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133745956-133796640	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 711.5"	"Cell line enriched"	"Detected in some"	48	"Hep G2: 129.1"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	120000000000	120000000000			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favourable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavourable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	7.8	1.3	6.7	1.2	26.7	1.3	1.9	3.7	20.4	1.4	1.3	57.2	0.0	1.2	1.3	1.3	1.8	1.3	1.3	2.4	11.3	7.4	1.5	711.5	1.3	1.3	50.8	12.3	1.4	1.6	1.4	0.8	1.3	40.2	1.5	1.3	14.0	4.0	1.3	1.3	1.3	1.2	1.3	46.9	1.3	1.3	2.4	39.9	0.0	1.4	0.0	1.4	1.3	0.6	1.1	1.0	2.6	1.1	0.9	0.8	0.4	0.3	0.2	0.3	0.2	0.9	0.6	0.1	0.3	0.3	0.1	0.1	0.5	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.1	0.1	2.7	0.4	129.1	0.2	0.7	0.4	0.4	0.6	0.1	0.2	0.3	1.0	0.3	0.4	0.2	0.1	0.2	0.2	0.3	0.2	0.5	0.1	0.1	0.5	0.3	0.2	0.3	0.4	1.0	0.3	0.2	0.4	0.4	0.2	0.2	0.1	0.3	0.4	0.2	0.3	0.2	0.2	2.6	1.1	0.7	0.6	0.7	0.6	0.6	0.6	0.6	0.6	1.1	0.8	0.8	2.4	0.9	0.7	1.0	0.4	0.4	6.7	26.7	3.7	19.6	11.3	7.4	50.8	12.3	40.2	39.9
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945246-136946974	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 165.8"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 59.5"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.5;T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	1500000000	1500000000			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.2	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	6.0	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.5	0.0	0.1	0.0	3.4	0.3	0.1	0.8	0.1	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	1.1	0.6	1.1	0.7	0.0	0.9	0.0	0.1	0.0	1.1	0.1	0.3	1.6	4.5	0.0	0.0	59.5	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.2	0.8	0.1	0.5	0.0	0.2	0.1	0.2	0.8	0.2	0.5	0.2	0.2	0.2	1.7	0.3	1.5	0.4	0.6	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.2	0.5	0.2	0.0	0.1	0.0	3.4	0.0	0.4	0.0	0.7	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.9;Hep G2: 45.8;HSkMC: 19.0;RPTEC TERT1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	11000000000	11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	28.9	0.0	9.2	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	0.1	45.8	2.0	0.0	0.0	19.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		440000	440000	Mitochondria	Mitochondria	"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favourable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.6	1.3	2.3	0.0	0.1	0.0	0.4	1.7	0.0	0.1	0.0	1.8	0.3	0.0	0.0	0.0	11.3	3.1	0.0	0.0	2.7	3.3	3.5	2.5	0.0	0.0	3.6	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 10.3;SCLC-21H: 12.2;T-47d: 7.8"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Low region specificity"	"Detected in all"			HPA027501	Enhanced		Approved	Cytosol		150000	150000	Cytosol	Cytosol	"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favourable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.0	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.6	0.2	0.4	0.5	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.3	0.0	1.1	2.4	0.4	0.0	0.4	0.2	0.0	1.4	1.9	0.3	2.2	2.0	3.7	0.2	0.5	1.7	1.6	1.0	0.8	0.2	12.2	1.7	0.1	1.7	0.6	7.8	3.5	0.4	0.9	0.9	0.5	1.0	1.3	1.1	1.4	0.2	2.0	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1
HEPACAM	"FLJ25530, GLIALCAM, hepaCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919193-124936412	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 17.3;brain: 64.7;liver: 19.6"	"Cell line enriched"	"Detected in single"	31	"Hep G2: 24.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB025486: , HPA017613: "	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			17.3	1.8	25.6	1.7	25.7	1.5	2.6	8.5	64.7	1.6	1.8	55.4	0.0	1.6	1.6	1.7	1.6	1.6	1.6	1.7	31.0	10.8	1.6	19.6	1.6	1.7	30.3	22.4	1.5	1.6	1.5	0.6	1.5	27.9	1.6	1.8	0.0	1.7	2.1	1.6	1.6	1.6	1.6	21.5	1.5	1.6	1.7	35.5	0.0	1.6	0.0	2.3	1.5	0.3	1.5	1.2	3.0	1.4	2.0	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	1.1	1.2	1.1	1.2	1.5	1.5	1.4	1.0	1.2	1.3	1.7	1.5	1.3	2.0	1.4	1.0	1.1	1.5	25.6	25.7	8.5	29.7	31.0	10.8	30.3	22.4	27.9	35.5
KRTAP5-6	KRTAP5.6	ENSG00000205864	"Keratin associated protein 5-6"	Q6L8G9	11	1697195-1697755	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"liver: 6.7;placenta: 2.6;skin 1: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;SK-BR-3: 1.9"	"Cancer enriched"	"Detected in single"	21	"liver cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"prognostic favourable (6.04e-5)"			"unprognostic (3.70e-1)"					"unprognostic (2.93e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0		0.0	0.0	0.0	0.0	2.6		0.0	0.0		0.2	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.1	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.0	1.9	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 35.1;Hep G2: 27.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	9500000000	9500000000	Nucleoplasm	Nucleoplasm	"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.4	4.0	5.9	6.7	5.2	7.3	35.1	9.8	4.2	6.6	4.7	13.1	3.0	1.3	1.8	14.1	8.7	1.4	13.4	4.1	0.6	3.6	1.7	8.7	27.3	7.1	0.3	4.7	12.6	12.8	13.7	4.8	4.8	3.7	0.5	4.7	4.0	1.6	4.2	3.9	2.2	1.7	6.5	1.4	1.8	4.3	0.2	3.0	14.8	0.7	1.6	8.4	2.6	9.2	8.6	13.4	9.4	3.5	8.1	2.1	3.7	4.1	1.1	7.4	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536409-4540474	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 636.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.0;HMC-1: 8.2;SK-BR-3: 8.7;THP-1: 14.5;U-937: 26.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 58.9"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	74000000000	74000000000	Vesicles	Vesicles	"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.60e-2)"	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3.0	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0.0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3.0	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0.0	0.2	0.4	5.8	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	4.3	2.1	7.5	0.0	0.8	0.0	0.9	0.0	7.6	0.2	0.1	0.1	8.0	0.0	0.2	8.2	2.3	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.3	0.0	5.8	0.1	0.0	0.0	0.1	6.1	0.5	1.1	0.0	0.0	0.0	8.7	0.1	2.5	14.5	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	26.8	0.0	0.5	1.4	3.0	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	58.9	0.0	0.2	0.0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;RH-30: 3.9;U-698: 2.0;U-937: 1.6"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	41000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: "		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favourable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.8	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266174-18269977	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 216.6;liver: 849.2"	"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 160.1"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdTCR: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;monocytes: 2.6;T-cells: 1.1"														"Secreted to blood"	22000000000	22000000000				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	216.6	4.3	0.8	17.4	0.8	0.0	31.9	0.8	0.8	28.5	3.2	0.8	0.8	0.0	0.8	1.1	1.0	1.0	2.9	1.0	0.8	0.0	1.1	849.2	1.7	2.4	0.8	0.8	0.8	4.7	0.0	1.0	0.9	0.8	1.1	0.3	0.8	50.3	1.0	11.5	1.2	1.2	1.5	0.8	0.8	0.6	0.8	0.8	1.0	1.0	1.1	1.1	1.1	1.3	2.1	0.3	0.0	2.6	0.0	1.1	0.0	10.8	0.0	0.0	0.0	7.9	0.0	4.3	0.3	0.2	0.0	0.0	0.0	3.8	0.0	8.8	0.0	10.3	0.0	160.1	0.0	0.1	0.0	0.1	0.0	0.0	34.9	0.2	0.0	14.2	19.0	0.0	18.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.4	0.2	0.0	0.0	0.9	1.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.6	0.0	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8
SAA2		ENSG00000134339	"Serum amyloid A2"	P0DJI9	11	18239223-18248643	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 752.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.3;EFO-21: 11.8;HaCaT: 14.4;HBEC3-KT: 31.3;HSkMC: 10.2"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 150.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"	11000000000	11000000000				"unprognostic (1.73e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (1.30e-8)"	"unprognostic (1.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	68.6	1.7	0.7	16.3	0.7	0.0	9.8	0.7	0.7	33.1	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.3	1.2	0.7	0.7	0.0	0.7	752.1	0.8	0.7	0.7	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.8	0.0	0.7	46.0	0.7	5.2	0.3	0.7	0.7	0.7	0.7	0.2	0.7	0.7	1.1	0.7	0.7	0.7	1.1	0.7	2.0	1.0	3.1	1.2	0.6	0.9	0.4	15.3	0.0	0.1	0.1	0.6	0.0	2.1	0.0	0.5	0.0	0.2	0.0	6.9	0.1	11.8	0.1	14.4	0.0	31.3	0.0	0.6	0.0	0.5	0.2	0.0	4.5	0.4	0.1	10.2	4.3	0.0	5.1	0.1	0.0	0.7	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	7.0	0.7	0.1	0.0	1.1	4.8	0.0	0.2	0.3	0.1	0.1	0.6	0.3	0.6	0.2	0.4	1.0	0.0	0.6	0.2	3.0	1.2	1.0	0.6	0.6	0.9	0.8	0.6	0.4	0.3	2.0	0.4	0.6	3.1	0.6	1.0	1.0	0.9	0.4	0.7	0.7	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.7
SLC22A9	"FLJ23666, OAT4, OAT7, UST3"	ENSG00000149742	"Solute carrier family 22 member 9"	Q8IVM8	11	63369789-63410294	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 32.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.1;Karpas-707: 1.8;U-266/70: 2.4"	"Cancer enriched"	"Detected in single"	166	"liver cancer: 19.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																											"unprognostic (2.45e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.86e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.08e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.09e-2)"	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	2.8	0.8	0.9	0.5	0.3	0.4	0.5	0.0	0.6	0.2	0.0	0.9	0.0	0.3	0.1	0.2	0.2	0.4	0.5	0.2	0.1	0.4	0.0	0.5	0.1	1.3	0.3	0.3	0.4	2.1	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.2	0.3	1.8	0.1	0.6	0.2	0.9	0.7	0.2	0.1	1.1	0.1	0.0	0.4	0.1	0.2	0.0	0.3	0.2	0.4	0.5	0.0	0.5	0.3	0.6	0.3	2.4	0.5	1.0	0.3	0.6	0.3	2.8	0.8	0.7	0.4	0.5	0.2	0.5	0.2	0.3	0.2	1.0	0.4	0.5	2.2	0.9	0.2	0.6	0.3	0.3	0.4	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0
TMPRSS6	FLJ30744	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109563	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 59.3"	"Group enriched"	"Detected in some"	4	"Hep G2: 7.5;SCLC-21H: 12.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enriched"	"Detected in single"	10	"basal ganglia: 1.8"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.2"												"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.0	0.1	0.1	1.8	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	59.3	1.9	0.1	0.1	0.1	0.5	0.9	0.0	5.3	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.6	0.1	0.1	0.1	2.3	2.6	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.2	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	2.3	0.3	0.1	7.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.2	0.3	0.0	0.0	12.9	0.4	0.2	1.0	0.0	0.1	0.0	0.6	0.5	1.6	0.1	0.0	1.5	0.4	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.2	1.3	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111774315-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"brain: 5.3;liver: 3.2"	"Cell line enriched"	"Detected in single"	6	"NTERA-2: 6.2"	"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.6	5.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	0.4	3.2	0.0	0.0	0.9		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.7;EFO-21: 10.8;Hep G2: 47.1;U-2 OS: 14.2"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	180000000000	180000000000	"Golgi apparatus"	"Golgi apparatus"	"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.6	10.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	47.1	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	14.2	0.0	1.0	0.0	0.6	4.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;RPTEC TERT1: 6.3"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Supported	Centrosome		24000	24000	Centrosome	Centrosome	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.0	1.5	0.8	0.5	0.2	1.4	0.4	0.5	0.1	0.9	0.5	0.7	0.4	0.5	0.0	1.1	1.1	0.0	0.8	1.2	5.5	3.6	3.8	5.2	0.6	1.4	2.0	1.5	1.8	0.4	0.9	0.4	5.3	2.2	0.2	0.0	1.7	2.3	0.3	1.1	0.1	0.5	0.5	6.3	0.8	1.6	0.5	0.3	0.1	1.3	0.9	0.3	0.4	0.8	3.1	1.2	1.5	5.5	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 81.0"	"Group enriched"	"Detected in some"	27	"Hep G2: 26.2;MCF7: 15.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	320000	320000	"Golgi apparatus"	"Golgi apparatus"	"HPA042131: "	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	8.0	0.1	0.0	0.6	0.0	0.0	5.1	0.0	0.1	0.1	5.7	0.0	0.0	0.2	0.1	0.8	0.1	0.1	1.0	0.6	0.0	0.0	1.5	81.0	0.1	3.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.7	26.2	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.5	0.1	0.0	0.1	0.3	0.7	0.0	0.2	0.0	0.2	0.2	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069717-79089466	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 87.9;liver: 122.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.9;Hep G2: 37.2;hTEC/SVTERT24-B: 22.8;U-87 MG: 9.6"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044573	Enhanced					1400000	1400000			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	9.3	4.4	1.7	0.9	2.0	0.2	8.2	1.1	1.0	1.7	3.4	1.1	2.9	0.6	3.2	10.5	3.5	1.4	2.9	3.3	1.5	1.5	87.9	122.9	0.6	0.4	1.6	1.0	1.9	0.5	0.5	3.2	0.3	3.5	3.0	0.8	8.2	0.8	4.0	2.2	0.4	1.3	10.5	2.2	0.3	2.4	1.4	0.9	0.0	4.6	1.9	0.4	6.4	4.4	0.9	0.5	3.2	0.4	2.4	0.7	0.3	0.0	0.0	0.0	0.0	4.3	3.1	1.4	3.7	8.9	2.1	4.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	37.2	3.4	0.2	0.0	3.8	0.0	22.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.6	0.2	0.0	2.5	0.4	0.7	0.4	0.3	0.5	0.5	0.6	0.4	0.2	0.9	0.6	0.7	3.2	2.4	0.2	0.5	0.4	0.3	1.7	2.0	1.1	1.0	1.5	1.5	1.6	1.0	3.5	0.9
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"liver: 611.7"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 47.4;EFO-21: 99.9;Hep G2: 103.2;HSkMC: 73.7;SiHa: 27.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 1213.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.2;monocytes: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	250000000000	250000000000			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	59.7	34.1	9.3	20.0	19.6	1.0	47.3	0.7	10.2	28.3	17.8	13.9	3.7	3.2	9.1	19.9	17.9	38.8	37.9	57.6	7.0	4.1	21.6	611.7	22.6	25.2	12.3	2.2	42.4	22.2	3.1	3.0	2.7	12.8	12.7	9.6	3.9	18.7	7.6	6.8	5.8	15.1	19.1	29.6	1.6	12.6	11.2	10.7	0.1	10.3	3.2	14.1	25.2	38.2	1.2	0.8	4.2	13.3	2.0	0.4	0.8	8.3	3.0	0.0	0.0	1.5	5.0	10.0	0.6	47.4	0.9	1.7	0.5	6.5	0.2	99.9	0.0	6.1	0.0	5.7	0.9	3.0	0.0	0.4	4.4	103.2	2.2	0.8	1.2	73.7	1.7	8.2	3.7	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.0	4.3	0.8	0.0	0.0	27.6	0.0	0.0	2.3	1.1	0.4	0.7	0.9	0.6	0.4	0.2	0.5	0.5	10.2	0.6	0.0	1.7	1.5	0.9	0.4	2.7	0.3	0.7	0.3	0.2	0.8	1.2	0.4	0.4	4.2	2.0	13.3	0.7	0.2	0.8	9.3	19.6	0.7	10.2	7.0	4.1	12.3	2.2	12.8	10.7
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063224-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 151.4"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 32.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	77000000000	77000000000	Vesicles	Vesicles	"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		0.2	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0			0.1	0.0	0.1	0.0	0.0	0.1	15.2	0.7	0.8	0.1	151.4	0.0	0.1	2.1		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	1.1	2.9	1.1	1.0	0.4	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	1.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.3	1.0	0.1	0.5	0.4	0.4	0.3	1.1	2.0	1.1	0.3	0.4	0.3	2.9	2.3	0.3										
MPPED1	"239AB, C22orf1, FAM1A"	ENSG00000186732	"Metallophosphoesterase domain containing 1"	O15442	22	43411196-43507848	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 33.0;liver: 11.0"	"Group enriched"	"Detected in some"	5	"HaCaT: 11.6;SCLC-21H: 4.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.6"	"Group enriched"	"Detected in many"	4	"amygdala: 9.3;basal ganglia: 11.0;cerebral cortex: 32.1;hippocampal formation: 16.2;olfactory region: 17.4"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.8;granulocytes: 1.3"	"Group enriched"	"Detected in many"	5	"amygdala: 108.6;basal ganglia: 66.9;cerebral cortex: 165.8;hippocampal formation: 190.7"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 131.1;hippocampal formation: 116.7"												"unprognostic (1.15e-1)"	"unprognostic (4.29e-1)"		"unprognostic (8.17e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-1)"		"unprognostic (6.92e-3)"	0.5	0.8	9.3	0.6	11.0	0.5	0.8	0.5	33.0	0.6	0.6	0.8	0.0	0.7	1.2	1.2	0.5	0.7	0.5	0.7	16.2	2.2	0.6	11.0	0.5	0.6	3.8	17.4	1.9	0.5	0.5	0.9	0.5	0.7	1.2	0.6	0.0	0.6	0.6	0.5	1.4	0.7	0.6	2.9	0.6	0.9	2.1	0.1	0.0	0.5	0.0	0.6	0.6	0.1	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	9.3	11.0	0.5	32.1	16.2	2.2	3.8	17.4	0.7	0.1
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027602-200177424	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 38.7;liver: 36.1;pancreas: 100.4"	"Cell line enhanced"	"Detected in some"		"A549: 19.3;HAP1: 11.7;HMC-1: 5.1;HUVEC TERT2: 16.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"					"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	2.9	0.2	0.2	4.5	0.3	0.0	2.6	0.2	0.2	2.3	23.8	0.2	0.6	8.1	3.5	1.3	0.7	1.3	5.7	0.5	0.2	0.4	0.4	36.1	1.6	0.7	0.3	0.3	1.0	100.4	0.0	0.3	0.3	0.3	1.1	6.3	0.3	0.5	1.3	1.0	0.7	38.7	1.8	0.4	0.3	0.6	0.6	0.2	0.2	0.8	0.3	0.4	0.8	1.1	1.3	1.4	5.5	1.2	1.5	1.1	0.3	0.0	19.3	0.0	0.1	0.0	0.2	0.5	0.0	0.3	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	11.7	0.0	0.0	2.5	0.8	0.0	0.2	2.0	0.4	0.0	5.1	0.1	0.0	0.0	0.1	16.1	0.0	0.3	0.0	0.5	0.0	0.3	0.8	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.7	0.3	0.1	0.8	0.2	0.1	0.1	2.7	1.7	2.0	0.3	0.1	0.1	5.5	1.2	1.1	0.6	0.7	0.7	0.7	1.0	0.8	0.4	1.3	1.1	1.0	4.2	1.5	0.5	1.4	0.9	0.3	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	0.3	0.2
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684100-20701215	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 366.2"	"Group enriched"	"Detected in many"	4	"ASC diff: 30.8;ASC TERT1: 34.9;Hep G2: 43.4;HSkMC: 20.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"												"Secreted to blood"	27000000	27000000				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	29.6	1.7	1.5	5.7	1.8	0.2	28.7	1.0	1.2	25.2	16.3	2.5	12.3	4.9	19.2	18.4	14.7	15.7	23.4	10.3	2.3	1.0	18.9	366.2	12.8	5.2	3.0	1.4	30.8	16.3	3.8	3.0	4.4	2.7	30.4	15.0	10.5	35.0	14.2	7.1	10.6	13.6	17.4	3.8	3.2	19.2	13.2	1.9	0.3	8.4	10.5	7.3	25.1	26.3	4.0	9.7	0.5	17.0	0.4	2.5	5.0	0.8	4.1	0.8	0.0	30.8	34.9	0.2	3.3	7.6	0.5	1.4	1.0	1.1	0.0	0.8	7.7	0.8	0.4	0.8	0.6	5.3	0.4	0.0	0.9	43.4	3.4	0.4	0.1	20.8	1.9	0.5	3.5	4.0	0.0	3.7	2.2	0.5	0.2	0.0	0.1	3.3	0.1	0.6	1.1	0.7	0.7	0.0	0.1	1.2	0.6	0.8	0.9	0.1	4.1	0.9	0.5	1.2	0.1	0.7	0.9	0.1	1.4	0.3	0.8	0.1	17.0	0.0	0.6	0.9	0.8	4.0	1.1	0.4	9.7	2.2	0.2	0.4	0.5	0.4	0.1	2.3	2.5	5.0	1.5	1.8	1.0	1.2	2.3	1.0	3.0	1.4	2.7	1.9
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 94.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 5.6;ASC TERT1: 12.3;HSkMC: 14.6;U-87 MG: 9.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.2;monocytes: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	11.1	1.1	1.9	0.7	2.1	0.4	3.2	1.3	1.6	1.0	1.0	2.9	0.0	0.5	0.3	2.8	0.5	0.6	1.0	0.9	3.0	1.9	8.9	94.6	0.9	1.6	2.9	2.1	0.4	1.4	0.4	0.1	0.7	2.0	0.4	0.6	0.5	0.5	0.5	4.4	0.6	0.6	0.5	2.9	1.7	0.9	1.0	3.0	0.1	1.7	0.6	0.4	0.5	0.7	0.3	3.2	0.3	2.8	0.0	0.3	0.5	0.0	0.0	0.1	0.1	5.6	12.3	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.0	14.6	0.0	0.8	0.1	0.0	0.1	0.6	1.7	0.0	0.0	0.3	0.2	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.1	0.0	0.3	2.8	0.1	0.1	1.9	0.1	0.1	0.3	0.2	3.2	0.3	0.2	0.3	0.1	0.0	1.3	0.1	0.0	0.5	1.9	2.1	1.3	1.6	3.0	1.9	2.9	2.1	2.0	3.0
AL121845.2		ENSG00000273047			20	63738270-63740398	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"liver: 75.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 10.8;HHSteC: 2.4;U-266/70: 2.2;U-698: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.6"	"Group enriched"	"Detected in many"	26	"dendritic cells: 7.6;T-cells: 5.7"																										"unprognostic (3.96e-2)"						"unprognostic (1.60e-1)"					2.0	0.1	0.1	0.0	0.2	0.3	1.2	0.2	0.1	0.3	1.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.1	0.1	0.0	8.5	75.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	2.3	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.1	2.4	0.1	0.2	7.6	0.0	0.2	0.0	5.7	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	2.2	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	1.3	0.2	4.7	5.7	0.0	0.2	3.2	1.9	0.0	0.0	0.2	7.6	4.4	1.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943293-95968716	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"A-431: 19.1;HMC-1: 21.1;Karpas-707: 26.1;SiHa: 17.5;SK-BR-3: 19.6;U-266/70: 21.1;U-266/84: 24.7"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		410000	410000	Cytosol	Cytosol	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.1	5.7	0.5	2.4	0.8	2.0	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99.0	1.3	1.4	0.5	0.4	0.7	1.1	0.0	1.2	0.6	1.0	0.7	0.0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.1	4.2	0.3	2.8	0.1	0.0	4.3	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0.0	3.6	0.1	0.0	0.1	6.6	0.7	1.8	2.9	3.7	0.0	2.5	21.1	0.0	0.1	0.3	0.0	0.1	1.3	26.1	0.0	2.9	1.6	4.7	2.0	1.0	3.5	0.1	2.1	0.0	1.8	2.2	3.1	17.5	19.6	2.2	2.0	3.6	0.0	2.7	9.5	3.4	2.4	21.1	24.7	2.6	1.9	5.1	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1.0	1.0	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1.0	0.5
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 31.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 36.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	550000	550000				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.7	2.1	1.6	2.6	0.3	0.7	2.7	0.2	0.5	0.7	0.5	0.7	0.1	0.2	0.7	0.7	0.9	0.7	0.6	0.7	0.9	31.8	0.5	3.3	1.6	0.2	0.4	1.2	0.0	0.4	2.3	1.4	0.2	0.4	0.1	0.5	0.0	0.1	0.3	2.9	0.2	0.9	3.0	1.6	1.3	0.5	0.3	0.3	0.0	3.4	0.6	0.9	2.9	0.6	0.0	1.4	1.3	2.6	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.0	0.3	36.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.7	2.7	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.1	0.7	1.7	0.1	0.4	0.4	0.0	1.3	0.0	2.6	1.4	1.8	2.9	1.6	1.8	0.6	2.8	1.0	1.6	0.0	1.3	0.7	0.4	2.0	0.9	0.7	1.6	0.7	2.7	0.6	0.7	1.6	0.2	1.4	0.5
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 127.8;liver: 147.0"	"Cell line enriched"	"Detected in single"	27	"U-87 MG: 25.3"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	20	"neutrophil: 127.8"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074762, CAB075684"	Enhanced									"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	7.8	0.3	0.6	12.9	0.7	9.8	0.6	0.7	1.4	0.2	0.3	0.1	1.0	0.0	0.2	7.8	0.7	3.0	0.8	2.0	0.4	0.2	0.8	147.0	8.6	12.0	2.4	0.4	1.2	0.3	2.8	0.4	1.4	0.6	0.4	0.0	0.5	0.4	0.8	0.4	6.9	0.3	1.0	0.5	15.8	0.7	2.5	0.4	0.4	0.5	0.1	0.4	1.3	0.6	0.0	0.2	127.8	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	25.3	0.1	0.0	0.0	6.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	127.8	0.0	2.3	0.0	0.0	1.7	0.6	0.7	0.7	1.4	0.4	0.2	2.4	0.4	0.6	0.4
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell line enriched"	"Detected in single"	69	"U-266/84: 41.2"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008933	Enhanced				"Secreted in brain"	1900000000	1900000000			"HPA008933: AB_1847033"	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	41.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 88.4;SK-BR-3: 26.7"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	Nucleoli		2100000	2100000	Nucleoli	Nucleoli	"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.3	6.2	4.2	4.1	7.2	6.6	2.2	2.7	2.6	4.1	0.6	0.0	1.0	0.1	2.4	1.1	0.2	3.7	6.6	0.0	1.9	3.9	88.4	5.5	1.3	2.0	0.0	3.7	2.8	5.2	5.3	0.2	3.9	0.3	4.3	1.1	0.1	0.2	2.4	0.6	0.2	5.7	0.5	5.6	0.0	0.1	0.4	15.5	26.7	3.0	0.0	0.6	2.9	6.8	2.1	2.0	4.8	0.0	0.3	0.0	4.5	4.3	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 201.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	37	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	2000000000	2000000000	Vesicles	Vesicles	"HPA002130: AB_2666554, HPA005960: , HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.2	201.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0
FP565260.4		ENSG00000279493			21	5011799-5017145	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"kidney: 3.4;liver: 10.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 5.9;HeLa: 2.5;MCF7: 4.2;SiHa: 6.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.3		0.2	0.0		0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.0	0.0			3.4	10.1	0.0	0.7			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.1	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.9	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009499	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	41000	41000	"Golgi apparatus"	"Golgi apparatus"	"CAB009499: AB_2105095"	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.1	8.6	1.9	8.7	14.3	9.2	22.2	17.8	13.6	7.4	5.2	12.6	15.5	0.5	45.9	12.9	25.5	3.9	9.2	1.6	40.7	10.1	24.8	15.5	16.5	7.6	3.4	40.9	10.4	10.4	8.4	3.8	23.6	18.9	2.5	4.9	9.7	1.3	11.2	6.2	2.5	2.2	7.5	3.2	11.5	10.8	3.9	2.6	15.1	8.2	12.6	2.9	9.1	34.7	8.3	17.8	12.7	26.1	4.4	25.1	1.1	15.9	11.2	16.8	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9
G6PC	"G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42913369	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 305.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 2.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced									"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favourable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favourable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.0	0.0	5.8	0.1	0.0	0.1	0.1	1.9	0.1	0.1	0.1	23.7	305.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	33.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.5	1.1	0.2	0.5	0.4	0.0	0.4	0.2	0.2	0.5	0.6	0.0	0.7	0.2	0.2	0.0	0.1	0.2	0.3	0.7	0.2	0.2	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.5	0.8	0.0	1.3	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.1	0.5	1.1	0.3	0.3	0.6	2.2	0.2	0.1	0.7	0.4	0.6	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.7	0.2	0.9	0.3	1.4	0.2	1.1	0.2	0.1	0.3	0.1	0.2	1.0	0.2	0.2	0.0	2.2	0.4	0.4	1.1	0.5	0.1	0.5	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in some"	4	"RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		620000	620000	Mitochondria	Mitochondria	"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.7	8.8	0.3	0.0	0.6	4.4	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.2	5.1	0.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.1	3.1	0.0	0.1	55.9	0.4	0.9	14.7	6.5	1.1	1.8	0.1	0.3	0.7	5.8	0.0	0.0	0.1	0.0	1.7	34.5	43.6	0.2	0.4	0.1	0.3	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 91.2;liver: 115.1"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.7"					"HPA040251, HPA044094"	Enhanced									"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favourable (1.31e-6)"	"unprognostic (2.69e-1)"				11.1	0.0	0.1	0.1	0.1	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	4.5	0.1	0.0	0.1	0.2	0.1	0.0	91.2	115.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.3	1.1	0.7	2.9	0.7	0.2	0.8	0.0	1.5	0.6	1.0	3.2	3.2	2.1	2.1	0.8	0.9	1.5	0.8	0.4	2.0	2.4	1.3	1.4	1.5	2.3	2.4	1.9	0.1	0.7	3.1	0.6	3.3	2.4	1.8	1.8	2.4	7.5	2.6	2.6	2.9	0.9	1.3	3.7	1.2	2.0	3.5	2.9	1.0	1.3	2.2	0.5	6.7	1.6	0.8	2.5	1.7	1.3	1.4	2.3	1.5	1.6	1.8	1.9	2.1	1.2	1.5	2.2	1.1	0.6	4.5	2.0	1.0	0.7	0.3	0.4	0.3	0.4	0.1	0.4	0.8	0.2	1.1	0.5	0.5	2.9	0.2	0.3	0.7	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536189-21604847	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 75.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;HEL: 1.8"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039482	Approved									"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favourable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	75.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	2.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.6	1.8	0.2	0.0	0.3	0.5	0.4	0.5	0.2	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.3	0.2	0.0	0.5	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066571	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 55.4;liver: 146.5;pancreas: 80.1"	"Group enriched"	"Detected in some"	9	"EFO-21: 19.4;Hep G2: 27.5;T-47d: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					1000000	1000000			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	0.2	0.0	0.3	0.1	0.5	0.0	3.2	0.4	1.1	0.3	0.3	0.2	8.4	0.2	1.1	10.7	0.1	1.9	3.2	0.7	0.6	0.3	55.4	146.5	4.9	0.1	0.9	0.2	0.4	80.1	2.6	3.2	0.2	0.4	5.3	0.0	0.4	4.1	8.5	8.5	0.0	0.2	0.1	0.9	0.3	6.9	0.8	0.3	0.1	4.3	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.1	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.1	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.1	13.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.6	0.2	0.5	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.5	0.4	1.1	0.6	0.3	0.9	0.2	0.4	0.3
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"kidney: 81.4;liver: 248.6"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"liver cancer: 162.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					5700000	5700000			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favourable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	8.3	9.4	16.8	2.5	18.8	1.6	4.2	5.6	11.6	2.6	4.7	4.5	2.7	5.8	2.1	4.8	2.8	2.2	4.3	5.2	11.7	12.5	81.4	248.6	2.2	2.1	19.1	9.5	4.6	5.2	3.5	1.8	2.4	11.8	4.0	4.8	2.3	3.2	2.7	6.8	2.3	4.2	2.5	7.9	1.8	4.6	3.3	9.5	0.6	3.2	3.5	2.6	3.2	1.8	12.1	10.0	5.0	8.3	8.4	12.8	7.1	17.1	14.9	12.1	14.7	27.3	21.3	13.2	15.9	11.2	10.6	12.8	20.2	11.5	24.4	20.4	11.6	12.2	26.4	22.5	21.5	8.5	11.4	17.7	10.1	21.6	12.5	6.5	2.8	18.4	7.8	14.9	16.4	13.7	31.5	5.3	14.2	22.3	13.8	17.8	19.0	27.3	16.0	8.8	7.0	25.6	12.4	13.1	6.5	10.1	7.0	11.0	17.9	8.6	8.3	8.3	5.2	13.9	6.3	12.7	17.4	12.0	14.4	13.8	5.3	0.1	8.3	5.0	6.5	7.0	8.3	12.1	9.4	9.5	10.0	9.5	12.2	12.8	1.5	8.4	7.0	7.6	12.3	7.1	16.8	18.8	5.6	11.6	11.7	12.5	19.1	9.5	11.8	9.5
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 43.4;liver: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4;CAPAN-2: 8.8;EFO-21: 6.7;HDLM-2: 6.8;RPMI-8226: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"				"Endoplasmic reticulum, Plasma membrane"	"Endoplasmic reticulum, Plasma membrane"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	1.4	1.8	1.1	3.2	0.9	0.0	1.5	0.9	2.3	1.7	19.6	0.9	0.9	14.3	1.3	0.9	0.9	1.6	2.5	2.2	0.9	0.4	2.5	47.4	0.9	0.9	0.9	0.9	1.8	4.8	0.1	1.4	0.9	1.0	0.9	1.6	0.9	1.4	0.9	3.9	0.9	43.4	0.9	0.9	2.7	4.0	0.9	0.9	0.9	1.4	0.9	1.0	0.9	1.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	2.3	1.9	0.1	1.9	2.4	8.4	0.1	1.9	0.6	0.1	0.8	1.2	8.8	0.7	6.7	1.5	0.0	0.4	0.2	0.1	6.8	0.1	0.0	0.0	4.1	0.2	0.1	0.0	4.9	0.6	0.3	0.1	2.6	0.0	6.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.7	0.1	0.2	0.8	1.5	0.1	0.2	1.0	0.1	1.6	0.9	1.3	0.2	0.8	0.0	1.9	0.8	0.1	3.3	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.1	0.9	0.9	2.3	0.9	0.4	0.9	0.9	1.0	0.9
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA055564	Approved									"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.7	5.7	0.0	0.2	0.3	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
TIMD4		ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919282-156963255	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 32.0;lymphoid tissue: 83.9;testis: 58.9"	"Group enriched"	"Detected in some"	18	"U-266/70: 45.7;U-266/84: 12.4"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 6.4"									"HPA015625, CAB026027"	Approved					18000000	18000000			"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favourable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	6.7	0.4	0.4	3.5	0.4	5.3	0.5	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.4	1.0	1.5	0.4	0.3	0.8	0.4	0.4	1.7	32.0	0.6	83.9	0.5	0.0	0.4	0.4	0.0	0.4	2.8	0.0	1.1	0.1	0.0	6.5	0.0	0.7	0.4	1.1	0.2	0.5	12.5	0.4	58.9	0.0	21.7	0.8	0.2	8.5	5.3	0.4	0.4	0.0	0.0	0.0	0.0	6.4	1.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	45.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	2.3	4.5	0.0	0.0	3.0	3.0	0.0	0.0	0.0	0.0	6.4	1.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.0
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"intestine: 80.9;liver: 69.8"	"Group enriched"	"Detected in some"	14	"CACO-2: 24.3;Hep G2: 42.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	45.1	0.1	0.1	50.5	0.1	0.2	0.1	0.1	7.0	0.1	0.1	0.1	3.1	69.8	0.1	0.1	0.1	0.1	0.1	0.9	4.1	0.1	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	80.9	0.1	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917398-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"liver: 16.7;prostate: 44.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.1;RPTEC TERT1: 10.6;SK-MEL-30: 10.6;WM-115: 6.4"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Low region specificity"	"Detected in many"														"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favourable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	44.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.2	3.0	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.7	10.6	0.0	0.7	0.4	0.0	0.1	10.6	0.4	0.7	0.0	0.0	0.1	0.3	0.0	1.5	2.4	0.0	0.9	0.0	6.4	0.5	0.2	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.3	0.3	0.9	3.0	0.1	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.9
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 11.7;WM-115: 22.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"				"Nucleoplasm, Plasma membrane, Actin filaments"	"Nucleoplasm, Plasma membrane, Actin filaments"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	11.7	0.0	0.5	2.2	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.7	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	38000000	38000000	Vesicles	Vesicles	"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.4	3.4	4.7	2.7	2.5	1.2	1.1	0.9	0.5	0.7	0.5	3.7	0.4	1.5	0.8	0.6	0.3	0.6	0.1	2.0	3.1	0.4	1.4	0.7	2.0	0.1	1.1	6.6	1.7	0.5	1.3	0.3	0.1	1.4	0.5	5.6	0.1	1.5	3.6	2.0	0.4	0.4	1.6	1.5	1.4	2.2	6.9	2.4	1.3	1.8	5.9	0.6	0.8	2.5	1.4	1.6	0.0	2.5	0.6	0.5	2.1	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230702523-230714297	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 309.0"	"Group enriched"	"Detected in some"	6	"Hep G2: 108.5;THP-1: 41.4"	"Group enriched"	"Detected in all"	10	"glioma: 275.3;liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	110000000000	110000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	2.8	3.2	23.6	1.9	25.0	1.4	1.6	17.1	37.0	3.8	2.1	24.2	0.0	1.9	1.7	1.8	2.0	2.3	22.5	30.9	18.0	11.9	9.3	309.0	1.6	1.5	19.5	15.0	1.8	2.3	1.8	2.6	1.5	23.8	2.5	2.2	0.0	1.5	1.9	7.8	1.4	2.2	2.6	29.8	1.4	2.4	2.0	15.9	0.0	1.9	0.5	1.4	3.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	108.5	0.3	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	41.4	0.0	0.0	0.2	0.0	0.1	0.5	7.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	25.0	17.1	20.0	18.0	11.9	19.5	15.0	23.8	15.9
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Group enriched"	"Detected in some"	19	"CACO-2: 27.8;Hep G2: 75.2"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	97000000000	97000000000	Nucleoplasm	Nucleoplasm	"HPA065365: AB_2732733, HPA073918: "							"prognostic favourable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavourable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	27.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	75.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131573144-131584332	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 284.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;HL-60: 3.9;RH-30: 1.6;SiHa: 1.8;U-698: 2.2"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 24.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Low region specificity"	"Detected in single"			"HPA003595, CAB009434, HPA024006, CAB056159"	Enhanced					15000000	15000000			"CAB009434: AB_2058955, CAB056159: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	1.0	0.0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.1	3.0	0.2	0.0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0.0	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0.0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0.0	4.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.6	0.0	3.9	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.5	0.1	0.3	0.1	0.0	0.0	1.6	0.4	0.0	0.3	0.2	0.1	1.8	0.4	0.2	0.1	0.5	0.0	0.0	0.2	0.3	0.1	1.0	0.1	2.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	24.4	0.0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 156.0"	"Cell line enhanced"	"Detected in many"		"U-937: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030947, HPA058709"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favourable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favourable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	3.5	2.8	6.6	5.2	11.2	4.7	4.6	18.1	13.8	4.0	13.9	4.6	6.3	9.6	2.1	3.6	12.9	5.5	6.1	19.6	6.3	5.8	6.0	156.0	2.0	4.2	5.9	9.1	3.0	2.8	5.8	3.6	1.4	7.7	4.5	11.1	6.2	8.6	4.4	7.3	8.0	13.7	2.4	3.5	2.3	4.7	1.8	3.6	5.4	5.2	11.3	7.4	3.6	3.6	6.1	4.6	2.9	1.6	4.7	9.9	4.0	10.5	1.4	0.6	5.4	0.9	0.0	0.0	1.2	1.0	5.5	3.1	9.5	3.5	0.0	15.7	0.3	4.9	4.8	2.5	2.1	0.1	0.0	5.6	3.6	3.2	4.0	12.4	5.9	1.6	3.0	2.1	4.6	1.3	0.0	4.2	0.1	18.8	9.5	8.4	4.1	1.9	9.1	2.0	14.4	5.8	4.8	10.0	4.3	3.8	0.5	2.0	12.7	10.4	0.1	0.3	1.8	0.0	9.9	4.9	9.2	0.1	0.3	35.3	0.7	2.9	1.6	0.6	5.9	0.2	8.2	6.1	6.5	5.3	4.2	5.5	9.9	5.9	0.0	4.7	0.3	4.6	4.2	4.0	6.6	11.2	18.1	13.8	6.3	5.8	5.9	9.1	7.7	3.6
CYP26A1	"CP26, CYP26, P450RAI, P450RAI1"	ENSG00000095596	"Cytochrome P450 family 26 subfamily A member 1"	O43174	10	93073475-93077890	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"liver: 23.2;retina: 7.3"	"Cell line enriched"	"Detected in some"	7	"AF22: 36.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 6.8"												"unprognostic (2.80e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.04e-11)"	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.11e-1)"	0.1	0.3	0.3	0.0	0.6	0.1	0.3	0.4	1.8	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	23.2	0.1	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.8	0.3	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	36.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.4	1.8	0.6	0.3	0.2	1.4	0.3	0.2
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HMC-1: 1.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056505	Enhanced					3600000	3600000			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.1	0.1	0.1	23.0	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	23.9	7.6	0.1	8.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.4	0.1	0.1	0.1	1.0	0.1	0.5	0.6	0.1	0.2	0.1	0.2	0.2	0.1	9.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.9	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 87.7"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	87.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6
IGF2		ENSG00000284779	"Insulin like growth factor 2"		11	2129112-2158658	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	8	"liver: 24.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;RH-30: 3.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"																							1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717276-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 323.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 4.4;HL-60: 2.4;RH-30: 3.9;SiHa: 2.6"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	64000000000	64000000000			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	41.9	323.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.4	2.3	0.2	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.4	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.1	3.9	0.0	0.2	0.0	0.5	0.1	2.6	0.4	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.9	0.0	1.9	0.0	2.0	0.0	2.3	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	1.6	0.7	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	8	"liver: 117.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 41.5;NB-4: 8.4;U-266/70: 11.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;memory B-cell: 1.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"					"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favourable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.7	3.5	4.0	0.3	4.8	1.4	1.0	4.9	5.4	0.9	1.4	2.5	1.9	14.4	1.2	3.3	0.8	1.7	1.9	0.5	6.5	1.1	8.8	117.0	1.6	0.7	2.0	2.9	1.7	1.9	3.8	4.8	1.5	4.8	1.5	0.5	1.6	3.4	3.7	2.8	4.0	8.2	1.3	4.2	1.7	0.8	9.9	2.3	0.9	5.0	0.3	1.1	0.8	0.7	1.2	0.9	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.6	1.0	1.9	4.0	1.9	0.5	0.7	0.3	0.4	1.9	0.6	0.1	1.3	0.6	0.4	0.3	0.8	0.3	0.6	0.3	0.3	0.9	41.5	3.0	0.0	0.8	5.4	1.3	0.3	1.1	0.7	0.3	5.0	0.9	0.3	0.2	8.4	0.1	0.5	0.2	0.2	1.1	2.2	0.3	0.1	1.4	0.0	0.9	0.2	0.7	2.8	0.4	1.0	0.3	0.0	0.1	11.3	1.4	0.2	1.1	1.5	0.7	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	4.0	4.8	4.9	5.4	6.5	1.1	2.0	2.9	4.8	2.3
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893581-72933033	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 49.1"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.6;Hep G2: 5.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	150000000	150000000				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.0	0.6	49.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	6.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	5.6	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.3	5.9	0.2	0.2	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1
OR10J5		ENSG00000184155	"Olfactory receptor family 10 subfamily J member 5"	Q8NHC4	1	159535078-159536007	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"liver: 1.8"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.6;BEWO: 12.7;REH: 4.1"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																		"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.4	0.9	3.3	0.6	5.6	0.0	12.7	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.6	0.1	0.7	2.8	2.1	4.1	1.2	0.0	0.1	0.6	1.1	0.5	0.4	0.6	1.0	3.6	1.4	0.2	0.2	0.5	0.3	0.4	1.3	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 157.6"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007292, CAB056160, CAB068239"	Enhanced									"CAB056160: AB_2665590, CAB068239: , HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favourable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	1.3	2.0	5.4	1.4	5.3	1.1	2.0	1.9	3.9	1.7	1.0	1.7	1.2	1.0	1.1	1.1	1.4	2.6	1.1	1.3	3.7	3.8	1.9	157.6	0.9	1.4	4.3	2.5	1.4	2.6	1.1	1.3	0.8	3.4	1.4	0.8	1.3	2.7	2.1	1.4	1.1	0.9	1.5	2.7	1.1	1.1	2.3	3.0	1.4	1.8	0.6	1.4	1.1	1.6	13.3	10.8	2.2	3.0	9.6	18.7	8.9	15.9	21.8	3.9	4.1	3.7	3.9	2.4	0.9	2.1	3.0	4.2	1.7	3.4	20.7	2.6	1.1	3.3	4.4	14.0	1.3	9.6	14.7	13.9	22.7	18.1	5.6	7.3	4.9	4.5	2.4	0.4	8.4	1.5	12.8	0.0	3.6	13.0	17.9	15.4	2.3	12.8	9.1	0.1	28.2	10.0	7.6	5.3	7.3	0.0	21.6	4.7	6.4	6.3	1.2	0.0	2.8	0.0	1.8	13.6	15.3	8.4	4.5	13.6	0.8	0.0	2.4	2.2	8.7	3.0	18.7	13.3	11.2	11.4	6.5	8.9	13.9	14.3	0.3	9.6	2.1	10.8	13.3	8.9	5.4	5.3	1.9	3.9	3.7	3.8	4.3	2.5	3.4	3.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Group enriched"	"Detected in some"	68	"CACO-2: 7.1;Hep G2: 23.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favourable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.1;RH-30: 1.2;RPMI-8226: 1.1"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"									HPA045108	Approved									"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favourable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favourable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Cell line enriched"	"Detected in single"	42	"RH-30: 24.7"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 32.5;liver: 99.7"	"Group enriched"	"Detected in some"	23	"CACO-2: 13.5;Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.1	0.1	0.1	1.7	0.1	0.0	0.1	0.1	0.1	0.1	14.4	0.0	0.0	8.7	0.1	0.6	0.1	0.1	3.0	0.1	0.1	0.1	9.5	99.7	0.1	0.0	0.1	0.0	0.1	5.6	0.0	0.1	0.0	0.1	0.1	3.8	0.0	0.1	0.0	0.1	0.1	32.5	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	1.6	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200318-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 41.9;liver: 57.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.0;Karpas-707: 8.5;NTERA-2: 3.8;SCLC-21H: 3.6;TIME: 4.3;WM-115: 16.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057900			Uncertain	Vesicles				Vesicles	Vesicles	"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	6.8	0.2	0.8	1.0	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0.0	0.7	0.4	0.7	0.4	0.3	0.0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2.0	0.0	0.7	0.1	0.1	1.0	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0.0	0.0	2.4	0.0	2.1	0.2	3.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.2	0.0	0.7	3.6	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.5	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	16.8	3.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	3.1	0.6	0.0	0.1	0.0	0.0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2.0
AL645922.1		ENSG00000244255			6	31927698-31952048	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	7	"liver: 115.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;Hep G2: 1.5;Karpas-707: 2.4;U-266/84: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"				"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				5.3	0.9	0.6	2.9	0.7	0.3	3.9	0.6	0.7	0.7	3.7	0.3	0.0	0.8	0.9	3.0	0.9	1.1	0.8	4.4	0.7	0.6	10.8	115.5	15.8	9.7	0.7	0.0	1.5	0.7	0.3	0.7	5.0	0.6	0.8	0.6	1.1	0.8	0.3	0.8	0.7	4.3	1.5	0.8	9.7	1.3	1.3	0.0	0.3	0.7	0.0	1.3	1.5	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.7	0.6	0.7	0.0	0.6	0.0
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	4	"EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced									"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	15.0	0.0	0.0	5.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 132.7"	"Group enriched"	"Detected in some"	5	"Hep G2: 16.9;Karpas-707: 52.8"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016775	Supported				"Secreted to blood"	52000000000	52000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	9.2	3.2	0.9	4.8	1.5	0.8	5.0	1.2	1.3	2.0	5.3	1.8	1.6	2.5	2.0	4.8	1.9	3.3	3.2	5.4	0.8	0.8	13.1	132.7	19.4	13.1	1.2	0.3	2.7	2.1	0.8	2.8	7.6	1.7	1.8	4.3	2.9	2.4	1.5	0.7	1.6	6.6	3.5	1.8	12.1	1.9	2.0	1.0	1.8	1.2	0.8	3.4	2.7	1.5	0.2	0.5	0.8	6.5	0.1	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.6	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	16.9	0.3	0.0	0.2	0.9	0.1	0.2	0.0	0.0	0.1	52.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	2.3	0.1	0.1	0.2	0.2	0.0	0.2	6.6	1.0	0.2	0.3	0.0	0.1	2.9	0.0	0.1	6.4	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.2	0.8	0.1	6.5	0.0	0.1	1.2	0.9	1.5	1.2	1.2	0.8	0.8	1.2	0.3	1.7	1.0
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"endometrium 1: 6.8;liver: 25.9;pancreas: 20.4;pituitary gland: 21.9"	"Cell line enriched"	"Detected in some"	18	"RPTEC TERT1: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.3	1.0	0.5	1.3	0.4	0.3	0.5	0.2	0.7	1.0	1.2	0.1	0.1	2.2	6.8	0.3	0.2	0.1	0.9	0.2	0.4	0.9	2.5	25.9	2.0	0.3	0.3	0.1	0.4	20.4	0.0	21.9	0.8	1.3	1.1	1.4	0.2	1.2	0.1	0.8	1.1	1.1	0.1	0.4	0.2	2.2	0.2	0.1	1.2	0.9	0.1	1.2	1.3	0.1	0.8	0.9	2.5	0.5	0.9	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	25.8	0.6	1.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.5	0.4	0.4	0.2	0.4	0.5	0.4	0.2	0.1	0.8	0.5	0.3	2.5	0.9	0.2	0.9	1.0	0.1	0.5	0.4	0.2	0.4	0.4	0.9	0.3	0.1	1.3	0.1
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 5.1;ASC TERT1: 7.1;HSkMC: 18.8"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	7600000000	7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favourable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	18.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1
CIDEB		ENSG00000136305	"Cell death-inducing DFFA-like effector b"	Q9UHD4	14	24305096-24311430	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 123.9;liver: 215.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 14.9;HEL: 7.6;Hep G2: 16.7;HL-60: 10.7;Karpas-707: 7.7;U-266/84: 9.9;U-937: 12.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001272	Approved									"HPA001272: AB_2666255"	"unprognostic (2.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.35e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.64e-1)"	2.3	5.6	0.9	1.9	1.2	3.9	2.2	3.1	0.9	2.7	43.4	1.1	1.9	26.0	2.2	2.7	7.1	2.5	3.1	1.2	1.0	0.6	24.2	215.9	2.0	3.3	1.2	0.9	5.5	3.9	0.5	2.5	0.8	1.3	3.1	1.3	2.4	2.8	2.2	0.6	4.0	123.9	1.5	1.0	19.5	1.4	0.9	0.9	0.8	1.4	3.2	4.5	1.3	3.8	0.7	7.1	8.7	7.1	6.3	4.9	2.5	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.3	0.1	0.1	0.0	1.0	0.3	0.0	0.0	0.4	1.4	0.0	0.1	0.0	14.9	0.0	7.6	0.0	16.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	3.5	0.0	7.7	0.0	0.0	0.0	5.0	0.0	0.0	1.2	0.1	3.8	0.0	0.5	3.3	0.0	4.2	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	6.1	9.9	0.1	0.0	12.6	0.0	0.9	7.1	8.7	4.9	2.4	4.5	0.7	3.2	3.1	7.1	0.6	2.0	2.6	4.1	6.3	1.2	1.7	1.6	2.5	0.9	1.2	3.1	0.9	1.0	0.6	1.2	0.9	1.3	0.9
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"kidney: 7.4;liver: 25.0"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 68.6"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles				Vesicles	Vesicles	"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favourable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.1	0.3	0.0	7.4	25.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.8	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.4	0.0	0.5	1.4	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.2	2.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	1.3	0.0	0.2	0.1	1.8	3.6	0.0	0.3	0.1	0.0	0.7	0.2	2.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.2	1.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0
CLEC4M	"CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN"	ENSG00000104938	"C-type lectin domain family 4 member M"	Q9H2X3	19	7763149-7769605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"liver: 38.5;lymphoid tissue: 30.1"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.5;K-562: 3.4;Karpas-707: 1.3;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.7"									"CAB033689, CAB033691, HPA042661"	Supported				"Intracellular and membrane"	890000	890000			"CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101"	"unprognostic (1.56e-1)"				"unprognostic (3.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"		"unprognostic (1.27e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.15e-2)"		"unprognostic (1.43e-1)"	0.9	0.9	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.1	1.2	0.6	0.1	0.1	0.1	0.0	0.1	38.5	2.5	30.1	0.1	0.1	2.7	0.1	0.0	0.1	4.8	0.2	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.5	0.1	0.1	0.2	0.0	1.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	3.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.0;hTCEpi: 13.1;HUVEC TERT2: 12.6;SK-BR-3: 9.8"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB018654	Uncertain									"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.1	0.0	0.3	0.0	7.8	0.0	0.1	0.4	0.2	24.0	1.0	0.2	6.5	0.0	7.5	0.5	4.8	0.2	0.0	0.7	0.3	1.7	3.5	0.1	0.2	7.7	0.0	13.1	0.2	1.0	12.6	1.4	0.2	0.0	0.5	0.0	0.2	0.1	1.9	0.7	0.0	0.3	0.0	1.6	0.4	0.2	1.1	9.8	2.5	0.3	0.1	0.6	1.1	0.3	3.5	0.0	0.5	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 78.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.3;HMC-1: 6.0;REH: 3.5;T-47d: 2.3;U-266/70: 4.2"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045223	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	78.0	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.2	0.0	0.6	0.2	3.5	0.0	1.1	0.0	0.0	0.1	0.3	1.2	0.1	0.0	2.3	0.0	0.0	0.0	1.6	0.0	0.3	4.2	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 8.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	8.8	0.0	0.9	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.1	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in some"	7	"CACO-2: 25.6;Hep G2: 81.3"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		32000000	32000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	25.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	81.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.0	1.4	7.5	0.0	0.1	0.8	5.6	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880812-134887520	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 77.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.0;intermediate monocyte: 5.6"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	1800000000	1800000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		2.0	11.4	0.2	0.2	0.2	0.0	4.0	0.2	0.3	0.2	0.3	0.3	0.5	0.0	0.3	0.6	0.2	0.0	0.2	0.5	0.2	0.0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0.0	0.2	1.4	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0.0	3.3	1.3	6.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.9	0.0	0.0	6.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.3	0.0	2.5	0.0	0.0	7.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 76.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;Hep G2: 4.4;NTERA-2: 1.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035132	Supported				"Secreted to blood"	4500000000	4500000000			"HPA035132: AB_10601650"		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	2.6	11.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.5	0.0	0.9	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.6	0.4	0.2	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176020-56185775	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 4.4;liver: 4.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;EFO-21: 1.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 29.0"	HPA053938	Uncertain				"Secreted in brain"					"HPA053938: AB_2682315"				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.2	1.2	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.1	1.1	0.7	0.4	0.0	4.4	0.0
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 10.2;U-698: 10.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	3700000000	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.8	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.2	0.1	10.2	1.2	0.2	0.0	1.7	0.3	0.2	1.3	3.4	1.4	1.3	4.3	0.0	1.8	0.2	0.1	0.2	0.1	0.0	0.0	0.6	0.5	0.3	0.7	1.0	0.6	3.9	0.5	2.0	0.3	0.1	0.4	5.1	3.3	3.4	1.1	0.1	0.5	0.5	0.5	0.1	1.2	1.3	0.1	1.4	3.0	4.7	10.4	0.1	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;NB-4: 3.9;THP-1: 15.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		67000	67000	Cytosol	Cytosol	"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.5	0.0	0.2	0.1	0.0	0.0	3.1	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.6	0.0	0.9	0.4	0.4	0.3	0.0	0.2	0.1	0.0	0.2	3.9	1.3	0.6	0.2	0.1	0.1	0.1	0.8	0.2	0.4	0.4	0.1	0.0	0.0	15.1	0.2	0.1	0.2	0.2	0.2	0.6	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734950	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 183.4"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 148.3"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					77000	77000			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	4.6	1.6	1.1	3.0	3.1	0.3	2.4	9.9	3.9	0.6	1.0	1.6	2.7	0.5	0.8	8.7	1.5	0.9	1.9	3.0	1.8	0.9	2.6	183.4	7.2	1.3	8.2	2.0	12.6	0.9	0.3	1.5	26.5	3.3	7.1	0.9	1.5	0.6	3.0	1.5	6.3	0.9	2.7	1.3	3.5	1.4	2.3	2.5	0.0	1.0	0.6	0.6	3.9	1.4	0.2	0.0	0.2	0.1	0.4	9.2	0.8	0.0	0.0	0.0	0.0	148.3	15.4	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.2	9.2	2.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	2.4	0.8	1.1	3.1	9.9	3.9	1.8	0.9	8.2	2.0	3.3	2.5
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"liver: 9.7;placenta: 21.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;U-266/70: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	9.7	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406853-39451536	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 17.3;liver: 49.2;pancreas: 21.4"	"Group enriched"	"Detected in some"	23	"ASC diff: 6.4;Hep G2: 22.9"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					290000	290000			"HPA021136: "	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	17.3	0.0	0.2	1.9	1.0	0.2	3.9	0.4	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.5	0.3	0.1	1.3	0.5	1.0	0.2	0.1	49.2	1.4	0.5	0.1	0.0	0.2	21.4	0.2	0.2	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.4	0.5	0.6	0.3	0.0	0.0	1.5	2.5	0.2	0.0	0.1	0.4	0.0	0.3	0.2	0.5	2.5	2.3	0.7	0.4	0.4	0.2	0.0	0.2	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	22.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.7	0.2	0.3	0.4	0.2	0.4	0.2	0.2	0.1	0.5	0.2	0.4	2.3	0.4	0.5	2.5	0.1	0.2	0.2	1.0	0.4	0.2	1.0	0.2	0.1	0.0	0.4	0.2
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 4.7;Hep G2: 15.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"											HPA011940	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.1	0.4	0.6	0.0	0.0	0.0	4.7	1.1	0.3	0.6	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.6	0.6	15.8	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.3	0.3	0.5	0.2	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818485	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 7.1;intestine: 15.4;liver: 22.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 17.3"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"					"Cell type enriched"	"Detected in single"	18	"NK-cell: 7.1"	"Lineage enriched"	"Detected in single"	18	"NK-cells: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.6			15.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	22.2	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.5		0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.1	0.7	0.0			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.1										
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836885-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 65.1;liver: 220.0"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 71.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.1	1.3	0.5	0.0	0.5	0.0	0.1	0.2	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	20.3	0.1	0.8	0.3	65.1	220.0	0.0	0.0	0.3	0.7	0.1	1.7	0.0	1.6	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	1.0	0.8	0.3	0.3	0.7	0.8	0.4
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;LHCN-M2: 15.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol				Nucleoli	Nucleoli	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.2	13.3	5.4	3.8	4.2	0.4	2.4	1.4	3.3	7.1	3.8	7.0	0.0	2.0	4.0	3.3	8.3	3.9	2.7	0.0	0.7	0.2	3.1	7.1	6.1	0.0	0.2	4.8	3.0	10.4	0.5	0.4	0.0	0.0	15.0	0.6	0.2	0.0	9.1	0.0	0.0	7.2	0.1	1.4	0.2	1.2	0.1	2.7	1.0	3.7	4.2	4.5	0.4	1.3	4.0	0.1	0.1	0.0	0.0	0.0	11.4	0.0	4.7	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell line enhanced"	"Detected in some"		"A549: 19.8;CACO-2: 6.4;CAPAN-2: 4.8;Hep G2: 21.9;T-47d: 12.3"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	350000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460549-57477534	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 44.3;liver: 38.1;thyroid gland: 24.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.9;Karpas-707: 25.6;REH: 15.4;RPMI-8226: 49.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 17.7;basal ganglia: 17.9;cerebral cortex: 44.3;hippocampal formation: 12.4;olfactory region: 17.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 1.0;intermediate monocyte: 2.5;MAIT T-cell: 1.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.4;monocytes: 2.5;T-cells: 1.1"	"Group enriched"	"Detected in many"	4	"amygdala: 23.2;basal ganglia: 10.6;cerebral cortex: 29.8;hippocampal formation: 23.6"	"Low region specificity"	"Detected in many"								"Intracellular and membrane"	25000000	25000000				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	2.7	0.9	17.7	0.9	17.9	1.4	2.4	1.6	44.3	1.5	1.0	1.0	0.0	1.8	1.5	0.8	1.2	1.2	3.8	2.1	12.4	1.5	2.0	38.1	1.9	1.0	2.0	17.6	1.0	2.8	5.4	2.5	2.7	1.0	1.9	0.7	1.9	2.8	1.0	2.3	5.3	1.2	1.4	0.7	1.3	1.9	1.5	0.1	1.0	24.9	0.5	1.0	1.3	1.2	0.0	3.4	0.0	2.5	0.0	1.1	0.0	2.6	3.8	2.9	4.9	1.2	1.7	0.3	0.0	1.0	0.1	1.0	0.5	0.5	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.6	1.8	0.7	0.3	2.6	1.7	0.6	16.9	4.6	0.5	0.4	0.4	0.0	0.6	25.6	0.0	0.5	0.1	1.9	5.0	2.9	15.4	2.0	49.3	0.0	0.0	5.4	0.4	0.4	0.2	2.8	3.2	0.7	0.0	0.2	8.9	1.2	0.9	1.5	3.2	0.5	6.4	2.7	2.1	0.0	1.0	0.0	0.2	2.5	1.1	0.0	0.3	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	17.7	17.9	1.6	44.3	12.4	1.5	2.0	17.6	1.0	0.1
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612377-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 1244.8"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 96.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	95000000000	95000000000			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favourable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	11.1	2.1	5.4	5.7	17.6	1.2	26.0	1.9	16.1	43.8	2.3	10.0	1.4	2.3	2.2	2.4	3.3	4.3	18.1	10.7	13.4	6.5	61.9	1244.8	4.9	53.0	16.3	0.8	8.3	182.4	1.0	14.0	2.7	34.2	18.3	2.6	10.2	62.1	7.9	6.8	1.5	2.3	10.2	47.2	8.2	9.7	9.5	7.4	0.0	3.5	0.5	1.7	7.6	11.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	1.0	0.0	0.2	0.0	0.9	0.0	0.5	0.0	0.2	0.0	96.2	13.1	0.4	0.1	11.9	14.3	0.0	0.5	0.0	0.0	0.0	0.0	3.6	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.4	0.5	14.0	0.5	0.0	0.1	0.0	1.8	0.0	4.1	0.2	0.3	0.4	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.4	17.6	1.9	9.6	13.4	6.5	16.3	0.8	34.2	7.4
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039249	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 56.2;liver: 75.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 4.5"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favourable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavourable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.8	2.1	32.2	1.6	31.0	3.0	1.8	15.1	56.2	2.0	1.7	25.4	0.0	1.7	1.9	3.9	4.3	2.4	2.3	3.3	22.2	16.6	2.1	75.6	2.5	1.7	22.7	25.3	2.4	1.4	9.3	1.0	2.0	17.0	2.1	1.8	1.7	1.6	5.0	3.3	1.7	1.7	1.8	13.7	1.9	1.7	4.4	14.3	0.5	1.9	0.0	1.7	1.9	0.9	1.0	0.8	1.2	0.3	0.2	0.8	0.2	0.8	0.6	1.8	1.3	1.5	0.4	1.0	0.7	0.2	0.8	1.1	1.4	1.0	1.6	0.3	0.4	1.3	2.3	0.9	0.7	0.2	1.7	1.3	4.5	2.7	0.7	2.2	2.2	1.1	0.2	0.2	1.2	0.3	1.1	3.6	0.2	1.0	0.7	1.7	0.8	1.4	1.2	0.2	0.1	0.6	1.7	0.8	0.3	1.0	0.6	0.2	1.0	1.0	0.3	0.8	0.5	0.7	0.6	1.1	0.3	1.2	0.9	1.7	0.4	0.3	0.3	1.1	0.5	0.1	0.8	0.9	0.6	0.5	0.3	1.0	0.3	0.5	1.2	0.2	0.3	0.8	0.3	0.2	32.2	31.0	15.1	41.5	22.2	16.6	22.7	25.3	17.0	14.3
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB003695, HPA036174, HPA036175"	Enhanced					28000000	28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: "	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favourable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.9	9.0	12.2	12.9	4.2	7.9	9.3	5.1	12.5	20.9	2.5	3.6	7.3	4.9	4.0	25.7	3.7	7.0	5.1	9.0	4.6	38.5	16.7	6.0	5.8	14.0	21.3	8.2	22.2	3.5	13.5	8.0	9.1	11.2	0.0	11.0	5.7	13.6	3.1	3.3	22.6	24.4	15.1	5.5	5.0	5.3	17.6	9.3	14.2	7.9	1.7	6.7	6.4	8.3	5.0	21.0	4.9	3.8	7.9	12.6	8.1	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7
APOM	"ApoM, G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 94.6"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	18000000000	18000000000	"Golgi apparatus"	"Golgi apparatus"	"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	1.3	1.5	1.8	1.5	1.6	6.8	1.9	1.3	2.0	1.3	1.8	2.2	1.9	2.4	2.3	3.0	1.6	1.5	1.4	1.5	1.5	1.3	15.2	94.6	1.0	3.6	1.7	1.9	3.7	3.3	1.4	1.9	0.7	1.6	1.1	0.9	2.1	3.1	1.6	2.2	2.4	2.4	1.5	2.4	1.3	1.4	6.6	1.1	3.6	2.7	1.7	3.1	1.1	1.0	3.3	1.6	5.8	2.1	1.0	2.2	1.0	2.1	1.1	2.5	4.1	2.0	2.5	0.5	1.5	2.7	1.0	2.4	1.5	3.2	3.4	0.8	2.6	3.5	1.4	1.6	2.1	2.1	2.5	2.4	1.8	3.1	3.3	4.2	1.1	3.3	1.6	1.0	3.0	0.9	4.2	2.2	2.7	3.2	3.6	4.1	2.1	0.5	2.2	1.8	3.8	2.8	3.2	2.2	1.0	2.1	0.2	1.8	4.5	3.0	0.4	1.4	0.5	2.8	0.6	3.9	3.4	4.1	1.3	6.5	0.6	5.8	1.9	1.7	1.1	0.9	1.7	3.3	1.3	1.1	1.6	1.9	1.7	1.8	1.7	1.0	2.1	1.4	2.2	1.0	1.8	1.6	1.3	1.8	1.5	1.3	1.7	1.9	1.6	1.1
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085679-104115581	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 29.7;liver: 88.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.4;HMC-1: 3.1;RPTEC TERT1: 1.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA069761	Enhanced									"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	0.7	0.5	0.4	0.4	0.5	0.0	2.1	0.4	0.5	1.5	2.3	0.5	0.4	0.5	1.6	1.0	10.2	2.0	0.8	29.7	0.4	0.0	9.8	88.7	1.3	0.9	0.4	0.4	4.9	0.4	0.7	0.4	0.8	0.7	0.4	0.8	1.2	0.8	0.4	0.4	5.2	0.8	1.1	0.4	0.4	1.6	0.9	0.4	0.4	1.3	0.6	1.7	0.5	2.8	0.2	0.0	1.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	1.8	0.8	2.6	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.0	2.4	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.7	0.0	0.7	0.6	1.8	1.9	1.4	1.2	0.0	0.1	0.8	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.7	0.4
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		470000	470000	Vesicles	Vesicles	"HPA021251: , HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favourable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.0	0.7	0.4	0.5	0.1	0.2	0.3	1.0	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 145.4"	"Cell line enriched"	"Detected in some"	9	"Karpas-707: 128.6"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	13000000000	13000000000			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	14.0	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20.0	18.0	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1.0	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1.0	0.8	0.4	0.5	9.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	5.3	0.0	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	4.1	0.2	0.0	1.3	0.6	0.0	128.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	4.7	10.7	0.1	0.0	0.0	0.1	0.0	0.0	7.4	5.7	0.0	0.0	3.2	0.0	0.0	1.3	0.5	0.0	0.2	1.3	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014762-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 30.7;liver: 52.4"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 52.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	97000000000	97000000000			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	3.7	30.7	0.9	0.0	0.7	0.0	1.3	0.0	0.9	0.7	2.3			0.9	1.4	0.0	0.0	4.7	2.4	2.6	0.4	0.9	7.2	52.4	2.0	0.7	0.7		7.2	2.7	1.0	1.8	0.5		0.5	2.7		2.0	0.4	0.0	0.0	1.0	3.8	0.6	1.4	0.8	0.7			5.7		1.6	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	3.3	0.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936529	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 26.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.3	0.8	0.4	2.7	0.0	0.1	0.7	0.0	0.0			0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	26.4	0.2	0.3	0.4		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.0	0.0	0.3	0.7	0.1	0.0	0.3	0.8	0.0	0.3			0.1		0.0	0.0	0.0	1.9	1.6	4.7	1.1	1.9	1.1	0.4	0.2	0.3	0.3	0.7	0.1	0.0	0.5	0.4	0.1	0.0	0.1	0.5	0.6	0.6	0.2	0.2	0.5	0.2	0.2	0.1	0.4	0.3	0.4	1.1	6.7	0.0	0.4	1.7	0.7	0.0	0.2	0.4	0.3	0.4	1.6	0.1	0.5	0.2	1.0	0.5	0.6	0.4	0.4	0.2	0.2	0.5	0.4	0.2	0.2	0.3	0.1	0.6	0.3	0.4	0.8	0.2	0.5	0.3	0.7	0.4	0.4	0.5	0.9	0.4	4.1	1.1	1.0	0.8	0.7	0.8	0.9	0.8	0.6	0.3	1.9	1.1	1.1	4.7	1.9	0.7	1.6	0.5	0.4										
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 93.9;THP-1: 101.2"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	40000000	40000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.1	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	101.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.3	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;HHSteC: 31.8;HSkMC: 31.0;RH-30: 23.2;RT4: 56.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	110000000000	110000000000	Vesicles	Vesicles	"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: "	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	16.1	0.0	0.0	25.2	14.3	0.0	6.5	15.9	0.9	3.5	0.0	3.0	0.0	2.4	0.0	0.5	0.0	5.9	0.6	0.3	0.0	4.8	19.1	0.0	31.8	0.2	0.0	31.0	0.1	4.7	2.0	19.8	18.1	0.6	22.5	0.0	0.1	0.0	0.1	0.0	0.0	23.2	5.1	0.0	56.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	19.2	0.2	0.2	0.2	0.2	0.0	0.0	3.4	0.0	1.4	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9
CLEC1B	CLEC2	ENSG00000165682	"C-type lectin domain family 1 member B"	Q9P126	12	9985642-10013424	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.5;liver: 44.1"	"Group enriched"	"Detected in some"	6	"Karpas-707: 9.9;U-266/84: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8"	"Group enriched"	"Detected in many"	37	"dendritic cells: 2.1;granulocytes: 7.8;monocytes: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									1500000	1500000				"unprognostic (2.03e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"		"unprognostic (4.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-2)"	0.1	0.3	0.0	0.4	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.0	0.0	0.1	44.1	2.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	4.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.1	7.8	4.9	0.1	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	2.8	0.0	7.8	4.9	6.7	0.0	4.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	3.3	0.1	3.7	1.2	0.0	12.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
COLEC10	CL-L1	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119106582	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HHSteC: 3.4;SK-BR-3: 14.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	5700000	5700000				"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.79e-4)"	"unprognostic (6.25e-3)"	"unprognostic (1.80e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (5.79e-4)"	"unprognostic (1.05e-1)"		"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.02e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-5)"	"unprognostic (7.12e-2)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.1	0.3	47.4	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.1	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	8.2	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 104.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7;Karpas-707: 30.6;SK-MEL-30: 40.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;T-cells: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					25000	25000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favourable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	2.2	8.3	2.3	1.0	3.2	2.2	2.0	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1.0	2.4	2.2	18.3	11.6	1.5	1.7	1.0	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1.0	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0.0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.0	0.7	3.4	4.8	4.2	2.4	7.6	2.0	1.8	1.7	7.6	1.4	3.1	2.7	1.6	1.4	2.4	13.3	1.4	3.5	8.4	2.9	3.2	2.5	4.3	19.7	3.7	0.8	3.7	11.9	3.6	4.2	1.5	6.4	30.6	1.1	1.4	1.3	0.8	3.5	2.7	1.3	1.8	7.7	3.5	0.0	1.9	1.6	3.2	3.8	40.0	1.3	2.0	0.5	0.5	3.9	2.7	1.9	11.8	6.9	1.4	4.7	7.5	1.3	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1.0	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 88.6"	"Cell line enhanced"	"Detected in some"		"A-431: 7.5;CAPAN-2: 29.9;EFO-21: 11.2;Hep G2: 14.4;RPMI-8226: 7.8;RT4: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favourable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.4	2.2	3.6	0.5	4.4	0.5	1.7	1.8	5.4	1.1	2.5	4.4	0.0	7.5	0.5	11.8	7.9	2.2	12.9	0.4	3.9	1.4	4.9	88.6	2.4	0.4	2.1	3.8	0.3	3.5	0.2	0.6	0.2	8.3	2.4	1.9	0.6	2.6	3.4	0.5	0.8	15.7	0.2	9.7	0.9	2.7	1.0	3.0	0.0	2.2	2.8	1.8	4.8	2.0	0.1	0.1	0.8	1.2	0.0	0.2	0.1	7.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.1	11.2	0.0	0.9	0.0	3.9	0.0	0.0	0.0	0.0	2.3	14.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	7.8	2.0	8.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.0	0.8	0.5	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.1	3.6	4.4	1.8	5.4	3.9	1.4	2.1	3.8	8.3	3.0
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced									"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.2	3.5	1.0	0.0	5.2	4.5	1.1	4.0	1.2	2.6	2.9	15.1	5.2	0.0	15.7	3.9	4.0	0.0	3.3	5.5	11.0	3.7	5.8	0.9	15.2	3.4	0.7	0.1	6.3	4.3	2.6	2.4	3.8	3.8	4.3	5.0	4.3	0.1	3.4	2.1	4.4	0.0	7.0	0.3	10.8	4.7	3.1	4.5	7.8	4.5	7.2	16.6	6.8	1.8	1.7	2.6	1.3	0.3	1.2	3.7	0.3	0.5	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9
FGL1	HFREP-1	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 450.7"	"Group enriched"	"Detected in some"	15	"A549: 21.7;Hep G2: 51.0"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	1800000	1800000				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavourable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	450.7	0.2	0.1	0.1	0.1	0.1	71.3	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814013	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 68.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;MCF7: 6.0;SK-BR-3: 5.2;U-87 MG: 6.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			HPA071228			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	3.9	0.1	0.6	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	11.4	68.8	0.1	0.1	0.1	0.1	0.1	0.5	3.9	0.1	0.1	0.5	0.2	0.0	1.4	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	5.2	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 92.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 25.1;SCLC-21H: 7.1"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"B-cells: 1.8;T-cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain									"HPA038608: "	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"	0.9	1.7	5.7	1.0	8.6	0.9	1.4	12.8	15.0	1.0	1.2	0.2	0.0	1.0	1.2	2.0	1.4	2.8	0.9	1.0	4.2	4.1	1.6	92.2	1.4	1.2	1.9	9.7	1.2	15.8	3.0	6.2	0.8	8.6	1.4	1.7	2.5	1.4	2.0	0.9	2.0	1.0	1.1	3.2	1.1	1.4	1.1	1.4	0.0	1.4	0.0	1.4	1.1	0.8	1.8	0.0	0.0	0.0	0.0	3.8	1.4	4.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.4	0.9	25.1	0.4	0.0	0.6	0.0	3.7	0.0	0.0	3.7	0.0	0.3	4.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	0.4	0.0	0.1	4.5	2.6	1.7	7.1	0.4	0.8	0.2	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	1.8	3.3	1.0	0.0	0.6	3.8	3.5	0.0	0.0	0.0	0.0	0.6	1.4	5.7	8.6	12.8	15.0	4.2	4.1	1.9	9.7	8.6	1.4
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell line enriched"	"Detected in some"	16	"RT4: 66.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		820000	820000	Mitochondria	Mitochondria	"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favourable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	66.2	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Cell line enhanced"	"Detected in many"		"HEL: 18.5;Hep G2: 26.9"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		320000	320000	Cytosol	Cytosol	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	13.9	10.6	1.6	6.4	1.2	0.3	1.4	0.9	0.6	1.3	0.8	5.1	3.0	2.1	3.4	0.0	6.2	5.5	1.8	0.4	4.9	10.0	18.5	2.8	26.9	0.6	2.5	2.2	0.1	0.8	1.6	0.1	1.2	3.3	3.5	0.1	9.1	3.0	2.0	2.3	4.2	10.6	0.8	11.8	1.6	1.7	6.0	9.3	2.0	3.6	3.9	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.8	3.6	1.8	6.0	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6
MT1B	"MT1, MT1Q"	ENSG00000169688	"Metallothionein 1B"	P07438	16	56651899-56653204	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 21.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;EFO-21: 2.1"	"Cancer enriched"	"Detected in single"	209	"liver cancer: 57.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"																															"unprognostic (2.66e-1)"						0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.3	0.9	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 49.0;placenta: 17.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 16.7;PC-3: 9.3;RPMI-8226: 29.2;SCLC-21H: 50.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA064874	Approved				"Secreted to blood"					"HPA064874: AB_2685378"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.9	0.6	0.6	1.3	0.8	2.3	0.4	0.6	1.6	1.6	1.3	0.0	3.1	1.4	5.9	3.0	0.9	1.1	0.7	0.3	0.5	0.9	1.0	49.0	0.4	1.3	0.4	0.7	1.0	2.0	0.3	5.9	17.7	1.2	1.5	0.7	1.1	0.5	3.4	0.3	2.3	0.7	0.6	0.5	2.8	6.0	4.3	0.4	3.7	0.8	0.9	1.0	0.6	1.3	1.6	2.0	4.7	2.1	1.6	1.8	0.6	0.1	0.8	0.1	1.0	0.1	0.0	0.2	0.3	0.1	0.2	0.3	1.8	0.6	0.1	0.0	0.3	0.3	0.5	0.2	0.2	0.6	1.0	0.0	1.1	0.5	0.8	0.1	0.0	0.5	0.5	0.3	0.8	0.0	2.8	0.6	0.0	0.5	0.1	16.7	0.7	9.3	3.3	0.0	29.2	0.1	0.0	50.8	4.1	0.3	0.8	0.1	2.2	1.3	0.6	0.1	0.2	0.1	0.0	1.3	0.4	0.3	0.2	0.3	0.1	3.6	2.1	1.9	0.6	1.3	1.8	1.4	0.3	0.2	2.0	1.6	0.9	0.3	4.7	1.6	0.6	1.1	1.1	0.6	0.6	0.8	0.6	1.6	0.5	0.9	0.4	0.7	1.2	0.4
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568112	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 419.5"	"Cell line enriched"	"Detected in some"	10	"ASC diff: 21.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA006277, HPA006507, CAB017027"	Approved					380000	380000			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	10.0	0.1	0.4	2.2	0.4	0.0	11.1	0.2	0.6	0.1	52.0	0.2	0.1	19.2	0.1	0.7	0.2	0.1	5.6	0.4	0.3	0.2	72.0	419.5	0.2	0.3	0.2	0.2	0.4	0.2	0.0	5.0	0.1	0.5	0.2	14.0	0.2	0.2	0.1	0.3	0.1	58.5	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.3	0.2	0.2	0.2	0.5	0.2
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72935170-72954778	"Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 47.8;liver: 42.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.8;Hep G2: 19.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"					"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	25.6	0.0	0.0	15.4	0.1	0.3	0.1	0.1	0.0	3.5	0.1	0.1	8.0	42.8	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	47.8	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347146-133352683	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 196.7;liver: 112.7"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 44.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 72.9;liver cancer: 348.8"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.1"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9;NK-cell: 3.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;NK-cells: 3.6"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	330000000	330000000			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.2	0.1	145.3	0.2	0.4	111.1	0.1	2.4	0.1	0.2	3.4	0.1	0.1	0.1	24.4	112.7	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	1.1	0.1	3.1	3.6	0.2	0.1	0.1	0.1	196.7	0.1	0.1	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.7	2.9	0.2	3.6	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	10.4	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	44.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.3	0.0	0.0	0.0	2.9	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.8	0.4	0.4	1.8	3.6	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.1
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	11000000	11000000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB008659: AB_1620984, CAB027389: , CAB047362: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	24.2	33.5	14.2	27.4	77.4	39.6	20.0	32.7	35.7	29.7	43.4	35.1	30.6	20.9	15.4	42.4	29.4	40.8	20.3	28.5	12.7	78.5	14.8	29.6	44.3	32.3	19.0	14.1	41.9	26.3	28.9	29.0	37.2	28.5	77.1	27.4	36.1	9.7	29.8	49.0	49.2	13.5	35.5	117.8	26.5	8.5	20.8	17.7	30.1	35.8	24.1	37.8	24.3	24.5	21.2	14.0	54.7	24.5	25.3	30.6	22.3	38.0	24.7	30.2	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7123684-7128942	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3"	"Cell line enhanced"	"Detected in many"		"HEL: 6.8;Hep G2: 15.2;K-562: 31.3"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.3;T-cells: 2.4"					"Low region specificity"	"Detected in all"			HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favourable (3.68e-4)"	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0.0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0.0	6.2	2.0	0.7	10.1	2.3	1.4	0.1	0.0	1.3	0.0	0.0	2.4	0.1	1.8	3.1	0.0	1.0	0.0	0.0	0.7	1.1	0.0	0.0	0.2	1.7	1.9	1.1	0.5	0.0	2.2	0.1	0.0	0.0	2.7	0.0	6.8	4.9	15.2	0.0	0.4	2.0	0.3	0.1	0.0	0.0	0.0	31.3	1.4	0.0	0.0	0.1	0.4	0.4	0.1	0.4	0.0	0.1	0.1	2.6	0.1	0.3	2.7	1.1	0.0	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.4	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0.0	0.1	0.0
SERPING1	"C1-INH, C1IN, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57614853	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 693.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 144.9;ASC TERT1: 75.1;HSkMC: 124.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	143	"dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026161, HPA048738"	Supported				"Secreted to blood"	38000000000	38000000000			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favourable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	88.8	16.3	3.6	18.2	5.4	1.6	75.0	3.8	6.3	62.7	37.8	7.3	16.7	6.2	63.4	58.8	58.3	63.4	61.6	55.5	3.4	3.0	53.4	693.2	73.8	22.4	5.7	4.1	116.4	38.1	8.0	18.4	33.1	14.9	70.3	11.9	82.6	20.7	33.2	36.5	23.1	20.3	38.7	17.3	42.7	30.3	39.2	3.6	1.8	41.5	24.4	16.8	68.7	122.2	0.0	28.5	32.1	11.0	0.1	0.0	2.8	0.0	0.0	5.5	0.0	144.9	75.1	0.9	9.2	6.5	1.9	3.5	0.3	0.0	0.0	11.1	4.7	0.0	0.0	0.6	1.2	0.0	0.0	4.5	0.0	0.2	19.2	0.2	0.9	124.5	1.8	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	5.6	0.0	0.7	0.4	0.0	0.8	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.4	0.0	0.3	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.9	0.1	0.0	11.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	32.1	0.1	4.4	28.5	0.0	2.8	3.6	5.4	3.8	6.3	3.4	3.0	5.7	4.1	14.9	3.6
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 88.9"	"Cell line enriched"	"Detected in single"	19	"Hep G2: 14.5"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA030220	Approved									"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favourable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favourable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	88.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"liver: 55.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;Hep G2: 17.4;K-562: 3.1;RPMI-8226: 4.6"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.7	1.3	2.3	0.5	0.7	0.0	1.4	4.3	3.3	1.5	0.7	0.4	0.4	0.1	2.6	1.7	0.4	0.9	0.4	1.7	1.5	0.0	8.6	55.5	0.4	0.4	0.4	0.4	1.5	2.7	0.0	1.3	0.6	0.4	0.7	0.3	0.5	0.9	0.7	6.0	0.1	0.4	2.1	0.7	0.9	0.2	2.4	0.4	0.4	0.7	0.7	0.5	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	17.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.8	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	4.3	3.3	1.5	0.0	0.4	0.4	0.4	0.4
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Group enriched"	"Detected in some"	6	"A549: 15.9;RPTEC TERT1: 24.6"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.4	0.2	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.3	0.9	24.6	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 53.9"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 12.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038731	Enhanced		Uncertain	Nucleoplasm		20000	20000	Nucleoplasm	Nucleoplasm	"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	2.9	0.4	0.2	0.4	0.3	0.0	3.7	0.6	0.2	0.1	5.5	0.1	0.1	3.4	0.3	8.3	0.1	0.1	0.6	0.7	0.1	0.2	3.2	53.9	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.5	0.1	0.1	0.2	0.0	0.1	1.0	0.6	0.4	0.1	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.8	2.4	0.0	0.0	0.7	0.5	0.0	0.2	0.2	0.2	0.8	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.2	0.5	0.3	1.7	0.0	0.8	0.1	0.0	0.0	1.5	2.0	0.1	0.1	0.5	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.5	0.0	0.4	2.6	0.6	0.5	1.3	0.0	0.0	0.7	1.7	0.6	12.2	0.0	2.1	0.0	0.3	0.0	0.9	0.0	0.2	1.0	1.4	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.2	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.0	2.4	0.0	0.0	0.2	0.3	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HUVEC TERT2: 1.9;U-266/70: 3.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"											"HPA017261, HPA045108"	Uncertain									"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 85.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 10.9;NB-4: 4.5;THP-1: 6.0;U-937: 6.8"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"basophil: 11.4;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 11.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA000728	Enhanced					790000	790000			"HPA000728: AB_1080471"	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favourable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.1	0.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.6	0.1	0.5	0.1	0.0	0.1	0.5	0.1	0.0	13.5	85.7	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	11.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	10.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.3	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	1.1	1.3	0.3	0.0	0.0	6.0	0.5	0.1	0.1	0.0	0.0	1.1	0.0	1.3	1.3	6.8	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006554	Enhanced				"Intracellular and membrane"					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favourable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.7	1.1	2.1	71.5	0.5	0.8	0.2	0.4	0.3	0.2	1.2	0.3	0.8	0.5	0.3	1.4	0.9	0.4	0.2	1.1	1.6	2.0	1.8	1.2	0.3	1.7	0.5	0.8	0.4	0.7	0.1	0.1	0.2	0.1	0.2	0.5	1.2	1.6	1.2	3.8	0.6	1.5	0.4	0.5	0.6	0.7	1.7	1.8	0.8	1.1	0.8	1.7	0.1	0.7	0.4	0.8	0.6	2.7	1.5	1.2	1.7	1.3	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 385.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		16000000	16000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	385.0	56.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 30.5"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in some"			"HPA067946, HPA069081"	Enhanced					480000	480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Cell line enriched"	"Detected in some"	190	"Hep G2: 214.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	930000	930000	"Golgi apparatus"	"Golgi apparatus"	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		16000	16000	Nucleoplasm	Nucleoplasm	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099678-56233359	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7"	"Group enriched"	"Detected in some"	6	"HEL: 23.9;HMC-1: 12.4;NB-4: 15.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3"	"Group enriched"	"Detected in many"	67	"granulocytes: 13.1;T-cells: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.9	0.5	3.3	1.3	20.0	1.4	0.5	0.5	6.7	0.3	0.5	1.5	0.0	0.5	0.3	0.2	0.6	0.6	0.8	0.4	4.3	7.8	1.1	5.7	0.6	6.1	2.3	3.5	0.5	0.3	0.2	0.5	1.4	9.9	0.3	0.7	0.7	2.1	0.3	0.3	0.9	2.4	0.5	4.1	3.0	0.7	16.7	1.8	0.0	0.4	0.0	3.8	1.0	0.3	0.0	0.0	13.1	0.2	0.0	14.3	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.1	0.9	0.0	1.1	12.4	0.0	0.0	0.0	0.0	3.0	1.9	0.8	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.3	12.6	0.2	13.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	14.3	0.5	1.2	0.0	0.0	0.0	0.6	2.1	3.3	20.0	0.5	6.7	4.3	7.8	2.3	3.5	9.9	1.8
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.9;kidney: 24.7;liver: 59.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 13.3;MOLT-4: 15.5;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		51000	51000	Nucleoplasm	Nucleoplasm	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	1.3	3.2	11.7	1.6	16.2	1.3	0.9	7.4	26.9	0.9	1.0	8.9	0.0	6.9	1.1	0.9	1.2	0.9	2.3	1.2	12.9	8.3	24.7	59.8	1.1	1.6	9.2	9.8	0.9	1.5	0.9	7.7	0.9	4.1	1.2	0.9	1.0	2.3	0.9	1.1	1.8	2.9	0.9	5.1	1.4	1.1	1.1	6.6	1.3	1.7	0.0	0.9	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.3	0.0	0.5	3.7	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	1.6	15.5	0.1	0.0	0.3	0.3	0.3	1.0	0.0	0.2	1.7	9.2	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.7	0.0	0.0	3.7	0.7	1.9	0.2	2.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.7	16.2	7.4	26.9	12.9	8.3	9.2	9.8	4.1	6.6
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		4500000	4500000	Cytosol	Cytosol	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.6	1.1	1.3	2.2	8.8	22.5	4.2	13.9	86.6	2.7	8.4	4.9	3.2	0.0	9.4	28.6	82.0	5.7	0.5	1.9	2.0	2.6	0.0	1.8	12.7	30.7	1.7	0.1	14.8	79.7	4.4	8.0	0.1	0.4	51.7	2.7	57.6	0.6	24.3	1.8	2.5	0.1	1.5	132.8	7.6	5.8	33.4	0.5	49.5	52.2	3.9	35.8	99.5	0.0	1.1	6.9	0.2	1.2	8.6	8.2	2.9	21.8	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 139.4;liver: 39.3"	"Group enriched"	"Detected in some"	5	"hTCEpi: 15.9;RPTEC TERT1: 9.8"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		25000	25000	Vesicles	Vesicles	"HPA007600: AB_1845284, HPA027823: "	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0.0	2.2	2.0	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0.0	8.9	1.6	0.7	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.2;Hep G2: 21.9;NB-4: 14.6;THP-1: 8.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"						"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	21.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10308026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 30.2;K-562: 30.7;PC-3: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					590000	590000			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	5.7	13.9	8.1	6.1	7.7	2.0	13.1	4.1	7.8	5.6	38.3	2.9	5.2	47.0	4.3	6.1	3.0	5.1	21.6	11.4	7.8	5.1	81.7	83.7	5.5	2.1	5.8	7.6	10.6	6.5	13.9	6.0	1.3	5.1	8.6	17.8	4.8	3.5	8.4	70.6	1.4	71.4	5.0	7.0	1.4	14.4	3.9	4.1	1.3	7.3	10.5	1.6	6.4	4.8	0.8	0.6	3.0	1.2	0.7	2.1	0.8	3.6	4.3	5.0	12.6	20.1	23.1	27.4	6.2	6.7	2.0	2.8	1.7	18.7	0.0	10.4	4.5	0.1	11.7	7.9	2.4	0.2	8.8	16.4	19.7	14.1	6.2	0.1	0.1	30.2	5.2	4.1	3.8	6.0	30.7	0.2	7.0	0.7	0.1	0.6	7.7	29.6	3.6	0.0	0.4	18.5	2.3	4.0	6.2	14.8	1.3	0.4	10.3	0.6	1.7	3.0	3.9	4.8	0.0	0.1	0.0	0.0	4.9	0.0	0.0	2.1	1.2	0.5	1.5	0.5	2.1	0.3	1.7	0.7	0.6	0.8	0.8	1.6	3.0	0.7	0.3	0.5	0.2	0.8	8.1	7.7	4.1	7.8	7.8	5.1	5.8	7.6	5.1	4.1
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94989391	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 233.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.4;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123"	Enhanced				"Intracellular and membrane"					"CAB016123: AB_629363, HPA015066: AB_1847433"	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favourable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	45.8	0.0	0.0	13.6	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.5	233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	43.8	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;CACO-2: 12.1;CAPAN-2: 8.1;Hep G2: 8.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072245			Uncertain	Cytosol				Cytosol	Cytosol	"HPA072245: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	3.1	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	12.1	8.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.4	0.1	0.1	0.2	0.0	2.6	0.0	0.1	0.0	2.6	0.2	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.8	0.7	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149741	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 71.0"	"Cell line enriched"	"Detected in some"	4	"RH-30: 5.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.0	14.4	71.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.4	0.2	0.1	0.6	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.5	0.5	0.2	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.1	0.5	0.0	0.0	0.6	0.6	0.2	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.1	0.4	0.4	0.4	0.0	0.0	5.2	0.0	0.0	0.4	0.5	0.2	0.4	0.1	0.0	0.4	0.7	0.7	0.2	0.1	0.2	0.0	0.0	0.5	0.7	0.2	1.2	0.0	0.0	0.2	0.4	0.5	0.0	0.4	0.5	0.5	0.6	0.1	0.6	0.5	0.6	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 159.2"	"Cell line enhanced"	"Detected in some"		"A549: 5.3;CAPAN-2: 24.2;HaCaT: 11.1;Hep G2: 13.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 33.1"	"Lineage enriched"	"Detected in single"	166	"granulocytes: 33.1"									HPA058960	Approved									"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0.0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0.0	0.4	1.9	0.1	0.2	0.0	0.2	0.0	1.6	0.3	0.5	0.0	1.3	0.1	0.1	1.2	13.4	0.1	1.0	2.6	1.7	0.2	1.8	0.0	0.1	1.1	0.8	1.8	2.7	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	24.2	0.1	0.1	0.0	11.1	0.0	0.1	0.0	0.4	0.0	0.1	2.3	13.2	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 64.9;MCF7: 79.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		2700000	2700000	"Nucleoli, Microtubules"	"Nucleoli, Microtubules"	"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.3	5.7	10.3	23.0	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.5	9.0	6.4	10.6	10.4	9.2	4.4	3.9	26.7	17.7	9.2	64.9	24.7	13.6	21.8	8.4	11.5	4.0	14.6	7.1	20.2	13.5	6.7	79.8	11.4	32.7	6.6	13.1	10.5	7.7	24.2	9.4	12.7	15.9	9.4	6.4	55.0	8.0	41.2	13.5	3.6	6.7	8.4	9.0	8.6	13.9	10.2	8.7	5.7	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.3	15.4	4.5	7.4	2.4	3.2	8.5	6.3	2.5	9.6	7.4	12.1	6.8	16.6	8.6	3.4	7.8	8.8	6.8	11.3	3.7	8.3	9.1	7.5	11.8	6.8	12.6	6.7	3.1	7.0	11.6	12.2	6.9	13.9	3.0	5.8	19.6	11.9	12.1	10.1	6.0	15.1	5.9	17.5	5.8	4.9	5.3	6.3	8.5	9.1	4.1	8.1	6.4	3.0	8.8	5.5	8.3	9.2	5.8	10.8	28.1	4.6	13.8	8.0	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Cell line enhanced"	"Detected in some"		"AF22: 4.8;BEWO: 4.9;Hep G2: 9.3;NTERA-2: 5.4;REH: 7.1;SH-SY5Y: 16.8;U-2 OS: 5.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.8	1.7	0.0	0.0	4.9	0.2	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	2.2	0.0	0.0	0.1	2.1	0.0	0.0	9.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.4	0.0	7.1	0.6	0.0	0.0	0.1	0.0	16.8	0.2	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152003	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 65.9;liver: 80.5;testis: 45.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.4;MCF7: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdTCR: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 1.5;T-cells: 4.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 24.7"	HPA057167	Enhanced									"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favourable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	3.3	2.3	4.0	0.8	4.7	0.9	6.3	0.9	4.0	5.1	1.6	1.9	6.5	0.8	3.1	11.0	8.3	4.9	1.9	2.6	2.6	2.5	65.9	80.5	1.2	2.0	2.7	1.9	13.1	4.3	6.2	8.8	2.3	2.7	3.8	0.9	4.8	7.6	7.8	0.6	5.1	0.8	2.4	1.5	2.4	1.1	45.0	1.9	1.1	4.0	3.9	12.9	3.8	6.2	0.2	0.0	0.2	0.2	1.5	4.8	1.0	5.2	1.8	5.3	10.1	2.0	0.6	5.3	5.4	12.0	7.5	3.3	9.0	2.6	0.2	9.1	1.3	4.7	9.3	7.6	5.2	0.2	8.4	0.1	1.0	13.8	8.0	0.2	0.3	2.7	26.4	1.6	0.3	5.4	0.7	0.2	0.9	25.5	1.5	0.1	11.1	4.0	0.4	6.3	0.2	6.5	2.0	1.4	7.6	3.4	16.1	2.5	15.6	0.3	0.3	2.1	11.7	0.4	3.9	0.2	0.1	0.2	0.1	0.2	3.0	0.1	0.2	0.0	4.8	0.0	4.6	0.0	1.3	2.9	0.0	0.2	2.9	3.6	0.2	1.5	0.1	0.0	0.7	1.0	4.0	4.7	0.9	4.0	2.6	2.5	2.7	1.9	2.7	1.9
EXOC3L4	C14orf73	ENSG00000205436	"Exocyst complex component 3 like 4"	Q17RC7	14	103100144-103110559	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 15.3;liver: 26.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;HEL: 7.0;Hep G2: 4.9;RPMI-8226: 4.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043661	Approved									"HPA043661: AB_10965693"	"unprognostic (8.71e-2)"	"unprognostic (7.42e-3)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.81e-4)"	0.4	0.2	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.4	1.5			15.3	0.1	0.0	0.3	0.2	2.0	0.4	0.0	0.0	2.4	26.4	1.1	4.4	0.0		0.2	0.8	0.0	0.1	0.3		0.8	0.7		0.2	0.0	0.0	0.1	7.4	0.0	0.0	3.5	3.2	0.1			0.1		1.9	0.2	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	1.2	0.3	0.3	0.0	0.2	0.0	0.0	0.0	6.8	0.0	7.0	0.1	4.9	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.0	4.7	0.0	0.1	0.2	0.0	0.0	1.7	0.0	0.3	1.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122814-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 116.7"	"Cell line enhanced"	"Detected in some"		"BJ: 8.3;CACO-2: 7.1;fHDF/TERT166: 7.4;Hep G2: 32.8;HHSteC: 6.8;SH-SY5Y: 16.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	16000000000	16000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	8.1	3.7	0.3	2.9	0.7	0.0	5.4	0.4	0.8	20.3	5.9	0.6	7.6	4.5	12.6	21.4	4.5	9.9	10.0	18.4	0.5	0.5	2.3	116.7	4.9	1.6	0.5	0.7	18.2	3.0	0.0	1.7	3.6	1.0	18.1	0.7	6.9	2.0	6.1	2.6	7.8	7.6	11.7	0.6	1.3	3.2	9.5	0.6	0.6	3.1	5.6	1.8	7.8	10.3	0.0	0.0	0.0	0.0	0.9	1.0	0.3	0.0	0.0	1.4	0.2	4.8	4.9	0.0	8.3	6.6	0.5	0.2	7.1	0.0	0.0	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	32.8	6.8	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.8	0.5	0.5	0.5	0.7	1.0	0.6
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186265945-186288806	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 88.9"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 13.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039808			Approved	Vesicles	"Secreted to blood"	4400000000	4400000000	Vesicles	Vesicles	"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favourable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	2.7	0.1	0.1	5.5	0.2	0.3	0.1	0.1	4.8	0.1	0.1	0.1	10.2	88.9	2.8	0.1	0.1	0.1	0.1	19.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.1	6.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369112-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 83.2;lung: 153.7"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.7;MCF7: 2.2;U-2197: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	33000000000	33000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	7.2	5.0	0.1	1.7	0.2	0.0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1.0	0.5	0.5	25.0	0.4	0.0	13.0	83.2	153.7	1.0	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1.0	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.8	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.8	0.4	0.6	0.0	1.0	0.0	0.4	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	1.1	0.2
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 44.4"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		580000	580000	Cytosol	Cytosol	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	44.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2
GGCX	VKCFD1	ENSG00000115486	"Gamma-glutamyl carboxylase"	P38435	2	85544723-85561547	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 74.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018284	Approved									"HPA018284: AB_1849641"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (1.82e-6)"	"unprognostic (5.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.23e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.38e-2)"	7.1	7.8	4.8	4.2	6.3	1.6	10.8	6.3	6.6	6.4	4.9	5.4	8.3	4.0	6.3	8.1	6.5	5.9	7.0	6.8	5.4	3.6	9.0	74.8	8.1	5.4	5.4	5.0	7.0	11.4	15.1	5.6	13.8	5.9	6.3	5.5	5.8	7.4	7.9	6.8	4.9	5.5	7.2	5.1	4.5	6.0	3.6	5.7	3.4	8.5	5.3	5.4	7.3	6.0	0.9	4.9	6.0	7.2	2.2	3.2	3.2	6.8	11.1	7.9	8.8	40.0	11.4	17.6	12.2	14.4	9.0	12.8	19.0	8.4	2.4	12.5	20.0	11.1	5.6	15.4	10.0	4.3	7.7	4.4	7.4	18.0	14.9	2.7	4.2	14.1	9.1	18.2	12.5	12.7	5.3	3.6	26.1	8.9	1.4	2.1	3.7	9.6	2.6	18.6	6.1	12.5	13.1	3.0	5.0	10.9	21.6	11.3	10.5	2.7	11.6	11.6	10.2	11.2	8.3	2.8	7.8	2.0	11.1	2.8	16.2	6.0	7.2	3.6	3.2	7.2	3.0	0.7	1.3	1.2	4.9	0.9	3.2	3.0	3.2	2.2	4.4	4.0	1.9	3.2	4.8	6.3	6.3	6.6	5.4	3.6	5.4	5.0	5.9	5.7
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Group enriched"	"Detected in some"	5	"HSkMC: 13.3;T-47d: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	21000000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.0	2.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.3	4.3	0.0	0.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.1	33.9	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.5	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52293476	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 108.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.9;Hep G2: 25.1"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"				Cytosol	Cytosol	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	6.4	4.9	1.9	8.4	5.0	5.2	4.8	2.7	6.2	2.3	7.9	7.1	4.2	23.8	4.3	4.8	2.8	2.5	7.2	2.7	1.9	2.2	10.7	108.4	3.1	6.5	2.5	4.9	2.3	3.6	1.9	2.5	3.1	3.9	2.8	3.5	4.7	3.2	3.0	7.0	1.9	17.8	1.9	1.8	5.5	6.0	2.7	1.8	3.3	3.1	2.4	5.9	2.7	2.2	8.3	9.1	10.9	9.5	5.7	11.8	6.3	2.2	5.5	3.0	1.1	16.0	2.2	1.8	2.5	2.6	4.7	3.5	18.9	1.9	5.9	1.5	2.2	1.5	1.7	6.2	0.9	1.6	1.9	8.3	6.7	25.1	1.5	2.7	5.0	2.1	3.1	6.9	2.7	9.0	2.2	4.3	3.6	1.7	4.6	2.2	1.6	4.6	1.5	2.7	8.9	4.8	3.1	2.2	2.2	2.4	1.3	2.5	3.1	1.3	3.8	3.7	4.4	2.4	4.8	4.5	3.1	3.8	2.5	4.5	2.8	3.0	9.5	10.9	11.8	5.1	6.1	8.3	9.0	10.3	9.1	5.7	6.8	10.1	7.8	5.7	6.1	5.6	11.7	6.3	1.9	5.0	2.7	6.2	1.9	2.2	2.5	4.9	3.9	1.8
GPR182	"ADMR, AM-R, G10D, hrhAMR"	ENSG00000166856	"G protein-coupled receptor 182"	O15218	12	56994446-56998441	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"liver: 9.5;lymphoid tissue: 29.1;testis: 12.9"	"Cell line enhanced"	"Detected in some"		"A549: 2.2;RH-30: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027037	Enhanced									"HPA027037: AB_1844622"	"unprognostic (6.13e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.10e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.94e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.34e-3)"	0.4	3.2	0.0	0.8	0.0	0.0	0.6	0.1	0.3	0.7	0.4	0.0	0.6	0.0	1.2	0.7	1.3	0.7	0.1	0.3	0.0	0.0	1.3	9.5	1.9	7.5	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.3	0.3	0.7	0.0	29.1	0.2	12.9	0.0	0.2	1.4	0.3	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	1.3	1.0	0.7	0.0	0.0	0.3	6.2	0.0	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.4	0.3	0.0	0.4	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 135.4"	"Cell line enriched"	"Detected in some"	6	"RPTEC TERT1: 33.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	3200000000	3200000000			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.6	0.3	0.0	0.4	26.4	0.4	0.0	0.0	20.9	135.4	0.2	0.0	0.0	0.0	0.8	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628173-120682571	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 176.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.1;EFO-21: 23.3;Hep G2: 44.9;RPTEC TERT1: 58.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 119.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		210000	210000	"Golgi apparatus"	"Golgi apparatus"	"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.2	0.2	0.2	0.6	0.6	0.0	1.8	0.2	0.5	3.7	7.2	0.3	1.4	4.7	0.6	4.0	0.2	0.4	11.5	0.3	0.2	0.1	33.3	176.7	0.7	0.3	0.2	0.2	0.3	6.9	0.0	0.4	0.3	0.3	6.7	2.7	5.9	3.3	1.0	0.4	0.3	15.0	0.3	0.4	0.3	3.9	0.3	0.2	0.2	8.1	0.3	0.3	0.2	0.2	0.0	0.3	2.8	0.4	0.0	0.0	5.1	0.0	2.9	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.1	3.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	44.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	5.1	0.2	0.6	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 267.5"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 104.7"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enriched"	"Detected in single"	29	"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	4	"eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;granulocytes: 9.8"	"Region enriched"	"Detected in single"	8	"amygdala: 0.4"	"Low region specificity"	"Detected in many"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		23000000	23000000	"Nuclear speckles"	"Nuclear speckles"	"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	0.1	0.5	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.2	0.1	2.1	0.3	0.0	0.3	0.4	0.1	0.7	0.2	0.3	0.4	0.0	51.3	267.5	0.2	0.4	0.1	0.0	0.7	0.7	0.0	0.1	0.0	13.7	0.5	0.0	3.8	0.0	0.8	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.1	5.0	9.8	1.4	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	104.7	2.5	0.3	3.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.8	9.8	0.0	1.0	0.1	0.1	0.1	0.1	1.3	0.1	0.3	0.2	4.8	0.0	1.4	5.0	0.0	0.3	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.0	13.7	0.1
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA051811: AB_2681621, HPA054591: AB_2682535"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.6	0.0	0.6	13.7	0.4	0.0	1.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.1	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	6.3	2.2	0.0	0.3	0.0	2.5	0.4	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 17.7;SK-MEL-30: 17.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0.0	0.0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0.0	0.0	2.7	31.6	2.2	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	2.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	17.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.6	1.3	0.0	0.0	0.5	17.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0.0
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938210-1943326	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 195.6;liver: 94.8;pancreas: 107.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 85.8;neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 195.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: "	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	7.9	4.0	5.2	9.0	6.3	27.3	5.1	3.2	6.1	5.2	13.1	5.6	7.5	8.7	7.9	13.5	16.9	9.6	13.5	13.7	4.7	4.1	24.9	94.8	9.6	15.6	5.5	4.1	7.3	107.2	2.9	3.9	11.6	4.1	11.0	5.1	6.2	4.7	9.4	20.5	8.0	17.0	14.3	4.3	18.2	9.6	8.1	3.6	3.7	5.5	19.8	4.5	14.8	4.8	1.7	10.9	195.6	26.2	2.4	2.8	12.2	6.6	17.0	6.3	14.9	11.8	5.2	10.8	8.3	10.4	12.1	10.5	27.2	7.4	6.5	27.1	9.5	11.0	10.5	7.2	3.8	36.3	11.9	5.0	6.3	43.4	10.8	14.1	11.9	9.6	6.4	8.7	1.7	12.1	7.8	3.6	6.4	36.8	7.9	23.2	8.6	9.7	11.6	8.7	30.5	18.9	11.2	6.1	8.1	9.3	10.4	5.0	11.3	25.1	7.2	3.7	10.2	7.2	4.8	9.6	15.2	12.4	3.8	13.4	6.4	26.0	26.2	85.8	2.2	12.0	2.1	1.7	1.8	1.8	10.9	1.7	1.4	1.6	195.6	2.4	10.7	4.6	2.8	12.2	5.2	6.3	3.2	6.1	4.7	4.1	5.5	4.1	4.1	3.6
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666731-56668065	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	10.1	1.0	11.7	10.4	50.7	0.7	2.8	1.1	27.4	1.0	78.1	3.1	1.9	49.6	1.5	15.9	21.7	4.6	23.2	0.9	25.1	7.6	210.7	396.4	2.4	7.0	23.6	11.3	0.6	217.1	0.4	1.0	0.6	46.9	21.6	48.9	22.4	2.4	1.0	0.6	2.9	101.1	7.9	7.7	0.5	47.4	0.6	3.6	0.0	278.4	1.9	1.8	2.4	1.2	0.1	1.1	0.7	1.1	0.3	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.4	0.6	0.1	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.5	34.8	0.0	0.0	0.0	0.1	9.9	5.8	0.0	3.1	0.4	0.0	0.1	0.1	0.0	15.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	152.3	0.0	0.7	1.1	0.3	1.5	1.1	1.4	0.1	1.7	2.6	1.1	0.0	1.6	2.9	0.1	0.3	0.5	0.3	2.8	1.5	11.7	50.7	1.1	27.4	25.1	7.6	23.6	11.3	46.9	3.6
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		250000	250000	Cytosol	Cytosol	"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: "	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.1	41.1	15.6	34.0	16.8	13.7	25.3	28.3	19.5	36.8	36.5	39.9	33.3	30.4	13.4	16.8	35.5	48.2	28.2	43.1	30.1	31.7	37.6	41.2	30.2	12.4	28.8	20.5	10.7	9.1	32.8	17.8	22.9	28.0	25.0	27.8	59.9	46.4	16.9	28.6	43.6	37.1	54.3	27.5	27.6	42.3	33.8	13.1	47.4	25.8	14.2	40.1	14.6	14.1	27.8	48.1	25.5	33.9	16.7	20.5	53.5	25.4	33.4	31.4	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192592-36242279	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 128.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced					28000	28000			"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	5.7	10.2	13.7	4.1	12.5	4.4	6.8	6.7	13.4	6.6	6.0	13.3	5.9	7.0	5.9	4.1	4.9	6.0	5.5	8.3	14.3	8.5	10.0	128.6	4.0	4.2	11.6	12.0	8.8	12.2	4.8	3.1	7.2	11.6	9.5	6.2	3.9	5.6	7.7	11.1	3.3	5.5	24.8	20.3	3.8	7.6	7.3	11.4	2.5	7.6	3.5	5.1	15.2	5.9	5.1	3.3	9.1	4.2	9.5	3.2	1.7	8.9	5.9	9.0	10.3	13.8	11.8	12.3	8.4	5.6	7.8	5.7	16.5	11.3	32.2	6.3	9.6	6.3	8.4	6.1	10.8	8.9	7.4	8.6	17.4	9.6	10.1	18.7	3.5	12.9	9.5	8.5	12.9	8.1	22.7	11.6	7.7	3.6	17.4	7.2	5.0	8.5	16.9	22.3	6.9	9.9	7.7	4.0	9.2	43.4	13.8	4.5	9.8	16.4	6.1	15.1	8.2	11.3	10.0	10.5	12.7	9.5	6.4	24.3	5.9	9.1	2.0	1.9	2.1	2.0	2.7	2.2	3.2	2.5	3.3	5.1	2.7	2.2	0.1	9.5	4.2	1.5	2.9	1.7	13.7	12.5	6.7	11.4	14.3	8.5	11.6	12.0	11.6	11.4
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968632-84002776	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 30.6;brain: 42.5;kidney: 12.4;liver: 15.1"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;SCLC-21H: 28.6;U-87 MG: 10.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 30.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA013998, HPA014144, CAB068211"	Enhanced	Supported								"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	1.8	1.1	34.1	1.3	42.5	1.3	0.9	0.2	35.2	0.7	1.1	2.2	0.0	1.9	2.2	0.9	0.7	0.7	1.3	1.0	9.5	21.7	12.4	15.1	1.0	0.8	5.0	14.0	0.7	2.1	1.6	3.3	0.9	7.4	0.8	0.9	0.1	0.6	0.8	0.5	0.7	1.7	1.2	1.9	1.1	2.8	5.4	5.9	0.0	0.8	0.0	0.5	1.1	0.0	0.0	0.0	30.6	0.4	0.0	0.0	0.0	0.1	3.7	7.5	0.0	0.0	1.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.2	0.1	0.0	1.3	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.1	0.0	1.2	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.0	4.3	0.0	0.0	3.9	0.5	0.0	0.0	0.4	0.0	0.0	28.6	1.2	0.0	0.1	2.2	3.8	1.3	0.2	0.1	2.2	0.3	0.0	0.1	0.0	0.0	10.1	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	34.1	42.5	0.2	21.2	9.5	21.7	5.0	14.0	7.4	5.9
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241808825-241817413	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 27.1;liver: 42.9"	"Group enriched"	"Detected in some"	21	"Hep G2: 22.0;HMC-1: 30.7"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037394	Enhanced									"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.6	0.5	6.5	0.7	5.3	5.7	0.3	1.9	7.0	0.6	13.9	4.9	0.0	9.3	0.3	0.3	0.7	1.1	2.6	0.6	6.4	5.8	1.4	42.9	0.4	0.5	6.9	4.4	0.4	0.3	0.3	0.4	0.4	3.8	0.5	6.1	0.0	0.4	0.4	3.6	0.3	27.1	0.4	4.1	0.5	0.5	0.6	2.3	0.0	0.4	2.8	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	5.3	1.9	4.0	6.4	5.8	6.9	4.4	3.8	2.3
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541315	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 77.0;liver: 29.8"	"Group enriched"	"Detected in some"	7	"CACO-2: 6.7;Hep G2: 16.8;SCLC-21H: 14.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Low region specificity"	"Detected in all"			"CAB070127, CAB070128"	Enhanced									"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.5	0.1	0.1	0.0	0.2	0.0	0.4	0.5	0.2	0.3	42.0	0.0	0.0	30.5	0.4	0.3	0.3	0.3	11.4	0.1	0.1	0.1	0.7	29.8	0.2	0.0	0.1	0.0	0.5	1.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	77.0	0.0	0.1	0.1	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		3300000	3300000	Mitochondria	Mitochondria	"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.4	3.1	0.9	5.8	3.6	3.7	14.8	6.8	8.2	5.7	9.3	5.1	6.3	13.9	0.8	10.5	8.0	6.0	8.8	4.7	7.1	0.2	2.5	1.7	27.2	34.9	4.8	11.0	4.3	33.9	3.6	8.8	4.6	7.1	25.8	2.2	23.7	1.2	2.4	1.0	4.1	2.8	3.4	7.9	1.7	8.5	3.7	5.9	5.2	6.8	32.1	9.1	7.5	0.8	1.2	6.6	1.8	1.9	17.7	5.5	3.4	3.5	7.7	3.0	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen-like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in many"	5	"liver: 66.8"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"						"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	0.3	1.3	2.0	0.7	3.4	1.7	0.7	14.3	2.1	0.4	0.5			0.7	1.3	2.1	0.3	0.8	1.0	0.6	1.9	2.1	1.0	66.8	0.6	1.5	1.4		1.5	0.4	0.7	1.6	0.3		1.0	0.3		1.1	0.5	1.9	3.4	0.8	0.2	1.1	1.3	0.7	0.8			1.1		0.5	0.7	0.5	2.7	1.6	5.1	0.8	0.9	2.7	0.4	3.0	4.3	4.8	2.6	4.6	5.4	5.1	3.4	2.5	2.1	2.8	3.3	7.7	7.7	3.5	1.2	2.6	1.3	0.6	2.1	9.2	3.6	6.6	6.4	3.5	3.1	4.1	1.6	5.6	4.6	5.6	5.7	0.9	3.2	6.6	2.6	4.4	13.4	11.4	6.9	2.7	2.2	2.1	4.5	4.7	3.1	3.8	4.2	2.9	2.6	3.0	1.3	7.1	5.5	3.9	2.5	2.2	2.1	7.0	5.4	3.4	2.1	5.5	2.6	5.1	0.4	0.9	1.9	0.2	1.2	2.7	2.0	1.4	0.2	2.2	2.7	1.6	1.9	0.9	0.8	1.6	2.6	0.4										
PRAMEF15		ENSG00000204501	"PRAME family member 15"	Q5VWM5	1	13315581-13322598	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"liver: 2.2"	"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429246	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 137.5"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 57.5"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 29.2"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005550, CAB016721, CAB016792"	Supported				"Secreted to blood"	6400000000	6400000000			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.2	4.2	137.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.4	29.2	3.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.3	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	2.7	57.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	29.2	0.0	0.1	0.4	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.4	0.0
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.7;RH-30: 8.3;SH-SY5Y: 40.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000842, HPA001030"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA000842: AB_2666112, HPA001030: AB_2666177"	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.3	0.0	15.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.8	2.7	0.0	0.2	0.0	0.2	0.0	0.8	0.7	0.0	8.3	1.2	0.1	0.2	1.2	40.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158654-113172383	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 45.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.8;Hep G2: 7.6"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;T-reg: 1.5"	"Group enriched"	"Detected in many"	12	"monocytes: 2.7;T-cells: 1.5"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	510000000	510000000			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	9.3	45.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	2.7	0.0	1.5	0.2	0.9	1.4	0.7	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	3.0	1.8	0.8	0.0	0.0	4.8	0.0	0.0	0.0	0.8	2.4	1.0	2.8	7.6	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	1.0	0.6	0.8	1.8	0.4	1.3	0.2	0.3	0.0	1.1	2.9	0.2	0.0	0.3	1.3	0.0	1.0	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0.0	0.0	0.0	0.3	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRSS51		ENSG00000253649	"Serine protease 51"	A0A1B0GVH4	8	10482878-10547585	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;CAPAN-2: 1.6;T-47d: 1.9;U-2 OS: 5.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted - unknown location"						"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	0.0	0.0		0.0		0.4	3.4		1.4	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	1.5	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.1	0.0	2.3			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2										
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 33.6;PC-3: 6.8;SCLC-21H: 8.2;SH-SY5Y: 8.9;TIME: 19.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046512			Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to extracellular matrix"	59000000	59000000	"Focal adhesion sites"	"Focal adhesion sites"	"HPA046512: AB_2679679"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.2	0.0	0.1	0.0	0.0	2.4	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	0.0	8.2	8.9	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 51.0;liver: 118.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.1;fHDF/TERT166: 5.1;Hep G2: 24.1"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103"	Enhanced		Approved	Nucleoplasm		47000	47000	Nucleoplasm	Nucleoplasm	"HPA029102: AB_10599846, HPA029103: AB_10602097"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favourable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	2.6	51.0	6.7	0.6	6.5	0.4	1.5	8.4	6.2	2.8	1.9	6.2	2.5	4.5	2.3	6.1	1.5	1.7	2.0	4.5	6.1	4.2	17.6	118.8	4.9	0.7	5.9	4.5	7.5	12.7	6.2	2.5	4.2	5.0	4.8	1.1	8.4	7.5	6.3	3.8	0.6	4.6	4.9	4.4	1.1	2.9	1.5	5.2	0.0	6.5	1.6	0.6	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.3	0.6	0.0	0.0	16.1	0.0	0.0	0.8	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.1	0.8	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	6.5	8.4	6.2	6.1	4.2	5.9	4.5	5.0	5.2
RPRD1B	"C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60"	ENSG00000101413	"Regulation of nuclear pre-mRNA domain containing 1B"	Q9NQG5	20	38033546-38127780	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 113.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066290, HPA072645"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA066290: AB_2685650, HPA072645: "	"unprognostic (3.14e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.47e-1)"	8.8	9.4	7.5	14.5	8.3	20.9	9.6	9.8	10.0	9.0	10.2	12.5	11.4	7.3	12.9	10.7	10.7	11.5	10.4	16.4	7.6	6.5	10.2	113.9	8.9	13.4	7.9	7.6	10.5	16.2	13.7	8.6	9.4	8.3	10.7	8.6	11.0	9.1	15.5	24.3	9.6	10.2	9.6	7.5	10.7	9.1	10.2	7.2	11.4	10.4	8.4	19.3	12.7	9.0	5.5	8.3	7.3	10.7	5.6	8.9	6.3	15.5	7.0	13.4	6.8	8.7	12.1	13.8	11.2	9.0	12.6	11.3	35.9	14.7	13.0	16.4	7.4	18.7	11.9	18.2	15.1	6.1	6.8	21.9	9.2	17.9	10.5	16.6	7.5	9.4	18.1	13.0	15.2	7.9	19.1	10.5	9.5	11.0	24.6	11.9	7.7	14.9	15.8	27.3	13.1	6.8	13.0	14.7	10.1	19.4	29.1	13.6	15.5	15.1	9.1	25.5	15.0	9.5	12.3	13.1	12.3	23.9	15.1	9.7	8.3	0.7	8.3	7.3	7.0	9.4	8.9	5.5	6.8	6.3	8.3	5.1	8.7	7.8	6.7	5.6	10.7	4.4	4.0	6.3	7.5	8.3	9.8	10.0	7.6	6.5	7.9	7.6	8.3	7.2
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	10.0	17.9	4.2	2.6	2.6	1.5	1.8	1.0	2.6	2.3	5.3	5.8	11.3	6.4	1.7	1.6	15.9	3.3	5.5	0.9	7.9	2.2	2.6	1.4	13.8	3.0	0.9	6.2	1.7	6.3	3.4	2.8	9.5	3.0	1.8	2.4	5.0	3.8	1.6	1.7	1.4	1.8	1.4	1.1	2.2	2.8	0.2	1.1	3.1	1.8	1.4	4.8	1.4	3.5	1.5	3.5	2.4	1.5	3.2	6.6	0.4	4.4	2.3	0.7	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40810111	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 26.0;liver: 66.4;pancreas: 24.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042146	Approved									"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (5.46e-4)"	1.0	1.1	1.4	4.7	1.7	1.6	2.6	1.0	2.0	1.3	13.2	1.0	0.2	16.3	1.6	1.5	1.8	1.2	3.1	1.9	1.3	1.6	4.0	66.4	1.6	2.0	1.6	0.9	1.8	24.9	0.8	1.0	1.8	1.5	1.0	2.6	0.9	1.4	1.6	2.5	1.3	26.0	1.5	1.4	1.5	2.0	3.8	1.0	2.7	8.0	2.9	3.8	1.2	1.1	1.7	3.4	0.0	3.1	2.4	5.0	1.6	5.0	9.9	9.8	13.5	3.6	4.8	12.5	3.7	1.9	4.2	2.7	10.5	9.7	32.0	4.3	6.2	8.2	15.4	10.2	3.7	7.6	7.7	24.2	4.9	13.6	6.9	8.6	3.1	5.2	4.5	5.3	13.0	6.5	12.4	5.1	6.5	16.3	6.4	3.8	21.2	5.1	15.8	8.1	6.9	5.1	4.6	5.5	13.6	6.9	10.9	5.9	9.1	12.8	6.2	5.3	8.5	8.1	10.7	5.8	5.5	18.8	5.6	7.0	10.6	0.0	1.3	0.0	4.3	3.1	2.7	1.6	2.9	2.8	3.4	1.7	3.0	5.0	0.0	2.4	1.0	0.7	1.8	1.6	1.4	1.7	1.0	2.0	1.3	1.6	1.6	0.9	1.5	1.0
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 33.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HEL: 2.2;Hep G2: 4.2;K-562: 2.7"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced									"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.3	0.3	2.9	0.7	3.5	0.4	0.3	1.8	3.9	0.3	7.1	1.9	0.0	5.9	0.3	0.3	0.3	0.3	0.5	0.3	3.5	1.6	0.3	33.4	0.3	0.3	1.7	1.7	0.6	0.3	0.3	0.4	0.4	2.5	0.3	1.7	0.6	0.3	0.3	0.3	0.3	6.8	0.3	0.8	0.3	0.3	1.9	1.9	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	2.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.5	1.8	3.9	3.5	1.6	1.7	1.7	2.5	1.9
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 107.8"	"Group enriched"	"Detected in some"	4	"Hep G2: 31.7;SCLC-21H: 10.5"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"					"Cell type enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol				Cytosol	Cytosol	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	0.7	0.3	3.4	0.3	5.2	0.5	0.7	2.4	10.5	0.3	0.3	10.3	0.0	0.7	0.4	0.4	0.6	0.4	0.4	2.0	4.1		1.5	107.8	0.3	0.4	3.4	4.0	2.4	11.6	1.8	0.7	0.6	7.8	0.4	0.3	22.2	0.9	0.3	10.4	0.5	0.4	0.3	4.7	0.3	0.9	0.7	5.2	0.0	0.6	1.9	0.4	0.3	0.0	1.1	1.0	5.6	0.8	1.5	0.8	0.2	0.0	0.0	0.8	4.8	0.0	0.0	1.2	0.0	0.0	0.9	0.4	2.9	0.1	0.1	0.8	0.0	0.0	1.2	0.0	0.6	0.1	0.4	0.0	0.6	31.7	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.4	0.5	0.0	0.4	0.3	0.0	0.1	0.2	10.5	0.9	0.5	0.1	0.0	1.3	0.2	0.0	0.2	0.9	0.0	0.6	0.3	0.0	0.1	0.1	0.2	0.1	5.6	0.8	0.9	0.6	0.2	0.4	0.7	0.5	0.4	0.2	1.1	0.6	0.8	3.3	1.5	0.2	1.0	0.4	0.2										
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515786	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 27.0;liver: 91.8;pancreas: 100.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.5;NB-4: 27.9;U-937: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"	"Golgi apparatus, Vesicles, Plasma membrane"	"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favourable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (7.30e-2)"	4.7	3.3	0.8	2.2	0.8	9.3	7.4	0.7	1.3	6.0	4.8	0.9	3.9	2.5	5.0	6.8	4.1	3.3	27.0	3.2	0.7	0.6	3.4	91.8	2.9	3.3	0.8	1.1	6.5	100.5	0.1	1.3	1.8	0.7	6.2	2.8	11.4	14.9	2.1	7.5	5.6	2.6	7.0	0.9	2.5	7.6	3.1	0.7	0.8	7.4	2.9	3.1	7.6	3.5	3.1	8.2	8.1	6.0	6.9	11.1	5.2	0.4	0.6	0.7	7.9	10.3	7.6	0.1	4.1	5.3	1.2	3.0	2.5	1.1	22.7	1.0	3.0	0.3	7.0	0.4	1.5	1.1	1.8	11.7	0.2	23.5	13.6	20.4	2.9	9.6	1.7	2.0	9.2	5.2	16.3	4.2	1.5	0.8	0.1	27.9	2.6	5.3	19.4	3.9	10.1	0.2	0.0	9.3	1.4	0.7	0.1	9.1	0.6	10.4	2.1	1.2	2.9	10.4	0.6	4.8	1.5	13.3	0.6	26.9	1.6	8.1	6.0	0.7	11.1	2.4	9.5	3.1	5.2	8.0	8.2	1.7	5.1	7.2	0.5	6.9	0.1	1.9	9.1	5.2	0.8	0.8	0.7	1.3	0.7	0.6	0.8	1.1	0.7	0.7
SPRYD4	DKFZp686N0877	ENSG00000176422	"SPRY domain containing 4"	Q8WW59	12	56468567-56479707	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 58.4"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053469	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053469: AB_2682162"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavourable (8.85e-5)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-3)"	"prognostic favourable (4.52e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-1)"	3.8	9.6	3.3	6.0	4.6	4.4	6.2	4.2	6.1	3.8	5.1	6.0	6.7	4.2	4.5	6.3	7.1	3.8	7.4	7.2	3.6	3.6	12.0	58.4	3.1	3.5	4.4	4.3	4.9	12.3	5.0	7.0	4.3	3.7	5.2	6.5	5.8	8.2	6.3	10.5	4.6	6.4	4.3	3.3	4.8	5.0	2.6	3.3	3.8	7.6	7.3	6.1	5.2	4.1	4.6	5.0	3.8	3.8	4.8	3.2	2.5	2.7	3.7	3.2	2.5	2.8	1.8	4.3	2.3	2.3	4.8	2.9	3.4	4.9	3.4	3.1	2.9	4.8	2.7	3.9	3.0	1.7	5.6	5.0	3.8	5.0	2.7	3.4	5.0	4.0	2.6	3.5	2.9	4.9	2.7	14.9	4.0	4.5	1.6	2.4	2.1	4.2	2.0	2.4	7.1	5.1	3.5	3.2	1.5	4.4	5.3	3.4	9.0	1.0	2.3	2.1	3.9	3.0	1.8	2.5	1.4	1.2	1.7	2.9	2.6	3.8	3.8	2.0	3.0	3.0	3.2	3.8	2.8	3.0	3.3	4.6	3.2	3.2	3.8	4.8	3.2	5.0	1.2	2.5	3.3	4.6	4.2	6.1	3.6	3.6	4.4	4.3	3.7	3.3
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 82.3;parathyroid gland: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.9;U-87 MG: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		28000	28000	Cytosol	Cytosol	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	8.1	2.8	2.5	1.2	4.2	5.1	9.2	3.0	2.2	6.4	6.1	3.0	3.7	7.9	1.3	3.1	5.1	4.0	2.8	6.6	2.9	1.4	3.4	82.3	3.9	4.9	3.9	0.4	5.2	9.0	47.4	5.1	4.3	6.1	4.8	2.4	2.1	12.6	9.1	10.9	3.0	9.8	0.9	6.4	1.0	6.7	1.5	3.2	0.2	3.3	6.9	4.0	4.2	3.7	0.8	7.0	0.7	4.3	2.1	0.2	1.5	6.5	7.9	0.0	2.7	3.9	36.9	7.0	2.1	2.3	4.2	3.8	6.0	9.0	0.0	15.9	11.9	11.2	3.4	6.9	4.7	0.0	11.2	12.8	7.1	11.7	9.7	3.1	2.4	21.8	12.2	24.7	8.9	3.6	6.2	1.3	11.7	6.2	0.0	1.8	10.8	16.5	0.0	4.6	5.6	5.1	16.7	13.3	2.4	5.8	20.2	1.5	4.0	4.2	15.3	26.0	15.3	5.5	11.4	0.0	0.0	0.0	47.8	8.1	5.4	0.0	4.0	0.7	0.2	4.3	0.0	0.8	0.0	0.0	7.0	0.2	0.0	0.0	0.1	2.1	0.6	0.3	0.0	1.5	2.5	4.2	3.0	2.2	2.9	1.4	3.9	0.4	6.1	3.2
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870466-47886397	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 211.7"	"Group enriched"	"Detected in some"	34	"Hep G2: 26.0;RT4: 17.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		210000	210000	Cytosol	Cytosol	"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	46.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0.0	0.1	0.1	3.9	0.1	0.0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1.0	5.3	0.8	2.3	1.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	26.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.2	0.0	17.7	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1.0	0.6	0.3	1.3	1.3	1.0	3.1	2.3	0.4	1.0	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;EFO-21: 20.8;HaCaT: 74.4;RT4: 37.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009819, HPA054065"	Enhanced									"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.4	0.0	20.8	0.0	74.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	37.6	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in some"	5	"EFO-21: 20.5;RPTEC TERT1: 81.6"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain									"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favourable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	81.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;REH: 1.5"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.1	1.2	1.3	1.5	0.3	0.0	0.3	0.6	0.7	0.4	0.5	0.5	0.0	0.8	0.2	0.0	0.2	0.3	0.0	0.0	1.3	0.1	0.4	0.4	1.3	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0
USH2A	"RP39, USH2"	ENSG00000042781	Usherin	O75445	1	215622894-216423396	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"liver: 13.7;retina: 36.6"	"Group enriched"	"Detected in some"	4	"AF22: 1.5;SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.38e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.62e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.28e-11)"	"unprognostic (2.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.09e-4)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	0.1	0.2	0.3	13.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.1	0.1	0.5	0.0	0.0	36.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.1	0.2	0.1	0.0	0.5	0.0
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132681590-132714049	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 131.9;liver: 112.2"	"Cell line enhanced"	"Detected in some"		"A-431: 4.0;CAPAN-2: 4.2;EFO-21: 14.8;HBEC3-KT: 3.9;LHCN-M2: 4.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 13.4"	"Group enriched"	"Detected in many"	71	"dendritic cells: 4.9;granulocytes: 8.0;monocytes: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064145	Uncertain				"Intracellular and membrane"	1100000000	1100000000			"HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	1.8	0.4	0.3	0.6	0.3	2.4	0.7	0.2	0.3	0.4	128.6	0.1	0.0	40.6	2.5	0.2	0.6	1.7	27.0	1.1	0.3	0.3	6.5	112.2	7.9	2.4	0.4	0.1	0.4	0.9	0.0	0.3	1.0	0.5	0.4	0.3	0.2	1.5	0.1	0.4	0.5	131.9	0.0	0.5	5.6	0.8	0.5	0.1	0.2	0.4	0.0	0.4	0.4	0.9	0.1	4.9	8.0	13.4	0.0	0.0	3.6	4.0	0.0	0.5	0.1	0.1	1.3	0.9	0.3	0.3	0.0	0.0	0.1	4.2	0.2	14.8	0.0	0.1	0.0	3.9	1.0	0.1	0.0	0.2	0.2	2.3	2.3	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.2	0.0	0.6	0.1	0.2	0.1	0.2	1.7	0.9	0.3	0.2	0.6	0.1	0.0	0.0	0.0	0.0	2.6	1.0	0.1	0.4	0.2	0.4	0.0	0.1	0.4	0.1	0.6	2.3	13.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	8.0	0.0	10.2	0.2	0.0	3.6	0.3	0.3	0.2	0.3	0.3	0.3	0.4	0.1	0.5	0.1
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.1	5.4	16.4	0.0	3.2	12.8	5.9	5.6	2.7	3.2	3.3	5.2	0.6	0.0	0.9	6.2	1.9	7.3	2.6	2.3	0.0	6.3	0.0	6.1	8.8	2.6	0.0	2.4	5.2	1.6	2.6	3.4	3.0	0.9	0.1	12.3	5.5	2.6	0.1	12.4	4.9	0.0	5.1	0.0	2.9	9.8	13.2	15.5	4.4	1.1	5.4	0.0	1.0	2.0	8.3	8.9	9.3	8.7	0.0	0.0	0.0	8.3	0.0	9.7	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		3200000	3200000	Mitochondria	Mitochondria	"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favourable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.7	13.9	23.2	21.2	30.7	16.2	11.8	7.1	11.6	12.0	9.3	29.5	12.0	12.4	15.2	26.1	0.9	38.6	4.5	11.9	37.9	9.1	8.8	18.1	34.9	14.5	0.1	16.6	21.4	1.5	19.4	6.1	19.6	7.6	11.7	33.2	16.0	0.5	19.1	21.0	5.6	30.4	49.6	45.4	40.5	0.6	33.3	26.4	0.5	16.3	1.1	9.2	12.8	9.3	10.2	12.9	15.4	7.7	23.8	27.4	31.6	7.3	17.9	9.3	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041458	Enhanced		Supported	Mitochondria		63000	63000	Mitochondria	Mitochondria	"HPA041458: AB_2677491"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favourable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.5	6.8	5.1	9.3	7.0	8.7	4.5	5.9	12.0	5.9	6.0	6.0	3.1	10.0	4.1	5.0	4.0	7.9	4.1	9.9	6.5	8.2	5.2	2.1	34.6	4.9	7.3	5.0	6.4	4.2	3.7	3.4	5.7	5.0	7.4	7.4	4.4	7.0	6.1	3.1	4.3	8.3	10.7	3.1	8.5	10.6	1.0	5.9	9.1	2.7	9.3	8.3	3.6	6.0	3.2	2.9	7.4	7.1	8.3	9.4	5.3	5.0	7.0	2.4	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.2;ASC TERT1: 20.2;fHDF/TERT166: 6.6;Hep G2: 7.8;HSkMC: 13.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		190000	190000	Vesicles	Vesicles	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.2	20.2	3.5	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.8	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 51.9;placenta: 104.9"	"Cell line enhanced"	"Detected in many"		"A549: 25.2;Hep G2: 23.5;hTERT-HME1: 23.9;HUVEC TERT2: 46.1;MCF7: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 3.5"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					70000000	70000000			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.6	1.4	1.1	4.1	1.0	0.0	6.1	0.5	1.1	4.1	14.0	1.0	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12.0	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5.0	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0.0	3.5	0.0	0.2	0.0	0.1	0.0	4.7	25.2	0.5	2.6	0.1	0.0	0.0	6.5	1.2	5.0	3.1	20.1	14.6	0.0	5.9	3.7	11.8	0.7	6.3	8.3	0.0	1.9	1.0	4.3	23.5	4.9	4.0	0.0	0.0	10.2	0.1	23.9	46.1	0.1	0.0	2.0	43.2	0.0	0.0	0.2	5.7	0.0	2.2	4.9	2.6	10.7	0.0	0.0	1.9	8.9	4.1	4.8	0.0	1.5	0.0	2.2	2.2	3.2	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.1;HSkMC: 15.1"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		9700000	9700000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.55e-4)"	"prognostic favourable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.1	1.7	5.1	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.5	1.4	0.3	15.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.9	0.4	0.1	0.1	0.9	2.1	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1										
AL163636.2		ENSG00000259171			14	20684587-20700576	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"liver: 164.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.5;ASC TERT1: 28.9;Hep G2: 18.0;HSkMC: 12.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 12.8;memory B-cell: 4.4;myeloid DC: 6.9"	"Group enriched"	"Detected in many"	12	"B-cells: 4.4;dendritic cells: 6.9;monocytes: 12.8"																				"unprognostic (1.88e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.34e-1)"		"unprognostic (1.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.58e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.11e-2)"	34.3	2.1	1.3	6.1	1.6	0.0	33.2	1.0	1.2	29.1	18.6	2.5	13.9	9.8	22.0	21.0	16.8	13.3	26.8	9.1	2.2	1.4	21.5	164.0	14.5	5.5	3.0	1.2	35.6	18.7	1.4	3.0	4.7	2.6	35.2	14.2	11.8	40.5	16.1	7.8	9.9	15.5	19.9	4.0	3.3	22.6	15.0	1.8	0.0	9.3	11.8	8.1	28.9	30.3	4.4	6.9	0.2	12.8	0.0	0.6	3.2	1.6	0.5	1.4	0.0	13.5	28.9	0.0	1.8	4.5	0.0	1.1	0.2	1.9	0.0	0.3	6.8	0.6	0.4	0.2	0.0	4.2	0.4	0.3	0.0	18.0	1.0	0.0	0.1	12.8	1.0	0.0	0.6	0.8	0.0	7.5	1.8	0.0	0.1	0.2	0.0	0.4	0.2	1.0	1.3	0.4	0.7	0.0	0.1	3.0	1.1	1.2	1.4	0.0	1.6	2.1	0.6	1.5	0.2	1.5	1.3	0.0	2.3	0.3	2.4	0.0	12.8	0.0	0.0	0.7	0.3	4.4	0.6	0.3	6.9	0.9	0.2	0.1	0.2	0.0	0.0	1.4	0.6	3.2	1.3	1.6	1.0	1.2	2.2	1.4	3.0	1.2	2.6	1.8
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		9100	9100	Mitochondria	Mitochondria	"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favourable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.8	10.2	9.2	3.2	6.1	3.5	6.0	9.0	5.2	5.4	7.2	6.9	2.7	12.9	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.7	1.3	1.2	15.0	6.5	4.5	11.4	6.1	4.0	7.5	2.4	17.7	3.7	2.0	4.5	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	29.6	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.1	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 83.9;ASC TERT1: 43.1;HSkMC: 17.3;hTERT-HME1: 17.3"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040199, HPA040215"	Enhanced					410000	410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favourable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	83.9	43.1	0.0	1.3	2.5	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	3.8	4.7	0.0	0.1	0.0	1.0	4.2	5.6	0.1	0.0	17.3	1.0	5.5	17.3	0.0	0.0	0.0	3.8	0.1	0.0	0.0	1.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.6	2.9	2.3	0.0	0.5	0.0	0.0	0.5	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837950	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 573.5"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 247.4"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;T-cells: 2.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	220000000000	220000000000	Vesicles	Vesicles	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0.0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0.0	0.7	0.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	13.8	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	247.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	1.2	1.5	0.0	0.2	0.4	1.7	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	2.4	0.7	0.3	0.0	0.2	1.8	0.8	0.5	0.8	1.7	0.0	0.7	0.0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ARSE	"CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase E (chondrodysplasia punctata 1)"	P51690	X	2934632-2968310	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 43.0;pancreas: 99.4"	"Cell line enhanced"	"Detected in many"		"A549: 32.0;CACO-2: 19.8;Hep G2: 29.7;NTERA-2: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favourable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.2	0.1	0.9	2.4	1.1	0.0	0.4	0.3	0.7	0.8	7.9	0.7	1.3	6.5	1.1	2.3	0.3	1.3	8.4	0.4	0.9	0.8	16.6	43.0	0.8	0.2	0.6	1.0	2.5	99.4	0.0	0.4	0.7	0.7	0.4	6.4	0.6	0.2	0.9	0.2	0.1	7.8	0.5	0.6	0.2	1.2	0.7	0.6	0.2	0.2	0.3	0.2	0.2	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	32.0	3.0	0.0	0.9	1.7	0.5	1.3	2.8	1.4	1.7	19.8	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.8	0.0	2.1	0.0	0.0	29.7	0.8	0.0	0.0	3.2	0.0	1.1	0.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	14.9	0.0	0.9	0.4	0.1	3.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.7	0.9	0.8	0.6	1.0	0.7	0.6
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 102.0"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"			Vesicles	Vesicles	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.1	0.2	0.3	3.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.3	102.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 154.1"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 105.4"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 36.9;myeloid DC: 21.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 21.7;monocytes: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		4700000	4700000	"Endoplasmic reticulum, Plasma membrane"	"Endoplasmic reticulum, Plasma membrane"	"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	0.2	0.0	0.3	1.4	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0.0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	21.7	0.5	36.9	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	36.9	0.2	0.0	3.8	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1
ATOH7	"bHLHa13, Math5"	ENSG00000179774	"Atonal bHLH transcription factor 7"	Q8N100	10	68230624-68232103	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 10.4;liver: 3.9"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"cerebellum: 32.2"	"Low region specificity"	"Detected in many"			HPA027008	Uncertain									"HPA027008: AB_10600783"	"unprognostic (7.17e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.20e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.28e-4)"	"unprognostic (4.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.06e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.18e-2)"	0.4	0.4	5.5	0.2	5.7	0.3	0.4	4.9	10.4	0.5	0.7	0.2	0.0	1.4	1.1	0.9	0.3	0.4	0.4	0.4	3.9	0.9	1.6	3.9	0.2	0.2	0.5	5.0	0.3	1.5	0.2	0.2	0.2	0.2	0.3	0.5	0.0	0.4	0.4	0.5	0.3	1.6	0.5	0.2	0.3	0.7	0.8	0.5	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	13.1	0.5	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.7	4.9	10.4	3.9	0.9	0.5	5.0	0.2	0.5
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell line enhanced"	"Detected in many"		"A549: 8.9;CACO-2: 13.6;SiHa: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Supported	Vesicles	"Secreted to blood"	15000000000	15000000000	Vesicles	Vesicles	"CAB033631: AB_781932, CAB072865: , CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	8.9	0.1	0.5	1.2	0.3	0.4	0.8	4.1	1.3	1.6	13.6	2.1	0.4	0.6	4.9	3.8	0.0	1.6	0.2	0.1	0.9	0.3	0.5	1.8	4.8	1.0	0.4	3.9	0.2	0.2	1.3	0.0	0.2	0.2	1.2	0.3	0.0	0.5	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.3	0.4	0.5	0.3	1.7	0.6	0.2	0.3	1.5	1.2	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Golgi apparatus,Cytosol"		7500000	7500000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favourable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.8	9.0	9.5	12.7	9.4	8.8	7.2	7.8	12.6	9.2	11.7	9.7	11.4	8.0	7.8	10.2	17.8	6.9	19.7	7.2	7.1	9.6	7.9	5.1	18.2	13.3	10.3	13.8	12.7	37.3	13.0	21.9	6.8	11.0	5.9	15.5	4.3	9.1	8.6	5.1	9.1	10.8	9.6	9.4	26.1	12.0	6.2	8.1	25.5	6.4	6.6	11.1	12.8	8.4	12.1	6.5	7.5	5.9	11.9	14.2	9.5	18.7	8.1	9.1	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 39.8;ASC TERT1: 88.7;HSkMC: 78.7;THP-1: 125.5;U-138 MG: 37.2;U-87 MG: 37.1"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	13	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus"	"Secreted to blood"	230000000	230000000	"Golgi apparatus"	"Golgi apparatus"	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.8	88.7	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	78.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.5	0.0	37.2	0.1	0.0	0.0	0.2	4.7	0.0	37.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.4;liver: 38.8;parathyroid gland: 21.6"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 7.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6"	CAB034064	Uncertain									"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.6	0.8	5.2	0.6	8.7	0.6	0.6	3.1	14.5	0.6	0.6	11.0	0.0	0.6	0.6	0.6	0.6	2.0	0.6	0.6	5.1	6.8	2.1	38.8	0.7	0.6	11.3	8.2	0.7	0.6	21.6	1.0	0.6	16.4	1.3	0.6	5.7	0.6	0.6	0.6	0.6	0.6	0.6	3.9	4.8	0.6	1.9	3.9	0.0	1.2	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	8.7	3.1	14.5	5.1	6.8	11.3	8.2	16.4	3.9
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728957-7733906	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 63.1;lymphoid tissue: 53.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.2;RT4: 1.2;TIME: 2.6;U-937: 2.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.8"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 13.9;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	19	"B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003789, HPA014044"	Enhanced									"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	11.2	0.1	0.9	1.5	1.2	0.9	2.6	11.8	1.6	0.2	1.5	0.2	0.2	0.4	0.2	1.3	5.2	2.7	1.0	7.3	2.6	1.0	0.3	63.1	0.5	53.5	0.8	0.2	0.5	0.8	0.0	0.2	0.8	0.2	0.8	0.7	0.3	4.9	0.5	0.2	0.4	0.7	0.7	0.2	1.3	0.3	0.7	0.2	0.3	0.5	0.6	0.2	2.0	0.6	4.1	11.9	0.5	13.9	0.4	0.1	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.6	0.7	2.6	0.0	0.1	0.7	0.0	0.1	0.0	0.2	0.0	2.2	0.1	0.0	13.9	0.0	0.0	3.3	0.0	0.3	0.0	0.0	11.9	4.1	0.1	0.0	0.5	0.4	0.4	0.6	0.0	2.8	0.9	1.2	11.8	1.6	2.6	1.0	0.8	0.2	0.2	0.2
CTNNA3	"MGC26194, VR22"	ENSG00000183230	"Catenin alpha 3"	Q9UI47	10	65912518-67696169	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 28.8;heart muscle: 27.5;liver: 12.9;skeletal muscle: 16.2;tongue: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.0;RPMI-8226: 3.9;SCLC-21H: 2.6;U-266/70: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.2;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061818	Enhanced									"HPA061818: AB_2684618"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-4)"	"unprognostic (8.13e-3)"	"unprognostic (6.43e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.60e-4)"	"unprognostic (8.27e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-3)"	"unprognostic (7.93e-5)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	1.8	1.4	6.3	3.6	19.3	0.8	1.5	6.6	10.3	2.1	2.5	26.0	0.0	1.1	2.5	0.8	2.9	1.7	1.6	27.5	7.6	2.3	1.1	12.9	1.1	0.9	25.9	5.8	3.4	1.1	1.2	1.1	1.2	16.2	1.2	1.6	0.0	1.2	1.0	16.2	1.2	1.9	4.5	26.8	1.1	1.8	3.6	28.8	0.0	1.4	7.9	1.1	1.3	1.9	0.7	1.4	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	4.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.1	0.0	3.0	1.2	0.2	0.0	3.9	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	11.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.2	6.3	19.3	6.6	10.3	7.6	2.3	25.9	5.8	16.2	28.8
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA066463, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"HPA066463: AB_2685670, HPA072245: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.1	0.2	0.2	1.2	0.7	1.5	0.2	0.3	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.4	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.5	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.0	0.9	0.0	0.2	0.7	1.6	0.5	0.4	0.6	1.7	0.0	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401826-412487	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 68.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes				Peroxisomes	Peroxisomes	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	5.7	10.8	3.2	4.3	4.0	3.5	4.0	3.8	5.0	2.9	10.2	2.7	5.0	14.2	4.0	7.3	4.1	2.5	7.8	4.4	2.8	2.3	16.9	68.2	4.3	3.9	2.0	3.0	2.6	9.7	1.8	2.6	2.3	2.0	4.1	2.4	3.0	6.2	5.6	15.9	2.9	14.4	5.1	1.9	1.9	5.9	4.1	1.8	1.2	1.7	4.3	2.9	2.7	2.2	3.3	9.5	0.4	6.1	2.7	5.1	3.9	1.1	10.9	1.4	6.5	1.2	3.0	4.1	3.3	2.5	2.8	3.0	6.9	7.5	3.7	7.2	4.1	2.5	1.1	2.8	0.4	8.3	3.5	0.9	5.3	16.4	8.6	3.3	5.3	4.2	2.1	1.9	2.4	3.6	2.3	3.4	2.4	11.4	1.9	4.6	4.1	5.7	4.5	0.5	6.8	2.8	2.9	2.9	4.4	6.3	7.1	3.7	10.2	4.2	7.4	2.4	2.7	3.4	2.5	4.9	3.9	1.6	3.4	5.0	8.0	0.0	6.1	0.4	3.6	5.6	2.5	2.8	2.2	2.4	6.5	3.3	5.1	3.0	0.3	2.7	4.5	9.5	1.7	3.9	3.2	4.0	3.8	5.0	2.8	2.3	2.0	3.0	2.0	1.8
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631352-111654351	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 41.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favourable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	5.1	10.2	3.3	3.9	4.6	1.9	5.8	4.5	4.2	3.4	5.1	2.5	5.7	4.6	4.1	7.7	3.4	3.8	3.6	6.7	4.3	3.8	7.8	41.9	3.5	4.1	2.7	2.3	5.7	7.0	7.4	9.0	4.4	3.3	5.9	3.0	3.6	9.7	4.0	3.6	2.4	6.9	5.0	2.9	2.9	3.7	4.2	1.9	1.4	4.3	2.4	2.2	6.4	4.5	0.6	1.1	1.2	1.9	0.4	0.8	0.3	2.6	2.0	1.4	2.3	14.5	6.5	5.3	10.1	4.8	4.0	3.9	3.8	1.6	2.2	4.0	6.9	8.4	1.5	2.9	3.8	1.9	2.0	2.2	0.0	7.8	4.7	4.2	3.3	5.6	8.2	3.0	5.8	3.3	4.6	2.0	5.0	2.8	1.3	0.2	2.5	4.7	2.2	7.4	2.1	8.2	2.9	2.3	1.2	5.6	7.9	3.5	4.1	1.1	6.3	4.9	2.2	12.8	5.7	3.6	5.5	1.3	8.2	2.1	4.2	0.0	0.1	1.2	0.6	1.9	0.2	0.3	0.5	0.0	0.5	0.6	0.5	0.2	0.8	0.4	1.0	1.1	0.8	0.3	3.3	4.6	4.5	4.2	4.3	3.8	2.7	2.3	3.3	1.9
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Cell line enriched"	"Detected in some"	7	"BEWO: 30.6"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742040-108763054	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.5;liver: 111.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 10.8;Hep G2: 4.2;NTERA-2: 2.2"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favourable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	1.2	1.9	50.8	1.3	51.3	1.2	1.3	7.9	53.5	1.3	1.2	13.4	0.0	1.3	1.4	1.2	1.3	1.2	1.4	3.2	37.5	20.1	6.2	111.0	1.2	1.2	26.0	28.7	1.3	1.2	1.4	0.1	1.2	15.7	1.2	1.2	0.5	19.9	1.3	1.6	1.2	1.2	1.2	7.3	1.6	10.4	1.5	18.7	0.0	1.9	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.1	10.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	2.2	0.5	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.9	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	51.3	7.9	24.9	37.5	20.1	26.0	28.7	15.7	18.7
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.0	1.9	0.5	0.6	0.4	0.3	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.3	0.0	0.0	0.0	1.0	0.1	1.1	0.0	28.4	0.6	0.9	6.4	0.9	0.1	0.3	0.0	0.4	0.1	0.1	1.1	0.9	0.2	0.5	2.0	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	1.9	0.9	1.4	7.2	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138808-35143109	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.7"	"Group enriched"	"Detected in many"	5	"B-cells: 11.7;T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	28.2	8.1	35.7	5.2	40.7	2.0	21.8	16.8	34.7	46.5	16.9	25.5	7.1	5.0	26.3	17.9	18.8	31.1	14.8	134.1	23.8	19.9	4.5	137.1	14.1	3.0	36.1	23.7	34.0	6.2	2.1	4.3	8.6	21.5	21.6	7.9	14.1	6.4	20.7	299.8	5.8	7.5	27.7	19.0	6.2	8.4	7.5	14.8	0.0	3.9	29.0	3.5	12.7	23.7	11.7	0.7	1.2	0.7	2.0	7.1	0.7	0.7	0.0	0.0	0.1	30.3	8.8	0.8	3.6	0.1	0.0	0.0	0.0	0.2	2.4	0.9	0.0	0.6	0.7	0.4	0.0	2.1	0.8	0.4	0.0	1.1	3.5	0.2	0.2	12.5	0.0	0.1	0.3	0.1	0.6	2.5	0.1	0.0	0.0	0.5	0.1	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.4	0.1	1.0	0.1	3.9	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.6	0.4	5.0	1.2	0.3	0.0	1.4	0.7	0.9	11.7	4.1	1.7	0.3	6.6	0.8	1.0	0.6	2.0	0.7	0.7	7.1	0.7	35.7	40.7	16.8	34.7	23.8	19.9	36.1	23.7	21.5	14.8
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		570000	570000	Mitochondria	Mitochondria	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.5	7.0	0.0	0.1	65.3	0.0	0.0	0.0	0.0	15.5	0.1	0.1	1.5	0.0	0.1	0.0	0.1	0.0	0.3	3.7	0.0	0.0	10.3	0.0	0.0	14.2	0.0	0.0	0.5	0.0	2.7	0.0	0.1	0.3	0.3	0.2	0.0	7.6	1.2	0.3	0.0	0.1	27.0	0.3	6.2	3.2	0.0	6.0	0.0	1.4	0.0	0.9	0.1	0.2	0.7	0.3	0.3	8.9	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 113.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;Daudi: 9.6;RPTEC TERT1: 3.2;U-2197: 2.5"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favourable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	27.7	113.8	0.1	0.0	0.2	0.0	0.2	0.2	0.9	0.1	0.0	0.5	2.1	0.0	0.5	1.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.1	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	1.3	0.0	0.5	0.2	1.1	0.8	3.9	0.0	9.6	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.4	3.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.1	2.5	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1
GOLT1A	"CGI-141, FLJ42654, GOT1, MGC62027, YMR292W"	ENSG00000174567	"Golgi transport 1A"	Q6ZVE7	1	204198160-204214092	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 35.9;liver: 74.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.2;CAPAN-2: 10.6;Hep G2: 13.1;MCF7: 22.2;RT4: 14.6;SK-BR-3: 14.6"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 80.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.5"					"Not detected"	"Not detected"														"unprognostic (3.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (6.20e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (6.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-3)"	"prognostic favourable (1.51e-4)"	0.3	0.0	1.2	0.8	8.8	0.0	1.7	3.8	0.8	3.5	13.7	0.4	1.7	15.5	0.3	3.6	0.3	1.0	3.4	0.3	1.0	3.8	5.9	74.9	3.1	0.3	0.8	0.4	0.4	12.5	7.1	8.7	1.0	0.9	2.9	1.6	0.5	1.0	3.7	0.6	0.0	35.9	1.6	0.6	0.3	1.9	0.5	0.3	0.4	0.6	0.3	0.4	10.9	2.5	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.2	4.3	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	9.2	10.6	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	22.2	0.0	0.0	2.1	0.1	0.0	0.0	0.2	4.5	14.6	0.7	1.0	0.4	14.6	0.0	4.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.4	1.4	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.6	1.2	8.8	3.8	0.8	1.0	3.8	0.8	0.4	0.9	0.3
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022971	Uncertain		Approved	Nucleoplasm,Cytosol		1400000	1400000	Cytosol	Cytosol	"HPA022971: AB_1849975"	"prognostic favourable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.3	45.2	25.6	23.4	23.6	26.2	26.0	25.1	33.3	34.2	37.2	17.1	13.6	30.1	14.8	29.4	14.2	14.7	32.7	20.5	40.2	18.4	17.6	42.1	30.3	37.3	16.7	18.3	31.3	28.7	19.8	25.5	29.6	32.2	12.4	30.0	24.0	16.3	17.2	15.6	19.7	16.1	18.8	16.7	45.6	17.8	10.7	19.2	21.6	41.2	23.4	23.2	21.6	32.2	18.8	30.2	13.0	21.6	9.8	7.6	20.1	26.7	9.6	27.5	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		62000	62000	Cytosol	Cytosol	"HPA004701: AB_1078990"	"prognostic favourable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.4	12.4	9.8	6.9	6.2	8.6	16.6	4.1	4.1	7.6	10.8	4.2	16.4	14.4	5.8	4.8	8.3	6.7	7.8	7.3	7.6	6.6	7.0	4.7	8.8	9.8	2.6	5.8	8.1	8.5	4.4	7.5	6.5	5.8	13.3	5.1	60.2	4.0	5.5	2.9	9.9	6.9	10.3	11.2	11.6	8.0	10.8	9.8	9.0	18.0	12.7	29.4	3.8	4.4	5.9	20.2	6.7	3.0	10.0	10.7	12.7	15.5	3.9	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell line enhanced"	"Detected in many"		"AF22: 15.2;BEWO: 10.9;Hep G2: 13.2;HSkMC: 15.1;U-251 MG: 13.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"									HPA064126			Approved	Vesicles				Vesicles	Vesicles	"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.2	0.0	4.6	5.2	10.9	4.3	6.3	3.9	4.1	0.0	0.1	0.0	0.0	5.9	0.0	0.4	2.4	2.0	1.2	3.1	0.3	2.0	13.2	6.0	0.5	2.3	15.1	0.8	1.3	3.6	0.0	4.5	0.0	3.1	0.8	0.7	0.6	0.5	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	3.8	0.0	0.0	13.9	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 121.2;liver: 46.2;lymphoid tissue: 40.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 21.9;Karpas-707: 16.7;U-266/70: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 121.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 121.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012369	Uncertain		Approved	"Focal adhesion sites"	"Intracellular and membrane"			"Focal adhesion sites"	"Focal adhesion sites"	"HPA012369: AB_1858095"	"unprognostic (5.97e-3)"	"prognostic favourable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favourable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	5.3	7.3	4.5	17.8	7.6	10.1	4.1	2.0	5.3	3.1	5.0	3.8	0.0	5.6	2.6	4.7	3.4	4.5	5.9	5.8	4.5	3.1	17.0	46.2	8.5	40.7	7.7	1.6	4.5	6.9	1.1	3.4	3.8	5.6	4.0	5.4	2.2	7.4	1.8	3.9	4.6	8.4	3.5	5.4	20.2	6.3	3.5	4.5	14.6	10.0	3.2	19.3	8.0	4.9	22.3	121.2	28.6	26.5	18.1	17.4	16.3	1.3	6.4	2.2	5.3	0.7	1.1	1.3	1.5	0.7	1.2	3.1	1.9	1.5	2.8	2.1	0.4	1.0	1.3	1.3	0.6	2.0	3.2	9.8	2.6	6.7	1.9	1.3	21.9	1.8	0.8	2.2	0.5	1.2	3.0	16.7	0.3	5.4	3.1	10.3	1.6	1.7	3.8	2.1	5.1	1.0	2.3	1.6	3.0	2.1	1.5	1.1	2.3	5.3	0.3	2.7	1.3	1.7	2.4	22.1	4.6	1.7	3.2	3.8	2.1	16.2	26.5	23.6	13.3	22.2	15.2	22.3	15.4	12.6	33.9	21.8	13.9	11.1	28.6	18.1	15.5	121.2	17.4	16.3	4.5	7.6	2.0	5.3	4.5	3.1	7.7	1.6	5.6	4.5
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	260000000	260000000	"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.8	1.0	1.6	0.2	2.8	2.3	3.0	1.7	3.5	4.0	3.9	1.6	8.6	0.6	17.9	4.7	10.0	0.8	16.7	5.6	0.7	1.0	0.8	1.7	4.1	6.0	5.7	2.8	3.1	6.9	5.8	18.5	1.7	0.1	0.0	1.8	1.8	0.4	2.6	2.5	1.8	2.7	2.5	1.3	1.5	4.1	0.3	0.0	7.8	4.4	71.2	2.8	4.1	2.3	3.1	3.2	9.5	7.8	1.4	0.0	0.1	5.2	5.1	18.2	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9
LIME1	"dJ583P15.4, FLJ20406, LIME"	ENSG00000203896	"Lck interacting transmembrane adaptor 1"	Q9H400	20	63736283-63739103	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 87.5;liver: 43.7;lymphoid tissue: 80.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 13.1;MOLT-4: 13.7;RPMI-8226: 50.3;U-266/70: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdTCR: 39.4;MAIT T-cell: 35.4;memory CD4 T-cell: 54.9;memory CD8 T-cell: 51.2;naive CD4 T-cell: 37.5;naive CD8 T-cell: 40.6;plasmacytoid DC: 87.5;T-reg: 77.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 87.5;T-cells: 77.8"									CAB015363	Approved				"Intracellular and membrane"					"CAB015363: AB_629890"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-3)"	"prognostic unfavourable (5.04e-5)"	"unprognostic (2.39e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.67e-1)"	"prognostic favourable (6.92e-6)"	1.9	0.6	2.1	17.9	4.9	4.0	0.7	4.4	2.1	2.0	5.2	0.4	0.5	2.2	0.9	0.3	4.2	0.7	8.4	0.8	2.0	1.8	13.6	43.7	5.0	20.3	1.4	1.1	1.2	0.5	0.4	1.8	0.6	0.4	2.3	0.6	1.1	9.9	0.7	0.9	4.9	3.7	0.7	1.7	10.0	16.9	0.7	0.5	80.4	1.6	2.4	22.8	2.5	1.1	9.6	87.5	1.3	0.1	9.2	77.8	22.3	0.7	0.2	0.0	0.1	0.0	0.0	1.8	0.9	0.0	0.1	0.0	0.4	0.7	2.1	1.4	0.0	1.8	0.0	0.1	0.1	0.9	1.7	0.4	0.7	8.4	0.0	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.7	13.1	0.0	0.4	13.7	3.8	0.7	2.4	9.5	0.3	50.3	0.1	0.1	0.7	1.1	0.4	0.5	0.9	0.4	0.3	0.2	0.7	1.0	0.7	0.5	27.2	1.0	4.3	0.5	0.4	0.2	0.1	0.1	0.2	39.4	0.1	35.4	9.6	54.9	51.2	0.2	3.7	37.5	40.6	1.3	9.2	0.1	87.5	77.8	22.3	2.1	4.9	4.4	2.1	2.0	1.8	1.4	1.1	0.4	0.5
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favourable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.5	2.5	1.4	2.8	0.6	0.1	18.5	2.7	0.3	0.3	0.6	2.0	1.6	1.3	0.6	0.7	2.2	0.3	1.3	0.0	2.0	0.9	0.8	5.2	2.2	1.2	0.1	4.8	0.8	1.7	1.4	0.6	0.6	2.6	1.2	0.2	4.1	0.9	3.6	1.4	0.7	1.6	0.4	2.4	0.9	1.3	1.6	2.0	0.5	1.2	1.1	4.3	0.8	0.8	7.5	4.7	1.5	0.4	3.1	1.6	0.4	1.7	1.9	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681546-55684611	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	56	"B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038644	Enhanced		Supported	Vesicles,Microtubules				Microtubules	Microtubules	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (2.43e-1)"	1.3	0.9	1.2	2.1	0.9	0.1	0.5	0.5	2.2	0.4	15.2	3.0	0.0	15.2	0.4	35.7	0.3	0.7	8.1	46.1	4.6	0.6	12.6	82.4	0.8	0.8	1.8	1.5	0.3	1.2	0.0	1.3	4.3	3.2	0.3	6.0	1.4	0.4	0.1	2.7	0.5	44.7	0.4	1.0	3.1	1.0	0.4	0.6	0.0	1.0	0.1	0.0	0.3	0.3	2.5	8.6	0.0	5.4	0.0	0.0	0.4	0.2	9.1	0.0	0.2	1.9	6.7	0.1	0.3	1.3	0.1	0.6	11.8	23.9	4.8	17.9	0.5	0.0	1.7	0.1	0.3	0.0	2.3	0.4	1.5	11.6	0.0	0.2	0.0	1.7	0.0	0.4	0.0	0.0	0.1	0.0	19.8	8.2	0.0	0.1	2.4	1.1	0.0	0.6	1.1	0.2	0.0	0.0	0.1	0.9	0.0	1.6	1.6	17.5	0.0	1.3	1.6	0.2	1.2	0.0	0.2	1.4	18.2	4.1	0.1	0.0	1.0	0.0	0.0	5.4	0.0	0.7	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.4	1.2	0.9	0.5	2.2	4.6	0.6	1.8	1.5	3.2	0.6
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564413	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 109.4"	"Group enriched"	"Detected in some"	32	"Hep G2: 17.9;HHSteC: 10.8;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047699: "			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.1	11.3	0.1	1.4	0.4	0.0	0.2	0.1	0.2	0.2	5.8	0.4	0.1	11.3	0.1	0.4	0.1	0.1	7.0	0.1	0.1	0.0	25.0	109.4	0.6	2.4	0.1	0.1	7.7	2.7	0.0	2.9	0.2	0.3	0.5	0.4	0.6	0.1	0.1	0.1	0.0	19.5	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA046840: , HPA060085: AB_2684199"	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	5.4	6.2	3.9	8.0	3.3	14.6	5.3	6.0	3.6	6.4	7.0	3.2	7.2	5.8	5.4	6.8	4.1	5.3	12.0	3.8	2.8	2.0	9.1	73.9	11.4	12.1	2.7	1.6	7.8	7.4	2.5	8.0	4.7	3.7	7.3	1.7	7.7	7.4	4.7	1.9	3.0	5.9	4.9	2.7	9.9	5.7	5.2	2.1	17.3	17.1	2.6	13.6	6.6	6.0	1.3	1.1	13.3	1.6	1.5	3.5	1.3	15.4	4.3	1.0	4.1	1.9	0.9	6.1	5.4	3.5	3.0	2.6	6.6	6.7	0.4	12.4	3.9	6.5	0.4	6.1	0.7	7.8	4.1	1.0	0.7	8.6	19.1	3.5	9.2	5.2	3.8	1.5	0.4	6.1	1.7	7.8	4.3	6.6	3.4	6.8	4.9	7.0	7.4	2.3	4.4	9.9	13.2	0.3	1.9	2.3	5.0	9.9	2.1	3.7	8.8	6.8	4.8	5.5	2.0	12.2	6.4	2.4	6.2	0.7	7.3	0.5	1.5	2.6	1.9	1.6	0.9	0.6	1.8	1.5	0.7	1.3	3.5	3.0	13.3	1.5	0.7	1.1	2.7	1.3	3.9	3.3	6.0	3.6	2.8	2.0	2.7	1.6	3.7	2.1
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792869-4885917	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"liver: 108.1;pancreas: 37.5"	"Group enriched"	"Detected in all"	4	"HDLM-2: 34.3;HEL: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA071308: AB_2686384"	"prognostic favourable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favourable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	15.9	6.8	4.2	6.7	5.9	17.2	12.9	5.5	6.3	5.6	3.8	6.2	6.3	2.4	5.5	5.4	5.5	5.6	3.8	3.7	4.1	3.6	5.7	108.1	6.9	9.1	5.8	4.2	9.0	37.5	3.8	5.1	6.8	5.6	3.6	4.2	4.5	4.8	9.1	10.9	10.5	4.1	5.2	7.1	5.0	5.2	6.8	5.6	5.7	4.5	8.1	7.2	5.3	6.8	10.4	6.8	12.9	2.3	10.8	9.1	3.5	5.5	6.6	2.5	4.0	3.8	2.5	6.7	2.6	2.8	4.9	4.1	3.3	3.3	10.6	1.8	2.3	3.5	11.6	7.8	5.7	34.3	5.9	88.1	7.9	6.6	5.4	7.9	7.2	5.7	4.5	4.7	7.2	4.8	8.9	6.9	2.9	7.1	6.4	13.7	8.7	2.7	8.0	3.3	5.6	6.0	6.2	7.3	6.0	3.3	4.8	3.8	4.6	9.3	3.3	2.9	3.2	4.0	8.0	2.8	8.0	11.5	5.3	4.9	1.9	12.9	1.5	3.8	5.6	2.3	6.8	8.0	6.6	7.6	4.0	10.4	8.9	9.1	0.6	10.8	1.2	6.8	5.5	3.5	4.2	5.9	5.5	6.3	4.1	3.6	5.8	4.2	5.6	5.6
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 43.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	43.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8										
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"	"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;Hep G2: 18.4;MOLT-4: 13.3;RH-30: 11.4;RPMI-8226: 23.0;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		190000	190000	Mitochondria	Mitochondria	"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.8	10.9	0.0	0.3	1.4	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.1	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.4	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.1	0.0	0.2	6.9	1.9	13.3	1.4	1.7	0.1	0.9	11.4	23.0	0.0	0.1	1.0	9.2	0.0	0.3	2.3	1.5	0.1	0.0	2.1	1.9	0.2	0.0	0.1	0.0	0.7	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;CAPAN-2: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	30.4	28.0	59.8	40.9	199.5	115.1	12.2	3.2	72.1	7.8	41.8	24.1	138.2	12.8	2.6	7.6	54.4	32.9	116.8	6.9	4.3	13.6	7.2	17.8	48.2	38.6	10.0	7.8	62.6	35.4	30.4	53.6	14.8	20.0	39.2	3.1	47.6	11.3	12.0	20.7	8.1	5.3	22.1	40.2	34.2	34.1	3.7	14.4	6.4	30.5	62.7	34.2	21.6	5.9	0.7	9.3	0.7	6.7	11.0	5.8	19.8	14.3	31.3	5.0	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633383	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 14.2;liver: 51.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;Hep G2: 5.0;HSkMC: 7.5"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"olfactory region: 0.4"										"Secreted to blood"	15000000000	15000000000				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.5	0.9	1.0	0.0	1.3	0.1	0.2	0.4	0.8	0.6	2.7	0.4	0.0	3.5	0.3	0.6	0.2	0.5	0.4	0.9	0.9	0.5	2.3	51.1	0.3	0.1	0.8	0.7	0.5	0.8	0.3	1.4	0.3	1.1	0.3	0.2	1.1	0.3	0.3	0.5	0.0	14.2	0.2	1.1	0.2	0.2	8.0	1.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.2	4.1	3.8	0.6	7.7	3.6	0.2	1.0	1.6	1.7	0.8	1.6	0.6	0.0	0.9	1.4	0.6	0.2	0.3	0.9	0.2	0.6	0.0	1.0	5.0	2.5	0.0	0.1	7.5	0.6	2.9	1.4	0.1	0.4	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.1	0.3	0.5	0.6	0.5	0.2	0.6	3.1	0.0	0.4	0.6	0.0	1.3	0.8	0.0	0.0	0.3	0.6	0.6	0.3	1.9	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.8	0.9	0.5	0.8	0.7	1.1	1.0
SIGLEC12	"S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG"	ENSG00000254521	"Sialic acid binding Ig like lectin 12 (gene/pseudogene)"	Q96PQ1	19	51491357-51501789	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"liver: 13.1;lymphoid tissue: 29.6"	"Group enriched"	"Detected in some"	10	"HMC-1: 52.8;U-937: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.58e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.79e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-1)"	2.8	1.0	0.2	6.2	1.2	1.3	0.3	0.1	0.3	0.3	1.5	0.2	0.6	0.4	0.4	0.5	0.6	0.4	1.6	0.7	0.2	0.2	0.4	13.1	5.3	3.9	0.2	0.0	0.3	0.3	0.0	0.2	0.0	0.3	0.5	2.6	0.6	1.2	0.0	0.2	0.2	2.5	3.4	0.3	29.6	0.5	1.4	0.0	2.4	0.2	1.0	1.7	0.6	0.3	0.7	0.8	3.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	2.0	3.0	0.0	0.9	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.2	0.1	0.3	0.2	0.2	0.2	0.0	0.3	0.0
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236395	"Enzymes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 168.1"	"Cell line enhanced"	"Detected in many"		"A549: 18.9;HaCaT: 34.0;HeLa: 17.5;HL-60: 24.4;NB-4: 16.5;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	27	"basophil: 27.3"	"Lineage enriched"	"Detected in many"	27	"granulocytes: 27.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 2.5"	HPA026089	Enhanced									"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favourable (6.40e-4)"	1.1	8.1	0.7	4.1	0.8	1.2	3.4	1.5	1.0	0.5	4.2	0.4	1.3	2.5	0.2	17.5	1.2	2.6	1.3	0.2	1.1	1.1	39.4	168.1	1.7	0.8	0.3	1.0	0.7	6.3	2.0	10.4	7.4	3.0	1.2	4.0	3.2	0.6	0.3	0.2	0.6	5.3	0.1	0.3	0.4	0.4	0.7	0.1	0.1	1.0	0.2	1.3	1.4	0.8	0.1	0.0	27.3	0.0	1.0	0.5	0.2	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.5	9.8	2.6	0.0	0.2	0.4	34.0	8.7	0.2	0.9	13.3	10.7	14.0	17.5	8.8	0.1	24.4	10.0	0.0	0.8	0.0	0.0	0.0	4.2	0.0	0.0	3.0	0.6	16.5	0.6	0.7	0.0	0.0	0.6	1.8	17.3	15.7	1.0	3.3	0.4	0.0	1.8	8.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	27.3	0.0	0.4	0.4	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.1	0.2	1.0	0.0	0.0	0.5	0.2	0.7	0.8	1.5	1.0	1.1	1.1	0.3	1.0	3.0	0.1
SPDYC	Ringo2	ENSG00000204710	"Speedy/RINGO cell cycle regulator family member C"	Q5MJ68	11	65170154-65173244	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"liver: 8.0;testis: 5.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HEL: 7.4;Hep G2: 3.2;K-562: 17.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039891	Uncertain									"HPA039891: AB_10795260"	"prognostic unfavourable (1.20e-5)"	"unprognostic (7.35e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.08e-2)"		"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"		"unprognostic (6.60e-4)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	8.0	0.7	0.1	0.1	0.0	1.3	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.3	0.0	0.1	0.2	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	7.4	0.0	3.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
SPSB3	"C16orf31, SSB-3"	ENSG00000162032	"SplA/ryanodine receptor domain and SOCS box containing 3"	Q6PJ21	16	1776712-1793700	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 138.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046602	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA046602: AB_2679717"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.25e-7)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.72e-4)"	8.5	19.4	7.8	8.2	8.3	12.8	9.5	25.3	11.3	10.5	10.4	10.1	11.0	10.0	7.6	9.5	14.1	9.0	17.7	9.1	6.7	5.7	8.2	138.5	8.3	7.8	11.1	8.8	15.9	19.5	7.5	5.6	7.6	8.4	9.3	4.2	10.6	14.0	12.9	29.4	18.1	8.3	9.4	6.9	8.3	8.6	5.8	8.3	16.3	10.5	6.5	8.9	8.5	9.3	18.0	15.9	32.6	16.8	15.6	34.5	17.0	3.4	5.2	6.4	7.6	9.0	8.8	10.5	4.2	7.0	7.5	8.3	3.8	11.6	1.7	8.5	3.9	6.9	3.2	6.6	1.2	6.0	7.7	3.4	7.5	5.0	12.5	1.3	6.0	7.7	17.2	4.9	5.7	11.5	3.9	9.1	3.7	12.5	8.7	8.6	4.4	2.6	14.7	2.5	14.0	6.7	0.7	8.5	8.4	5.5	17.1	15.6	8.4	8.1	8.1	3.5	5.2	6.1	2.9	13.5	15.6	4.4	2.8	4.9	3.9	32.3	16.8	29.7	26.1	15.2	32.6	18.0	24.4	24.1	15.4	16.8	17.6	18.4	32.6	15.6	13.3	15.9	34.5	17.0	7.8	8.3	25.3	11.3	6.7	5.7	11.1	8.8	8.4	8.3
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favourable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 12.1;intestine: 29.3;liver: 14.1"	"Cell line enriched"	"Detected in single"	24	"HEL: 19.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA047527	Uncertain		Approved	"Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	8.6	0.0	0.2	0.2	0.0	12.1	0.0	0.0	0.0	4.3	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 96.9"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Group enriched"	"Detected in some"	9	"hippocampal formation: 0.8;pons and medulla: 1.1"	"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	96.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.3	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 125.8"	"Cell line enhanced"	"Detected in all"		"A549: 84.2;Hep G2: 97.5;U-2197: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		42000	42000	Nucleoplasm	Nucleoplasm	"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavourable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	25.9	11.3	4.4	24.7	3.2	0.2	12.7	4.0	3.1	13.0	29.3	3.8	10.2	13.7	11.5	9.7	22.9	9.9	12.9	10.1	3.6	3.5	28.2	125.8	13.5	4.7	4.0	2.2	20.6	24.9	5.1	4.7	26.8	5.3	13.2	23.3	7.5	8.2	7.3	7.5	5.5	24.2	17.7	3.7	3.3	14.1	5.0	3.8	1.7	16.7	12.7	7.1	30.2	24.1	12.0	12.3	17.1	12.0	21.8	22.4	10.2	4.8	84.2	9.3	12.1	30.4	33.8	7.8	16.0	19.1	15.9	14.6	11.8	18.2	3.1	10.1	22.2	5.0	9.6	4.5	16.7	3.9	1.7	3.4	10.9	97.5	12.0	4.2	3.5	11.3	2.5	27.1	8.5	10.1	4.5	2.6	10.9	14.3	4.1	4.6	7.5	6.2	7.1	14.4	3.1	8.7	19.3	4.7	6.9	9.9	5.8	6.7	3.2	3.5	11.8	16.3	7.6	60.6	7.6	5.9	4.3	3.1	13.7	3.6	8.5	17.1	12.0	10.9	14.3	10.6	22.4	10.9	11.4	14.8	10.7	12.0	9.8	12.0	2.3	21.8	6.1	12.3	7.3	10.2	4.4	3.2	4.0	3.0	3.6	3.5	4.0	2.2	5.3	3.8
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;hTCEpi: 2.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"														"Secreted to blood"						"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 231.0;lung: 227.4"	"Group enriched"	"Detected in some"	5	"AF22: 111.0;ASC diff: 33.0;Hep G2: 89.4;SK-MEL-30: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 4.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.4;T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	220000000000	220000000000			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	77.4	20.5	12.5	14.7	16.8	0.3	39.6	6.1	16.1	41.8	27.3	25.3	10.5	15.0	54.6	28.2	39.5	30.6	49.7	68.0	12.4	10.2	50.0	231.0	227.4	14.9	16.9	8.0	40.8	13.0	20.9	20.4	48.0	20.5	77.3	35.9	47.5	20.5	26.3	26.0	10.2	23.1	57.7	20.9	42.3	25.8	26.2	13.0	4.0	29.5	17.0	8.6	68.9	59.0	0.2	1.4	0.0	0.4	0.0	4.4	0.3	0.0	0.0	111.0	0.0	33.0	2.4	0.3	13.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	89.4	0.0	0.1	0.1	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	32.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.0	0.4	0.0	4.4	0.2	2.6	0.2	0.5	1.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	1.4	0.0	0.3	12.5	16.8	6.1	16.1	12.4	10.2	16.9	8.0	20.5	13.0
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;ASC diff: 4.4;EFO-21: 6.3;HBEC3-KT: 5.6"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA002911	Approved									"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (5.58e-6)"	"prognostic unfavourable (5.02e-4)"			"prognostic unfavourable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.4	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.3	0.0	0.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.3	0.2	0.4	2.1	0.0	2.2	0.2	1.9	0.3	0.1	0.0	0.0	0.0	2.5	0.0	2.4	1.3	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		1500000	1500000	Mitochondria	Mitochondria	"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.36e-5)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	11.8	6.7	1.9	0.6	0.5	1.4	0.8	0.7	0.2	4.4	0.3	1.4	0.5	0.8	3.0	0.7	2.8	0.9	0.8	0.6	1.9	0.0	44.3	3.1	0.4	3.0	2.5	1.2	1.2	0.5	0.2	0.3	1.0	0.2	28.5	0.7	0.2	1.0	0.1	3.4	25.1	0.6	0.4	7.0	1.9	5.7	0.6	0.4	0.0	15.6	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.0	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141888	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 29.3;HSkMC: 12.8;HUVEC TERT2: 27.3"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favourable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	31.4	4.3	1.4	2.0	6.6	0.4	12.1	0.7	1.9	12.3	9.9	4.7	2.9	1.8	7.9	6.9	10.5	4.9	7.2	13.2	1.5	0.9	3.0	53.9	9.3	3.6	10.9	0.2	22.0	1.9	1.1	6.0	1.8	11.2	8.0	3.4	4.2	7.1	1.9	6.6	5.0	3.9	9.8	21.0	1.8	4.4	5.0	9.3	0.0	6.7	6.6	2.5	16.6	11.7	0.0	1.2	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	20.2	29.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.8	0.0	1.6	0.4	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.3	1.4	6.6	0.7	1.9	1.5	0.9	10.9	0.2	11.2	9.3
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Group enriched"	"Detected in some"	5	"A549: 59.0;Hep G2: 58.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004860, CAB037271"	Enhanced									"CAB037271: AB_2221326, HPA004860: AB_1844433"	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	59.0	0.9	2.9	4.5	3.5	1.0	0.1	0.3	0.1	0.2	12.6	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	58.8	0.1	0.0	0.2	0.5	4.1	0.4	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.3	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.0	4.8	0.9	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell line enhanced"	"Detected in many"		"A549: 33.9;CAPAN-2: 25.9;HeLa: 14.3;RPTEC TERT1: 14.8;RT4: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavourable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.4	33.9	0.0	0.1	1.9	3.0	0.0	4.5	5.7	0.3	0.3	1.8	25.9	0.0	3.5	8.8	6.2	0.0	0.4	0.4	0.0	0.0	0.7	14.3	10.3	7.7	0.0	0.0	3.4	2.5	1.3	2.8	0.6	0.0	0.0	3.5	7.9	0.0	0.0	0.0	4.5	0.0	0.0	0.1	14.8	14.7	0.0	0.3	8.2	1.4	0.0	1.1	0.0	7.5	0.2	1.5	0.1	3.6	0.0	0.0	0.0	3.7	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 37.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.5	0.9	3.7	1.4	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	37.7	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.0	0.4	0.1	4.8	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2										
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA017283: , HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favourable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.1	8.0	1.2	5.3	15.1	2.7	14.0	5.6	5.1	5.9	8.1	4.2	2.9	4.0	0.5	3.1	6.3	5.4	2.5	5.3	6.9	2.7	3.4	5.4	5.8	5.1	1.0	18.4	2.6	11.6	5.4	2.7	3.3	4.1	9.4	4.8	1.6	7.0	0.4	3.9	17.7	2.6	2.4	9.1	9.1	2.9	7.0	2.8	6.2	3.4	11.6	2.3	2.8	3.5	4.3	4.7	10.6	6.6	2.8	8.0	0.2	11.0	10.3	5.8	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3
AC009119.2		ENSG00000260300			16	83908132-83951445	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"heart muscle: 6.3;liver: 3.9;pancreas: 3.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 2.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.5"																				"unprognostic (3.40e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.36e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	0.8	0.0		0.1		0.0	0.5		0.0	0.0	0.3			0.6	0.1	0.5	0.0	0.0	0.0	6.3			1.3	3.9	0.1	0.1			0.5	3.9	0.0		0.0		0.0	0.7		0.1	0.9	1.7	0.0	0.0	0.1		0.0	0.0	0.3			0.0		0.0	0.0		0.1	0.3	2.5	0.6	0.0	0.2	0.1	0.9	2.6	2.3	2.1	1.6	0.0	3.6	0.9	1.2	0.7	0.5	0.0	1.8	0.0	3.1	0.8	1.1	0.8	0.7	0.8	0.1	2.5	0.6	1.1	3.0	4.6	1.4	2.0	0.0	0.8	0.3	0.1	0.7	1.1	0.2	1.4	1.4	0.2	2.0	2.0	0.0	1.9	1.4	0.5	1.2	0.0	1.2	0.1	2.9	1.9	3.9	4.2	3.9	0.0	2.7	0.5	1.0	0.0	2.4	0.5	1.6	0.8	0.2	2.8	2.5	0.2	0.7	0.1	0.6	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.1										
AC068533.4		ENSG00000249319			7	66087761-66152277	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 10.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 14.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (7.24e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-3)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-1)"		"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	1.2	1.3	1.9	1.7	2.0	1.6	2.1	3.2	2.4	2.8	4.4			2.7	1.1	1.4	1.1	1.2	0.8	0.8	1.7	2.6	3.6	10.0	1.5	0.2	1.9		2.1	1.6	5.4	1.6	0.6		1.7	3.9		1.0	1.6	0.6	0.8	1.4	1.8	2.2	1.0	2.2	0.2			1.2		1.2	0.9	1.1	6.5	2.9	6.5	7.9	4.8	6.4	2.3	3.1	0.0	3.2	2.4	5.3	7.2	0.7	3.8	4.4	1.6	2.4	1.5	4.0	2.8	3.7	9.1	4.4	0.9	2.2	6.3	0.8	2.2	1.0	2.1	1.6	3.1	1.9	3.8	4.8	4.6	7.4	12.2	2.3	2.5	1.6	2.1	1.3	2.4	2.6	2.5	2.3	1.2	1.9	4.3	5.2	1.7	2.9	5.3	2.7	14.9	1.0	5.3	0.9	5.5	2.2	2.2	3.9	4.5	2.8	3.5	1.4	10.6	5.6	2.1	5.9	3.7	4.8	6.4	4.3	6.4	6.5	2.8	4.9	2.9	5.0	4.4	5.4	6.5	4.8	7.9	2.2	4.7	2.3										
AC135050.2		ENSG00000255439			16	31083439-31094956	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042720	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA042720: AB_10961864"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.84e-8)"	"unprognostic (4.96e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.29e-4)"	4.5	2.6	1.6	4.8	1.7	3.0	6.4	1.9	2.6	5.4	3.9	3.3	3.2	3.3	5.1	5.9	3.7	4.0	4.9	3.7	1.8	1.8	6.9	47.1	3.6	3.7	2.4	1.1	5.6	14.1	4.6	3.1	4.8	2.3	4.8	2.2	4.4	8.3	3.8	2.0	7.8	6.0	6.3	1.8	4.3	3.5	3.6	1.5	3.0	5.7	2.4	2.6	6.5	3.9	2.3	2.6	2.9	2.7	1.4	3.8	2.0	1.2	1.2	0.0	1.2	2.7	3.5	0.3	3.6	0.9	0.0	0.5	0.6	0.6	0.7	1.9	0.3	0.5	0.0	0.4	0.0	0.4	1.7	1.5	1.2	0.5	0.0	0.0	1.5	0.9	0.6	0.6	0.0	0.0	0.0	1.5	0.3	1.2	1.0	3.1	0.3	1.5	2.8	0.2	1.1	0.0	0.8	1.0	0.9	1.8	1.0	1.8	0.0	0.4	0.0	1.2	0.0	3.1	0.9	3.5	0.8	0.0	2.8	0.9	0.4	0.8	1.6	2.9	2.7	1.6	3.5	2.3	3.4	3.8	2.3	1.8	2.1	2.8	1.5	1.4	2.7	2.6	3.4	2.0	1.6	1.7	1.9	2.6	1.8	1.8	2.4	1.1	2.3	1.5
AC135586.2		ENSG00000256632			12	132688049-132714912	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 29.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.0;REH: 3.7;THP-1: 3.5;U-698: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.17e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"		"unprognostic (3.82e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (2.00e-2)"		"unprognostic (2.76e-1)"	"unprognostic (5.99e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.98e-1)"	1.3	1.3	1.5	1.7	1.4	1.3	3.4	1.3	2.2	1.2	6.8	0.5	2.1	12.6	1.2	1.7	1.3	1.6	5.0	6.0	1.4	1.2	4.6	29.6	1.3	1.3	1.4	1.5	1.6	13.0	0.9	1.2	1.0	0.8	1.4	1.2	0.9	2.8	0.9	3.1	1.3	10.2	0.9	1.2	1.3	3.3	2.3	0.9	4.9	2.3	1.4	0.9	1.2	1.3	1.0	0.0	0.2	0.3	0.0	1.3	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.7	3.7	0.4	0.6	0.0	0.7	0.5	1.5	0.0	0.0	0.2	1.0	3.5	0.0	0.0	0.7	0.7	0.0	0.0	0.8	4.4	0.0	0.2	0.6	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.8	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.5	1.4	1.3	2.2	1.4	1.2	1.4	1.5	0.8	0.9
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Enhanced	Peroxisomes		4300000	4300000	Peroxisomes	Peroxisomes	"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favourable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favourable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favourable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.4	9.2	3.1	9.9	13.6	7.9	10.9	7.8	11.3	8.9	8.5	12.3	9.5	5.0	5.6	12.4	5.6	8.5	13.1	4.9	7.3	8.8	6.5	8.1	34.8	8.8	14.8	14.5	14.7	9.4	7.6	5.5	12.0	6.0	5.9	9.9	11.0	14.3	10.6	3.3	11.2	3.3	6.0	8.4	25.1	25.1	2.7	4.2	7.6	85.3	5.4	8.8	11.9	8.7	5.4	5.2	10.7	10.6	7.8	5.0	3.9	8.8	12.9	8.5	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660723	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 35.0;liver: 42.7"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced									"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	10.0	7.6	4.9	2.6	9.6	6.3	5.2	5.4	8.0	7.4	9.8	7.2	6.8	11.1	7.2	8.3	3.2	6.4	4.2	8.8	6.6	3.9	35.0	42.7	4.9	3.2	12.9	3.8	7.6	5.9	3.8	13.9	5.9	8.7	4.7	2.7	5.5	4.7	7.4	3.7	6.9	18.8	4.9	12.6	4.5	4.0	5.3	10.2	4.0	5.5	2.3	3.3	5.4	4.7	1.9	2.3	0.2	0.8	2.4	3.7	0.9	3.9	4.0	5.8	8.0	6.1	6.4	7.5	8.6	12.4	4.5	5.7	11.5	1.3	2.7	5.2	3.3	3.3	3.2	5.6	4.8	4.9	4.1	3.3	3.3	8.4	8.8	2.3	2.3	4.8	3.9	5.9	11.4	4.1	1.8	5.3	4.7	5.3	2.3	2.6	3.6	4.3	2.4	4.6	4.0	7.8	2.2	3.4	5.4	7.4	3.0	17.9	8.1	2.5	4.0	3.4	1.9	2.5	3.4	5.6	1.8	3.0	4.5	0.9	2.6	0.0	0.7	0.2	1.6	0.8	1.6	1.3	1.4	0.7	0.5	1.9	3.7	1.7	0.0	2.4	0.8	2.3	0.7	0.9	4.9	9.6	5.4	8.0	6.6	3.9	12.9	3.8	8.7	10.2
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Cell line enhanced"	"Detected in all"		"Daudi: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		1200000	1200000	Mitochondria	Mitochondria	"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favourable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	6.9	5.5	17.4	7.6	15.0	12.3	4.9	13.0	10.6	12.8	10.8	10.3	11.1	75.9	11.5	9.3	6.4	14.7	11.0	15.9	29.3	7.2	24.9	16.9	15.8	10.5	21.2	6.9	14.2	6.4	11.1	6.7	10.0	25.3	17.2	13.7	2.6	24.9	10.0	14.0	13.3	32.5	22.9	7.9	21.2	18.3	9.4	11.9	10.5	31.4	27.1	9.3	26.9	5.4	8.7	8.6	7.4	21.3	11.2	16.0	33.7	7.4	17.3	9.9	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		15000	15000	Mitochondria	Mitochondria	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.3	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	3.3	4.3	1.3	0.5	10.5	5.3	5.2	2.2	12.0	6.2	0.4	23.7	10.3	2.0	1.7	0.1	4.0	4.2	0.0	1.7	4.2	7.2	12.0	1.3	3.0	5.4	2.7	1.4	7.3	11.6	0.7	4.0	6.2	0.0	9.9	5.0	8.2	4.4	0.1	3.1	3.0	0.6	10.1	5.7	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		870000	870000	Mitochondria	Mitochondria	"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	15.8	13.0	10.3	29.6	33.3	29.5	5.7	15.2	16.3	16.5	19.3	35.8	16.4	8.8	26.2	17.0	16.8	29.8	14.4	18.0	17.5	24.4	25.3	14.8	32.5	23.0	23.9	15.0	26.7	16.0	14.4	27.0	17.5	35.1	13.1	26.3	9.1	14.1	22.3	10.1	29.1	19.7	20.3	85.2	22.6	10.4	16.5	19.6	24.8	32.2	16.6	27.5	19.6	19.5	17.8	10.4	16.2	18.3	4.4	12.9	16.5	7.9	47.9	12.6	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 48.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Supported	Nucleoplasm,Cytosol		16000000	16000000	Cytosol	Cytosol	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (1.12e-4)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.9	6.5	44.3	16.9	6.3	11.8	1.5	6.2	7.3	14.7	25.4	25.4	8.9	5.9	3.1	4.8	6.7	18.3	48.0	17.4	3.5	18.8	13.6	10.6	42.2	6.4	7.8	3.7	6.4	3.5	24.2	10.4	7.1	14.6	9.9	8.9	12.4	13.5	12.5	14.9	4.8	8.4	9.9	18.0	34.2	9.1	11.9	6.7	7.1	4.6	2.4	8.9	15.7	4.4	5.4	4.7	7.6	15.8	4.7	8.7	14.4	1.6	15.5	8.1	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2										
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favourable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favourable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.53e-4)"	7.5	9.5	8.1	8.5	15.3	3.5	6.7	10.8	10.9	8.6	19.6	4.9	14.4	25.9	9.2	6.8	8.3	10.1	10.7	6.2	8.1	6.8	12.3	43.1	6.3	8.0	6.1	11.1	10.4	14.2	13.6	8.5	5.4	6.3	11.1	5.4	9.9	12.3	13.6	5.4	7.5	29.0	10.3	4.8	8.3	7.3	2.5	6.3	3.9	11.3	4.4	7.3	8.5	7.2	8.8	3.5	5.6	4.3	6.3	7.7	5.4	5.9	11.7	1.5	3.3	2.7	5.2	4.1	2.2	4.8	3.7	7.3	4.5	8.4	6.4	5.8	3.2	5.7	2.0	3.8	1.5	9.1	4.6	3.1	7.5	8.9	6.1	1.2	8.7	5.1	3.6	1.3	1.9	3.6	2.0	10.2	1.8	4.0	4.4	1.6	0.2	3.2	3.7	0.3	14.0	9.2	3.8	2.5	1.1	1.6	2.4	6.4	15.7	2.3	1.3	0.9	2.9	1.4	1.4	16.1	4.4	1.9	5.4	1.6	1.6	5.5	3.8	5.6	5.3	4.3	5.7	6.8	6.2	5.9	3.5	8.8	6.7	7.7	1.0	6.3	2.8	2.2	7.1	5.4	8.1	15.3	10.8	10.9	8.1	6.8	6.1	11.1	6.3	6.3
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		8000000	8000000	"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.4	8.7	6.7	10.6	52.5	28.5	3.0	17.9	44.1	8.2	6.5	9.1	2.9	1.9	5.7	18.7	1.3	13.3	17.1	16.6	6.0	3.6	13.8	9.4	9.9	26.4	1.3	5.6	24.8	5.3	21.2	15.0	21.3	4.9	4.1	23.4	2.4	7.3	6.6	7.0	9.2	5.7	10.0	1.9	31.4	8.7	0.8	2.8	18.6	0.7	1.9	4.3	3.4	23.0	30.1	10.2	10.0	4.6	2.0	3.8	3.7	21.0	4.6	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9
ACOD1	"CAD, IRG1"	ENSG00000102794	"Aconitate decarboxylase 1"	A6NK06	13	76948497-76958642	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 3.0;lymphoid tissue: 5.8"	"Group enriched"	"Detected in some"	6	"PC-3: 1.1;U-87 MG: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040143	Uncertain									"HPA040143: AB_10793916"	"unprognostic (2.39e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.37e-1)"			"unprognostic (3.54e-2)"		"unprognostic (3.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.30e-2)"			"unprognostic (1.64e-5)"	"unprognostic (7.70e-2)"	"unprognostic (3.68e-2)"		"unprognostic (6.51e-3)"	1.4	0.1	0.0	5.8	0.0	0.6	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.1	0.0	0.0	0.3	3.0	1.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.9;T-47d: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043705	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favourable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.1	5.0	1.9	0.1	9.8	6.0	0.1	1.3	5.3	4.4	8.1	1.9	2.0	0.0	0.0	3.5	2.5	0.0	0.9	2.1	2.3	1.6	2.6	1.2	17.9	9.4	0.1	2.9	7.8	0.4	3.5	0.0	2.0	0.0	0.0	3.4	1.6	0.3	0.5	1.8	1.9	5.1	3.9	0.1	4.3	4.6	2.2	3.8	4.1	12.2	6.7	24.7	6.1	2.2	2.5	3.2	2.2	0.0	0.0	0.0	1.3	3.6	0.0	3.9	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019881	Approved		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA019881: AB_1857978"	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	10.0	9.7	13.5	7.0	14.5	4.7	7.9	8.2	13.1	5.8	12.8	5.6	5.9	9.4	5.2	6.2	5.4	5.9	9.9	24.2	11.1	11.6	26.3	41.7	7.0	7.1	13.8	10.6	6.4	9.7	8.9	12.2	6.3	12.3	9.8	11.0	4.0	7.4	6.4	15.7	8.2	8.6	5.5	10.1	6.8	8.1	19.8	8.8	10.5	8.7	8.5	5.2	6.9	4.7	12.8	8.7	11.5	10.5	7.8	12.0	8.8	4.3	5.6	5.7	10.2	8.1	10.2	3.2	3.6	4.3	2.6	4.2	7.5	5.5	8.1	12.2	4.1	4.8	5.0	7.2	4.1	12.5	4.6	7.5	5.8	5.1	4.1	4.8	3.5	5.9	7.1	3.5	7.0	6.2	12.0	4.2	5.2	4.4	8.6	9.3	3.8	4.5	7.5	5.0	10.1	8.8	4.0	11.4	4.0	4.2	14.2	10.0	9.8	4.0	7.1	4.7	2.7	1.3	3.3	8.1	20.7	8.1	5.0	17.4	14.1	6.9	10.2	6.4	8.8	10.5	12.0	12.8	9.9	10.0	8.7	8.7	11.7	10.2	11.5	7.8	9.9	7.0	9.5	8.8	13.5	14.5	8.2	13.1	11.1	11.6	13.8	10.6	12.3	8.8
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.1	10.9	2.3	9.6	10.2	4.0	0.4	6.0	13.8	9.7	12.9	7.7	7.4	0.0	4.3	3.2	6.1	0.0	0.6	5.1	14.0	13.8	6.7	4.4	26.5	6.6	0.0	19.1	9.0	0.0	3.6	0.0	4.2	0.0	0.0	8.3	4.6	1.0	7.6	3.3	16.5	15.9	9.7	0.1	3.5	4.7	10.0	12.1	14.6	11.4	11.9	27.3	5.4	7.5	8.6	21.4	5.5	5.6	0.0	0.0	4.0	7.1	0.0	8.0	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591706-73596496	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 11.4;T-47d: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced									"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavourable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favourable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	6.3	2.2	2.9	1.4	3.6	0.6	4.4	1.6	5.7	3.6	2.6	1.0	1.5	3.9	1.0	2.4	2.0	0.9	3.3	2.9	2.1	2.0	13.0	15.6	3.9	1.1	1.6	2.8	0.9	2.2	1.1	0.7	4.9	2.7	1.4	3.1	1.8	3.1	3.4	0.7	0.9	7.4	2.5	0.8	1.4	1.9	2.8	0.9	0.3	1.2	0.8	1.2	1.1	1.3	1.7	0.6	5.0	0.4	4.6	10.6	3.2	4.2	1.2	0.1	0.0	0.5	0.2	0.0	0.2	0.0	0.3	0.4	0.1	7.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	1.5	0.0	0.8	0.0	4.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.2	5.5	0.1	0.7	0.3	1.1	0.0	0.0	0.0	0.1	2.0	0.6	0.1	2.7	11.4	0.8	28.5	4.3	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1.0	10.6	0.4	5.5	1.6	5.2	6.0	0.2	1.7	3.2	6.5	0.3	4.6	0.2	0.6	4.8	3.2	2.9	3.6	1.6	5.7	2.1	2.0	1.6	2.8	2.7	0.9
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.8;liver: 6.1;skeletal muscle: 6.5"	"Cell line enriched"	"Detected in some"	5	"T-47d: 14.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"											HPA058258	Uncertain									"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	2.6	1.0	1.5	0.0	2.0	0.0	0.1	0.8	1.2	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.8	0.6	6.8	6.1	0.0	0.0	0.8		0.7	0.4	0.0	0.0	0.0		0.0	0.0		0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9			1.4		0.0	0.0	0.0	0.1	1.8	0.0	0.6	0.0	1.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	2.7	0.1	14.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.8	1.8	0.1	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.1										
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 34.6;RT4: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		160000	160000	Peroxisomes	Peroxisomes	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favourable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.3	7.6	2.5	3.8	13.0	5.5	34.6	3.9	3.9	4.7	5.4	5.3	8.8	3.1	4.2	6.6	3.2	10.5	4.1	7.4	2.8	3.1	4.0	4.3	17.3	7.1	3.4	2.6	9.1	3.2	5.3	3.5	11.7	4.0	3.0	5.2	15.7	7.4	2.5	1.8	6.5	4.1	7.6	3.6	8.0	46.6	3.0	4.5	11.1	17.5	3.7	10.7	3.8	7.8	6.5	4.8	5.3	3.7	5.0	3.4	1.2	3.8	3.1	3.8	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.8;ASC TERT1: 35.9;HSkMC: 78.5;RPTEC TERT1: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	5.9	1.8	1.1	3.1	147.8	35.9	1.0	3.3	1.6	2.0	1.4	0.4	1.7	2.5	0.3	3.9	3.7	5.3	2.1	1.6	12.1	1.9	1.8	1.6	4.9	23.8	4.8	4.5	78.5	18.2	1.6	8.5	2.6	0.8	7.6	9.6	3.1	0.3	6.7	0.2	2.6	0.9	1.0	3.1	46.8	17.1	4.5	4.2	3.0	9.1	10.2	3.4	4.9	2.8	1.7	2.0	4.2	1.0	2.9	1.5	1.1	5.7	6.7	2.7	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6;ovary: 47.7;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"HEL: 19.9;HMC-1: 84.0;K-562: 59.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 18.3;T-cells: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain									"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favourable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	2.1	1.8	0.3	3.7	1.0	3.4	18.6	0.4	0.4	10.9	7.0	0.5	4.3	1.7	10.4	5.3	2.9	11.2	5.0	4.0	0.3	0.3	33.1	58.6	6.4	3.7	0.4	0.3	47.7	46.6	5.1	1.0	1.8	0.7	9.6	7.2	1.4	3.6	6.5	1.0	2.0	3.1	3.2	0.5	1.3	10.9	14.7	0.3	1.5	1.5	1.6	1.8	3.9	6.6	2.2	1.9	18.3	2.9	1.9	7.4	2.3	0.2	2.7	0.5	0.1	0.8	0.5	0.3	0.0	0.2	0.0	0.2	0.2	3.9	0.3	4.4	0.0	0.3	0.0	0.4	0.3	0.9	1.4	19.9	0.0	1.5	0.2	2.2	84.0	0.8	0.4	0.1	0.3	0.0	59.1	3.3	0.0	0.3	0.1	0.7	0.1	0.7	0.6	0.0	4.2	4.0	0.2	0.1	0.1	0.0	1.1	0.0	1.3	0.1	0.3	0.2	0.2	0.2	0.1	4.8	3.7	0.2	0.2	1.5	0.1	2.3	1.6	18.3	3.3	1.0	3.8	1.4	4.1	3.0	0.2	2.2	6.5	7.4	0.5	1.9	2.9	1.9	4.6	2.3	0.3	1.0	0.4	0.4	0.3	0.3	0.4	0.3	0.7	0.3
ADGRA3	"FLJ38547, GPR125, PGR21"	ENSG00000152990	"Adhesion G protein-coupled receptor A3"	Q8IWK6	4	22345071-22516054	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell line enhanced"	"Detected in many"		"RH-30: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008904	Uncertain				"Intracellular and membrane"	160000	160000			"HPA008904: AB_1849258"	"unprognostic (3.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-3)"	5.3	6.9	15.5	3.0	14.7	1.2	7.6	5.7	11.6	8.2	11.8	12.8	5.9	5.0	10.9	7.1	3.8	15.6	5.4	7.4	17.8	8.6	7.5	51.8	3.5	2.4	13.1	8.5	6.6	14.6	9.7	5.5	6.4	14.2	8.9	12.3	6.7	5.7	10.6	11.8	3.1	4.8	10.0	12.8	1.8	6.4	4.5	11.8	3.2	17.9	4.1	1.8	4.6	3.6	0.0	0.3	0.0	0.0	2.9	0.6	0.0	8.2	6.2	16.0	13.3	13.0	5.9	14.4	10.1	11.1	6.8	3.7	7.0	16.5	1.3	5.2	4.8	9.2	10.0	14.4	9.8	0.0	7.1	0.7	4.8	15.5	4.3	7.1	0.0	5.5	18.0	4.4	7.7	10.2	7.4	0.2	11.3	3.6	6.3	0.2	17.6	6.3	29.7	32.8	2.0	8.2	8.5	12.0	13.8	4.2	0.3	7.1	4.4	6.2	0.2	10.3	7.4	4.6	9.4	1.2	0.0	0.0	5.6	5.1	7.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.3	0.0	0.0	15.5	14.7	5.7	11.6	17.8	8.6	13.1	8.5	14.2	11.8
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;RPTEC TERT1: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA023062: AB_1844611"	"prognostic favourable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favourable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favourable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	17.2	13.1	10.0	21.5	27.1	6.1	32.1	11.6	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151185-74709303	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 71.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409"	Approved		Supported	Nucleoplasm,Cytosol		320000	320000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798"	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.93e-4)"	"prognostic favourable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	13.8	10.7	11.8	13.6	25.4	12.1	14.5	11.2	11.8	9.5	9.3	9.0	9.6	8.8	6.6	10.6	29.4	8.9	6.3	15.7	9.8	11.1	19.0	71.9	15.1	17.9	12.3	9.3	5.2	12.6	15.1	23.5	43.2	11.6	8.7	10.8	8.5	13.1	11.4	18.1	20.8	6.4	8.3	13.2	11.3	7.4	11.9	10.3	13.4	20.8	24.1	21.9	12.6	14.7	49.3	23.0	5.4	21.6	6.5	15.7	9.8	37.5	8.5	9.0	12.0	9.0	13.9	20.7	32.6	25.9	25.3	28.4	23.7	39.2	19.7	8.2	13.1	34.4	10.5	34.7	40.6	13.2	12.1	12.5	13.9	25.5	10.3	20.0	5.1	12.8	23.0	18.4	45.9	22.0	9.9	6.4	19.0	21.0	23.5	27.1	2.5	60.0	22.7	15.6	16.9	27.7	20.7	7.1	8.4	14.3	55.8	10.8	37.1	15.1	18.8	8.4	15.5	22.4	26.9	9.2	10.4	22.2	15.9	28.8	5.1	1.3	10.1	1.4	4.5	18.0	10.0	29.7	9.5	8.2	23.0	49.3	7.9	6.5	5.4	6.5	21.6	16.7	15.7	9.8	11.8	25.4	11.2	11.8	9.8	11.1	12.3	9.3	11.6	10.3
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867273	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 45.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 1.3;HAP1: 1.8;NTERA-2: 2.4;U-2 OS: 1.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029678, HPA029679"	Approved	Supported								"HPA029678: AB_10602108, HPA029679: AB_2673143"	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	14.5	0.7	7.1	1.1	3.9	0.3	3.4	6.2	4.9	0.9	1.5	5.9	4.9	1.0	1.8	2.0	0.9	0.6	0.5	10.1	11.6	2.0	0.8	45.1	3.9	1.4	4.7	4.7	1.0	0.5	0.3	0.6	0.3	3.8	10.2	0.7	0.6	4.6	11.2	0.6	0.9	1.3	2.4	1.9	7.0	1.2	0.5	4.2	0.0	0.6	0.1	0.6	0.6	0.7	0.3	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	7.1	3.9	6.2	4.9	11.6	2.0	4.7	4.7	3.8	4.2
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159972544	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;liver: 20.3;lymphoid tissue: 17.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HaCaT: 6.6;TIME: 11.0;U-2 OS: 9.2;U-251 MG: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA074416: AB_2686688"	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.00e-5)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favourable (3.19e-5)"	"unprognostic (1.59e-2)"	5.3	2.9	5.3	0.9	9.0	0.4	2.3	1.3	21.6	0.9	1.2	0.7	0.8	1.2	1.5	3.6	1.1	3.6	1.3	3.3	6.2	5.8	7.4	20.3	4.7	2.3	1.2	13.9	6.2	0.8	1.0	0.8	1.1	5.2	1.6	1.1	0.9	1.0	1.9	1.6	1.3	1.7	1.2	0.9	17.4	0.9	0.8	0.5	0.0	2.0	0.0	1.1	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.3	0.0	2.4	0.9	0.1	0.5	0.2	0.6	0.3	0.0	4.2	0.0	13.0	3.8	6.6	0.0	0.5	0.3	0.0	0.3	0.0	1.6	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.7	0.0	4.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.0	11.0	0.1	9.2	0.0	7.0	0.0	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	9.0	1.3	21.6	6.2	5.8	1.2	13.9	5.2	0.5
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.7"	"Cell line enhanced"	"Detected in all"		"Hep G2: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.5"	"Group enriched"	"Detected in all"	5	"B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	5.9	3.5	12.1	5.4	17.1	4.6	33.0	27.1	18.3	6.1	7.5	44.8	11.7	8.5	7.5	7.0	7.7	11.3	11.4	9.4	17.3	12.0	39.4	78.7	10.6	5.2	29.7	13.3	15.9	27.7	6.9	4.1	12.4	18.1	10.7	9.2	5.8	24.7	11.8	7.9	15.5	7.1	6.6	27.0	6.2	10.2	6.2	23.9	3.9	6.5	5.6	6.2	6.7	7.4	5.1	6.7	1.7	14.5	1.6	1.1	1.5	6.9	9.9	8.7	7.9	9.8	11.5	4.7	10.0	5.7	7.0	8.5	10.5	5.8	21.8	6.6	7.6	6.0	14.7	8.7	9.9	13.8	11.7	17.5	11.6	61.2	8.6	14.4	9.0	15.4	9.3	8.2	10.7	13.1	17.7	7.6	5.4	6.9	11.0	22.0	7.1	17.0	12.6	8.9	26.0	9.5	6.4	19.3	14.4	8.6	25.9	8.1	7.8	14.0	6.4	10.8	7.1	6.8	7.0	11.7	7.7	22.3	8.9	7.1	2.7	1.1	6.1	0.7	0.7	14.5	1.1	5.1	1.0	1.1	6.7	2.0	0.6	0.6	1.7	1.6	9.3	4.4	0.9	1.5	12.1	17.1	27.1	18.3	17.3	12.0	29.7	13.3	18.1	23.9
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;kidney: 54.7;liver: 66.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.6;Hep G2: 45.0;RPMI-8226: 11.2"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.6;T-cells: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA026443, HPA028321"	Enhanced					250000	250000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1.0	0.2	14.9	0.3	0.0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0.0	12.3	0.2	21.3	0.1	0.3	1.0	0.5	0.5	0.1	1.0	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	3.9	3.2	0.2	0.1	0.0	0.4	0.1	0.7	0.7	0.4	0.2	18.6	2.6	0.0	0.1	0.5	0.0	0.0	0.0	0.5	3.8	0.0	2.4	2.6	45.0	0.5	1.9	0.0	0.5	0.2	1.3	0.0	0.4	0.0	5.3	1.0	4.2	0.0	1.8	4.2	1.8	0.0	0.0	11.2	0.1	1.0	0.7	0.5	5.4	0.2	0.6	0.7	3.8	0.4	0.1	0.1	1.0	0.0	0.1	3.0	2.5	0.2	0.0	0.0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3.0	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1.0	0.6	0.8	0.7	0.3	0.6	0.1
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.6	20.6	2.4	11.4	17.7	5.5	10.4	9.7	7.7	6.7	5.1	23.3	29.0	4.8	21.9	5.5	39.7	3.4	6.0	0.7	50.0	15.8	7.1	8.5	5.1	12.2	7.5	17.5	5.3	8.4	5.7	3.0	3.4	8.6	0.8	2.8	26.4	0.5	23.3	6.2	37.5	10.9	8.8	26.6	7.8	9.3	5.5	8.8	12.6	13.3	15.9	8.4	29.5	6.8	8.9	9.1	2.8	6.2	1.2	0.1	3.1	0.1	16.1	8.8	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 29.6;placenta: 44.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 62.9;ASC TERT1: 8.8;BJ hTERT+ SV40 Large T+: 12.0;HBF TERT88: 18.9;HSkMC: 11.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003596	Enhanced		Uncertain	Vesicles				Vesicles	Vesicles	"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	18.8	11.6	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.8	5.5			0.0	0.6	0.5	0.5	2.2	1.6	3.1	0.0	0.1	5.7	29.6	2.6	0.0	0.9		0.8	0.6	0.6	0.8	44.9		1.3	1.0		1.0	1.0	2.9	4.4	0.7	1.1	0.0	2.3	1.7	0.2			4.1		0.0	4.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	62.9	8.8	0.0	0.0	1.3	12.0	6.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	1.1	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143340304	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavourable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavourable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	18.4	14.9	20.1	5.6	18.7	13.0	16.8	15.6	22.3	8.1	15.1	26.6	7.9	22.3	7.7	18.8	14.7	16.7	14.2	21.9	21.7	26.0	51.4	115.7	8.6	5.7	23.3	15.7	17.1	14.2	9.7	19.2	6.3	25.7	12.5	9.7	21.1	11.5	12.8	10.1	8.2	25.6	8.9	28.6	9.4	8.7	10.0	14.7	1.7	23.0	11.2	11.3	14.5	10.5	6.4	19.0	8.2	18.7	6.3	10.0	5.7	9.3	7.0	6.7	18.6	9.5	8.3	2.3	8.1	18.1	8.1	19.9	10.4	27.6	6.2	11.7	18.7	13.3	8.0	26.7	20.2	18.2	17.7	1.5	10.9	43.0	14.1	13.4	0.9	10.0	27.5	10.3	44.0	3.2	1.1	21.9	20.7	12.5	4.0	3.4	12.4	8.1	6.0	18.0	10.3	32.5	21.4	23.4	13.1	10.5	9.9	4.8	10.4	31.1	1.0	7.8	8.4	7.7	10.0	29.3	23.2	0.5	19.1	3.2	8.0	5.8	3.9	5.9	4.4	16.8	10.0	6.4	8.2	6.7	19.0	4.2	8.8	6.8	8.2	6.3	18.7	1.9	5.7	5.7	20.1	18.7	15.6	22.3	21.7	26.0	23.3	15.7	25.7	14.7
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971174-22982642	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 55.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.0;hTCEpi: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	2.9	2.0	1.1	2.4	1.8	0.0	4.1	1.1	1.6	11.1	2.0	1.6	4.9	0.5	8.8	4.4	12.3	4.7	7.9	3.2	2.3	0.6	15.6	55.0	8.5	2.2	1.5	1.3	8.2	5.6	5.5	1.4	12.5	2.6	9.2	1.1	7.1	5.5	11.0	1.5	31.3	1.7	4.3	0.5	2.9	2.6	4.1	1.3	7.1	15.4	5.3	6.6	3.7	10.0	1.3	1.0	2.6	1.2	2.9	2.5	0.6	10.2	12.2	16.3	6.2	1.6	2.9	13.1	10.1	13.4	23.7	21.3	26.0	10.7	0.2	10.6	20.8	33.4	12.4	49.0	29.0	0.9	1.1	0.7	19.8	29.2	18.6	1.0	0.7	9.1	51.3	9.9	38.3	9.1	0.4	0.6	21.9	8.2	1.0	1.2	1.0	16.8	2.8	13.6	0.2	23.8	16.0	0.0	1.4	30.5	9.0	1.9	12.6	1.0	8.1	10.3	20.8	1.6	9.6	0.1	0.3	0.1	1.6	0.9	4.6	2.2	1.2	0.5	1.4	0.5	0.5	0.4	1.2	2.5	0.4	1.3	1.5	0.9	2.6	2.9	0.8	1.0	0.2	0.6	1.1	1.8	1.1	1.6	2.3	0.6	1.5	1.3	2.6	1.3
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	18000	18000	Mitochondria	Mitochondria	"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (4.36e-4)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.2	1.4	1.6	6.9	15.3	14.6	3.5	3.4	4.3	7.4	20.8	30.4	2.4	10.9	9.0	5.3	13.1	5.4	25.6	30.0	9.1	6.2	10.6	6.8	58.2	0.7	8.2	1.3	8.1	14.4	7.3	21.4	0.2	13.1	0.1	11.3	8.7	0.3	0.3	7.1	12.2	0.0	11.9	1.9	11.0	0.9	5.9	4.5	6.1	0.4	4.8	8.5	3.6	1.2	12.4	10.7	0.9	5.8	11.5	5.1	0.6	20.1	3.0	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Group enriched"	"Detected in many"	10	"ASC diff: 186.6;Hep G2: 316.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"											"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.6	0.1	25.8	186.6	22.5	0.0	0.8	5.7	0.3	0.2	0.5	0.0	0.0	0.3	5.8	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.2	316.4	1.8	0.1	0.0	11.4	1.6	2.7	1.6	0.6	5.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Group enriched"	"Detected in some"	4	"A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	134.6	0.1	14.2	167.1	5.7	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	3.8	0.0	0.7	0.0	0.0	0.0	0.0	38.0	251.2	0.3	0.0	0.0	14.9	8.4	0.7	0.7	0.0	5.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	76.9	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.9	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282558-19289250	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"									HPA064638			Approved	Cytosol		1000000	1000000	Cytosol	Cytosol	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	0.7	0.4	0.7	0.7	0.7	0.0	0.7	0.7	0.9	0.7	5.1	0.7	0.7	48.5	0.7	1.3	0.7	0.0	6.9	0.7	0.7	0.2	13.4	27.4	0.7	0.7	0.7	0.7	1.0	59.0	0.0	0.7	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.7	0.2	27.0	0.7	0.7	0.7	35.5	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.3	1.9	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.4	0.4	0.2	1.9	0.1	0.1	0.2	0.1	0.5	1.5	0.2	0.4	0.3	0.7	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.9	0.2	0.1	0.3	0.3	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.6	0.4	1.5	0.3	0.7	0.7	0.1	1.5	0.0	0.3	0.9	1.4	0.3	19.3	0.4	3.5	0.4	0.3	0.3	0.2	1.0	0.3	1.4	0.3	0.3	0.5	0.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.2	0.7	0.7	0.7	0.7
AL136295.3		ENSG00000259371			14	24120956-24131829	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"liver: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;HMC-1: 2.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.38e-1)"	"unprognostic (4.35e-3)"			"unprognostic (4.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.61e-5)"	"unprognostic (5.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.52e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.36e-2)"	"unprognostic (2.23e-1)"	0.2	0.2	0.1	0.2	0.2	1.5	0.3	1.1	0.2	0.3	0.6			1.2	0.2	0.8	0.5	0.1	0.1	0.0	0.1	0.0	0.5	3.0	0.2	0.6	0.1		0.4	0.9	0.6	0.3	0.3		0.4	0.5		0.5	0.7	0.0	1.1	1.5	0.0	0.1	1.1	1.2	1.4			0.5		0.4	0.2	0.3	0.2	0.0	0.1	0.1	0.7	0.4	0.1	0.4	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.6	0.4	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.5	0.4	0.9	0.0	0.0	0.0	0.0	0.4	2.9	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.4	1.0	0.0	0.8	0.1	0.0	0.0	0.3	0.6	0.5	0.0	0.5	1.0	0.8	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.4	0.1										
AL162231.3		ENSG00000258728			9	34646645-34657113	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 17.6"	"Cell line enhanced"	"Detected in some"		"A-431: 1.0;BEWO: 1.1;HeLa: 1.3;HHSteC: 2.1;NB-4: 2.2;THP-1: 1.6;U-2 OS: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							3.2	1.9	2.4	5.0	4.4	3.1	2.6	3.0	2.5	2.8	7.5	1.4	4.4	1.5	4.6	2.6	2.5	4.8	3.6	3.7	1.9	1.9	4.1	17.6	2.7	2.3	1.7	1.5	3.5	1.7	1.5	3.5	8.5	2.2	2.1	1.5	3.8	6.1	4.8	2.5	3.5	10.5	3.0	1.6	3.1	2.4	1.9	2.0	3.9	2.6	2.1	3.6	3.2	2.8	1.5	1.0	0.0	0.7	0.0	0.9	1.2	1.0	0.0	0.0	0.7	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.4	0.3	1.5	0.0	0.4	1.0	1.0	0.5	0.9	0.0	0.0	0.0	0.2	0.0	1.2	2.4	4.4	3.0	2.1	1.9	1.9	1.7	1.5	2.2	2.0
AL355315.1		ENSG00000249967			10	97584374-97673910	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"kidney: 22.2;liver: 15.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;EFO-21: 3.9;HaCaT: 1.9;HBEC3-KT: 2.9;HBF TERT88: 2.0;T-47d: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.0"									HPA076857			Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA076857: AB_2686817"																		2.4	1.1	1.9	0.3	2.3	0.3	1.0	4.6	3.3	1.9	0.9	5.5	0.6	0.3	1.1	2.5	0.8	2.7	2.3	4.9	2.6	1.0	22.2	15.1	0.8	0.3	6.4	3.3	0.8	2.4	5.7	0.9	0.6	4.8	0.8	0.3	2.1	0.8	3.9	2.2	0.9	0.8	0.8	5.5	0.9	0.9	0.9	4.6	0.0	0.8	2.5	0.4	1.0	0.9	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.6	3.6	0.0	1.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	3.9	0.6	1.9	0.0	2.9	2.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	2.3	4.6	2.3	2.6	1.0	6.4	3.3	4.8	4.6
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386317-113401333	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced					44000000	44000000			"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavourable (7.33e-5)"	"prognostic favourable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favourable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	19.9	70.3	24.1	6.4	26.3	27.3	13.7	14.0	24.8	8.3	10.5	28.3	8.8	11.6	7.5	11.5	14.6	6.8	13.0	23.3	24.6	20.8	29.9	84.2	8.4	5.9	37.5	20.6	12.3	18.8	24.1	7.2	10.2	27.9	14.5	10.2	9.8	37.2	15.1	10.6	15.6	10.7	8.9	40.1	5.9	18.1	5.4	28.6	4.7	10.9	6.6	7.5	9.0	8.0	7.6	12.1	19.1	13.1	5.5	9.7	7.6	3.4	6.0	4.7	6.6	32.9	22.7	30.0	9.3	15.7	6.2	7.8	8.3	7.2	4.8	5.7	13.2	12.7	3.4	6.4	3.6	12.0	4.3	9.6	7.5	10.9	7.5	8.7	8.2	19.1	4.8	5.6	2.5	12.1	3.6	7.2	10.1	25.1	10.0	8.7	2.4	11.9	7.9	8.2	8.3	9.6	7.2	4.3	4.1	11.8	14.4	8.5	15.2	10.0	13.1	5.5	4.2	10.8	5.2	10.7	10.0	3.8	15.5	8.1	5.9	7.2	11.5	19.1	9.7	13.1	5.4	5.9	8.4	5.4	12.1	7.6	8.1	8.9	5.6	5.5	12.7	4.9	8.5	7.6	24.1	26.3	14.0	24.8	24.6	20.8	37.5	20.6	27.9	28.6
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favourable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.4	16.2	11.5	10.6	18.0	13.4	31.4	15.4	14.3	20.6	20.0	21.6	19.8	9.8	3.9	10.7	6.2	16.5	12.6	16.9	19.0	6.4	12.6	12.8	16.4	25.5	20.4	25.3	16.7	11.9	32.7	10.9	18.8	7.4	8.1	18.7	8.5	9.6	31.0	9.9	28.2	5.8	7.2	15.5	18.1	63.4	6.1	4.0	24.9	12.3	13.9	7.0	29.0	13.5	11.5	11.4	23.7	22.2	12.0	20.8	14.8	12.9	22.1	18.3	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell line enhanced"	"Detected in some"		"A549: 287.9;Hep G2: 88.6;RPTEC TERT1: 51.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"					"Region enriched"	"Detected in many"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Approved	Approved	Enhanced	Cytosol		62000000	62000000	Cytosol	Cytosol	"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favourable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	287.9	0.0	0.0	1.6	0.0	0.1	10.0	0.0	0.0	0.0	9.6	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	88.6	1.0	0.0	0.0	0.5	0.0	0.0	0.0	10.3	1.1	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	3.2	0.1	51.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 23.4;Karpas-707: 24.1;RPMI-8226: 12.6;RT4: 64.5;U-266/70: 13.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		640000	640000	Cytosol	Cytosol	"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.1	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.4	3.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.3	64.5	0.1	0.1	0.3	3.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.3	4.1	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;HHSteC: 29.4;SK-BR-3: 59.1;THP-1: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"									HPA051065	Approved					1400000	1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favourable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favourable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favourable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.8	5.5	9.4	26.2	3.9	18.0	2.6	4.9	1.2	0.9	6.7	3.5	0.1	13.5	5.9	4.7	0.0	1.3	0.8	0.1	1.8	0.2	2.4	18.2	29.4	0.2	0.2	7.2	6.7	4.4	0.1	7.8	4.9	0.8	1.2	0.1	0.2	6.6	7.3	0.6	0.1	0.1	0.5	9.1	0.1	2.2	6.8	6.6	59.1	0.0	5.9	26.3	0.3	0.1	5.0	0.1	0.1	1.6	0.8	7.1	6.5	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9;SK-BR-3: 35.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401"	Enhanced					40000	40000			"CAB004645: AB_425775, HPA006401: AB_1844731"	"unprognostic (1.17e-1)"	"prognostic favourable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.0	7.9	4.0	11.9	17.0	2.5	9.8	4.8	3.0	5.0	4.0	5.7	3.8	3.4	6.5	6.2	13.5	6.8	14.4	1.8	1.9	6.0	1.9	1.8	33.9	5.3	1.6	6.1	6.6	8.1	2.8	2.7	5.6	7.5	2.5	3.4	12.9	1.6	8.2	1.9	4.0	10.5	3.3	3.9	5.2	12.8	7.9	3.0	8.5	35.0	6.3	15.9	2.6	4.6	4.3	5.7	5.2	1.7	2.7	6.5	0.9	1.5	13.2	5.7	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 40.3;U-698: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		44000	44000	Mitochondria	Mitochondria	"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favourable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	2.9	2.1	3.1	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.5	0.8	40.3	6.1	0.3	0.0	3.4	0.4	0.5	4.1	5.6	6.3	1.9	13.1	0.5	9.7	0.8	0.3	1.6	0.1	0.0	0.0	3.1	0.0	0.6	7.5	11.8	5.8	0.8	1.5	13.6	0.6	0.3	2.4	6.4	3.6	3.2	3.8	0.4	3.9	5.7	5.3	0.0	0.4	2.0	0.1	2.0	5.7	8.5	50.3	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023296	Enhanced		Supported	Mitochondria,Cytosol		140000	140000	Mitochondria	Mitochondria	"HPA023296: AB_1844738"	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	14.8	9.8	27.8	46.0	23.2	13.8	35.5	17.8	22.0	20.7	26.8	27.6	14.3	0.0	18.2	13.9	11.1	8.6	60.2	19.1	0.0	10.4	2.8	14.7	23.4	11.3	0.0	0.0	16.9	14.2	16.1	11.6	16.5	0.0	0.0	18.2	9.7	0.6	0.0	18.8	8.3	8.9	31.6	0.0	19.7	11.3	9.5	11.3	0.0	9.8	10.3	17.7	0.6	20.0	6.0	18.6	6.9	12.2	0.0	0.0	0.0	3.2	0.0	9.6	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3, alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Approved									"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavourable (1.58e-5)"	"prognostic unfavourable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	14.2	24.1	7.7	12.2	10.3	11.6	15.4	7.2	12.9	11.5	15.5	13.7	15.2	14.3	12.8	11.2	20.5	11.5	15.4	13.0	7.3	6.5	19.7	74.4	12.9	16.8	11.5	7.3	12.7	37.7	18.4	11.7	26.6	10.2	14.0	16.0	12.4	20.9	13.7	18.9	18.4	16.3	14.0	7.9	14.9	15.0	20.8	10.1	13.9	15.9	14.9	18.8	17.4	15.8	14.2	30.1	6.0	25.4	18.7	18.0	15.5	20.3	17.7	4.8	16.3	19.6	11.2	16.5	11.0	12.5	15.1	12.9	27.1	13.7	17.9	30.0	13.5	24.6	17.5	23.8	9.4	12.9	20.3	16.1	13.6	21.8	18.0	26.0	14.5	13.3	20.0	17.8	25.1	8.2	15.8	36.3	9.7	25.0	12.6	21.1	15.3	23.2	13.1	7.5	71.2	16.9	6.8	12.2	10.3	10.2	40.3	17.5	38.2	14.8	6.5	16.0	10.0	13.9	23.4	19.9	34.9	19.0	14.3	34.2	14.3	0.2	25.4	6.0	16.0	25.0	18.0	14.2	17.3	16.2	30.1	12.3	15.6	15.1	0.9	18.7	19.7	27.4	18.0	15.5	7.7	10.3	7.2	12.9	7.3	6.5	11.5	7.3	10.2	10.1
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	7300000	7300000	Cytosol	Cytosol	"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		65000	65000	"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	1500000	1500000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB033770: AB_2057427, HPA007879: "	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.1	3.5	0.1	1.2	0.1	0.2	0.0	0.0	5.9	0.0	8.8	2.4	0.8	0.0	64.0	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.6	0.2	9.8	0.2	4.9	0.3	0.2	17.3	0.5	0.0	0.5	0.1	0.5	0.3	0.0	0.2	3.2	1.1	0.0	0.1	7.4	0.7	1.1	1.9	0.1	32.2	19.0	0.1	9.5	0.0	0.0	0.0	0.0	13.0	0.0	3.5	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233665-21253845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 64.5;kidney: 16.2;liver: 15.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 5.3;Hep G2: 12.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.0"	HPA043523	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043523: AB_10966687"	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.1	0.1	0.1	4.3	0.2	0.0	0.1	0.9	0.1	0.1	26.9	0.0	0.0	9.3	0.1	1.5	0.1	0.1	9.2	0.1	0.1	0.1	16.2	15.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.5	0.1	64.5	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.6	2.0	0.4	1.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.1	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.5	0.4	0.4	0.3	0.3	0.2	0.5	0.3	0.2	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.6	0.3	0.1	0.1	0.2	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.0
AP000781.2		ENSG00000254979			11	57387365-57424059	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 11.8;liver: 8.1"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 63.9"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	7	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.3"									HPA038515	Supported									"HPA038515: AB_10675800"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.55e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-10)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.10e-1)"	7.3	0.0	0.0	0.3	0.0	11.8	3.0	0.0	0.5	0.5	0.5			0.5	0.4	0.0	1.2	0.0	0.9	0.6	0.0	0.0	0.1	8.1	1.0	0.7	0.0		0.2	3.0	0.0	0.1	7.9		0.1	0.2		1.6	0.0	0.9	6.6	0.4	0.0	0.0	0.4	0.3	0.0			1.4		0.7	0.8	0.6	0.7	0.9	6.3	0.6	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.3	9.4	63.9	0.6	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	2.9	0.1	0.0	1.3	0.0	2.8	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.3	0.3	0.4	6.3	0.6	0.6	0.7	0.3	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.7										
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.8;liver: 100.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Uncertain		Approved	"Plasma membrane"		80000000	80000000	"Plasma membrane"	"Plasma membrane"	"HPA012863: AB_1845683, HPA064700: AB_2685328"	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	43.5	13.0	14.8	12.4	16.1	44.5	23.1	47.3	22.7	11.7	12.3	15.7	17.9	8.9	14.8	31.8	7.5	13.0	13.4	10.2	18.2	20.9	12.9	100.5	14.4	15.9	15.4	17.2	12.3	12.2	18.9	20.2	28.3	17.0	12.5	12.4	11.6	10.6	18.7	9.8	14.0	9.3	13.8	13.7	16.9	10.2	19.9	15.4	10.6	57.9	5.7	9.2	13.0	10.6	5.2	13.9	93.8	13.9	43.2	53.4	40.1	23.0	40.0	20.6	30.8	40.0	21.9	20.9	30.1	33.0	29.1	30.2	23.6	40.9	9.5	35.2	36.2	42.5	18.8	35.0	34.2	12.7	14.7	10.5	14.4	47.9	31.5	20.6	25.4	29.6	49.6	34.1	24.5	41.4	12.4	43.0	28.2	34.6	14.1	23.2	12.9	36.4	11.8	68.3	19.9	31.0	21.1	33.7	13.0	31.0	53.7	33.3	19.0	17.3	36.2	35.0	31.4	29.6	44.8	24.5	27.1	10.6	18.4	31.3	33.2	7.4	13.9	26.1	53.4	13.4	33.0	5.1	15.1	38.8	13.9	5.2	11.9	30.9	93.8	43.2	9.0	6.8	9.9	40.1	14.8	16.1	47.3	22.7	18.2	20.9	15.4	17.2	17.0	15.4
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905754-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;liver: 508.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 163.3;Hep G2: 75.9;HSkMC: 119.7;SK-MEL-30: 151.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	63000000000	63000000000	Vesicles	Vesicles	"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	76.8	226.8	78.4	14.6	106.8	9.7	12.8	26.6	109.8	13.6	15.1	40.3	0.8	7.7	9.4	10.9	2.6	4.3	17.1	6.9	41.4	57.9	121.8	508.1	21.5	46.0	104.0	34.5	23.5	5.2	2.7	4.9	17.2	54.1	6.6	5.2	11.2	8.5	3.4	5.7	33.0	10.2	3.6	35.1	89.2	13.4	12.6	33.9	4.9	6.0	1.3	8.6	11.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.2	163.3	6.7	5.9	0.1	0.3	0.7	0.1	38.7	0.2	0.1	0.8	0.0	0.5	1.0	0.1	0.0	0.1	0.3	0.2	0.1	75.9	16.8	0.5	0.1	119.7	0.2	1.2	0.1	0.0	9.9	0.2	0.1	0.2	0.1	0.2	20.4	0.1	0.2	0.6	0.1	0.2	0.0	0.4	0.2	0.3	0.1	151.8	14.0	4.3	0.2	1.1	0.2	0.1	0.1	0.4	0.6	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.4	106.8	26.6	53.4	41.4	57.9	104.0	34.5	54.1	33.9
APOL5	APOLV	ENSG00000128313	"Apolipoprotein L5"	Q9BWW9	22	35717872-35729483	"Plasma proteins, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 1.8;skeletal muscle: 5.4;testis: 2.6"	"Cell line enriched"	"Detected in single"	13	"U-698: 6.1"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040968	Uncertain									"HPA040968: AB_10963933"	"unprognostic (2.23e-1)"				"unprognostic (7.61e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.23e-1)"			"unprognostic (4.18e-2)"		"unprognostic (4.37e-5)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-1)"	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544032-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.0"	"Cell line enhanced"	"Detected in some"		"AF22: 11.0;BJ hTERT+: 9.6;HAP1: 14.1;LHCN-M2: 12.4;RH-30: 20.5;T-47d: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000001, HPA065701, CAB065764"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA065701: AB_2685535"	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	10.1	1.2	0.9	1.6	0.9	0.1	10.7	0.4	1.6	34.4	1.9	2.4	25.4	0.2	20.5	20.5	2.2	17.5	4.3	5.7	0.9	1.5	6.3	49.0	1.5	0.2	1.2	0.7	14.4	1.0	0.1	2.3	0.3	1.9	28.0	0.5	3.8	1.6	36.1	8.1	3.9	1.1	7.6	1.9	0.9	1.6	9.3	1.2	5.4	3.1	2.0	1.2	6.3	13.1	0.0	5.4	0.3	0.0	0.1	0.0	0.1	0.0	4.6	11.0	0.0	0.0	0.1	0.0	5.8	9.6	0.4	0.1	0.2	0.0	0.0	0.0	0.7	0.0	14.1	0.0	0.1	0.0	1.8	0.0	1.1	0.0	0.6	0.0	0.0	4.5	0.0	1.6	0.0	3.4	4.0	1.8	12.4	1.2	0.0	0.0	4.4	0.0	0.0	20.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	8.6	5.2	0.2	0.2	2.0	0.1	2.9	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	5.4	0.0	0.1	0.9	0.9	0.4	1.6	0.9	1.5	1.2	0.7	1.9	1.2
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539835-17697874	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	40	"classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	46	"dendritic cells: 9.7;monocytes: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles, Cytosol"	"Golgi apparatus, Vesicles, Cytosol"	"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	9.5	6.1	6.2	6.1	6.2	0.7	7.8	31.7	7.5	8.5	13.4	7.1	9.9	9.0	7.7	11.2	14.4	6.4	11.7	16.0	5.7	6.1	16.4	50.7	7.8	2.2	6.3	3.8	5.3	30.2	8.1	2.7	3.3	9.1	6.6	7.4	9.6	13.2	12.3	33.4	13.4	9.7	10.5	5.9	5.4	6.5	3.9	5.9	0.4	10.4	7.4	2.9	9.6	11.9	0.0	9.7	0.2	13.1	0.0	0.0	4.5	5.2	6.0	7.7	2.6	13.1	4.4	5.2	3.6	7.2	4.3	3.6	6.2	15.9	0.0	6.8	6.7	4.1	1.0	1.9	0.8	0.1	1.9	0.0	6.2	17.6	3.0	0.0	0.0	5.9	3.7	2.7	0.7	0.8	0.0	0.1	12.0	5.0	0.0	0.1	3.4	0.0	0.0	3.0	1.9	9.2	11.0	11.3	8.3	2.8	2.0	8.2	7.5	6.3	0.0	3.8	4.6	4.4	1.5	0.0	1.6	0.0	5.8	0.1	2.0	0.0	13.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	4.5	6.2	6.2	31.7	7.5	5.7	6.1	6.3	3.8	9.1	5.9
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol				Cytosol	Cytosol	"HPA041420: AB_2677469, HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	9.8	10.1	10.3	9.6	11.3	12.9	10.6	13.0	20.1	8.5	10.2	10.2	5.7	8.9	9.5	10.0	10.9	9.2	9.5	11.4	10.7	12.0	10.4	54.4	8.0	12.6	10.1	11.4	10.1	6.7	9.2	11.2	10.3	12.6	10.9	8.2	11.0	12.2	8.1	14.8	9.4	7.9	8.4	8.7	11.1	8.3	17.1	7.2	21.4	16.1	12.3	10.7	8.4	7.5	10.3	19.8	6.3	13.9	20.7	16.4	11.8	21.5	14.7	10.8	13.3	5.2	9.0	14.0	14.0	8.2	23.0	17.1	20.6	19.5	32.8	22.8	11.7	11.0	25.8	16.5	12.7	6.9	36.2	16.5	13.9	16.5	11.6	29.5	19.3	11.3	15.9	15.6	11.0	14.5	28.7	12.7	12.5	26.4	31.0	23.8	25.1	30.4	25.8	9.8	23.4	11.2	14.6	25.0	10.8	11.2	14.4	11.4	12.3	18.5	9.4	11.8	10.3	16.7	28.5	9.8	17.3	31.5	9.8	40.0	15.3	6.3	13.3	3.5	16.4	13.9	12.3	10.2	9.2	14.2	19.8	10.3	12.0	13.5	2.8	20.7	10.8	12.7	15.9	11.8	10.3	11.3	13.0	20.1	10.7	12.0	10.1	11.4	12.6	7.2
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;HEL: 10.0;Hep G2: 6.0;HUVEC TERT2: 22.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in many"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	11000000	11000000	"Rods & Rings"	"Rods & Rings"	"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	6.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957686-102960516	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;liver: 23.0;pituitary gland: 29.4"	"Group enriched"	"Detected in some"	22	"SCLC-21H: 32.6;SH-SY5Y: 17.6"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA029217: , HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0.0	0.9	1.0	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23.0	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1.0	0.0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6.0	1.0	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		10000000	10000000	Cytosol	Cytosol	"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.4	7.3	9.0	12.8	11.2	18.3	16.7	16.8	22.6	5.6	20.5	16.8	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	18.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	9.7	4.5	4.3	19.2	13.3	11.0	7.1	9.7	11.7	40.8	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 18.5;liver: 13.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.8;CACO-2: 10.8;HEL: 28.6;Hep G2: 9.9;RPTEC TERT1: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.4	0.7	1.8	2.4	2.9	1.8	1.6	7.0	2.8	1.4	6.8	1.1	1.1	10.5	1.6	1.9	1.1	1.9	18.5	1.8	2.1	2.1	2.1	13.5	1.2	1.1	1.6	1.1	2.0	1.7	7.7	1.2	7.1	3.5	1.9	2.6	1.4	3.0	1.1	1.1	0.7	9.6	1.5	1.1	1.6	4.5	7.1	1.6	1.1	1.1	1.1	1.1	2.1	1.1	0.0	0.0	1.0	0.3	0.0	0.5	0.1	0.4	1.6	2.9	2.6	0.6	0.5	18.8	0.8	0.2	0.9	0.6	10.8	0.1	0.0	0.3	1.4	0.2	2.0	2.4	0.6	0.2	4.0	28.6	0.3	9.9	0.9	0.3	6.7	1.2	2.8	0.1	1.1	2.0	7.6	0.0	0.8	0.5	0.1	0.7	0.9	0.9	1.0	0.8	0.0	16.7	1.8	2.2	1.2	1.0	1.6	1.1	4.5	0.2	1.1	0.1	1.0	1.6	0.3	0.3	0.4	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.8	2.9	7.0	2.8	2.1	2.1	1.6	1.1	3.5	1.6
AVPR1A	AVPR1	ENSG00000166148	"Arginine vasopressin receptor 1A"	P37288	12	63142759-63150942	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.9;liver: 71.2"	"Group enriched"	"Detected in some"	12	"ASC diff: 6.8;Karpas-707: 15.1;U-266/84: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 7.1;hypothalamus: 4.4"	"Low region specificity"	"Detected in all"														"unprognostic (1.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.90e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.58e-6)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.66e-4)"	26.4	34.9	0.3	2.8	0.3	0.0	6.3	0.2	0.4	9.7	4.2	0.5	1.1	0.2	16.5	2.1	2.5	3.7	3.4	2.5	0.3	0.3	4.2	71.2	0.7	1.5	0.3	0.0	3.8	1.5	1.1	1.0	1.2	0.6	3.2	0.5	0.5	1.1	2.4	4.4	1.3	0.8	7.5	0.3	0.5	1.5	1.8	0.0	0.6	6.1	3.0	0.4	6.2	2.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.2	0.2	0.7	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.0	0.6	0.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 19.8;Karpas-707: 11.3;RPMI-8226: 45.9;SK-BR-3: 9.3;T-47d: 15.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, CAB016087, CAB032276"	Enhanced				"Secreted to blood"	160000000000	160000000000			"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226"	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.4	5.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	1.9	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	45.9	0.0	0.0	0.0	0.7	0.3	9.3	4.5	15.4	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.3	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favourable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	6.9	2.6	9.9	13.2	10.0	8.8	7.9	4.9	10.3	8.1	11.2	4.2	9.6	19.7	5.3	11.8	7.0	5.5	6.5	11.5	24.5	8.1	9.7	6.8	5.7	11.2	13.9	4.4	8.4	6.8	5.6	7.0	9.7	8.2	17.7	18.2	3.8	5.0	8.1	7.3	3.4	12.8	30.7	16.8	22.6	10.6	6.6	9.3	8.4	7.0	4.9	9.0	10.7	4.1	4.9	3.4	4.5	6.6	12.6	12.3	6.5	6.0	10.4	7.3	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4
BCL2L10	"BCL-B, Boo, Diva"	ENSG00000137875	"BCL2 like 10"	Q9HD36	15	52109263-52112775	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 15.3"	"Cell line enriched"	"Detected in some"	8	"NB-4: 26.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.0"	"Group enriched"	"Detected in some"	6	"basophil: 4.1;memory B-cell: 1.6;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	28	"B-cells: 1.6;dendritic cells: 2.6;granulocytes: 4.1"									HPA042222	Approved									"HPA042222: AB_10794271"	"unprognostic (5.33e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.18e-9)"	"unprognostic (9.59e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.20e-2)"	1.0	3.5	1.0	2.4	6.0	0.3	2.1	1.4	1.6	2.8	3.6	0.1	0.0	3.9	1.1	1.2	6.1	1.3	3.4	0.1	0.5	1.7	6.5	15.3	0.1	1.2	0.3	1.1	0.9	4.2	0.8	3.7	0.2	0.3	2.5	1.7	0.3	1.8	0.4	0.3	10.0	8.1	0.5	0.3	1.6	1.8	0.9	0.5	0.5	0.8	4.3	1.0	2.3	3.9	1.6	2.6	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.1	3.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	1.0	6.0	1.4	1.6	0.5	1.7	0.3	1.1	0.3	0.5
BCO2	"B-DIOX-II, BCDO2, FLJ34464"	ENSG00000197580	"Beta-carotene oxygenase 2"	Q9BYV7	11	112175467-112224699	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.9;liver: 44.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;HHSteC: 16.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061542	Supported									"HPA061542: "	"unprognostic (2.92e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-1)"	2.3	14.7	4.0	0.9	6.8	0.8	1.3	1.9	4.6	1.2	1.5	5.9	0.3	1.1	2.0	2.8	2.1	9.5	6.0	28.9	3.5	3.9	1.6	44.0	1.8	0.9	10.5	2.6	1.5	1.3	0.8	16.3	3.9	9.5	1.3	1.1	12.4	1.1	1.5	17.3	1.5	1.6	4.4	11.0	1.0	1.1	2.4	9.8	0.0	1.9	1.0	1.3	1.3	2.7	0.3	0.5	0.3	0.6	2.8	0.2	0.0	0.1	1.3	0.6	0.7	0.5	0.5	0.0	0.4	0.3	0.1	0.7	0.0	7.4	0.5	0.6	0.8	1.6	0.0	0.3	0.4	0.1	0.2	1.0	0.7	0.5	16.0	0.5	0.3	0.1	3.0	0.2	0.4	0.1	0.2	0.4	0.1	0.1	0.6	1.6	0.1	0.2	0.4	0.2	0.2	0.2	0.3	0.6	0.3	0.6	0.3	0.0	0.4	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.0	3.3	0.4	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.5	0.2	0.0	0.0	0.3	2.8	0.2	0.2	0.0	0.0	4.0	6.8	1.9	4.6	3.5	3.9	10.5	2.6	9.5	9.8
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 61.6;liver: 47.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		13000	13000	Mitochondria	Mitochondria	"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favourable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	12.8	9.8	8.4	5.1	12.1	4.0	8.1	6.0	10.1	6.7	19.4	6.3	4.5	19.8	6.1	17.8	8.8	7.1	8.2	6.8	7.5	9.6	61.6	47.9	3.8	4.9	7.8	5.9	5.1	9.8	4.8	8.4	3.7	10.3	5.9	6.4	6.4	8.4	4.1	12.0	6.4	29.1	7.0	6.9	2.7	6.5	7.0	3.8	4.9	4.6	8.8	5.6	6.2	5.6	15.8	13.1	7.3	11.2	11.1	11.7	6.5	13.7	10.9	17.8	15.8	11.2	10.4	8.5	7.0	11.8	15.7	13.8	12.8	14.8	16.4	14.1	11.5	13.6	16.0	16.2	36.5	19.4	10.3	8.0	8.2	16.6	3.6	9.9	4.3	8.4	7.5	15.4	22.8	23.0	7.1	8.3	24.1	20.2	12.0	5.9	13.2	24.3	12.6	19.9	16.3	12.7	15.6	17.1	13.4	10.4	5.6	27.1	17.2	4.8	8.1	19.6	16.3	11.6	13.0	7.0	21.3	13.5	4.3	5.7	22.0	7.3	8.7	0.1	7.7	11.2	9.9	15.8	8.9	7.6	13.1	11.8	8.5	11.7	1.0	11.1	6.3	7.3	4.7	6.5	8.4	12.1	6.0	10.1	7.5	9.6	7.8	5.9	10.3	3.8
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 123.3;liver: 55.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		640000	640000	"Nuclear bodies"	"Nuclear bodies"	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	6.0	10.2	5.0	4.3	7.6	1.8	7.2	6.7	6.0	5.9	12.0	7.7	7.8	12.2	6.4	7.3	6.8	7.5	10.6	8.5	5.3	5.0	123.3	55.9	8.0	4.6	8.4	5.1	8.5	13.9	5.6	11.6	5.7	7.3	9.7	10.0	8.9	8.3	6.5	14.2	5.2	20.0	6.7	9.3	5.2	8.4	5.1	7.8	8.9	11.3	5.3	5.3	6.9	4.9	10.6	12.4	37.6	11.7	9.3	11.9	7.2	3.8	5.5	12.7	7.8	10.0	11.4	14.8	5.3	8.8	5.4	7.5	2.1	21.6	15.7	35.4	10.2	9.0	14.6	3.9	7.5	15.8	5.0	8.6	12.8	10.1	11.3	7.2	4.6	10.6	7.5	10.0	7.2	8.7	11.3	11.0	5.5	3.0	13.1	10.0	4.7	8.8	12.6	16.5	24.8	30.9	7.4	6.5	8.3	9.7	12.2	11.7	27.1	5.7	5.7	5.5	4.4	9.6	2.8	4.9	14.4	15.5	4.2	12.0	9.4	23.7	11.7	27.3	9.0	8.5	9.3	10.6	9.3	10.2	8.9	9.5	11.5	10.1	37.6	9.3	7.4	12.4	11.9	7.2	5.0	7.6	6.7	6.0	5.3	5.0	8.4	5.1	7.3	7.8
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"		17	6651718-6693202	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 18.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.7;SH-SY5Y: 11.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.8	1.5	1.4	1.6	3.3	0.1	1.4	3.8	5.6	2.3	2.4	4.0	1.2	3.6	1.5	2.8	2.1	1.7	1.5	0.3	1.5		2.2	18.4	1.2	3.5	1.3	2.5	1.1	8.5	2.5	9.1	0.6	3.0	2.2	1.6	0.8	5.2	1.1	0.3	9.3	4.3	0.7	1.6	2.2	2.8	3.6	2.3	1.6	3.3	0.2	1.1	1.7	0.5	5.7	3.1	7.5	2.4	2.5	5.5	1.9	1.3	2.6	5.7	1.8	0.8	1.6	2.7	0.7	4.1	1.7	3.4	3.8	1.8	1.5	2.9	1.3	4.9	1.1	2.6	2.5	6.6	7.6	1.4	2.6	11.7	2.0	0.2	3.9	2.3	2.5	0.8	1.8	1.0	1.8	1.5	2.2	2.8	1.6	2.4	0.8	1.7	3.1	0.9	2.3	3.4	1.1	5.9	11.6	3.4	0.4	3.9	3.0	0.4	1.5	1.6	3.3	0.9	1.3	2.1	1.4	1.0	1.4	0.5	3.7	5.7	1.9	7.5	2.5	2.4	3.4	4.3	4.6	2.9	3.1	5.7	5.5	3.0	1.8	2.5	2.3	1.0	3.0	1.9										
C19orf66	"FLJ11286, IRAV, RyDEN"	ENSG00000130813	"Chromosome 19 open reading frame 66"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042001: AB_10794167"	"prognostic favourable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favourable (1.35e-4)"	9.8	13.8	13.7	17.6	12.1	9.0	9.9	10.6	16.9	14.5	11.2	8.4	10.3	9.6	12.6	14.1	8.9	16.4	15.5	6.9	11.0	13.9	11.5	55.8	11.6	14.4	9.0	13.5	14.5	10.0	14.1	12.8	9.8	10.0	12.4	6.1	11.6	13.0	15.8	3.7	7.6	14.2	9.7	8.6	14.0	8.3	3.7	8.6	9.8	11.9	5.4	13.0	12.9	10.1	8.8	6.7	11.6	12.0	17.5	21.2	10.0	2.7	1.6	1.7	1.2	6.5	8.8	0.7	3.3	18.0	24.5	26.0	0.2	2.4	1.7	1.0	8.5	1.2	0.8	6.0	0.4	11.8	0.0	5.1	1.1	4.1	12.7	1.7	2.9	15.8	4.5	3.8	0.6	7.0	0.7	6.8	4.9	2.2	5.8	3.4	0.4	2.5	5.3	0.0	3.2	3.6	4.3	0.2	1.5	4.7	0.4	13.8	0.2	4.6	5.1	2.1	1.0	2.8	0.4	8.3	2.6	0.4	5.6	1.6	4.1	11.1	8.3	11.6	15.9	7.4	21.2	8.8	13.5	17.1	6.7	6.9	11.5	12.1	10.8	17.5	12.0	1.3	13.9	10.0	13.7	12.1	10.6	16.9	11.0	13.9	9.0	13.5	10.0	8.6
C1orf53		ENSG00000203724	"Chromosome 1 open reading frame 53"	Q5VUE5	1	197902647-197907367	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 10.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065352			Approved	Vesicles,Aggresome				Vesicles	Vesicles	"HPA065352: AB_2685477"	"prognostic favourable (1.63e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.37e-1)"	3.3	10.8	6.5	1.5	3.2	1.7	2.1	1.0	6.6	3.1	5.6	2.8	4.0	4.2	1.6	6.2	3.2	1.7	4.7	7.5	4.8	4.0	8.6	20.9	5.0	2.4	2.7	2.9	2.9	8.2	0.5	6.0	2.9	3.7	2.7	3.0	4.5	4.8	1.5	6.6	1.2	4.3	2.2	1.6	2.2	3.5	4.7	3.5	0.1	4.6	2.1	1.4	1.6	1.5	0.1	2.6	0.0	10.5	0.0	0.8	1.1	4.3	5.2	0.4	2.0	2.6	8.0	2.9	6.6	4.4	5.3	2.7	4.6	3.1	7.1	10.5	7.0	1.7	1.7	1.2	0.5	2.3	13.4	4.2	3.8	7.8	1.1	9.4	6.2	4.6	3.9	1.9	0.7	1.9	1.2	1.6	3.1	6.4	0.5	8.3	4.3	7.6	1.0	2.8	2.8	8.2	6.2	15.8	11.8	8.2	1.5	2.4	3.6	3.6	4.5	6.3	7.2	8.8	3.8	3.2	2.4	1.7	4.1	2.8	6.4	0.0	3.6	0.0	0.4	10.5	0.0	0.0	0.2	0.8	2.6	0.1	0.4	0.4	0.0	0.0	5.1	0.7	0.1	1.1	6.5	3.2	1.0	6.6	4.8	4.0	2.7	2.9	3.7	3.5
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 177.7;ASC TERT1: 90.7;BJ hTERT+: 78.2;BJ hTERT+ SV40 Large T+ RasG12V: 48.2;HSkMC: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdTCR: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"	14000000000	14000000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	177.7	90.7	0.1	19.9	78.2	23.7	48.2	0.2	0.3	0.0	0.6	15.6	0.2	1.7	0.8	3.3	1.8	0.1	0.0	0.6	0.6	34.2	0.1	0.2	105.0	0.5	10.8	0.8	0.4	0.0	2.5	3.1	0.0	0.8	0.1	0.8	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.4	0.4	0.4	0.0	0.0	0.0	5.6	0.9	26.1	0.1	0.1	0.4	0.0	8.1	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109273	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.6;HSkMC: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA011338, CAB026172"	Supported		Approved	Microtubules,Cytosol	"Secreted to blood"	20000000000	20000000000	Microtubules	Microtubules	"CAB026172: , HPA011338: AB_1847111"	"prognostic favourable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	16.5	31.2	3.8	10.0	5.5	6.1	14.2	1.2	4.9	12.1	13.5	3.2	10.5	6.0	12.4	14.9	13.3	14.5	14.7	10.0	2.5	1.6	21.4	96.1	14.2	13.1	4.5	2.7	21.3	23.8	5.2	15.7	4.2	6.4	16.5	7.2	11.3	16.9	11.5	11.1	7.8	9.5	15.4	9.3	12.7	11.1	7.2	4.7	2.8	14.4	8.1	7.0	15.5	16.4	2.2	1.7	11.7	2.5	0.6	1.4	0.9	2.2	5.9	0.6	5.9	18.4	31.6	4.2	3.7	17.2	3.6	11.3	3.8	10.3	0.9	3.2	2.9	5.0	1.6	6.4	1.5	9.3	0.3	3.5	5.9	8.8	14.9	0.7	17.2	35.0	12.0	2.3	7.4	3.9	2.8	2.2	2.3	0.1	0.5	0.7	1.1	0.1	2.0	0.0	0.7	10.5	10.0	0.4	1.3	12.6	1.5	2.2	1.5	3.1	3.3	3.4	6.3	3.9	0.6	1.7	0.7	0.1	6.4	2.5	1.5	7.2	1.5	8.0	1.4	2.3	0.6	2.2	1.4	1.0	1.7	1.1	0.9	0.8	11.7	0.6	2.5	0.9	0.8	0.9	3.8	5.5	1.2	4.9	2.5	1.6	4.5	2.7	6.4	4.7
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 97.0;ASC TERT1: 129.2;BJ hTERT+: 41.1;HSkMC: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	13000000000	13000000000	Nucleoplasm	Nucleoplasm	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favourable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.2	97.0	129.2	0.4	17.5	41.1	9.3	17.0	0.0	0.2	0.0	2.4	21.7	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.6	29.2	0.2	0.1	68.6	0.3	7.5	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.6	0.2	0.2	0.0	0.0	0.0	4.3	0.3	16.5	0.0	0.0	0.0	0.1	9.3	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037490-231049719	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 22.5;placenta: 23.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;SH-SY5Y: 2.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	1.0	0.9	6.5	0.9	8.4	0.8	1.6	1.7	10.1	0.8	7.8	9.9	0.0	2.3	0.8	1.1	0.9	0.9	1.8	0.8	7.7	4.7	1.4	22.5	1.2	0.8	5.1	7.9	0.8	6.1	1.7	1.7	23.9	8.2	2.0	2.5	0.8	1.0	0.9	0.8	0.8	2.6	1.0	2.2	0.8	4.2	0.9	5.9	0.0	0.8	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.1	1.5	0.8	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.4	1.7	10.1	7.7	4.7	5.1	7.9	8.2	5.9
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982024-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.8;HSkMC: 35.2;U-266/70: 8.2;U-266/84: 15.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	98000000000	98000000000			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: "	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	2.7	17.5	1.3	4.3	1.1	0.0	3.3	0.0	0.1	0.4	3.0			2.9	1.6	5.8	0.7	3.5	0.8	2.7	0.7	0.9	12.8	49.5	6.7	1.4	0.9		8.0	2.6	0.0	2.2	0.0		1.5	1.7		1.3	0.0	0.0	0.1	1.2	0.0	0.7	2.9	4.1	0.3			8.1		1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	24.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.2	15.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C7orf77		ENSG00000275356	"Chromosome 7 open reading frame 77"	A4D0Y5	7	124777292-124790689	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"liver: 2.1;lung: 2.4"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (9.32e-2)"		"unprognostic (1.05e-1)"											0.0	0.0		0.0		0.0	0.6		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	2.1	2.4	0.0			0.1	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.8	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.2	0.8	2.5	0.3	0.0	0.0	0.4	0.5	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.4	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.6	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1
CASC10	"bA418C1.3, C10orf114"	ENSG00000204682	"Cancer susceptibility 10"	Q5T4H9	10	21492658-21497262	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;liver: 13.6"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;AF22: 10.2;AN3-CA: 14.1;BEWO: 13.6;SK-BR-3: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"											HPA064131	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064131: AB_2685196"	"unprognostic (2.69e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (5.86e-4)"	1.8	2.6	8.9	0.9	6.2	0.9	0.9	2.0	8.0	2.5	0.8	6.1	0.1	1.0	1.3	1.1	1.2	2.4	1.7	3.8	11.8	3.8	6.3	13.6	1.5	1.3	3.3	4.2	2.6	1.3	3.7	3.3	7.2	2.7	1.9	0.7	2.0	1.0	1.8	5.0	3.3	0.9	1.5	2.2	0.8	0.9	2.6	5.3	0.1	5.6	0.0	0.8	2.3	1.6	0.6	0.4	2.2	0.3	1.0	0.4	0.2	1.7	10.1	10.2	14.1	1.9	1.0	13.6	0.9	0.4	0.1	0.2	1.5	3.5	0.5	1.5	0.8	2.2	1.8	0.5	0.1	0.3	1.9	0.1	1.4	2.3	0.5	0.0	0.1	1.3	1.8	0.1	0.1	0.9	0.6	0.1	0.1	1.6	0.6	0.6	1.4	0.9	0.7	0.1	0.0	2.0	1.4	1.3	5.0	4.7	8.9	0.6	1.6	7.7	2.4	0.8	8.0	0.2	1.0	0.1	0.2	0.1	4.4	0.0	4.4	1.5	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.1	0.0	0.6	0.2	0.4	2.2	1.0	0.3	0.4	0.2	0.2	8.9	6.2	2.0	8.0	11.8	3.8	3.3	4.2	2.7	5.3
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.2;THP-1: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		960000000	960000000	Vesicles	Vesicles	"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favourable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.1	6.8	5.0	7.8	48.4	21.1	10.6	7.8	9.9	8.8	9.7	3.8	6.2	15.2	7.6	15.5	14.7	8.4	8.5	9.8	13.2	7.7	12.8	7.3	21.9	5.7	75.2	6.4	11.3	5.9	2.6	1.0	10.6	26.5	6.3	11.1	5.8	15.4	13.4	0.0	16.6	10.9	23.8	12.4	24.1	23.3	2.6	4.0	8.8	14.2	11.6	20.3	62.8	7.5	5.3	5.2	13.2	4.6	5.1	2.9	3.2	10.4	51.8	3.8	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles				Vesicles	Vesicles	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.3	3.8	5.0	19.6	11.3	7.3	40.2	7.8	2.0	3.2	3.3	11.8	0.3	0.0	4.2	14.7	0.4	38.3	2.7	0.6	0.0	4.8	2.6	15.3	14.2	51.8	1.6	3.8	4.4	0.4	3.5	3.1	8.6	29.6	22.3	2.4	44.3	2.7	0.0	4.7	6.7	0.0	0.0	42.4	0.1	3.5	10.4	15.3	17.2	1.0	7.4	6.1	20.0	1.1	0.2	9.9	0.1	0.8	7.8	6.2	8.8	3.6	2.3	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3
CBSL		ENSG00000274276	"Cystathionine-beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;liver: 21.2;pancreas: 18.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.7;NTERA-2: 66.2;SH-SY5Y: 21.1;U-266/70: 20.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	47	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"									HPA001223	Supported		Approved	Nucleoli,Vesicles		190000	190000	Vesicles	Vesicles	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	0.0	0.0		0.0		0.0	0.0		11.5	1.8	0.0			0.4	0.0	0.0	0.0	0.3	0.0	1.0			0.0	21.2	0.0	0.0			1.6	18.5	0.0		0.0		1.8	0.0		0.0	3.5	0.0	0.0	0.8	0.0		0.0	0.0	0.0			5.0		0.0	0.3		0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	11.9	35.7	0.0	0.0	0.4	7.4	4.3	2.7	8.3	0.1	4.8	0.0	0.0	0.0	3.1	0.0	3.8	1.7	0.0	9.4	0.0	0.0	0.0	0.2	0.0	5.1	4.2	13.9	0.0	7.0	0.0	0.2	16.5	0.1	0.0	5.6	0.6	66.2	0.0	0.0	0.0	0.0	10.8	0.0	13.8	21.1	0.0	1.1	14.4	0.0	0.0	0.0	0.7	0.0	4.6	1.4	20.9	7.7	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0										
CBWD6	CBWD7	ENSG00000215126	"COBW domain containing 6"	Q4V339	9	41131306-41199261	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"blood: 9.3;liver: 6.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 19.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (9.48e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.28e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.94e-4)"	0.1	5.2	2.2	0.4	2.4	2.0	2.8	1.0	2.0	0.2	0.3			1.2	0.1	0.0	0.2	0.0	1.6	1.3	2.8	1.5	2.1	6.1	0.1	0.0	1.2		0.2	1.3	0.0	0.5	0.0		0.6	0.0		2.8	2.5	4.3	0.4	0.9	0.0	1.2	0.3	0.2	0.1			0.3		0.2	0.2	0.1	4.8	4.0	2.5	9.3	0.6	4.3	2.8	1.4	0.3	0.6	0.3	0.7	1.8	1.2	7.8	8.7	9.0	0.0	2.9	0.9	1.8	0.4	6.3	1.2	11.4	0.2	0.3	1.8	7.3	0.5	4.1	2.1	0.0	2.2	0.7	0.2	1.1	6.0	7.5	6.9	1.0	1.1	12.3	1.2	3.4	0.6	1.9	19.1	0.8	7.6	2.6	8.0	0.5	0.9	1.0	1.9	0.7	0.9	0.6	1.2	11.5	0.1	0.8	0.3	0.8	3.4	0.6	10.1	1.2	0.8	0.9	1.6	5.9	2.5	0.8	6.8	1.4	4.8	4.3	3.5	3.3	1.8	3.0	3.4	0.9	0.6	9.3	4.0	1.8	2.8										
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756801-42802360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.8;pituitary gland: 24.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 10.8;U-2 OS: 19.5;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	4.0	6.0	7.5	2.5	10.2	1.6	3.0	1.0	8.4	2.1	2.3	4.1	0.5	5.0	2.7	1.9	2.0	1.6	6.1	4.6	7.1	3.2	3.6	52.8	3.2	8.6	4.9	5.5	8.2	2.1	0.0	24.3	2.8	20.9	2.1	0.3	1.9	2.1	0.3	1.5	3.1	12.4	0.6	8.8	6.9	1.9	5.7	8.5	8.5	1.7	0.5	3.0	2.9	3.1	3.6	10.0	0.3	0.7	6.2	6.1	1.3	0.3	0.1	0.9	0.1	2.8	3.5	0.0	4.7	0.1	0.0	0.3	0.0	0.2	0.0	0.3	2.1	3.7	0.0	0.0	0.4	0.0	0.3	0.2	10.8	4.5	2.8	0.1	0.0	4.5	0.0	1.9	0.0	1.4	0.5	1.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.3	5.4	0.0	0.1	0.0	0.4	0.1	0.1	0.2	19.5	4.5	0.1	0.1	13.0	0.1	5.7	0.1	0.1	0.1	0.1	0.1	4.0	0.7	4.9	2.2	3.0	5.0	0.7	3.6	4.0	6.1	0.3	6.2	0.3	10.0	1.9	1.3	7.5	10.2	1.0	8.4	7.1	3.2	4.9	5.5	20.9	8.5
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106656765-106660996	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"				"Golgi apparatus, Actin filaments"	"Golgi apparatus, Actin filaments"	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavourable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	19.5	5.2	2.4	13.2	2.2	8.8	10.6	0.6	3.8	7.8	8.4	2.5	5.8	4.3	10.3	6.5	6.3	19.7	9.2	6.3	3.5	2.3	9.0	42.9	11.2	10.8	1.8	2.7	13.4	6.3	3.2	3.7	4.0	2.3	9.3	4.0	8.1	16.5	4.9	6.7	3.2	8.3	7.0	2.4	17.0	9.0	12.7	2.2	35.3	9.1	2.9	6.8	12.5	10.8	2.3	2.4	7.3	1.2	1.6	2.9	0.8	10.2	2.1	3.2	3.8	7.2	6.9	0.0	16.0	20.4	6.2	6.7	0.3	6.5	7.0	5.5	26.7	1.1	1.5	4.5	5.1	16.2	3.7	0.8	0.4	0.0	11.3	3.5	8.4	5.8	2.7	2.8	1.6	21.4	23.1	17.2	7.3	2.9	4.7	5.5	6.9	7.6	6.4	0.9	1.3	3.1	0.6	1.4	9.6	10.2	3.7	22.1	1.7	4.2	9.4	13.8	1.2	1.6	6.1	16.7	1.5	5.6	10.6	4.5	15.1	7.2	1.0	3.0	2.0	0.8	1.5	2.3	1.6	1.5	0.7	1.7	0.8	1.2	7.3	1.6	1.2	2.4	2.9	0.8	2.4	2.2	0.6	3.8	3.5	2.3	1.8	2.7	2.3	2.2
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36002038	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 36.4;liver: 17.9"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 26.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	7900000	7900000	"Golgi apparatus"	"Golgi apparatus"	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favourable (3.02e-4)"	0.0	0.0	0.0	6.1	0.0	0.0	0.6	0.0	0.0	0.1	18.0	0.0	0.0	11.6	0.0	0.4	0.0	1.1	7.4	0.8	0.0		6.4	17.9	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	15.8	0.0	0.0	0.0	0.0	0.4	36.4	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	1.0	2.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.7	0.4	0.2	2.2	0.9	0.1	1.0	0.3	0.0										
CD302	"BIMLEC, CLEC13A, DCL-1, KIAA0022"	ENSG00000241399	"CD302 molecule"	Q8IX05	2	159768630-159798255	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 113.8"	"Cell line enriched"	"Detected in many"	5	"ASC diff: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	190	"dendritic cells: 17.0;granulocytes: 19.1;monocytes: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									16000	16000				"unprognostic (2.52e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (2.37e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-3)"	27.1	9.4	5.0	6.1	5.9	10.1	28.6	3.3	4.3	13.8	13.8	4.0	2.6	8.7	11.4	11.0	7.9	9.7	11.7	13.7	5.6	3.3	9.3	113.8	22.9	23.3	5.9	2.7	16.3	9.0	4.7	4.0	7.0	6.3	11.5	7.7	13.7	7.7	7.8	6.1	4.9	13.9	12.1	8.7	18.9	8.5	9.2	5.9	0.7	26.6	6.3	3.4	12.4	23.8	0.0	17.0	19.1	20.8	0.0	0.0	7.5	0.0	0.5	0.4	0.0	76.1	15.9	0.0	1.9	7.6	2.2	3.3	0.6	0.7	0.1	0.8	4.0	0.0	1.6	0.8	3.1	0.5	2.6	2.9	0.5	1.1	3.8	5.7	2.1	12.6	0.4	2.4	0.0	5.6	0.2	2.7	2.8	0.2	0.0	4.1	0.7	2.3	0.0	0.6	0.0	0.4	0.1	0.9	1.0	0.6	1.8	1.7	1.5	5.5	1.9	4.4	0.0	0.1	1.2	0.3	0.0	0.0	3.0	0.5	0.9	6.2	20.8	19.1	0.0	16.4	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	19.1	0.0	15.6	4.5	0.0	7.5	5.0	5.9	3.3	4.3	5.6	3.3	5.9	2.7	6.3	5.9
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816954	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 142.1;seminal vesicle: 53.7"	"Cell line enhanced"	"Detected in some"		"AF22: 22.6;ASC diff: 27.9;ASC TERT1: 10.8;HAP1: 8.0;NTERA-2: 8.4"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"memory CD4 T-cell: 4.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036573: , HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	31.9	6.2	9.3	1.7	11.2	0.8	9.9	7.6	9.4	3.4	1.5	3.7	36.4	1.0	3.1	42.6	1.8	4.9	3.7	7.6	7.3	9.0	1.7	142.1	3.9	2.3	6.5	5.5	8.7	4.7	1.0	6.5	17.7	14.5	4.0	1.3	19.2	2.8	53.7	3.5	1.1	1.1	2.6	5.3	1.8	1.2	5.0	4.3	0.0	2.8	2.5	1.6	2.4	2.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	22.6	0.0	27.9	10.8	0.1	0.6	0.2	2.2	2.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	3.1	0.0	3.9	0.7	0.0	0.6	0.1	0.0	0.0	4.1	0.0	0.3	0.0	2.9	0.0	0.0	2.5	0.0	0.5	0.1	8.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	9.3	11.2	7.6	9.4	7.3	9.0	6.5	5.5	14.5	4.3
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"Carcinoembryonic antigen related cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 12.5;Hep G2: 35.4;RT4: 23.3;SK-MEL-30: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.6;neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.6"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	180000000	180000000			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favourable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	5.3	5.0	0.4	30.2	0.7	15.8	5.3	0.5	0.5	7.7	58.7	0.9	2.5	11.8	3.5	1.5	35.6	1.7	4.3	3.8	0.5	0.5	24.0	46.1	5.4	8.6	1.8	0.0	2.5	1.0	0.0	3.7	16.8	1.0	8.8	35.6	1.7	20.7	5.4	0.9	1.7	54.9	3.0	1.5	5.5	3.6	1.3	0.7	1.2	2.3	18.5	46.5	7.8	12.7	1.9	0.1	20.6	1.8	0.0	1.5	0.3	0.1	2.3	0.1	0.1	0.0	0.0	6.0	0.0	0.1	0.4	0.2	0.9	12.5	0.7	5.0	0.0	0.3	0.0	3.4	0.1	0.0	0.2	0.1	0.1	35.4	0.7	0.0	5.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.4	0.1	0.0	0.1	0.7	0.7	0.0	0.5	0.2	23.3	0.1	0.0	0.0	0.0	26.2	0.1	0.0	0.8	0.1	0.2	0.1	0.1	0.7	0.0	1.3	0.0	0.1	0.1	0.4	0.0	20.6	0.0	0.9	0.2	1.9	0.5	0.2	0.1	0.3	0.4	0.1	12.7	0.0	1.8	0.0	1.5	0.3	0.4	0.7	0.5	0.5	0.5	0.5	1.8	0.0	1.0	0.7
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT/enhancer binding protein alpha"	P49715	19	33299934-33302564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 52.3;liver: 44.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 42.6;Hep G2: 22.8;NB-4: 23.5;THP-1: 85.0;U-937: 27.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.0;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	40.7	1.5	2.3	7.6	4.6	8.4	52.3	2.1	4.0	3.5	9.0	5.2	1.1	9.0	2.2	2.1	6.1	2.4	6.4	6.6	3.9	2.4	2.0	44.3	39.9	10.3	4.1	3.1	1.3	9.0	4.5	1.7	17.4	2.7	3.8	5.1	1.9	5.6	1.6	15.4	23.7	12.7	2.9	6.6	3.0	3.5	1.2	2.6	2.2	2.5	10.7	3.5	5.4	7.9	0.1	4.1	11.0	11.8	0.0	0.6	1.5	0.5	1.0	0.0	1.5	12.3	0.0	42.6	0.0	0.3	0.0	0.0	5.1	0.0	0.0	0.6	0.0	1.9	1.2	0.1	0.0	7.3	1.5	0.0	0.0	22.8	0.2	7.5	9.1	0.4	5.5	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	23.5	1.0	0.5	0.0	0.0	0.2	0.0	3.7	0.0	0.3	0.1	0.1	0.1	2.9	85.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	27.2	0.0	11.0	6.0	0.0	0.6	9.4	0.6	0.0	0.1	0.4	4.1	0.1	0.2	0.4	2.1	0.0	11.8	0.2	0.0	1.5	2.3	4.6	2.1	4.0	3.9	2.4	4.1	3.1	2.7	2.6
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975004	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 142.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027262	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		24000	24000	"Nuclear membrane, Endoplasmic reticulum"	"Nuclear membrane, Endoplasmic reticulum"	"HPA027262: AB_1852717"	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	19.4	65.5	17.0	10.5	36.1	13.9	22.6	9.6	21.3	19.8	21.1	59.3	22.1	19.6	16.9	19.0	12.5	21.1	21.6	14.4	23.0	16.1	60.9	142.3	28.6	14.0	50.1	14.5	21.8	29.7	28.7	17.6	24.0	25.5	18.5	18.8	16.5	12.3	19.2	7.1	9.1	33.3	21.2	63.7	13.2	23.4	10.2	38.7	10.2	35.5	8.8	14.0	17.5	25.6	12.3	23.5	56.6	27.0	19.3	33.6	26.2	25.7	28.2	23.8	51.0	71.1	43.7	17.8	26.4	38.8	50.3	34.6	29.5	45.7	22.7	44.1	41.4	29.4	33.0	28.1	41.4	30.8	26.9	31.3	19.8	35.8	51.5	35.5	38.8	39.7	36.3	44.4	55.4	31.3	33.5	52.0	62.8	38.8	23.2	20.5	36.5	50.5	26.5	16.2	36.2	54.5	21.9	22.0	34.3	29.1	51.7	30.1	61.6	53.9	24.3	36.5	16.4	32.9	46.4	33.7	37.8	142.5	41.0	15.2	36.9	56.6	27.0	44.0	28.0	14.6	33.6	12.3	25.7	28.4	23.4	11.4	22.9	22.2	29.2	19.3	10.2	23.5	28.8	26.2	17.0	36.1	9.6	21.3	23.0	16.1	50.1	14.5	25.5	38.7
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.9;Daudi: 9.8;U-937: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	1200000	1200000	"Nuclear membrane, Endoplasmic reticulum"	"Nuclear membrane, Endoplasmic reticulum"	"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favourable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.5	3.5	0.4	8.9	0.3	0.2	1.4	0.3	0.2	0.4	0.6	0.5	4.4	9.8	3.0	0.0	0.7	1.4	0.7	0.2	1.6	6.5	4.9	1.4	2.9	0.1	1.1	0.7	0.4	1.1	1.0	0.2	0.0	3.1	2.1	0.4	1.4	1.6	1.7	1.5	0.6	1.5	0.8	1.5	0.1	0.5	0.5	1.0	0.3	6.7	0.2	5.9	7.5	0.4	0.5	2.8	0.8	0.2	1.1	4.0	1.4	0.3	8.3	0.3	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961850-56983845	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5;lymphoid tissue: 54.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.1;HUVEC TERT2: 8.6;TIME: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1;plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	380000000	380000000				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	16.0	1.9	0.6	4.8	1.0	2.0	4.8	0.3	0.7	0.3	0.9	0.3	0.2	0.3	0.3	0.7	1.3	0.3	1.8	3.1	0.7	0.5	4.1	23.5	2.9	54.5	0.7	0.7	0.6	0.6	0.3	3.0	17.7	0.9	0.7	0.1	9.7	7.7	0.5	0.4	0.5	1.7	0.2	0.7	36.7	0.5	0.4	0.0	3.7	4.6	0.1	3.4	0.7	0.3	1.7	5.8	0.3	5.1	4.2	0.2	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.9	1.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.4	0.0	0.6	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.2	1.2	0.0	1.7	0.0	0.0	0.7	0.3	0.1	0.0	0.3	4.2	5.1	5.8	0.1	2.3	0.6	1.0	0.3	0.7	0.7	0.5	0.7	0.7	0.9	0.0
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846390	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 24.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.4;Hep G2: 25.8;T-47d: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 6.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	15	"granulocytes: 6.4;T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036633, HPA058130"	Enhanced									"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favourable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.7	2.2	11.6	2.3	9.7	0.9	7.8	12.9	10.2	4.1	8.8	8.2	0.8	8.3	3.2	3.8	1.0	2.8	5.5	3.3	13.8	4.0	36.6	24.0	2.6	1.4	11.9	6.5	1.6	15.5	8.0	5.9	0.8	10.0	5.4	9.4	3.3	13.7	1.5	3.8	1.6	14.0	1.4	6.4	0.7	8.1	4.5	13.0	0.0	4.1	0.1	1.6	0.8	1.0	0.3	0.1	6.4	0.1	0.1	2.8	0.1	0.3	3.4	0.9	0.1	0.0	0.0	3.9	0.2	0.4	0.0	0.0	8.4	0.6	0.3	0.6	0.6	0.0	5.5	0.0	0.0	0.0	3.0	0.0	1.2	25.8	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.0	0.5	0.0	5.0	0.0	0.1	5.4	0.6	0.0	1.4	5.9	3.9	3.0	2.3	3.0	1.4	0.1	0.0	8.5	0.1	0.0	0.0	0.6	0.2	0.8	0.8	1.1	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	2.8	0.1	11.6	9.7	12.9	10.2	13.8	4.0	11.9	6.5	10.0	13.0
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8;liver: 48.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.6;Hep G2: 15.0;MCF7: 3.2;U-2 OS: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	120000	120000			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavourable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	8.9	6.2	8.9	3.1	6.4	0.4	4.2	32.8	15.9	13.0	2.9	2.4	1.8	2.7	14.9	6.4	3.2	5.7	3.9	4.6	6.5	1.1	10.1	48.3	3.0	2.2	1.8	7.0	7.9	13.9	0.8	2.5	3.8	4.7	4.2	1.6	2.6	2.0	8.3	4.9	3.2	3.0	7.0	2.9	4.6	3.4	1.2	1.8	0.0	3.2	2.3	0.9	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.1	0.1	1.9	0.5	0.0	0.3	0.2	3.6	0.0	0.0	1.4	0.4	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.1	15.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.9	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	32.8	15.9	6.5	1.1	1.8	7.0	4.7	1.8
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305701-190322475	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 134.3;skin 1: 73.9"	"Group enriched"	"Detected in some"	4	"EFO-21: 105.2;HaCaT: 36.8;hTCEpi: 45.9;RPTEC TERT1: 65.8;RT4: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB002602, HPA048319"	Enhanced									"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	11.4	14.7	1.0	4.9	0.5	0.0	5.8	0.2	0.7	10.1	7.2	1.2	11.4	0.1	46.5	18.8	13.8	18.8	9.2	3.2	0.7	0.6	7.2	134.3	5.5	0.0	1.0	0.4	13.3	18.0	0.0	1.3	30.5	2.0	13.0	0.3	0.5	10.6	18.2	0.6	73.9	0.4	31.1	1.3	1.2	0.4	7.1	0.1	6.7	8.5	12.2	19.8	9.7	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.6	0.0	0.0	0.0	0.0	0.0	0.3	8.2	0.1	0.3	2.7	10.7	0.0	105.2	0.0	36.8	0.2	12.0	1.0	0.1	0.2	0.0	1.5	6.3	8.0	0.0	0.0	0.0	45.9	0.9	13.9	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.8	0.0	0.1	0.0	65.8	41.2	0.0	0.0	4.8	0.9	2.7	8.4	0.0	1.9	0.1	1.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.7	0.7	0.6	1.0	0.4	2.0	0.1
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Group enriched"	"Detected in some"	20	"A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit"	O76031	15	65148219-65185342	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favourable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	10.4	12.8	11.3	8.9	12.7	7.7	10.2	10.9	10.7	11.7	13.4	11.2	4.7	9.3	9.8	10.3	15.5	8.9	9.6	15.9	10.7	9.2	16.8	50.9	9.4	8.8	12.8	8.1	10.8	10.6	11.0	6.3	10.6	9.8	9.7	8.9	7.4	8.9	7.1	25.8	15.6	12.6	10.8	9.7	9.7	9.9	9.3	12.6	17.8	12.9	14.7	10.2	12.5	9.5	7.7	9.8	11.4	7.1	8.2	9.2	4.4	5.2	9.0	7.8	9.9	8.4	10.8	8.5	6.0	6.8	6.6	7.0	8.9	7.4	16.3	5.1	8.1	11.3	28.7	8.0	7.1	6.4	5.2	12.2	8.7	11.3	12.0	15.6	7.1	12.8	11.0	6.1	11.7	8.4	11.2	5.8	7.7	6.6	7.3	13.8	8.8	4.0	14.5	9.4	16.8	12.5	12.2	6.8	5.5	8.1	13.1	8.8	5.9	13.2	7.4	6.7	5.9	5.4	5.6	6.2	9.4	8.6	6.6	19.8	5.2	3.5	7.1	10.3	7.6	5.7	7.0	7.7	6.7	5.6	6.4	7.2	9.2	7.3	11.4	8.2	5.1	9.8	5.7	4.4	11.3	12.7	10.9	10.7	10.7	9.2	12.8	8.1	9.8	12.6
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892947	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 69.3;kidney: 14.7;liver: 25.6"	"Cell line enriched"	"Detected in some"	6	"CACO-2: 7.0"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014482	Approved									"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favourable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.4	0.2	0.3	3.1	0.2	0.0	0.2	0.2	0.3	0.2	27.5	0.3	0.2	23.7	0.2	1.3	0.2	0.1	9.5	0.2	0.3	0.2	14.7	25.6	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	23.5	0.2	0.2	0.2	0.2	0.1	69.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	7.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.1	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27615031	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 580.4;liver: 590.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 233.1;SK-BR-3: 203.8;T-47d: 148.7;U-2 OS: 133.0"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 69.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253"	Enhanced				"Secreted to blood"	36000000000	36000000000			"CAB016253: AB_673562, HPA000572: AB_1078539"	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (7.66e-5)"	"unprognostic (5.29e-2)"	82.5	217.4	233.5	50.2	280.3	3.4	90.4	141.2	414.7	78.3	47.9	139.5	184.6	19.9	55.4	580.4	48.3	217.2	172.7	24.6	176.2	154.7	69.8	590.5	30.5	127.3	209.0	173.1	49.6	134.8	220.4	34.3	8.5	189.0	63.4	18.0	125.4	62.2	359.2	7.7	12.8	24.0	87.9	255.2	17.2	56.6	161.5	113.5	5.3	106.6	11.8	134.8	72.2	54.7	0.1	1.3	69.2	2.1	0.9	2.7	110.6	0.7	96.0	4.2	4.9	23.8	32.8	13.4	17.0	33.6	4.5	2.3	18.4	15.2	0.3	68.3	15.1	32.2	18.2	2.7	2.9	70.8	17.6	41.6	233.1	22.6	20.8	1.0	111.1	54.9	11.0	19.4	5.6	59.1	0.5	49.0	1.5	16.1	0.3	3.1	35.0	11.4	0.3	16.1	13.3	44.4	69.3	3.9	2.4	23.6	203.8	1.0	148.7	0.6	8.7	1.3	133.0	7.6	5.7	6.3	22.4	0.7	107.0	6.9	0.6	69.2	2.1	0.9	2.3	0.6	0.8	0.0	2.7	2.5	0.7	0.1	0.3	0.8	9.6	0.9	0.1	1.3	0.7	110.6	233.5	280.3	141.2	223.1	176.2	154.7	209.0	173.1	189.0	113.5
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.2"	"Cell line enhanced"	"Detected in all"		"CACO-2: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"				Vesicles	Vesicles	"HPA031505: AB_2673912, HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favourable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	14.1	21.0	9.6	10.4	12.4	7.8	10.2	16.0	20.9	7.6	17.5	10.6	7.4	29.4	8.4	6.9	28.7	7.6	11.2	31.8	8.5	6.9	28.6	75.2	7.4	8.2	7.0	9.7	8.3	20.3	7.0	8.2	6.2	12.5	9.4	8.1	9.9	18.9	8.4	65.6	20.0	20.9	9.9	6.5	9.9	13.6	11.4	7.5	6.8	10.1	22.1	15.9	12.4	10.0	4.5	5.0	0.4	5.9	1.1	4.7	1.5	18.6	33.3	2.4	8.4	5.0	3.6	27.8	10.0	3.5	10.8	7.8	67.1	7.6	34.1	12.0	4.7	34.2	11.1	13.0	3.6	12.2	24.6	18.7	25.8	23.2	4.6	14.8	12.2	6.0	7.8	12.2	6.3	5.5	22.8	10.3	3.2	20.1	16.6	14.5	7.6	19.2	27.2	10.4	18.0	6.8	28.9	11.2	8.9	11.4	31.5	11.7	18.9	7.7	10.5	9.0	12.4	24.6	21.9	5.2	5.9	12.9	9.3	19.8	10.6	0.0	4.3	0.0	3.4	5.9	2.6	4.1	2.0	1.8	4.4	4.5	4.7	4.1	0.4	1.1	3.6	5.0	2.6	1.5	9.6	12.4	16.0	20.9	8.5	6.9	7.0	9.7	12.5	7.5
CLYBL	CLB	ENSG00000125246	"Citrate lyase beta like"	Q8N0X4	13	99606669-99897134	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039959, HPA040691"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA039959: AB_10793857, HPA040691: AB_10794746"	"unprognostic (1.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.30e-3)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (6.66e-16)"	"unprognostic (3.74e-2)"	"unprognostic (5.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (7.82e-2)"	4.2	11.6	6.2	10.4	9.4	2.6	6.0	6.7	6.4	4.6	11.2	3.8	4.8	13.6	5.2	7.6	6.4	4.7	8.3	12.3	5.1	6.3	35.0	57.7	4.7	9.6	7.9	8.6	3.5	15.0	6.1	5.7	2.2	12.5	4.2	12.3	8.9	8.7	5.5	22.2	5.7	12.5	8.6	4.5	5.5	4.8	10.7	4.3	4.6	7.0	13.3	8.2	4.9	4.4	11.0	7.5	1.2	6.7	9.2	16.7	5.5	0.2	1.3	9.8	4.4	4.6	4.3	2.1	0.4	0.9	0.8	1.5	0.2	7.2	1.7	2.8	0.5	2.2	0.8	1.6	1.1	8.6	1.4	10.9	2.6	6.7	3.2	5.8	0.8	2.3	4.9	0.1	3.8	1.2	1.5	5.7	0.9	2.4	2.6	8.1	6.3	2.0	3.4	0.4	4.0	9.7	0.6	31.7	4.8	1.9	2.2	1.9	4.7	7.6	0.1	0.4	1.1	0.8	1.5	13.3	2.6	0.3	6.8	8.6	1.3	1.2	3.3	0.3	7.5	6.7	9.0	10.9	13.3	10.6	6.7	11.0	10.3	12.1	0.5	9.2	3.2	7.5	16.7	5.5	6.2	9.4	6.7	6.4	5.1	6.3	7.9	8.6	12.5	4.3
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.1;RT4: 10.5;U-2 OS: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.1	0.1	0.7	0.0	2.0	0.3	0.4	0.1	0.0	0.8	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	0.0	0.8	0.7	0.2	1.3	0.1	0.2	0.6	3.0	0.1	0.0	0.1	0.6	10.5	0.3	0.1	0.2	0.6	0.2	1.1	0.0	0.6	0.3	4.1	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.3	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2
CNTD2	"CCNP, FLJ13265"	ENSG00000105219	"Cyclin N-terminal domain containing 2"	Q9H8S5	19	40222208-40226697	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 8.0;brain: 12.0;liver: 7.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.8;Karpas-707: 1.4;SCLC-21H: 6.6;T-47d: 1.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 12.0"	"Cell type enriched"	"Detected in single"	81	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	81	"granulocytes: 8.0"					"Low region specificity"	"Detected in single"			HPA045615	Uncertain									"HPA045615: AB_2679390"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.79e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	3.9	1.0	0.7	0.1	1.2	0.3	1.4	12.0	1.8	1.0	0.2	0.4	0.0	0.4	0.3	2.1	0.1	1.9	0.7	1.5	1.1	0.8	5.6	7.9	0.3	0.2	0.5	0.0	0.4	0.1	0.1	3.5	2.8	1.3	1.5	0.5	0.4	0.4	0.3	0.7	0.6	0.6	0.4	0.8	0.6	0.7	1.0	0.0	0.0	1.4	0.7	0.1	0.2	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.9	0.7	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.1	0.0	6.6	0.3	0.5	0.0	0.6	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.4	0.0	0.3	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	12.0	1.8	1.1	0.8	0.5	0.0	1.3	0.0
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405137-45513720	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 273.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.2;EFO-21: 70.3;NTERA-2: 39.1;TIME: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.3"	"Region enriched"	"Detected in many"	6	"cerebellum: 24.8"	"Low region specificity"	"Detected in all"			"CAB001961, HPA011025, HPA036104"	Approved		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	250000000	250000000	"Golgi apparatus"	"Golgi apparatus"	"CAB001961: , HPA011025: AB_1078551, HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	25.5	14.4	2.2	12.7	13.0	5.6	17.7	3.4	8.5	40.4	12.7	26.0	19.6	12.6	22.2	72.5	12.0	18.8	25.3	18.5	3.5	5.3	36.2	273.2	11.9	7.6	35.5	3.5	43.3	21.8	2.6	17.8	16.5	20.8	13.9	2.3	17.3	8.8	20.2	8.1	23.1	10.6	33.4	31.9	14.5	7.1	11.0	23.6	2.3	16.0	12.0	6.7	28.7	18.2	0.4	0.4	7.3	0.4	0.0	1.2	0.2	2.5	19.1	4.8	4.3	8.9	7.4	1.0	18.4	31.2	8.8	2.4	11.9	6.8	0.5	70.3	18.2	8.6	1.0	1.1	1.7	0.2	5.3	11.0	0.3	16.2	8.6	0.4	1.1	8.7	0.7	0.8	1.0	27.1	11.1	0.1	3.2	4.4	0.4	1.1	39.1	7.1	0.5	3.0	1.1	29.7	0.4	5.4	4.1	1.8	2.0	5.8	1.8	3.0	41.3	0.2	2.8	0.1	4.3	0.1	0.2	0.3	0.0	0.9	7.6	1.0	0.4	1.5	0.1	0.4	0.2	0.4	0.4	0.0	0.1	0.1	1.2	0.6	7.3	0.0	0.3	0.4	0.0	0.2	2.2	13.0	3.4	8.5	3.5	5.3	35.5	3.5	20.8	23.6
COLEC11	"CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 61.9;liver: 57.4"	"Group enriched"	"Detected in some"	7	"HHSteC: 52.5;SH-SY5Y: 47.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035241	Uncertain				"Secreted to blood"	30000000	30000000			"HPA035241: AB_10600701"	"unprognostic (3.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.95e-3)"	"unprognostic (5.85e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-1)"	3.7	13.2	0.5	0.5	1.2	0.6	1.7	0.7	1.4	0.5	1.7	1.3	0.8	1.7	0.7	1.0	1.2	1.4	61.9	14.8	0.9	0.1	7.9	57.4	0.9	1.8	0.6	0.5	15.8	6.5	0.2	2.0	2.8	3.6	1.6	0.1	1.0	0.8	0.5	1.0	0.4	3.0	1.6	0.7	1.4	0.7	2.5	0.5	0.7	5.5	0.6	0.5	1.8	1.5	1.2	0.8	4.0	0.8	1.2	1.8	0.2	0.0	0.4	0.2	0.8	0.0	0.0	4.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.4	1.5	52.5	0.0	0.3	0.5	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.6	47.4	0.5	0.3	0.2	0.1	0.3	0.0	0.0	0.2	0.2	0.1	1.0	7.6	0.4	0.1	0.4	0.2	1.9	0.8	1.2	0.6	0.2	0.5	0.6	0.3	0.3	0.3	1.2	1.8	1.0	4.0	1.2	0.4	0.8	0.3	0.2	0.5	1.2	0.7	1.4	0.9	0.1	0.6	0.5	3.6	0.5
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		560000	560000	Vesicles	Vesicles	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favourable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favourable (5.67e-4)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.0	19.6	2.2	19.4	22.1	19.7	0.8	21.6	27.3	18.5	21.3	16.6	22.2	7.7	9.6	30.9	26.1	3.7	23.2	4.9	16.6	24.7	13.7	10.5	38.7	41.3	22.8	5.5	25.0	28.7	16.1	16.0	17.4	55.4	16.4	15.0	118.0	8.9	41.0	4.8	6.6	13.5	19.4	10.6	19.6	60.5	9.5	8.3	7.2	61.3	17.8	13.2	64.3	20.8	33.2	12.7	10.9	16.2	6.0	2.5	6.3	35.8	30.9	22.8	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291087	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.4;liver: 39.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 15.8;U-266/70: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059056			Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"				Nucleoplasm	Nucleoplasm	"HPA059056: AB_2683893"	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favourable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favourable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	3.1	6.1	11.9	3.0	10.9	2.9	5.0	33.4	24.6	4.0	3.8	4.4	5.5	4.8	3.3	6.8	6.0	3.3	3.4	7.0	10.7	11.5	7.0	39.5	3.6	3.0	10.3	15.1	5.8	5.4	6.6	8.6	2.8	16.4	6.5	4.2	3.0	10.2	8.0	23.4	5.3	4.6	3.4	4.6	4.1	4.5	20.5	7.0	0.3	9.3	5.4	3.4	3.3	4.5	1.8	0.9	6.5	1.5	0.5	0.7	0.5	1.1	0.3	0.4	2.6	0.7	0.7	1.1	1.1	0.8	1.6	1.3	0.8	2.6	1.4	1.3	0.5	3.3	1.1	0.9	0.9	1.6	1.4	1.8	1.8	0.9	2.0	0.9	1.9	0.6	2.0	1.0	3.1	1.5	1.3	15.8	0.6	0.9	1.2	1.0	0.2	1.2	1.5	2.3	2.7	1.6	0.5	2.0	0.6	1.0	3.0	1.9	3.8	2.0	1.2	0.8	0.8	0.6	1.0	8.8	2.3	1.5	0.4	3.0	0.2	6.5	1.1	2.2	0.7	1.4	0.5	1.8	0.4	0.7	0.9	0.5	0.4	0.4	1.3	0.5	1.5	0.6	0.3	0.5	11.9	10.9	33.4	24.6	10.7	11.5	10.3	15.1	16.4	7.0
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli, Mitochondria"	"Nucleoplasm, Nucleoli, Mitochondria"	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favourable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.8	3.3	7.7	7.5	6.6	3.9	8.8	4.9	5.0	7.1	6.6	1.6	6.7	13.5	7.5	2.3	7.9	14.3	11.3	6.0	7.4	8.4	7.7	4.5	1.3	9.8	7.3	7.4	8.4	9.7	5.1	4.4	4.8	9.8	4.8	4.4	4.6	5.7	6.0	14.4	8.8	6.6	7.3	14.3	8.8	7.4	11.5	7.7	9.8	12.5	18.5	14.5	15.6	4.7	4.0	3.2	7.0	4.0	14.9	9.1	8.3	5.1	8.4	5.8	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76952713-76981158	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;liver: 99.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;HBF TERT88: 8.7;U-698: 9.5;U-87 MG: 5.2;WM-115: 4.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 24.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	43000000	43000000			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0.0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4.0	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0.0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0.0	1.9	0.9	0.4	0.5	0.2	0.0	0.0	1.2	0.1	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	9.5	5.2	0.0	4.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	3.5	5.4	0.0	7.8	4.0	24.9	2.7	5.4	1.8	1.2
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308797	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;heart muscle: 24.8;liver: 29.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;HEK 293: 4.8;HeLa: 5.0;Hep G2: 9.0;NTERA-2: 8.2;RPMI-8226: 6.7;THP-1: 3.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	14	"myeloid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036198	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.4	0.5	4.2	5.6	5.8	2.5	2.1	9.4	3.0	0.8	0.8	0.6	3.1	2.2	0.8	2.7	0.9	1.0	4.6	24.8	3.5	3.5	10.4	29.0	0.6	5.3	2.3	2.2	1.0	2.4	0.8	1.1	0.7	2.1	4.1	0.5	1.0	0.7	9.5	0.5	1.8	4.5	1.0	1.7	4.4	0.3	13.5	0.4	0.6	1.1	0.4	6.1	1.8	0.5	1.7	25.5	0.5	1.5	0.2	0.0	0.9	0.0	1.1	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.4	0.0	0.9	4.0	0.1	0.0	0.0	4.8	0.0	5.0	9.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.2	0.0	0.0	0.0	6.7	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.5	0.0	1.0	0.0	1.4	0.0	0.0	25.5	1.7	0.0	0.0	0.4	0.2	1.3	0.2	0.0	0.9	4.2	5.8	9.4	3.0	3.5	3.5	2.3	2.2	2.1	0.4
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		210000	210000	"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.4	3.0	2.6	19.0	14.5	16.8	2.6	4.9	8.8	2.1	1.7	1.1	3.2	0.0	9.3	6.7	0.8	2.5	4.4	2.2	8.3	2.1	6.1	0.3	23.7	8.3	1.9	5.5	9.9	2.8	1.6	10.0	23.0	0.4	2.4	5.6	12.5	5.2	3.1	0.1	4.6	2.7	1.7	0.4	18.3	7.4	1.8	2.2	2.9	1.4	21.8	9.4	7.8	22.0	2.7	1.2	6.5	3.0	3.4	0.7	0.0	5.1	3.4	10.9	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		7200000	7200000	Cytosol	Cytosol	"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.3	12.6	3.6	14.5	15.9	8.5	7.8	12.4	11.4	12.8	19.0	10.0	13.6	13.8	15.2	6.7	10.2	9.9	18.6	15.7	4.1	5.6	7.6	38.0	7.6	4.8	11.7	7.3	8.8	18.2	3.3	9.5	17.8	4.9	23.7	5.6	8.7	8.1	9.4	15.8	5.6	11.8	5.0	96.4	7.8	3.5	6.2	1.8	13.2	8.6	11.8	1.6	4.6	2.7	6.8	8.6	11.8	3.5	6.8	6.7	22.3	1.9	7.8	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"		15	80195484-80252213	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"brain: 20.8;epididymis: 9.1;liver: 14.7"	"Group enriched"	"Detected in some"	6	"SK-MEL-30: 3.3;WM-115: 10.0"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 38.5"																"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.3	4.2	12.8	0.3	5.7	0.1	0.2	4.4	8.2	0.2	0.5	2.2	0.0	0.7	0.2	9.1	0.2	0.4	0.2	6.6	20.8		3.5	14.7	2.6	0.4	1.9	1.9	0.4	0.7	0.0	0.0	0.1	4.5	0.2	0.5	1.1	0.2	0.3	0.6	1.3	0.8	0.2	3.3	2.0	3.3	0.3	7.1	0.0	0.8	0.0	0.5	0.2	0.0	0.4	0.1	0.5	0.1	0.3	0.6	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	3.3	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.2	10.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.6	0.1	0.5	0.3	0.0	0.1	0.1	0.0										
CUX2	"CDP2, CUTL2, KIAA0293"	ENSG00000111249	"Cut like homeobox 2"	O14529	12	111034024-111350554	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.9;brain: 13.2;liver: 21.5;prostate: 13.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.3;HDLM-2: 3.1;hTERT-HME1: 4.0;SCLC-21H: 7.4;SH-SY5Y: 15.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 11.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	100	"plasmacytoid DC: 9.9"	"Lineage enriched"	"Detected in single"	100	"dendritic cells: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.87e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.83e-5)"	"unprognostic (2.67e-1)"	"unprognostic (3.54e-3)"	"unprognostic (4.31e-2)"	"unprognostic (9.03e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.90e-2)"	0.2	0.2	2.9	0.4	4.8	0.3	2.3	1.2	13.2	1.1	0.3	0.3	2.8	0.3	0.3	0.5	0.3	0.2	0.2	0.2	1.9	2.1	0.2	21.5	0.2	0.6	2.7	3.1	0.1	0.2	0.1	1.9	0.2	1.0	13.6	0.2	0.6	0.1	5.4	0.2	0.2	0.3	0.1	0.4	0.4	1.2	0.6	0.4	0.0	4.9	0.0	0.7	0.3	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.2	0.0	0.1	0.0	0.1	7.4	15.9	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	2.9	4.8	1.2	13.2	1.9	2.1	2.7	3.1	1.0	0.4
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097035-74099293	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;HHSteC: 17.2;hTCEpi: 18.1;hTEC/SVTERT24-B: 12.9;hTERT-HME1: 17.6;RPTEC TERT1: 12.3;U-87 MG: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.0;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	25	"granulocytes: 1.4;monocytes: 3.5"														"Secreted to blood"						"prognostic favourable (5.93e-5)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	22.8	3.8	2.4	19.9	4.3	20.7	10.9	0.8	1.7	20.4	5.7	2.3	0.9	0.9	4.4	3.8	6.2	5.8	15.2	14.2	1.7	2.0	3.2	113.1	22.4	35.0	2.8	0.5	5.8	24.9	0.6	2.3	1.4	4.3	5.1	6.4	5.1	4.8	3.6	30.9	1.3	3.8	4.1	4.6	3.7	7.5	3.1	1.6	0.0	2.1	18.5	1.8	11.7	4.1	0.0	0.0	1.4	3.5	0.0	0.0	0.1	0.6	1.7	0.1	0.0	0.6	2.1	0.0	1.9	24.4	1.0	2.9	0.1	3.8	0.0	3.4	0.1	0.0	0.1	5.3	4.0	0.0	0.0	1.5	2.0	0.0	17.2	0.6	0.0	1.9	18.1	12.9	17.6	2.1	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.0	12.3	0.0	0.0	0.0	1.1	0.1	0.5	0.0	0.1	3.2	0.9	0.3	3.8	1.8	0.0	0.0	0.0	14.9	4.0	0.1	1.4	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.5	0.0	0.0	0.1	2.4	4.3	0.8	1.7	1.7	2.0	2.8	0.5	4.3	1.6
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250847-74292016	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 266.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.3;RT4: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		780000	780000	"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB006333: , HPA047548: AB_2680084, HPA058547: "	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	25.0	13.2	4.3	11.0	5.8	1.5	39.4	6.9	5.9	7.5	68.2	4.3	38.5	37.7	4.9	16.0	8.3	7.0	34.8	14.5	4.1	3.7	76.2	266.8	67.0	9.2	6.5	3.4	25.1	75.3	10.1	6.5	7.2	5.2	13.5	9.0	6.2	7.6	54.9	4.3	11.4	70.7	21.2	11.5	10.3	18.0	12.2	5.5	4.6	4.6	7.9	4.3	21.6	18.8	34.9	16.9	2.1	12.9	10.2	38.0	13.5	9.8	16.8	8.8	0.0	151.3	26.9	11.7	6.8	14.7	14.5	21.8	19.8	10.7	12.0	4.8	12.4	22.0	0.0	9.3	11.6	22.4	11.7	4.4	9.2	52.5	23.5	8.4	5.8	45.0	7.4	8.2	4.2	7.9	7.1	4.5	12.1	17.7	4.7	10.0	3.9	10.9	11.7	2.8	0.2	14.4	66.0	25.1	10.4	6.6	18.0	8.0	35.6	8.0	7.4	0.0	11.4	3.5	8.6	3.2	13.0	3.7	8.9	2.3	8.4	1.1	9.6	2.1	16.7	10.8	38.0	28.5	18.7	19.6	16.9	34.9	18.4	23.1	1.1	10.2	12.9	14.8	14.4	13.5	4.3	5.8	6.9	5.9	4.1	3.7	6.5	3.4	5.2	5.5
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 72.6;HSkMC: 13.9;RPTEC TERT1: 18.5;SK-MEL-30: 29.8;WM-115: 11.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA059155: AB_2683933"	"prognostic favourable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favourable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.8	0.1	0.8	3.0	1.0	2.1	3.6	0.1	0.0	1.5	2.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.1	72.6	4.2	0.1	0.0	13.9	0.1	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.1	0.0	0.7	0.1	18.5	0.0	0.0	0.0	0.0	0.0	29.8	0.5	0.7	1.6	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;EFO-21: 1.5;hTCEpi: 2.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"														"Intracellular and membrane"						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.0	0.6	0.2	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.2	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Group enriched"	"Detected in some"	6	"RT4: 35.6;SK-BR-3: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.7	0.2	1.6	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.9	1.6	0.0	3.8	0.0	1.9	35.6	0.5	2.3	0.0	9.6	0.3	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.8;hTCEpi: 15.3;SiHa: 9.2;U-698: 10.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory region: 24.1"	"Low region specificity"	"Detected in all"														"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favourable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	2.6	2.0	1.7	2.9	1.9	0.0	2.9	19.3	1.9	3.6	1.9	1.5	6.4	0.4	1.9	12.0	4.9	2.3	3.4	4.8	1.6	1.1	3.3	52.2	2.6	0.2	2.3	0.9	6.5	8.7	8.6	8.3	0.2	2.3	8.2	1.9	8.0	21.0	1.8	0.5	8.5	1.4	1.7	2.2	0.6	2.7	3.3	0.9	0.0	9.4	2.3	2.1	2.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	2.0	0.3	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.6	6.8	4.9	0.0	1.9	0.9	1.6	0.0	0.0	3.0	0.0	1.7	2.0	4.7	0.0	0.0	0.5	15.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.7	0.5	1.3	0.1	3.3	4.3	0.8	0.0	9.2	0.0	0.2	1.6	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	19.3	1.9	1.6	1.1	2.3	0.9	2.3	0.9
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"		19	15672757-15697174	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 53.0;liver: 24.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.5;HaCaT: 22.0;Hep G2: 6.1;Karpas-707: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	39	"basophil: 5.3;eosinophil: 13.2"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 13.2"									HPA058960	Approved									"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favourable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (2.33e-4)"	1.9	0.7	1.6	6.1	0.9	0.6	3.5	0.0	1.9	3.9	24.6	5.6	1.4	24.6	1.4	1.8	11.5	2.1	10.8	1.7	1.9	0.3	1.1	24.2	0.9	0.3	3.0	3.5	1.9	0.2	0.1	0.3	0.4	2.7	4.4	5.1	1.4	3.0	1.5	0.4	12.9	53.0	5.1	0.8	0.7	8.0	0.4	4.8	0.2	0.6	8.9	6.3	10.1	6.5	0.0	0.0	13.2	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.4	0.0	0.0	22.0	0.0	0.0	0.0	1.2	0.0	0.0	0.9	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	13.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	1.9	1.9	0.3	3.0	3.5	2.7	4.8
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191520-186213456	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.9;SK-MEL-30: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	6.6	16.6	7.8	5.0	12.4	1.6	5.5	8.9	7.5	6.7	8.0	8.9	4.9	11.4	5.7	4.2	5.2	6.2	13.7	7.4	7.7	4.6	21.6	64.7	7.3	4.1	7.7	9.0	6.3	12.1	30.8	16.1	3.0	6.7	5.6	8.2	19.1	6.2	9.1	3.3	2.8	14.7	6.4	7.0	7.5	5.2	3.2	7.4	4.4	11.9	2.1	3.8	8.0	5.1	2.3	2.5	0.0	6.2	1.3	4.0	1.5	2.6	1.8	0.6	0.0	11.1	4.6	0.1	3.7	7.9	1.4	1.9	0.0	10.7	1.0	0.5	2.4	1.3	1.3	1.1	0.4	6.4	1.3	4.0	0.4	0.5	3.3	2.2	2.0	4.1	0.5	1.4	0.6	0.1	1.6	12.9	4.6	2.2	2.4	0.6	1.4	0.0	2.1	0.5	1.1	4.5	5.1	2.8	4.0	0.9	0.0	19.0	1.9	3.5	4.2	2.9	0.7	3.3	1.6	0.0	0.0	0.5	8.8	8.2	3.5	0.0	1.2	0.0	4.0	4.1	2.5	1.0	2.5	3.4	1.5	2.3	2.7	2.3	0.0	1.3	6.2	2.5	2.1	1.5	7.8	12.4	8.9	7.5	7.7	4.6	7.7	9.0	6.7	7.4
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	24.6	12.1	30.5	19.5	21.5	35.2	4.3	8.4	25.4	10.9	29.8	29.0	45.1	21.5	13.3	14.4	21.6	26.6	53.0	12.7	9.0	18.8	6.2	12.9	21.8	29.3	12.6	9.3	25.5	24.1	42.5	44.8	11.1	23.2	49.6	12.8	25.2	2.7	11.7	22.8	12.1	8.7	6.3	48.5	49.4	41.8	21.5	14.4	17.8	35.4	26.0	12.8	15.2	13.2	15.0	16.7	21.6	10.9	16.9	15.0	19.6	11.5	16.8	19.1	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5
DDT	DDCT	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23980469	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.8;liver: 58.4"	"Cell line enhanced"	"Detected in all"		"HEK 293: 67.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA049871	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA049871: AB_2680926"	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3.0	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4.0	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2.0	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38.0	23.8	29.0	28.6	26.7	11.4	4.0	9.3	7.6	6.7	24.2	7.8	5.3	6.8	7.1	10.1	7.7	25.6	7.3	4.1	22.2	9.8	9.7	4.5	10.8	67.6	15.4	15.6	21.9	7.7	33.8	15.5	6.7	7.4	6.8	6.0	7.3	13.9	10.4	6.8	13.1	7.4	30.6	12.0	34.5	16.3	7.4	36.6	12.1	9.9	13.5	13.0	16.1	30.4	22.9	7.7	10.6	8.4	7.1	15.8	7.2	8.1	32.0	10.6	16.1	13.9	12.6	13.6	20.7	38.0	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29.0	28.6										
DDTL		ENSG00000099974	"D-dopachrome tautomerase like"	A6NHG4	22	23966901-23972532	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 36.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (6.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (5.98e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.58e-3)"	3.1	4.7	2.3	5.9	6.8	6.6	6.3	3.3	4.3	2.7	7.8	2.6	4.3	8.3	3.5	4.6	4.7	2.8	5.9	10.7	2.7	2.2	7.0	36.5	3.4	6.5	2.6	4.6	5.0	22.6	0.6	3.3	3.7	4.5	6.1	4.3	2.9	9.0	6.1	10.1	7.0	11.0	3.9	3.0	5.4	6.1	4.4	1.7	3.2	4.6	7.2	3.5	4.6	3.5	2.0	1.6	6.4	2.0	2.5	2.9	0.9	2.9	2.1	2.4	2.5	1.5	0.5	3.0	1.6	0.0	0.0	0.0	4.5	3.0	5.1	1.1	0.2	7.6	2.5	0.6	0.1	1.9	9.9	2.8	7.5	4.3	1.8	7.1	3.2	0.9	1.1	0.5	0.0	0.5	2.8	3.8	0.0	2.2	1.3	4.2	0.9	1.8	4.2	2.5	1.6	1.4	4.2	2.6	1.3	2.3	4.4	7.4	3.7	1.4	1.1	4.5	3.5	1.3	1.2	2.8	0.8	2.1	1.1	3.5	2.6	6.4	1.4	2.2	2.0	2.0	2.1	1.9	1.4	2.9	1.2	2.0	1.1	1.7	0.6	2.5	0.4	1.6	1.4	0.9	2.3	6.8	3.3	4.3	2.7	2.2	2.6	4.6	4.5	1.7
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		740000	740000	Mitochondria	Mitochondria	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavourable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.3	5.9	17.4	19.7	12.2	19.9	3.7	9.1	15.7	5.9	9.3	2.3	10.3	7.9	7.2	10.9	7.8	6.4	9.2	9.9	11.9	0.7	19.0	5.3	9.4	15.3	4.1	3.9	15.7	7.1	4.7	8.0	17.7	19.7	15.7	28.5	11.9	11.8	6.1	1.1	17.8	10.0	4.6	14.1	29.2	26.0	0.7	6.6	13.8	129.9	10.9	16.6	10.7	15.9	10.1	4.8	13.3	5.4	7.9	6.0	9.3	9.6	9.4	12.8	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015864-33033582	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 51.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.5	2.0	1.4	4.1	0.9	2.0	0.5	2.6	1.7	15.3	4.3	1.2	14.1	1.2	1.4	3.1	0.8	3.1	0.9	2.6	1.4	10.9	42.2	0.7	0.4	4.0	1.5	1.3	2.7	3.5	0.8	1.2	2.8	1.4	3.1	1.2	1.7	1.0	3.3	3.4	51.8	1.0	3.2	0.5	2.2	15.6	3.3	1.8	0.6	2.0	0.9	0.9	2.4	0.0	4.4	9.0	0.7	3.0	3.1	0.6	4.5	2.5	3.7	1.6	1.9	1.9	2.4	8.0	2.7	4.9	6.6	6.5	0.4	0.0	1.8	7.9	4.6	5.3	1.9	5.8	0.0	7.4	1.2	7.8	9.2	1.6	4.3	5.5	2.3	2.9	2.8	2.1	0.0	2.9	0.0	26.7	0.5	0.0	7.0	2.4	0.0	0.0	20.2	0.0	1.6	0.6	0.8	2.1	18.4	3.3	15.9	0.8	2.3	0.0	3.2	5.3	17.1	5.1	0.0	0.0	0.0	1.1	0.0	15.6	4.0	0.7	9.0	0.3	0.2	0.0	0.0	0.6	0.3	4.4	0.0	2.9	3.1	0.0	3.0	0.0	1.8	0.0	0.6	2.0	4.1	0.5	2.6	2.6	1.4	4.0	1.5	2.8	3.3
DESI1	"D15Wsu75e, FAM152B, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621096	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	Cytosol	"HPA053415: AB_2682141"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	12.9	14.5	24.6	12.6	25.4	8.4	13.4	17.0	33.3	11.7	11.9	22.8	9.5	14.5	10.4	15.1	19.7	11.3	11.5	30.3	24.3	19.7	19.5	69.2	14.0	13.2	23.5	16.3	12.7	13.2	15.7	10.0	11.8	18.3	13.4	14.0	9.7	13.2	14.4	14.6	15.9	16.1	14.5	22.4	11.3	12.6	29.2	19.0	9.7	9.7	14.6	16.8	10.8	9.2	6.2	7.4	10.6	12.5	2.8	7.3	5.5	7.1	7.6	7.6	10.4	10.8	12.9	4.3	14.4	9.3	13.4	9.9	10.0	4.6	27.2	10.0	16.6	10.4	20.1	16.1	14.1	12.2	15.4	6.1	14.1	8.4	13.2	24.0	8.3	11.0	18.9	16.5	15.4	20.2	17.7	31.0	10.6	9.0	5.4	7.3	7.5	11.5	7.4	3.2	27.8	16.9	4.6	5.4	2.8	13.9	15.3	9.8	5.0	7.9	20.4	10.0	7.2	10.5	7.0	11.4	8.8	13.0	24.6	10.6	13.1	9.5	9.3	10.6	5.0	12.5	6.4	6.2	6.2	5.9	7.4	5.4	5.6	6.5	5.5	2.8	8.2	4.4	7.3	5.5	24.6	25.4	17.0	33.3	24.3	19.7	23.5	16.3	18.3	19.0
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.6;HDLM-2: 24.3;Hep G2: 25.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Low region specificity"	"Detected in all"																		"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	5.1	2.5	0.1	4.5	33.6	2.7	0.4	0.4	0.6	0.6	0.4	18.5	5.4	8.2	6.8	0.1	0.2	0.7	2.6	1.8	24.3	0.4	0.5	1.7	25.4	0.3	2.9	2.9	11.2	13.8	3.0	4.3	0.4	0.4	11.2	0.2	3.3	1.9	6.3	1.4	12.1	0.0	0.0	9.6	0.4	14.2	9.2	0.5	4.7	0.7	1.2	1.8	10.4	0.6	5.8	2.8	0.1	3.5	6.6	14.6	11.0	4.2	9.3	10.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849633-54887218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 164.5;liver: 119.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017981, CAB037247, HPA063005"	Enhanced									"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	10.6	164.5	6.6	3.9	22.1	0.7	22.0	6.5	27.5	7.7	11.1	43.8	1.2	11.9	2.2	1.1	40.8	12.3	8.6	3.7	12.0	9.2	6.4	119.6	40.9	2.0	36.2	13.0	7.8	4.6	28.4	2.6	4.4	47.9	26.1	8.3	4.8	20.2	2.1	24.6	47.6	7.3	2.7	71.7	24.3	17.6	14.1	31.1	1.7	4.3	17.1	14.3	2.5	13.0	5.4	7.0	7.3	3.1	3.7	9.0	5.5	39.9	7.4	26.1	31.5	131.0	28.2	6.1	11.5	20.0	16.7	34.4	41.0	25.3	6.4	23.3	10.1	38.4	31.3	60.9	14.9	0.9	19.6	35.6	17.4	49.0	21.3	14.8	8.3	20.5	53.1	51.5	9.5	8.1	25.9	0.0	6.1	16.8	3.1	13.0	72.3	20.2	0.0	6.6	19.7	91.6	32.5	18.0	6.6	21.9	41.4	15.1	53.9	17.3	7.5	5.6	16.2	8.0	21.8	2.8	6.3	11.0	4.0	25.5	7.2	7.3	2.4	1.1	9.0	3.1	0.5	5.4	4.0	4.2	7.0	2.4	3.9	4.7	0.1	3.7	1.0	4.2	0.7	5.5	6.6	22.1	6.5	27.5	12.0	9.2	36.2	13.0	47.9	31.1
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favourable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.6	19.6	19.2	21.2	9.0	14.0	6.0	8.9	23.8	7.6	20.8	73.0	71.1	15.1	14.3	8.5	41.6	22.8	48.3	8.1	5.7	17.1	5.7	16.6	31.2	23.1	10.8	2.8	16.2	21.4	28.6	19.7	11.2	27.0	32.3	7.6	58.1	8.9	12.2	27.5	11.7	8.1	27.0	65.0	28.6	32.7	26.1	9.7	8.5	28.2	20.3	27.3	5.9	10.6	2.1	11.6	0.6	10.7	10.7	12.9	16.1	6.1	19.2	8.6	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299833	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000599	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	Nucleoplasm	"HPA000599: AB_1078655"	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.18e-5)"	"prognostic favourable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	6.5	8.9	3.0	6.1	5.0	3.3	7.4	6.3	6.0	8.6	12.0	9.8	8.4	16.1	6.7	8.9	35.7	5.4	10.2	3.7	2.7	3.1	8.5	47.1	6.7	4.8	3.6	5.3	4.2	10.7	11.5	5.2	4.1	6.0	5.5	5.4	7.1	14.0	15.6	1.8	20.8	25.7	4.8	4.4	6.3	6.1	2.8	3.7	5.6	6.6	25.6	16.5	6.0	13.0	10.4	10.7	17.3	9.5	4.2	11.7	4.7	11.0	2.6	2.9	1.1	6.7	7.1	0.7	3.9	8.7	9.4	10.2	1.0	10.7	5.2	1.7	6.1	9.0	2.1	18.3	4.5	3.5	2.3	1.5	6.4	17.4	3.1	3.1	1.2	6.4	10.7	2.3	1.7	7.0	3.2	4.9	7.6	4.4	1.1	1.1	0.5	4.0	3.9	2.0	7.1	7.2	4.1	2.5	1.8	5.6	7.6	1.9	3.9	0.9	2.7	0.7	1.8	1.1	1.3	2.8	2.2	2.5	3.3	2.7	0.9	10.0	8.7	17.3	6.9	9.5	7.5	10.4	7.5	6.3	10.7	7.0	7.6	4.2	5.7	4.2	5.9	6.4	11.7	4.7	3.0	5.0	6.3	6.0	2.7	3.1	3.6	5.3	6.0	3.7
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: "	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.2	8.7	13.0	10.3	8.1	4.8	15.7	5.7	3.7	10.2	9.1	5.5	6.7	8.1	1.9	3.5	16.1	13.6	4.4	11.7	4.5	6.1	4.4	3.4	4.2	7.9	1.7	1.7	5.9	3.5	5.9	2.4	5.5	6.9	6.6	2.7	21.8	5.9	3.2	7.2	2.0	10.1	4.2	6.8	6.6	2.7	3.4	15.3	11.2	20.1	6.7	44.2	6.4	2.4	3.3	2.4	6.9	4.1	5.9	4.1	5.2	4.3	3.1	5.5	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446841-22455740	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.2;salivary gland: 16.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.1;LHCN-M2: 4.7;RPTEC TERT1: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 2.5"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favourable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	2.1	0.2	0.7	1.4	0.7	0.0	5.6	0.8	0.7	2.4	1.0	0.7	1.1	0.7	1.2	1.8	5.5	0.3	1.2	0.6	0.6	0.5	5.5	12.2	1.1	1.4	0.8	0.4	0.6	2.7	6.1	2.9	0.0	0.9	2.4	0.4	1.9	16.3	0.5	0.9	0.5	0.8	0.7	0.7	0.4	2.8	0.6	0.0	1.1	5.0	0.6	2.0	0.9	1.7	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.6	0.1	0.0	0.4	0.1	0.2	0.0	10.1	0.3	0.4	0.1	0.1	0.0	2.2	0.0	0.3	2.0	2.7	0.3	0.0	0.7	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.7	0.0	3.7	4.7	1.0	0.0	0.0	2.0	3.4	0.0	0.2	1.4	4.8	0.0	0.2	0.0	1.3	0.8	2.2	0.0	0.0	3.4	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.9	0.0
DNAJC12	JDP1	ENSG00000108176	"DnaJ heat shock protein family (Hsp40) member C12"	Q9UKB3	10	67796665-67838166	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.7;liver: 46.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 32.4;NB-4: 26.7;SCLC-21H: 26.7;U-698: 24.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 22.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036289	Enhanced									"HPA036289: AB_10670794"	"unprognostic (1.52e-2)"	"unprognostic (3.65e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.97e-2)"	"unprognostic (7.31e-3)"	"prognostic unfavourable (1.97e-10)"	"unprognostic (7.35e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.81e-3)"	"unprognostic (7.99e-2)"	1.3	31.4	14.7	1.9	21.6	1.3	22.3	34.7	16.8	4.9	6.5	6.6	1.9	2.6	5.5	4.6	1.2	2.5	4.1	3.4	11.3	18.6	19.7	46.2	1.5	0.8	13.4	10.1	11.2	14.7	9.3	22.5	0.5	13.7	3.0	10.2	1.0	6.4	4.9	6.9	0.5	3.6	4.5	10.4	1.1	5.5	5.1	12.6	0.6	0.9	1.1	0.9	1.9	1.2	0.2	10.5	0.0	0.0	0.0	0.4	0.0	0.0	11.6	1.8	0.3	2.7	2.1	0.0	0.0	0.7	0.4	2.4	0.2	0.0	32.4	4.9	0.0	0.0	0.3	0.3	0.1	1.5	13.3	7.6	10.2	3.0	2.9	14.5	0.1	7.1	2.8	1.2	0.7	4.1	14.0	0.4	1.1	0.6	0.7	26.7	0.5	13.2	0.3	1.1	16.9	0.3	0.0	26.7	15.1	0.1	5.2	0.4	0.2	0.1	0.0	1.3	0.3	0.3	0.3	3.1	0.3	24.1	2.4	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.2	0.2	0.4	0.0	0.0	0.0	10.5	0.0	0.0	14.7	21.6	34.7	13.6	11.3	18.6	13.4	10.1	13.7	12.6
DNAJC22	"FLJ13236, wus"	ENSG00000178401	"DnaJ heat shock protein family (Hsp40) member C22"	Q8N4W6	12	49346917-49357546	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 10.0;intestine: 10.0;liver: 18.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.2;CACO-2: 17.5;CAPAN-2: 11.0;EFO-21: 18.9;MCF7: 15.4;T-47d: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Low region specificity"	"Detected in many"			HPA039953			Approved	Vesicles				Vesicles	Vesicles	"HPA039953: AB_2676770"	"unprognostic (5.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.01e-2)"	"prognostic favourable (4.56e-5)"	"unprognostic (4.77e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (7.54e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-2)"	1.1	0.3	0.5	0.4	1.0	0.0	0.4	0.4	2.2	1.5	5.4	0.8	0.4	10.0	2.2	1.3	0.4	0.8	10.0	0.4	0.7	0.5	5.2	18.9	0.4	0.4	1.0	1.2	0.4	5.2	2.7	0.4	0.9	4.6	0.4	5.2	0.8	1.2	0.4	0.4	0.2	8.3	0.4	0.8	0.4	4.4	0.6	0.4	0.4	6.6	0.4	0.4	0.4	0.7	0.7	0.8	2.7	0.5	0.5	0.5	0.4	1.6	10.4	0.0	11.2	0.0	0.0	3.7	0.4	3.3	1.1	2.4	17.5	11.0	0.0	18.9	0.4	0.1	1.6	0.0	1.9	0.1	2.5	0.3	0.2	8.7	2.7	0.0	1.9	0.1	0.0	1.7	0.3	1.6	0.1	0.3	0.8	15.4	0.0	0.0	0.0	5.4	0.0	5.4	0.1	0.3	0.0	1.8	0.9	0.3	0.5	3.5	13.9	0.2	0.2	1.2	3.5	0.1	1.5	0.0	0.0	0.0	2.6	0.0	2.3	2.3	0.5	0.5	0.5	0.3	0.3	0.4	0.4	0.3	0.1	0.7	0.3	0.3	2.7	0.5	0.4	0.8	0.2	0.4	0.5	1.0	0.4	2.2	0.7	0.5	1.0	1.2	4.6	0.4
DNASE1L3	"DNAS1L3, LSD"	ENSG00000163687	"Deoxyribonuclease 1 like 3"	Q13609	3	58192257-58214697	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.1;liver: 72.3;lymphoid tissue: 46.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;Karpas-707: 3.1;RPMI-8226: 5.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"plasmacytoid DC: 78.1"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 78.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019955	Approved				"Secreted to blood"					"HPA019955: "	"unprognostic (7.49e-3)"	"unprognostic (3.08e-3)"	"unprognostic (9.75e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.01e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (4.74e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.95e-2)"	"prognostic favourable (1.06e-7)"	"unprognostic (7.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.64e-3)"	3.5	7.2	0.5	27.8	0.5	0.1	3.8	0.6	0.5	2.7	6.1	0.5	1.1	6.1	0.9	1.1	4.2	0.8	1.7	3.4	0.5	0.5	14.3	72.3	5.7	38.5	0.5	0.1	1.5	0.8	0.0	6.0	2.0	0.4	1.4	9.2	12.0	3.3	1.2	0.9	1.8	14.0	0.4	1.3	46.9	0.8	1.5	0.0	11.0	3.9	20.1	17.0	3.6	3.2	3.8	78.1	0.1	0.0	0.1	0.0	0.6	0.2	0.8	0.5	0.3	0.1	0.1	5.3	0.3	0.2	0.3	0.1	1.0	0.3	0.5	0.3	0.0	1.5	0.1	0.0	0.1	0.2	0.1	0.5	0.8	2.1	0.2	1.1	1.2	0.2	1.1	0.5	0.7	1.0	0.5	3.1	0.0	0.7	0.3	1.2	0.5	0.4	0.5	0.7	5.5	0.1	0.3	0.8	0.5	0.3	0.4	0.6	0.4	0.6	0.9	0.7	0.3	0.4	0.3	0.8	0.5	0.7	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.1	3.8	0.0	0.0	0.1	0.1	0.0	78.1	0.0	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.1	0.4	0.0
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.0	2.6	0.2	0.1	18.8	9.7	0.2	4.0	10.6	6.7	5.2	0.1	1.6	4.7	1.4	10.4	41.5	0.9	3.9	5.8	12.0	0.5	8.1	1.1	0.7	4.4	3.6	5.5	13.5	2.9	7.2	7.3	0.2	0.8	1.6	6.4	0.1	0.7	2.7	0.6	0.2	0.4	11.5	0.3	2.3	3.7	15.5	1.2	0.5	0.5	17.2	0.9	2.1	1.4	3.4	0.9	5.1	4.9	2.8	2.0	2.5	5.3	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.0	7.0	18.6	11.1	10.4	7.7	6.0	8.5	7.1	11.3	16.3	13.9	55.3	17.9	6.0	5.9	37.3	31.1	45.9	8.6	13.7	15.5	9.0	9.4	11.9	7.6	33.2	22.4	7.5	16.7	15.1	11.2	7.5	11.5	17.0	9.2	14.5	18.4	20.4	18.6	23.0	12.8	1.8	50.7	27.6	5.9	15.8	8.0	31.3	16.1	4.4	17.7	7.9	7.8	5.8	9.8	22.4	9.2	7.3	11.4	18.1	13.5	33.5	5.5	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8
ECHDC2	FLJ10948	ENSG00000121310	"Enoyl-CoA hydratase domain containing 2"	Q86YB7	1	52895910-52927212	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.2;HHSteC: 11.0;THP-1: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026731, HPA026768"	Enhanced		Approved	Mitochondria		410000	410000	Mitochondria	Mitochondria	"HPA026731: AB_1847969, HPA026768: AB_1847970"	"unprognostic (2.73e-3)"	"unprognostic (1.52e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.67e-2)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.11e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.62e-1)"	"prognostic favourable (2.70e-4)"	10.2	13.3	4.8	9.3	7.4	3.1	10.3	12.3	2.9	10.0	11.2	2.6	20.3	14.5	10.4	20.5	10.2	9.1	20.7	11.1	4.8	2.6	21.3	74.9	9.2	2.5	2.9	3.6	11.8	9.9	8.4	18.1	4.4	5.3	10.9	3.8	15.9	11.2	25.6	22.2	6.0	13.3	16.2	4.6	3.8	10.2	3.8	4.2	1.8	16.4	11.1	8.1	8.0	10.7	5.2	8.2	1.7	1.8	4.8	11.0	3.8	0.0	1.5	0.0	0.0	1.1	0.5	15.2	1.2	7.0	1.5	2.3	0.0	1.1	0.0	7.0	1.2	0.8	0.0	1.2	0.3	0.0	7.1	0.0	2.5	3.2	11.0	0.0	2.1	1.6	3.2	0.9	1.1	4.3	1.1	0.2	0.0	3.7	0.0	0.7	0.1	1.6	0.0	0.1	0.6	4.9	5.9	0.7	0.3	2.1	5.5	0.1	1.1	9.2	1.7	0.0	0.0	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.3	0.0	1.8	1.7	11.0	1.4	8.2	5.2	9.0	10.3	8.2	2.6	10.2	6.2	0.4	4.8	0.7	2.0	10.8	3.8	4.8	7.4	12.3	2.9	4.8	2.6	2.9	3.6	5.3	4.2
ECHDC3	FLJ20909	ENSG00000134463	"Enoyl-CoA hydratase domain containing 3"	Q96DC8	10	11742366-11764070	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.1;skeletal muscle: 77.7"	"Cell line enhanced"	"Detected in many"		"A-431: 28.3;BEWO: 16.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 7.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 14.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038306	Enhanced					93000	93000			"HPA038306: AB_10672586"	"unprognostic (8.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (3.91e-4)"	29.9	9.9	0.7	4.7	1.3	2.5	53.8	1.2	1.3	5.1	5.9	1.5	4.4	0.6	3.3	4.9	14.0	3.5	2.3	47.7	0.6	0.5	26.4	64.1	9.8	8.2	0.8	0.4	4.6	23.6	0.8	4.4	6.8	7.5	6.9	1.4	7.7	16.0	6.4	77.7	5.7	3.2	2.5	1.0	6.1	6.7	6.7	0.8	1.4	11.2	10.8	6.2	3.4	4.6	1.2	1.8	14.3	1.8	0.5	0.5	0.3	28.3	4.2	0.0	0.0	0.0	0.0	16.2	3.6	0.0	2.6	2.3	10.4	0.2	0.0	3.2	7.7	6.9	6.6	1.0	1.1	0.0	0.3	0.0	4.3	0.0	11.8	0.0	4.2	8.0	6.6	2.7	0.0	5.1	10.3	0.0	0.8	3.9	0.0	0.1	7.5	0.0	8.7	0.0	0.0	2.0	0.0	3.1	4.7	0.0	7.3	0.0	11.4	1.3	1.5	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	1.8	14.3	0.0	0.6	0.1	0.2	0.2	0.5	1.8	1.2	0.3	0.1	3.6	0.5	0.6	0.6	0.0	0.3	0.7	1.3	1.2	1.3	0.6	0.5	0.8	0.4	7.5	0.8
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		1500000	1500000	Mitochondria	Mitochondria	"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.7	36.1	19.7	49.1	28.6	18.4	18.0	21.2	28.0	29.6	25.1	79.2	28.0	21.7	18.4	23.8	27.0	25.5	21.5	21.4	16.6	44.8	21.6	21.8	56.3	24.0	28.0	15.4	20.5	18.6	19.6	25.1	26.2	19.5	19.1	28.8	68.2	13.9	54.7	13.7	43.4	24.0	23.9	11.6	36.5	36.9	12.7	20.2	21.9	36.4	27.5	28.3	27.0	21.0	13.4	19.4	27.7	27.9	14.4	8.8	24.6	31.7	15.3	11.0	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria				"Peroxisomes, Mitochondria"	"Peroxisomes, Mitochondria"	"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.4	20.5	30.5	2.0	25.3	26.0	27.7	24.8	7.3	2.7	0.7	31.9	27.5	9.4	18.5	14.7	40.3	6.7	21.2	9.4	13.8	39.3	11.9	8.5	4.7	21.0	9.1	23.5	13.2	57.6	30.8	6.9	26.2	7.1	24.0	21.2	11.0	34.9	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.4	24.5	4.0	58.1	20.9	11.5	18.4	15.0	10.6	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9;U-698: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	3.8	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	10.7	2.2	35.3	6.6	2.8	20.5	3.9	1.5	3.6	29.9	5.4	23.5	6.2	10.0	0.4	4.0	5.6	8.1	11.5	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	O60344	3	184249650-184259585	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 29.5"	"Low cell line specificity"	"Detected in all"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA062215			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA062215: AB_2684714"																		2.1	1.7	0.2	3.3	0.8	1.8	1.9	0.3	0.5	1.3	4.2	0.0	2.5	2.5	0.6	0.5	4.1	0.4	1.4	2.4	0.4		4.2	29.5	2.3	2.5	0.2	0.0	1.7	8.3	1.0	3.1	8.4	0.8	1.6	2.3	0.8	5.7	2.7	5.4	2.4	4.3	1.1	0.1	3.7	1.6	13.0	0.6	4.8	6.9	4.5	3.7	1.3	1.6	4.9	10.1	1.2	12.0	3.4	7.6	5.6	13.1	6.9	1.6	4.4	2.4	1.6	10.1	1.5	2.9	2.3	2.2	12.9	2.0	15.6	10.3	1.7	4.9	7.4	7.5	1.3	6.1	8.7	4.1	4.4	8.2	2.9	10.8	3.5	2.0	9.1	2.6	4.5	1.9	7.4	14.5	1.1	20.6	4.4	13.1	3.3	13.0	9.2	2.2	12.6	2.7	3.2	8.0	2.7	3.0	23.6	5.8	19.9	5.0	1.4	2.6	3.5	6.1	7.6	8.7	17.5	15.4	2.1	17.8	2.7	0.0	12.0	1.2	4.3	9.7	4.8	4.9	4.6	4.2	10.1	3.2	3.3	5.2	0.2	3.4	6.2	9.0	7.6	5.6										
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	O60344	3	184249695-184293031	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 22.6"	"Cell line enriched"	"Detected in single"	10	"REH: 5.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043346, HPA062215"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043346: AB_10794181, HPA062215: AB_2684714"																		1.2	6.6	0.0	2.1	0.1	0.3	0.3	0.0	1.5	0.6	2.9	0.0	1.5	0.9	0.3	0.3	2.8	0.5	0.6	2.1	0.0		2.8	22.6	1.3	1.5	0.0	0.0	0.9	6.0	1.5	2.0	6.1	0.2	1.4	0.6	0.2	4.0	1.6	3.8	0.3	2.9	0.4	0.0	2.4	0.3	9.7	0.0	3.3	4.9	3.1	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EFNA1	"ECKLG, EPLG1, LERK1, TNFAIP4"	ENSG00000169242	"Ephrin A1"	P20827	1	155127460-155134857	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 123.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 57.1;HaCaT: 19.9;SiHa: 32.9;SK-BR-3: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 12.1;naive CD8 T-cell: 6.0"	"Lineage enriched"	"Detected in single"	26	"T-cells: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032498	Uncertain				"Secreted to blood"	2100000	2100000			"CAB032498: AB_2262137"	"unprognostic (5.14e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	16.2	6.1	6.8	2.9	14.5	0.4	29.5	4.4	10.9	7.1	27.6	11.8	10.7	21.7	7.2	11.7	12.6	8.0	8.7	13.3	6.4	4.6	16.1	123.2	27.0	2.7	15.7	4.3	5.7	14.0	4.9	5.3	38.2	13.8	18.6	20.2	5.0	17.7	17.2	10.4	27.5	27.5	5.1	9.6	2.3	13.1	3.3	14.8	3.7	30.2	7.8	4.1	10.7	12.7	0.3	0.0	0.4	0.0	0.3	12.1	2.0	3.1	1.3	0.1	2.4	0.4	0.0	57.1	0.0	0.0	0.0	0.0	3.2	7.0	0.0	5.7	0.0	19.9	1.3	6.9	0.0	1.9	0.4	0.0	4.4	17.2	0.1	0.0	0.3	0.9	17.0	0.0	5.9	10.7	0.5	0.1	0.0	11.4	0.0	0.2	0.4	4.2	1.2	0.3	1.9	13.5	4.9	2.0	3.0	32.9	50.5	1.2	10.6	0.0	1.3	0.0	2.0	0.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.7	0.0	0.3	12.1	6.0	0.4	0.3	0.0	0.0	0.0	2.0	6.8	14.5	4.4	10.9	6.4	4.6	15.7	4.3	13.8	14.8
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.3"	"Cell line enhanced"	"Detected in some"		"REH: 19.1;U-138 MG: 12.0;U-2 OS: 17.6;U-2197: 20.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		11000	11000	"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	1.8	0.8	2.2	0.6	1.4	0.0	0.6	0.0	4.2	3.2	0.3			0.2	2.2	0.3	0.3	0.8	0.8	3.3	1.8	2.2	2.8	13.3	0.3	0.1	2.7		0.0	0.2	0.2	0.2	0.7		0.6	0.0		0.5	0.2	1.2	0.6	0.3	0.5	1.7	1.7	0.2	0.7			0.2		0.0	0.5	0.9	0.5	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	2.9	6.2	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.1	0.3	0.0	3.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.5	0.0	2.8	1.2	0.7	19.1	0.0	1.9	0.0	0.0	2.8	1.3	0.1	0.1	0.0	0.0	0.2	0.0	12.0	17.6	20.5	0.0	0.0	0.2	5.1	0.0	0.0	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.0										
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.3;HAP1: 12.0;HBF TERT88: 16.8;Hep G2: 12.8;RH-30: 18.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"prognostic favourable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.5	0.0	0.0	0.0	6.5	0.2	0.6	10.1	17.3	0.0	0.0	0.0	0.0	0.6	0.0	12.0	0.0	16.8	0.0	10.3	0.1	0.2	12.8	0.5	0.2	2.7	0.1	0.0	7.8	0.0	0.0	0.6	0.0	0.2	0.0	6.5	0.1	2.1	9.8	9.1	18.2	0.0	0.0	0.1	4.5	5.2	0.0	0.0	4.1	2.1	5.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 5.6;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain									"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favourable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	7.6	9.8	7.7	7.9	9.4	3.7	7.9	10.9	12.3	4.0	14.5	8.6	0.9	11.8	3.4	2.7	16.6	2.9	11.1	8.1	6.6	5.9	6.4	43.9	3.3	2.2	7.5	9.4	2.0	2.5	10.6	7.1	2.6	15.7	3.0	14.1	4.3	6.9	3.2	1.4	12.3	10.2	5.7	20.0	1.9	16.9	1.3	7.3	1.1	2.3	7.9	4.0	6.0	5.0	0.1	0.0	0.2	0.1	5.6	4.9	0.8	13.2	7.8	28.8	7.1	19.3	20.3	14.7	9.2	4.5	3.2	7.3	3.8	23.3	1.0	0.8	7.1	12.4	21.8	27.0	7.5	4.5	6.3	15.0	8.5	10.0	12.0	14.5	9.7	17.7	6.2	16.5	7.9	6.4	17.8	30.9	7.2	6.9	3.3	1.5	13.2	4.8	2.2	11.3	3.8	21.0	9.9	5.1	11.0	4.7	31.4	4.0	5.3	0.1	2.3	6.5	7.8	11.0	11.1	1.4	4.8	24.4	10.0	0.0	1.6	0.2	0.1	0.1	4.8	0.0	4.9	0.1	2.1	3.2	0.0	0.1	0.7	2.3	0.2	5.6	0.0	0.0	0.2	0.8	7.7	9.4	10.9	12.3	6.6	5.9	7.5	9.4	15.7	7.3
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell line enhanced"	"Detected in all"		"RT4: 33.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced		Approved	Cytosol	"Secreted to blood"	5000000	5000000	Cytosol	Cytosol	"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.3	4.3	4.9	9.1	9.8	9.3	5.7	5.6	4.6	3.7	4.3	3.3	6.4	6.0	2.8	7.6	6.3	4.9	8.1	4.2	5.1	2.3	4.5	3.2	17.8	9.5	2.7	5.3	7.6	8.2	5.3	11.0	7.5	5.0	9.3	5.5	7.6	3.0	3.3	1.5	9.4	3.5	4.7	2.9	6.6	33.8	3.5	3.7	9.5	7.5	5.4	10.9	2.4	6.2	7.6	7.9	4.5	4.1	6.0	9.4	4.9	4.8	5.0	6.8	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.4;hTCEpi: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042862: AB_10794534"	"prognostic unfavourable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.5	5.7	0.4	0.4	0.4	0.0	17.4	0.6	0.2	2.0	1.0	9.8	4.5	0.0	1.2	0.5	7.5	11.6	6.1	2.1	4.8	2.7	0.0	1.8	13.9	1.2	0.2	0.0	0.1	27.3	0.8	9.4	0.1	0.1	0.0	2.8	11.6	0.2	0.1	7.5	8.5	0.0	0.0	0.3	7.0	6.9	7.2	0.7	1.8	12.1	0.0	2.8	0.0	0.2	4.1	4.2	1.3	1.6	0.0	0.0	0.0	3.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810092-225845563	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4;liver: 265.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 153.8;SiHa: 73.1"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					83000	83000			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	39.5	156.4	16.8	5.7	20.1	3.4	31.3	8.3	25.1	31.3	12.6	28.7	15.3	16.6	21.8	15.7	24.9	26.2	17.8	11.5	16.3	11.2	36.8	265.0	24.1	6.9	17.1	14.5	45.6	85.0	39.5	14.0	5.4	23.6	25.9	8.4	27.3	26.3	21.3	16.4	8.8	9.6	18.6	10.7	8.3	12.1	22.7	12.6	3.6	24.9	15.6	14.9	20.9	32.3	0.5	2.2	0.5	6.6	1.4	1.3	2.3	4.4	42.3	1.6	15.6	153.8	16.0	3.4	5.1	6.4	3.7	5.2	8.7	45.0	0.1	19.3	19.2	4.9	4.6	2.4	1.5	0.9	8.0	3.1	17.9	48.8	16.7	1.9	1.8	15.0	5.6	10.5	1.0	2.7	2.2	3.9	6.6	5.1	1.9	3.6	9.1	11.9	4.1	2.0	12.8	11.1	27.9	14.6	1.9	73.1	26.2	6.7	19.4	5.7	8.1	6.3	5.1	8.5	8.1	1.3	6.7	0.5	9.5	2.1	8.3	0.0	6.6	0.2	0.5	1.9	0.9	0.3	0.9	0.5	1.5	0.5	1.3	1.0	0.5	1.4	0.8	2.2	0.7	2.3	16.8	20.1	8.3	25.1	16.3	11.2	17.1	14.5	23.6	12.6
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell line enhanced"	"Detected in many"		"K-562: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Approved		Enhanced	Cytosol		720000	720000	Cytosol	Cytosol	"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favourable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	8.4	5.7	3.6	4.7	0.2	0.0	2.7	0.7	0.5	0.4	0.1	4.5	5.8	0.0	3.4	2.1	6.1	0.6	1.4	0.3	0.0	2.7	12.5	0.6	13.7	2.0	0.0	2.6	5.1	6.2	0.0	0.7	0.3	28.2	0.1	0.0	2.6	8.1	0.3	5.8	9.9	0.0	0.0	0.2	5.1	1.2	3.0	9.4	6.9	8.2	8.2	12.5	2.3	0.1	0.0	2.3	1.0	0.1	7.3	5.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Group enriched"	"Detected in some"	7	"BEWO: 3.5;Hep G2: 13.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB010336	Supported				"Secreted to blood"					"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	1.1	0.1	0.0	0.0	13.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100188334	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	12.9	8.0	5.4	6.9	10.1	23.2	13.9	6.7	6.1	11.3	18.6	5.7	7.0	13.8	11.9	6.6	17.9	11.2	6.8	6.8	6.2	3.7	12.3	81.4	8.7	10.1	7.3	3.8	13.9	17.7	5.9	8.8	24.2	4.7	9.2	13.5	8.2	9.8	5.7	5.5	10.8	18.9	7.7	4.1	9.7	12.7	17.4	5.4	8.6	11.8	10.3	14.3	14.7	14.6	6.2	12.6	18.2	16.0	7.5	9.0	7.0	23.1	23.1	11.8	21.4	28.5	28.0	24.1	36.9	34.3	30.5	35.2	15.4	27.1	10.3	14.9	34.1	24.2	10.5	21.7	42.3	6.2	9.4	8.9	10.4	19.5	11.8	31.0	9.8	15.8	13.2	26.7	32.4	22.0	8.7	6.3	32.1	9.4	7.9	11.4	8.4	9.6	6.8	19.4	7.5	13.1	9.2	4.8	7.7	21.0	5.9	13.0	14.7	25.7	24.9	30.6	23.6	18.2	38.7	4.9	8.3	14.1	26.9	49.1	15.0	4.3	16.0	18.2	8.5	11.7	7.6	6.2	6.6	7.0	12.6	5.5	6.8	9.0	11.6	7.5	8.6	2.9	3.8	7.0	5.4	10.1	6.7	6.1	6.2	3.7	7.3	3.8	4.7	5.4
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026308	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 141.1;pancreas: 133.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 93.0;LHCN-M2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027206, HPA076543"			Enhanced	Cytosol				Cytosol	Cytosol	"HPA027206: AB_10600908, HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	38.6	8.8	4.4	6.3	6.3	0.6	27.8	9.6	7.0	17.5	13.6	5.4	8.4	6.8	15.9	9.6	13.6	12.2	27.3	8.8	4.7	2.5	32.6	141.1	15.5	7.7	7.5	3.7	29.7	133.6	7.7	41.9	33.7	8.1	9.3	5.1	12.0	14.5	5.9	68.3	20.2	26.5	22.9	12.5	2.1	22.3	7.4	5.2	0.6	19.4	4.7	3.8	20.0	19.5	0.4	0.3	0.2	4.9	0.0	1.3	0.2	13.2	7.8	3.3	4.5	32.0	23.9	35.1	13.0	3.8	2.4	2.8	3.4	35.0	0.2	7.8	4.3	2.8	0.9	23.0	11.2	0.4	2.5	0.2	2.3	40.4	93.0	0.1	0.5	32.5	23.2	8.0	19.5	6.1	0.9	0.1	71.0	5.7	0.0	0.8	8.0	19.5	1.1	37.9	0.2	11.2	4.2	2.3	1.3	2.5	5.9	4.0	4.0	0.3	8.6	9.4	5.5	7.9	18.3	0.2	0.1	0.2	36.4	0.6	8.7	0.0	0.4	0.0	1.3	0.1	0.2	0.3	1.2	1.3	0.2	0.4	0.9	1.2	0.2	0.0	4.9	0.3	0.6	0.2	4.4	6.3	9.6	7.0	4.7	2.5	7.5	3.7	8.1	5.2
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.4;liver: 54.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.7;Hep G2: 26.5;SK-BR-3: 54.3;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.0"	"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 4.8"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	1.4	0.6	2.5	0.8	6.7	2.9	6.0	0.7	13.3	44.8	0.6	9.2	27.1	1.2	19.7	9.9	6.3	1.2	0.6	1.0	0.1	14.3	54.9	1.6	0.6	0.6	0.6	2.4	0.6	12.9	12.1	1.3	0.6	2.6	1.7	19.5	2.9	4.7	0.6	27.1	70.4	1.0	0.6	0.6	0.4	37.7	0.6	1.2	0.7	2.4	3.2	0.8	5.9	0.0	0.0	0.0	0.0	0.0	3.6	0.3	4.5	0.2	0.2	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	9.9	0.5	0.1	2.2	0.0	10.8	0.8	0.0	0.0	0.6	0.2	0.1	0.2	26.5	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	9.2	0.0	0.3	0.2	4.1	0.0	0.1	3.5	0.0	0.0	7.1	0.3	1.3	54.3	1.6	18.1	2.4	5.2	0.0	0.2	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.6	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	0.8	6.0	0.7	1.0	0.1	0.6	0.6	0.6	0.6
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229111-68238102	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.2;pancreas: 41.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.1;MCF7: 35.4;RT4: 19.0;SK-BR-3: 19.0;T-47d: 29.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.4	0.2	0.2	7.6	0.5	0.0	3.9	0.6	0.3	4.7	8.0	0.6	4.1	4.6	1.2	10.2	30.1	2.1	12.4	0.6	0.3	0.1	13.4	45.2	15.6	0.2	0.2	0.2	1.3	41.5	7.0	2.5	11.3	0.7	6.6	5.6	0.8	17.3	5.0	0.3	17.6	8.5	0.6	0.2	0.2	12.8	7.0	0.3	3.0	18.4	25.7	17.1	6.4	9.4	0.0	0.0	0.0	0.8	0.0	0.8	0.0	12.2	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.0	0.1	11.5	6.1	0.0	0.5	0.0	12.7	0.0	9.4	0.0	0.0	8.3	0.0	3.4	9.2	0.1	0.0	0.1	0.0	13.4	0.0	4.4	0.0	0.0	0.0	0.0	35.4	0.0	0.0	1.3	4.1	0.0	0.0	0.0	4.8	19.0	1.3	0.0	6.1	19.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.3	0.1	0.2	0.2	0.7	0.3
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell line enriched"	"Detected in all"	4	"Hep G2: 185.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		640000	640000	Mitochondria	Mitochondria	"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favourable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favourable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.2	34.2	4.7	13.0	15.2	17.8	7.5	9.0	6.9	7.3	7.3	28.7	21.8	13.2	9.2	14.5	11.7	9.4	19.2	2.2	19.7	36.6	10.4	20.9	185.6	16.7	9.9	7.8	27.6	5.7	9.9	10.2	6.2	15.6	14.9	9.4	26.8	10.3	9.4	3.0	42.3	11.5	12.8	24.7	10.0	15.2	10.6	5.1	19.9	5.7	10.3	14.9	9.6	8.7	7.6	8.0	8.2	8.2	22.9	13.9	11.8	39.0	14.8	19.6	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced									"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favourable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	11.3	20.1	7.0	3.9	8.6	2.8	12.9	10.3	8.2	5.1	12.5	6.5	6.1	23.0	5.7	6.4	10.9	4.3	5.2	47.8	7.2	5.0	17.3	72.8	4.3	2.9	8.0	5.3	5.0	8.9	11.4	8.8	9.0	8.5	5.2	10.5	7.4	7.2	5.6	33.7	7.7	20.4	8.5	4.8	4.8	9.2	4.1	8.4	4.9	6.0	17.5	5.4	5.8	6.1	5.8	11.0	24.5	13.5	6.2	9.2	5.4	5.6	3.5	5.9	10.7	25.6	15.3	2.8	10.0	10.0	7.4	7.2	1.9	12.5	13.8	2.1	12.1	6.6	11.4	9.9	10.4	21.9	8.3	12.7	8.1	3.3	11.2	10.9	12.1	14.1	12.5	8.0	6.8	14.4	7.0	26.1	11.8	5.8	10.5	5.5	2.3	8.6	8.5	2.0	9.7	11.1	4.9	9.0	3.5	10.0	19.9	9.4	13.5	8.4	6.4	6.0	3.1	8.8	5.1	14.7	18.3	9.4	12.4	9.2	6.4	2.5	13.5	24.5	6.7	13.3	8.1	5.8	6.3	6.8	11.0	5.4	7.8	6.6	4.6	6.2	11.7	8.4	9.2	5.4	7.0	8.6	10.3	8.2	7.2	5.0	8.0	5.3	8.5	8.4
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;U-138 MG: 36.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.3	9.9	0.1	0.4	0.0	2.0	27.1	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.3	0.7	0.0	0.0	5.0	2.7	23.8	11.0	12.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.5	0.0	0.1	9.8	36.4	15.3	0.6	22.6	0.2	0.0	0.0	20.6	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111853	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 55.1;fHDF/TERT166: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					9600000	9600000			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (1.85e-1)"	13.8	11.9	5.8	20.5	4.6	2.1	16.5	7.3	7.4	13.3	17.1	4.1	8.7	23.2	11.5	12.5	11.2	8.8	19.3	14.4	4.6	3.1	8.8	66.4	19.9	8.3	3.0	6.8	10.4	17.9	7.1	6.4	15.6	4.8	9.8	16.0	13.2	9.8	13.3	4.2	12.3	32.0	16.8	4.3	20.1	11.5	5.0	2.7	8.7	12.0	10.3	7.2	11.0	18.5	0.8	1.7	1.2	4.5	0.7	2.4	1.0	17.2	5.0	7.5	2.9	13.6	11.0	3.4	32.3	55.1	23.8	21.9	5.1	1.7	0.3	14.5	55.7	10.9	3.3	18.9	33.5	6.5	5.6	0.6	4.7	4.1	6.4	0.0	1.2	6.9	5.1	28.9	26.6	14.6	0.4	4.8	11.0	1.4	0.8	0.0	2.4	6.4	0.0	2.8	0.5	9.4	6.3	2.3	2.2	4.9	2.3	4.8	3.2	0.2	19.4	20.1	18.4	18.4	9.5	2.7	2.7	1.6	18.6	0.0	5.3	0.3	4.4	0.2	0.2	4.5	1.3	0.8	0.5	0.6	1.0	0.1	0.5	0.9	1.2	0.7	2.2	1.7	2.4	1.0	5.8	4.6	7.3	7.4	4.6	3.1	3.0	6.8	4.8	2.7
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 26.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	13000000000	13000000000	"Golgi apparatus"	"Golgi apparatus"	"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Cytosol		230000000	230000000	Cytosol	Cytosol	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.4	7.5	3.1	3.8	14.5	14.8	7.6	5.7	13.1	6.0	5.2	4.5	8.2	0.0	9.4	12.0	6.6	11.0	13.6	5.9	2.8	6.2	38.1	4.4	23.3	75.2	18.0	21.1	25.6	8.5	5.2	9.4	8.4	15.9	8.1	11.3	6.7	4.9	9.0	2.2	8.6	2.7	4.4	28.5	17.5	5.4	0.1	1.9	6.4	17.7	17.8	13.5	12.3	29.3	11.1	7.0	5.9	9.6	7.4	15.2	3.0	23.1	42.2	6.2	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0
FAHD2A	CGI-105	ENSG00000115042	"Fumarylacetoacetate hydrolase domain containing 2A"	Q96GK7	2	95402721-95416616	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 59.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042145, HPA044987, CAB045971, CAB045972"	Enhanced									"CAB045971: AB_11126570, CAB045972: AB_11140511, HPA042145: AB_2677873, HPA044987: AB_2679170"	"unprognostic (6.52e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.77e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.55e-2)"	11.2	10.1	12.7	5.4	14.2	7.8	12.2	12.9	14.3	7.3	22.0	12.1	7.3	19.1	8.8	6.8	5.7	8.9	8.7	14.9	11.6	8.1	11.4	59.2	6.5	6.0	11.8	13.1	11.7	17.7	7.4	5.6	6.6	11.2	7.3	8.6	11.7	51.3	8.1	18.2	8.2	22.1	9.5	12.2	6.6	10.0	11.7	10.8	8.6	21.2	11.6	7.2	5.8	6.8	11.0	19.8	5.6	12.7	7.8	15.5	10.3	14.8	14.5	16.0	10.2	17.8	16.3	11.6	14.0	23.7	16.6	26.5	8.6	6.5	9.1	6.3	14.3	8.1	11.4	13.0	16.6	8.0	14.6	7.4	6.4	14.2	23.2	10.9	4.2	15.5	14.5	15.2	19.4	21.9	10.4	20.7	20.8	18.2	19.7	15.0	5.1	14.1	14.8	10.1	25.3	18.4	6.1	9.8	4.9	8.5	13.7	16.3	8.6	4.4	10.4	21.1	14.8	8.9	9.7	22.6	9.8	9.1	14.6	10.3	10.5	1.5	11.5	5.6	14.1	12.7	15.5	11.0	12.9	13.4	16.7	7.1	13.4	10.8	0.7	7.8	6.0	19.8	13.9	10.3	12.7	14.2	12.9	14.3	11.6	8.1	11.8	13.1	11.2	10.8
FAM149A	"DKFZP564J102, MST119, MSTP119"	ENSG00000109794	"Family with sequence similarity 149 member A"	A5PLN7	4	186104419-186172667	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.2;MOLT-4: 8.0;RT4: 9.3;SCLC-21H: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA044019, HPA055004"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA044019: AB_2732513, HPA055004: AB_2682667"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.64e-2)"	"prognostic favourable (2.67e-6)"	"unprognostic (7.08e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.36e-1)"	8.7	4.3	17.6	3.7	22.7	0.3	8.6	5.1	12.4	6.1	7.3	8.2	4.7	4.6	6.0	9.8	9.1	11.1	12.8	7.3	15.4	10.0	27.3	37.7	4.3	1.1	8.9	5.8	6.2	19.6	8.8	3.7	1.9	7.4	7.5	6.2	12.2	12.2	13.3	7.0	1.7	3.9	13.8	12.4	1.9	8.4	3.6	5.7	1.0	2.7	3.2	1.5	8.4	4.9	1.0	0.7	0.2	0.0	0.0	4.0	0.0	0.0	3.2	2.9	0.1	11.2	4.6	0.1	0.0	0.0	0.3	0.3	0.0	1.9	0.0	1.6	1.5	0.0	5.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.7	0.1	0.2	2.1	0.3	0.2	0.0	0.0	0.0	2.5	1.3	1.6	8.0	0.3	5.1	0.0	0.3	0.0	2.0	1.7	9.3	14.2	3.9	0.1	0.0	4.4	1.0	0.0	0.8	0.2	1.7	0.0	1.6	0.0	0.0	0.0	0.8	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.1	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.7	4.0	0.0	17.6	22.7	5.1	12.4	15.4	10.0	8.9	5.8	7.4	5.7
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Cell line enriched"	"Detected in some"	4	"U-2197: 73.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm	Nucleoplasm	"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	7.9	8.2	0.0	4.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	16.3	0.0	73.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1
FAM20A	DKFZp434F2322	ENSG00000108950	"FAM20A, golgi associated secretory pathway pseudokinase"	Q96MK3	17	68535113-68601389	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.2;salivary gland: 50.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.5;BJ hTERT+: 26.7;HSkMC: 22.3;U-2197: 7.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.8"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.0;granulocytes: 1.8;monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048964	Supported				"Secreted in other tissues"	10000000	10000000			"HPA048964: AB_2680575"	"unprognostic (3.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (9.16e-10)"	"unprognostic (1.25e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.39e-2)"	4.9	1.1	0.2	4.7	0.4	1.0	3.7	0.2	1.5	12.1	3.2	0.7	0.7	1.4	7.6	9.9	2.2	4.1	2.3	6.5	0.3	0.4	19.6	59.2	17.6	14.7	0.3	0.8	6.8	1.0	0.6	4.8	4.2	3.8	3.5	1.0	8.7	50.4	1.7	2.8	1.5	1.2	4.7	2.4	7.3	9.5	9.1	0.2	0.9	8.2	4.0	2.5	3.7	3.4	0.2	1.0	1.8	2.1	0.1	0.3	0.0	0.0	0.1	0.0	0.1	1.3	11.5	0.0	0.5	26.7	0.0	0.0	0.0	0.0	0.0	2.3	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	22.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.9	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.1	1.8	0.1	2.1	1.0	0.0	0.0	0.2	0.4	0.2	1.5	0.3	0.4	0.3	0.8	3.8	0.2
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 38.2;skeletal muscle: 41.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.5;Karpas-707: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	17.4	2.3	7.8	1.6	8.0	4.0	7.6	1.9	13.9	2.5	8.2	8.6	4.1	2.1	3.0	7.3	3.5	5.0	4.2	16.5	9.4	3.9	4.2	38.2	7.5	0.6	5.4	14.6	2.6	4.6	2.8	9.2	9.4	11.4	6.3	9.0	2.5	5.0	5.0	41.3	1.6	10.7	6.5	9.6	1.6	3.7	6.1	5.8	0.0	8.1	1.3	0.9	4.9	2.5	0.2	1.0	2.2	1.5	3.4	1.6	0.4	2.0	2.4	1.0	2.2	17.5	5.9	2.3	3.4	7.2	3.0	3.1	4.1	2.3	0.0	2.1	8.3	1.2	3.6	1.5	2.7	2.7	0.5	0.8	4.9	5.8	1.9	1.8	2.5	2.5	9.2	2.8	3.7	0.3	0.2	24.4	7.2	3.8	0.0	1.8	1.0	1.7	0.0	0.5	1.5	3.4	6.1	1.0	4.3	1.5	4.8	0.1	1.0	1.0	0.9	1.5	0.7	3.9	3.0	5.8	2.7	0.0	4.3	1.9	1.3	0.0	0.5	2.2	1.1	1.5	0.6	0.2	1.1	1.2	0.9	0.1	0.9	1.3	1.3	3.4	0.1	1.0	1.6	0.4	7.8	8.0	1.9	13.9	9.4	3.9	5.4	14.6	11.4	5.8
FAM96A	"CIA2A, FLJ22875"	ENSG00000166797	"Family with sequence similarity 96 member A"	Q9H5X1	15	64072559-64094018	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	13.6	32.3	11.2	19.1	12.8	17.0	13.9	9.0	10.3	8.5	24.3	13.6	17.7	31.3	8.1	14.9	13.6	8.3	14.0	20.6	11.2	10.8	39.4	89.7	18.1	22.7	15.2	8.0	7.8	27.0	10.6	15.4	25.2	11.2	17.2	20.2	10.7	16.5	15.7	28.2	7.6	45.5	6.4	14.9	25.2	17.9	8.9	13.8	20.5	30.1	18.3	19.3	14.6	9.0	51.8	63.7	23.7	48.6	11.8	21.3	38.2	19.5	28.7	17.6	10.9	14.9	18.3	11.6	15.4	17.2	20.6	21.8	28.3	31.7	32.5	27.1	9.7	21.6	34.3	15.1	17.5	26.5	18.5	26.5	26.0	26.6	11.8	42.9	22.9	14.4	15.2	13.4	12.0	20.8	36.2	25.2	14.5	33.1	16.3	37.1	25.4	15.2	26.2	23.2	72.0	26.5	23.0	18.8	14.2	12.3	28.1	29.8	20.6	44.8	12.5	16.3	23.2	18.6	33.1	24.4	57.5	29.2	19.8	77.6	15.5	16.2	48.6	16.9	10.1	44.1	12.4	51.8	15.3	13.5	42.6	48.8	12.3	11.6	23.7	11.8	36.7	63.7	21.3	38.2	11.2	12.8	9.0	10.3	11.2	10.8	15.2	8.0	11.2	13.8
FAM9B	TEX39B	ENSG00000177138	"Family with sequence similarity 9 member B"	Q8IZU0	X	9024232-9164639	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;liver: 3.7;testis: 11.4"	"Group enriched"	"Detected in some"	49	"U-266/70: 20.7;U-266/84: 22.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"									HPA035135	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA035135: AB_10669999"		"unprognostic (3.95e-1)"			"unprognostic (4.49e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"		"unprognostic (1.40e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-10)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"		0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.2			0.1	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0		0.6	0.2	0.0	0.0	0.0		0.4	0.0		0.0	0.2	0.2	0.5	0.5	0.1	0.0	1.1	0.2	11.4			0.1		0.0	0.2	0.6	0.8	0.7	3.4	0.7	0.7	0.4	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.7	22.2	0.1	0.0	0.1	0.0	1.0	0.7	0.4	0.3	0.3	0.3	0.5	0.4	0.3	0.2	0.8	0.4	0.4	3.4	0.7	0.4	0.7	0.3	0.4										
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 20.1;MCF7: 62.8;RT4: 41.2;SK-BR-3: 12.0;U-698: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Uncertain	Mitochondria		23000000	23000000	Mitochondria	Mitochondria	"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	20.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	62.8	0.0	1.1	0.2	2.2	0.0	0.2	0.4	0.0	41.2	0.2	1.2	0.1	12.0	0.0	7.2	1.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	29.9	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;HBEC3-KT: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"									"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.4	1.8	2.8	0.6	0.8	0.1	0.1	0.0	0.2	1.0	1.9	0.3	0.2	0.9	1.2	0.8	3.9	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.1	0.5	1.6	0.1	2.5	3.2	0.4	0.5	2.3	0.1	0.0	0.7	1.3	1.4	0.2	0.9	0.1	0.8	0.6	1.1	1.2	1.1	0.0	1.8	0.2	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.6;kidney: 37.7;liver: 45.3"	"Group enriched"	"Detected in many"	4	"CACO-2: 42.0;Hep G2: 42.0;RH-30: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	4300000	4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1.0	13.6	26.0	0.0	0.7	1.3	0.8	4.0	3.7	2.0	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3.0	1.1	0.4	0.4	0.0	0.7	11.8	0.2	2.9	0.0	0.0	5.8	0.0	0.0	0.0	0.0	42.0	1.6	1.2	5.5	0.0	0.6	2.3	0.4	0.0	0.7	2.8	0.1	0.6	42.0	1.3	0.1	1.0	0.2	0.0	2.1	0.0	0.0	3.9	0.1	0.9	9.6	0.0	0.8	7.1	1.0	1.9	67.6	7.1	5.7	0.1	0.4	0.7	0.4	3.0	1.4	2.9	0.6	0.2	0.0	5.7	0.0	0.1	0.4	0.4	0.7	0.0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0.0	0.1	0.6	0.4	0.4	3.0	0.4	0.3	0.9	0.2	0.0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1.0	0.8	0.4
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.2;RH-30: 18.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		110000	110000	"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.8	6.0	2.4	3.0	10.6	0.5	2.5	4.2	1.4	2.2	0.0	2.2	3.3	8.1	6.7	1.2	1.0	7.4	3.1	26.2	0.7	2.3	1.9	5.3	7.8	1.3	1.5	14.9	6.3	3.1	4.9	2.8	1.6	2.1	9.5	3.2	1.7	1.9	3.7	3.2	4.0	18.2	1.2	8.0	5.4	4.6	2.0	3.5	2.0	7.2	1.7	1.4	2.7	2.4	1.8	2.8	1.7	4.8	1.7	2.8	8.2	5.5	2.2	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		2800000	2800000	Mitochondria	Mitochondria	"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.2	24.5	23.3	21.0	22.9	27.0	36.9	36.3	28.5	41.0	25.8	35.1	18.3	18.6	24.1	27.8	41.7	35.6	27.0	35.8	21.2	11.5	17.4	26.0	29.9	20.5	40.7	15.9	19.5	16.8	23.0	26.0	25.2	53.0	24.1	29.8	14.6	35.1	27.2	24.7	52.7	29.0	25.5	83.5	39.5	24.9	30.0	25.9	30.6	36.3	23.2	27.6	27.7	24.7	18.4	23.8	32.5	60.5	21.6	23.1	22.6	20.6	46.8	26.4	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.2;EFO-21: 7.9;HSkMC: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favourable (1.09e-4)"	"prognostic favourable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.4	4.9	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.1	0.6	1.3	0.3	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.6	0.4	0.4	2.5	3.5	0.0	0.2	0.0	1.4	1.5	3.0	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.4	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495245	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.9;liver: 57.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.9;ASC diff: 17.3;HUVEC TERT2: 20.7;SH-SY5Y: 16.2;TIME: 18.9;U-87 MG: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA051804: AB_2681617, HPA063581: AB_2685048"	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavourable (6.11e-4)"	18.5	45.9	13.4	2.7	13.7	0.7	9.1	10.8	29.5	3.8	2.0	4.0	0.5	1.5	2.8	2.8	11.8	1.5	10.0	3.1	15.6	8.5	2.3	57.6	2.0	1.4	12.0	8.6	16.5	4.6	18.6	2.8	2.5	22.2	6.3	2.1	1.9	2.1	3.3	1.3	2.4	1.4	4.7	5.4	3.5	3.2	10.2	3.8	0.0	1.8	0.7	2.7	4.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	16.9	17.3	10.6	0.1	3.8	7.7	2.8	2.4	0.7	0.2	0.0	0.4	12.2	0.0	6.4	2.3	2.4	0.0	1.0	0.8	0.0	8.7	6.4	0.0	0.1	9.0	1.1	4.8	0.9	20.7	0.9	0.0	10.2	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	1.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	0.0	18.9	2.6	1.2	1.0	2.9	0.0	0.0	0.0	14.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.7	10.8	29.5	15.6	8.5	12.0	8.6	22.2	3.8
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589984-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 47.0;prostate: 44.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 16.3;MCF7: 35.4;PC-3: 24.7;RT4: 33.1;SK-BR-3: 33.5;T-47d: 47.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 127.0"	"Region enriched"	"Detected in single"	6	"midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1"	"Region enriched"	"Detected in some"	6	"midbrain: 6.1"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favourable (1.00e-4)"	0.1	0.0	0.1	6.1	0.1	0.0	23.5	0.1	0.3	1.5	9.4	0.1	0.1	4.6	0.1	0.5	7.2	1.3	6.5	0.1	0.1	0.3	0.4	47.0	13.2	0.1	2.0	0.1	0.6	0.2	0.0	1.1	0.1	0.2	44.4	6.0	0.2	9.4	0.7	0.1	0.7	5.1	2.4	0.1	0.1	13.0	0.6	0.1	0.2	0.1	4.4	9.9	12.5	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.3	0.9	0.0	0.5	0.0	8.2	4.6	1.1	0.0	0.0	8.1	0.0	1.4	16.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	35.4	0.0	0.1	0.0	24.7	0.0	0.3	0.1	3.4	33.1	4.2	0.0	1.6	33.5	0.0	47.5	0.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	2.0	0.1	0.2	0.1
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;PC-3: 15.1;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favourable (6.28e-4)"	"prognostic favourable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 36.7;pancreas: 63.3"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;CACO-2: 7.5;HDLM-2: 8.8;Hep G2: 20.3;K-562: 16.2;NTERA-2: 8.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.3	0.0	0.2	5.9	0.2	0.0	0.1	0.1	0.3	0.5	9.7	0.3	0.7	4.7	0.2	0.1	0.2	0.1	13.7	0.5	0.1	0.0	0.9	36.7	0.6	0.1	0.1	0.1	0.1	63.3	0.7	0.1	0.1	0.2	0.3	8.0	0.1	1.0	0.8	0.1	0.1	9.0	0.1	0.1	0.1	17.1	0.7	0.3	0.2	0.1	0.5	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.8	0.8	0.1	0.0	20.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.7	3.2	0.0	0.3	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.3
FRRS1	"SDFR2, SDR2"	ENSG00000156869	"Ferric chelate reductase 1"	Q6ZNA5	1	99708632-99766631	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.1"	"Cell line enhanced"	"Detected in many"		"HEL: 27.6;K-562: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017883	Approved									"HPA017883: AB_2294223"	"unprognostic (3.97e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.54e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.54e-2)"	10.3	6.2	0.6	2.7	1.2	1.5	5.1	0.5	1.2	6.4	6.1	1.2	14.5	2.6	10.7	6.5	11.2	2.0	3.4	2.9	0.6	0.6	1.9	27.1	3.8	1.7	2.1	0.0	5.3	2.0	1.5	2.3	9.8	0.9	4.4	4.0	1.6	8.4	13.4	2.0	7.2	8.0	3.3	3.1	1.5	4.2	2.9	1.3	1.4	5.6	5.4	6.0	5.1	7.0	0.3	0.5	5.5	0.8	0.0	0.1	0.1	5.5	1.0	2.4	2.1	7.6	4.1	12.2	1.4	2.7	1.7	6.5	6.7	7.3	3.2	5.7	1.6	12.7	3.8	5.9	2.1	6.5	2.4	27.6	2.7	7.2	1.1	3.1	7.4	6.1	7.5	3.4	1.3	0.3	18.5	0.1	1.4	1.7	1.0	1.2	1.7	5.1	0.0	9.0	1.3	1.1	13.8	0.5	0.1	2.3	10.4	5.4	3.8	3.9	0.6	3.0	4.1	2.6	1.5	2.3	0.0	5.4	6.6	1.3	1.4	0.5	0.4	5.5	0.0	0.8	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.6	1.2	0.5	1.2	0.6	0.6	2.1	0.0	0.9	1.3
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480409-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 58.2;HaCaT: 49.3;HBEC3-KT: 31.5;HMC-1: 35.4;PC-3: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	5	"monocytes: 1.0;T-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB026025	Approved				"Secreted to blood"	1800000	1800000			"CAB026025: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	12.4	3.2	2.0	3.1	0.8	0.1	7.1	0.2	0.7	3.5	5.2	0.3	1.1	0.9	2.3	9.5	3.6	4.9	4.1	5.6	1.0	1.0	1.7	42.7	4.3	0.8	0.4	0.6	20.7	19.4	0.0	2.9	13.5	1.0	9.3	1.7	5.7	5.5	6.5	12.6	9.0	4.3	3.7	0.4	0.2	4.8	4.9	0.5	1.2	2.0	6.7	7.1	6.2	13.8	0.1	0.2	0.0	1.0	0.0	2.0	0.1	3.2	0.3	5.8	0.0	6.6	2.3	9.6	12.7	58.2	7.8	7.7	0.0	0.0	0.0	0.1	3.3	49.3	0.0	31.5	5.6	0.1	0.0	0.6	0.2	5.2	3.5	0.0	35.4	5.4	0.0	14.4	9.4	6.6	0.0	0.1	4.9	0.0	0.0	0.2	8.9	95.2	0.6	7.4	0.0	0.0	5.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	21.6	6.2	2.2	1.8	0.0	0.0	0.0	2.5	0.6	19.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.8	0.2	0.7	1.0	1.0	0.4	0.6	1.0	0.5
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355154-133358035	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"liver cancer: 61.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Uncertain					2500000	2500000			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	4.9	3.3	1.9	7.1	2.1	2.2	4.5	1.1	2.4	2.2	15.2	2.6	4.9	20.5	2.1	6.3	3.6	2.8	5.8	6.8	1.6	1.3	14.2	68.3	7.5	6.7	2.1	0.9	3.7	6.9	0.8	2.3	2.0	3.0	2.4	2.2	6.7	18.8	3.0	1.9	2.6	28.3	2.4	1.7	9.7	3.0	2.4	1.2	2.8	2.4	3.3	6.1	2.9	2.6	13.0	28.7	2.1	25.6	5.7	6.0	10.1	10.9	3.5	6.8	13.9	1.9	4.9	12.4	8.8	10.3	3.3	4.1	22.1	6.1	0.0	10.3	6.7	0.6	2.4	3.0	0.3	3.9	2.4	10.7	5.3	23.8	10.2	11.8	7.3	4.9	0.1	1.3	0.7	4.5	10.3	14.7	6.8	10.9	1.8	15.8	4.7	1.6	10.3	0.2	6.4	3.7	0.0	0.7	5.4	3.3	10.1	12.1	0.1	18.2	9.0	0.0	9.3	0.0	0.0	7.7	1.2	7.6	2.7	4.9	3.4	0.0	25.6	2.1	6.0	25.6	5.6	12.6	5.4	5.0	20.7	13.0	5.8	5.0	1.2	5.7	5.4	28.7	3.5	10.1	1.9	2.1	1.1	2.4	1.6	1.3	2.1	0.9	3.0	1.2
FYB2	"ARAP, C1orf168, FLJ43208, RP4-758N20.2"	ENSG00000187889	"FYN binding protein 2"	Q5VWT5	1	56718804-56819696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.5;liver: 22.6;retina: 16.7"	"Cell line enriched"	"Detected in single"	18	"T-47d: 10.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 1.6;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in many"														"unprognostic (6.12e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.19e-3)"	"unprognostic (4.77e-3)"		"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-3)"	0.2	0.2	0.2	0.0	0.2	0.0	0.7	0.7	0.7	4.1	0.9	2.0	7.5	0.3	3.7	7.7	0.6	15.5	0.0	3.7	1.6	0.2	10.0	22.6	3.2	0.0	0.2	0.8	4.3	1.2	0.0	12.4	0.2	5.7	2.1	0.5	16.7	3.0	2.1	2.8	0.2	3.0	0.1	0.2	0.2	0.5	2.1	0.0	2.5	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.3	1.6	0.2	0.2	0.8	5.7	0.0
FZD5	"C2orf31, DKFZP434E2135, HFZ5"	ENSG00000163251	"Frizzled class receptor 5"	Q13467	2	207762586-207769563	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.2;liver: 36.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 47.3;CACO-2: 11.5;Hep G2: 15.9;NTERA-2: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA052361	Approved									"HPA052361: AB_2681799"	"unprognostic (4.97e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.15e-3)"	5.3	5.9	1.7	5.8	3.9	3.3	6.5	0.6	2.0	4.3	25.4	7.2	8.5	17.5	2.8	1.0	3.9	1.6	5.3	1.9	1.7	2.2	12.1	36.5	12.4	0.9	3.9	1.4	4.5	20.8	1.2	6.1	6.5	2.6	6.4	14.4	6.6	3.7	3.9	2.5	1.4	35.2	2.5	1.9	2.8	10.8	0.8	4.2	1.3	18.5	1.8	2.9	2.6	3.4	0.3	1.4	0.5	1.1	0.2	0.4	0.4	1.4	2.6	0.1	1.4	1.2	0.0	47.3	0.2	0.3	0.3	0.3	11.5	2.7	0.2	3.2	0.1	2.1	4.0	1.7	0.3	0.1	3.1	3.3	1.2	15.9	0.9	0.6	0.9	0.1	1.7	0.5	1.3	0.4	6.5	0.5	0.3	1.0	0.3	0.8	13.8	0.9	0.8	1.5	0.6	3.3	5.0	2.2	0.3	0.6	0.2	0.6	0.7	0.6	0.1	0.7	1.3	1.4	1.0	0.7	1.7	0.5	0.9	0.7	0.2	0.3	1.1	0.2	0.1	0.8	0.4	0.1	0.0	0.0	1.4	0.3	0.1	0.2	0.5	0.2	0.4	0.1	0.1	0.4	1.7	3.9	0.6	2.0	1.7	2.2	3.9	1.4	2.6	4.2
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675420-209676388	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 203.9;liver: 154.7"	"Group enriched"	"Detected in some"	6	"ASC diff: 75.4;HBEC3-KT: 113.8;PC-3: 28.6;RPMI-8226: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	62	"neutrophil: 89.5"	"Lineage enriched"	"Detected in single"	197	"granulocytes: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	130.1	23.3	1.1	18.5	1.1	203.9	85.2	2.0	0.9	2.0	11.3	1.4	29.9	1.6	6.1	9.3	2.0	4.0	13.5	43.7	1.1	0.8	22.2	154.7	51.6	6.4	1.8	0.0	18.4	5.3	0.5	1.2	2.6	1.3	8.7	1.1	3.1	49.2	73.5	97.9	3.0	3.5	3.8	1.5	6.3	7.1	5.3	1.1	0.0	3.1	14.3	6.1	12.6	13.1	0.0	0.0	89.5	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.0	75.4	2.6	0.0	0.1	0.2	0.3	0.3	2.9	2.3	0.0	0.6	0.5	0.0	0.0	113.8	0.7	0.1	0.2	0.0	0.2	0.0	6.1	0.0	0.0	7.8	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	28.6	0.0	0.0	36.3	0.2	0.0	0.1	0.2	2.5	0.0	0.6	0.0	8.7	11.4	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	1.1	1.1	2.0	0.9	1.1	0.8	1.8	0.0	1.3	1.1
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282124	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 140.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	11000000	11000000	"Golgi apparatus"	"Golgi apparatus"	"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	19.5	25.6	11.1	19.6	10.1	6.9	20.4	7.7	12.5	11.7	12.7	9.1	10.5	11.3	13.7	11.5	11.5	13.2	17.0	13.9	12.5	8.5	17.5	140.3	13.2	20.4	8.4	9.0	24.8	35.9	4.3	7.3	16.6	12.6	10.8	7.5	10.5	11.1	9.6	42.2	8.4	11.3	14.6	13.6	9.5	18.0	12.7	8.2	28.4	10.7	10.7	7.0	14.9	13.1	6.7	13.5	3.5	10.1	2.7	5.3	6.3	15.9	21.3	12.6	14.9	24.2	20.7	26.0	30.3	18.8	12.3	11.8	9.2	30.4	4.0	22.5	15.9	31.2	8.3	25.4	10.4	40.3	10.8	12.3	47.7	10.2	13.2	4.7	24.2	29.6	12.6	16.4	6.6	14.4	15.3	6.2	13.6	4.4	24.3	4.7	17.2	20.4	27.1	18.0	12.4	12.1	19.0	4.0	14.9	30.7	1.6	18.4	9.7	8.8	34.1	12.1	23.3	27.2	24.0	20.7	11.9	9.0	31.2	9.4	89.5	1.1	10.1	3.5	4.7	9.6	3.6	3.8	2.9	4.7	7.9	6.7	2.8	5.3	3.2	2.7	9.6	13.5	3.4	6.3	11.1	10.1	7.7	11.8	12.5	8.5	8.4	9.0	12.6	8.2
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		120000	120000	Cytosol	Cytosol	"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favourable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	4.9	6.6	6.0	2.4	8.3	8.3	7.0	3.7	10.6	3.9	4.4	8.2	4.6	5.6	3.8	4.4	2.7	1.1	10.3	0.7	8.3	4.5	2.3	13.2	8.3	8.1	1.3	2.9	12.1	6.6	2.5	3.1	9.3	1.9	6.1	6.2	4.3	4.7	9.4	2.1	1.2	7.3	5.5	2.9	10.7	6.9	1.4	5.3	4.7	9.3	5.0	8.3	7.2	1.4	1.7	3.2	3.3	0.0	3.5	2.0	1.1	4.0	3.9	9.8	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.0;skeletal muscle: 222.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 51.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					38000	38000			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	5.1	4.6	9.1	1.5	8.7	2.2	3.2	5.1	11.4	2.3	1.4	15.1	5.1	1.3	2.0	31.3	5.3	3.8	2.6	10.8	9.2	7.7	8.0	73.0	1.5	2.0	8.7	5.2	3.8	47.0	5.4	4.9	1.6	5.9	5.6	1.1	4.5	9.1	4.7	222.2	6.0	1.4	2.1	8.8	2.1	3.2	7.7	4.5	5.6	3.3	26.7	2.8	1.9	1.7	15.7	23.0	6.9	2.6	8.0	21.6	7.7	6.2	7.1	7.6	17.2	9.6	11.7	10.4	7.5	12.5	9.7	8.8	16.0	4.5	3.3	5.3	8.9	2.7	12.0	4.6	2.6	23.8	13.7	10.2	5.9	51.2	5.7	0.2	3.5	13.0	1.6	10.3	0.0	2.1	14.5	8.0	15.8	6.4	29.8	3.5	8.6	22.6	29.9	6.8	23.8	11.4	5.8	2.5	17.9	0.5	4.3	9.2	19.8	14.2	3.6	10.7	11.1	0.6	3.4	36.3	7.0	5.6	9.9	13.5	12.2	1.6	1.2	6.9	9.9	1.6	13.9	10.6	13.7	12.2	5.4	15.7	21.6	16.1	0.8	8.0	2.6	23.0	7.5	7.7	9.1	8.7	5.1	11.4	9.2	7.7	8.7	5.2	5.9	4.5
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891026-12914207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (7.28e-5)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favourable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	12.5	12.1	11.4	8.6	13.3	8.2	9.5	11.5	14.0	9.5	10.5	15.5	8.6	9.1	11.7	7.3	9.1	10.5	7.5	19.8	9.3	8.0	20.2	62.6	6.3	12.1	15.5	14.1	13.7	12.3	7.9	8.7	4.9	9.7	10.4	6.9	9.6	14.7	9.7	17.5	6.6	8.1	8.2	8.7	8.6	11.3	4.9	11.8	13.0	10.9	13.7	9.0	12.0	6.6	10.9	14.5	7.2	8.1	21.7	20.6	12.3	11.2	6.2	6.7	12.4	9.9	4.9	6.2	8.4	5.0	9.8	7.4	11.5	4.8	16.3	15.8	4.6	7.1	9.3	7.2	4.9	14.0	9.9	10.4	10.9	14.1	11.3	19.6	8.3	6.3	9.0	6.9	7.5	8.4	25.3	5.1	4.8	12.3	23.0	17.2	7.6	16.2	22.0	6.9	31.6	5.7	5.1	14.9	9.0	11.8	10.3	7.2	8.0	13.0	5.9	8.0	6.0	14.8	8.0	27.3	13.8	17.1	5.6	22.5	6.9	7.2	8.1	4.6	11.7	7.1	11.6	10.7	15.0	13.7	14.5	10.9	20.6	15.5	2.0	21.7	5.3	8.6	12.5	12.3	11.4	13.3	11.5	14.0	9.3	8.0	15.5	14.1	9.7	11.8
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favourable (8.69e-4)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.6	0.0	1.2	0.8	2.2	0.9	0.6	13.2	3.3	0.1	2.0	5.7	0.9	0.0	5.1	4.9	0.3	0.2	1.9	5.6	0.0	1.2	1.4	1.6	1.9	0.0	0.4	0.8	0.0	0.0	6.8	7.1	0.2	1.1	4.5	5.8	1.4	0.0	1.6	2.7	5.8	29.3	2.4	1.5	0.7	5.6	1.6	0.2	0.1	1.9	3.7	2.3	5.6	4.2	3.2	2.4	4.5	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764020-40767710	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.0;RPTEC TERT1: 41.1;SCLC-21H: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 11.6;midbrain: 14.1;pons and medulla: 9.8"					HPA046258	Enhanced		Supported	Nucleoplasm		59000	59000	Nucleoplasm	Nucleoplasm	"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favourable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	9.0	4.9	3.8	6.6	6.0	7.9	37.6	9.7	5.0	7.2	16.5	1.5	0.9	18.3	2.0	2.7	13.4	5.1	6.2	8.1	4.6	4.1	16.3	73.4	16.4	10.5	2.8	2.3	7.1	3.9	1.5	5.1	4.7	8.8	5.0	3.4	6.5	6.0	1.7	1.9	7.3	31.7	1.3	3.1	3.5	4.4	3.4	1.3	10.3	5.0	4.0	12.6	4.4	6.1	13.0	25.4	27.1	21.0	33.1	38.6	27.0	0.1	2.1	1.7	9.3	2.7	0.9	4.7	0.6	2.2	1.0	2.1	24.4	13.8	12.4	8.8	0.5	1.7	4.5	0.8	0.2	9.7	7.6	12.2	18.5	32.0	2.2	7.9	4.2	2.3	1.1	0.4	0.1	4.0	6.1	3.8	0.3	4.5	2.1	16.2	4.5	15.9	17.5	0.1	7.6	41.1	6.5	36.8	0.5	5.5	26.3	2.8	7.1	8.1	0.0	0.1	0.3	0.6	0.1	0.2	1.6	7.6	1.4	17.7	1.1	4.3	21.0	27.1	22.7	6.4	38.0	13.0	20.1	21.0	13.6	9.6	20.8	13.5	3.3	33.1	5.6	25.4	38.6	27.0	3.8	6.0	9.7	5.0	4.6	4.1	2.8	2.3	8.8	1.3
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell line enhanced"	"Detected in all"		"A549: 54.7;Hep G2: 46.7;RT4: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		3600000	3600000	Nucleoplasm	Nucleoplasm	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	8.1	54.7	4.5	10.6	5.4	2.4	6.0	4.1	6.7	3.1	3.7	8.0	19.0	15.5	7.9	3.7	11.6	13.7	30.1	4.2	12.2	8.4	10.4	10.6	46.7	6.2	13.6	6.4	3.8	12.8	3.5	15.7	4.7	5.7	4.9	1.5	8.6	11.7	5.4	8.3	5.1	3.9	2.7	13.7	10.1	50.4	13.0	6.4	6.9	11.1	7.2	7.6	6.5	6.5	2.8	9.8	7.1	6.1	6.6	10.1	9.0	7.0	9.8	4.7	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081938-81096425	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041368	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA041368: AB_10804001"	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favourable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	10.9	10.0	28.9	3.7	26.8	3.0	11.4	8.1	21.8	9.9	6.4	15.0	14.2	3.8	9.4	35.9	6.0	10.4	6.3	11.7	23.5	20.6	37.3	55.9	4.0	5.8	30.8	15.8	8.9	10.2	19.4	7.2	12.9	18.7	9.9	7.0	10.4	9.4	9.3	18.1	4.3	3.1	6.9	27.6	2.6	5.2	3.5	17.9	6.7	48.7	5.9	4.8	6.6	4.9	4.4	12.2	2.8	2.6	7.9	7.3	2.9	17.8	7.9	24.9	10.8	12.2	9.4	50.8	10.4	7.7	12.7	6.2	10.5	16.7	4.7	9.4	4.5	9.2	19.0	10.5	21.3	1.3	24.8	6.0	10.5	32.4	13.9	19.7	7.1	9.6	14.2	7.9	16.2	6.4	23.6	1.0	12.6	18.8	12.8	39.9	32.8	16.5	20.0	13.1	7.1	28.7	16.4	12.9	13.4	14.9	9.7	19.7	14.2	9.5	5.6	8.2	14.4	13.1	10.7	4.0	8.6	28.6	5.5	11.8	6.6	2.8	1.7	1.7	3.4	2.6	5.7	4.4	3.3	4.9	4.5	3.3	5.8	7.3	2.2	7.9	2.0	12.2	2.6	2.9	28.9	26.8	8.1	21.8	23.5	20.6	30.8	15.8	18.7	17.9
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;intestine: 54.5;liver: 27.6"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;BJ hTERT+: 9.2;EFO-21: 50.3;HeLa: 17.6;hTCEpi: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		1300000	1300000	Nucleoplasm	Nucleoplasm	"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favourable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.5	1.7	26.7	1.8	27.7	0.5	0.5	0.4	33.8	1.0	20.6	0.9	7.7	47.4	2.4	0.6	0.5	4.7	13.1	0.5	25.7	15.0	21.4	27.6	0.5	0.5	2.9	27.4	0.4	1.7	10.8	1.7	10.3	0.8	0.4	5.5	0.0	0.4	4.1	1.1	1.6	54.5	0.5	0.6	0.5	2.0	1.0	0.2	0.0	0.4	1.0	2.6	3.4	0.5	1.4	0.5	3.0	0.7	1.0	1.0	0.1	12.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	9.2	0.0	0.0	1.1	7.1	0.0	50.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	2.9	0.0	0.2	0.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.7	0.3	1.0	0.6	0.3	0.6	0.5	0.4	0.3	1.4	0.7	0.7	1.9	1.0	0.4	0.5	0.5	0.1	26.7	27.7	0.4	33.8	25.7	15.0	2.9	27.4	0.8	0.2
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.9;blood: 2.2;liver: 2.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;Karpas-707: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"pons and medulla: 0.3"	"Low region specificity"	"Detected in many"			HPA047372	Uncertain									"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			1.9	0.0	0.1	0.3	0.1	0.4	0.6	0.2	0.2	0.0	0.0			0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.1		0.1	0.0	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.9			0.0		0.1	0.0	0.0	1.2	0.7	2.2	0.6	0.6	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.3	0.1	0.8	0.6	0.2	0.2	0.1	0.1	0.8	0.2	0.1	0.0	1.2	0.3	0.3	2.2	0.6	0.2	0.7	0.0	0.0										
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63015079-63039171	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 42.5;liver: 59.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	1400000000	1400000000			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	3.5	3.6	7.4	4.7	8.6	12.3	11.8	15.5	9.9	3.5	17.6	1.5	1.0	3.7	2.6	3.7	11.0	1.6	2.8	5.9	7.9	7.6	42.5	59.5	3.5	5.0	4.7	7.0	1.9	4.2	1.0	1.6	17.7	14.8	1.9	26.4	2.2	6.5	1.8	1.7	11.1	3.6	4.2	7.6	3.7	3.2	14.0	3.8	5.2	1.4	14.5	7.6	3.9	6.6	4.1	18.2	2.1	1.9	2.9	1.4	1.4	20.4	19.7	20.2	3.1	19.9	8.4	14.9	12.6	21.6	20.0	29.1	27.5	36.3	14.0	3.6	15.6	17.1	20.0	21.1	29.8	28.4	15.1	23.0	10.6	18.6	3.8	10.7	13.8	6.1	6.0	20.2	9.7	24.2	12.2	51.3	37.5	11.6	5.2	10.7	9.5	18.6	15.6	19.7	18.8	15.5	7.2	8.1	13.8	18.4	20.1	19.1	22.2	11.9	12.8	21.6	24.2	20.7	22.7	24.0	24.4	16.4	33.4	0.0	38.1	0.0	1.9	2.1	1.1	1.1	0.5	4.1	1.3	1.3	0.6	1.9	1.0	1.3	1.8	2.9	1.2	18.2	1.4	1.4	7.4	8.6	15.5	9.9	7.9	7.6	4.7	7.0	14.8	3.8
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71215194-71225516	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4;liver: 114.4;pancreas: 37.1"	"Group enriched"	"Detected in some"	6	"Hep G2: 45.7;SK-MEL-30: 50.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain									"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favourable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.4	0.4	7.2	2.5	9.3	0.3	2.6	1.9	14.4	3.3	12.0	46.3	2.5	14.6	0.9	8.1	0.5	9.5	19.8	0.4	13.4	8.0	14.8	114.4	1.2	0.4	22.4	5.6	0.4	37.1	0.3	0.4	0.4	23.0	4.3	8.3	0.5	19.6	8.7	0.4	0.6	11.7	1.0	52.4	0.4	5.7	3.1	12.1	0.0	0.4	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.3	1.9	14.4	13.4	8.0	22.4	5.6	23.0	12.1
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761750-48773648	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.2;kidney: 10.2;liver: 7.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;K-562: 1.9;MCF7: 6.3;SCLC-21H: 1.3;T-47d: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010667	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.2	0.0	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.4	14.7	0.2	0.2	10.3	0.4	5.6	0.3	1.6	3.5	0.2	0.2	0.0	10.2	7.8	1.5	0.2	0.2	0.2	0.4	1.1	0.0	0.6	0.2	0.2	0.4	5.7	1.5	0.6	0.2	0.2	0.1	25.2	0.2	0.2	0.2	1.3	0.7	0.2	0.4	1.9	0.2	0.5	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.3	0.4	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Group enriched"	"Detected in some"	7	"MOLT-4: 12.2;NTERA-2: 17.6;SCLC-21H: 8.3"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA039051: , HPA039052: "	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.5;Hep G2: 15.1;MCF7: 5.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"			Vesicles	Vesicles	"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	11.5	0.9	1.2	1.3	0.0	2.2	0.0	0.1	0.0	2.2	1.7	0.1	1.0	15.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	5.3	0.2	0.2	0.2	1.0	0.9	0.6	0.3	0.0	0.9	1.5	1.0	2.2	0.4	0.6	1.3	0.1	2.4	0.8	0.9	0.5	0.4	0.2	0.6	0.1	0.3	0.6	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	26000000	26000000	Mitochondria	Mitochondria	"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavourable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.0	19.5	15.3	25.9	29.1	35.9	16.7	19.0	33.0	18.5	20.3	44.9	23.6	27.1	15.6	27.7	38.0	19.9	19.2	19.8	19.5	15.7	13.1	11.7	106.0	65.0	30.7	19.1	24.7	36.2	20.5	61.4	22.0	13.2	24.5	19.9	17.5	27.6	27.6	17.4	15.7	21.0	19.5	17.6	53.1	19.7	7.9	14.8	17.1	13.6	24.3	18.6	21.6	21.8	9.6	8.5	19.4	19.3	14.7	15.1	32.4	23.2	35.2	5.7	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.8;K-562: 8.6;SK-MEL-30: 11.1;THP-1: 5.5;WM-115: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA042492, HPA044839, HPA061369"	Uncertain		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.1	2.7	5.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852877-190892429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.7;kidney: 26.9;liver: 8.5"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 4.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043663	Uncertain									"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.1	0.1	3.5	0.1	2.9	0.1	0.1	0.2	0.7	0.8	0.1	5.0	0.0	0.1	2.0	4.4	0.1	12.7	0.1	0.9	4.6	1.4	26.9	8.5	0.1	0.1	0.6	0.9	0.5	1.1	0.1	0.2	0.3	4.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	2.0	0.1	0.1	2.3	3.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.9	0.2	0.7	4.6	1.4	0.6	0.9	4.2	3.0
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favourable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	3.6	6.3	12.1	8.3	0.7	8.1	2.6	5.1	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3
GNPNAT1	"FLJ10607, Gpnat1"	ENSG00000100522	"Glucosamine-phosphate N-acetyltransferase 1"	Q96EK6	14	52775194-52791668	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044647	Approved					17000	17000			"HPA044647: AB_10795986"	"unprognostic (4.55e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (8.52e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.05e-2)"	13.4	6.9	6.4	6.7	6.6	2.1	10.6	9.2	9.2	10.0	11.2	4.6	6.8	9.3	8.1	6.4	8.4	6.3	9.3	6.3	5.8	6.3	11.5	47.3	6.4	8.6	5.4	5.2	9.3	28.4	6.9	12.4	6.5	7.1	10.1	14.0	4.1	22.2	4.7	9.4	4.8	8.5	8.2	6.3	7.3	12.0	12.5	4.2	3.6	5.4	6.0	7.1	7.3	7.2	6.1	5.1	6.6	5.7	7.7	8.4	4.2	34.1	13.7	10.8	12.3	11.8	26.7	17.9	22.3	14.4	19.5	20.2	15.5	20.3	19.5	12.5	22.0	13.9	20.8	22.4	33.8	11.1	11.1	13.0	13.1	19.2	17.0	14.4	7.1	11.1	19.2	33.0	35.3	21.8	12.6	4.8	24.9	29.7	17.3	7.5	11.4	24.1	12.0	5.0	11.7	18.4	18.3	11.2	15.4	18.5	25.0	15.9	28.6	5.0	24.2	19.8	20.8	35.0	17.2	5.0	9.6	8.6	9.3	9.5	11.5	6.6	2.2	0.1	7.1	2.7	8.4	6.1	7.3	6.2	5.1	5.4	8.4	6.8	0.7	7.7	5.7	3.2	8.4	4.2	6.4	6.6	9.2	9.2	5.8	6.3	5.4	5.2	7.1	4.2
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		130000000	130000000	Nucleoplasm	Nucleoplasm	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favourable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	16.9	9.4	11.1	28.0	8.6	7.4	31.4	13.9	25.6	24.3	26.5	21.3	13.8	16.6	4.8	11.7	21.3	25.3	18.3	26.8	5.7	10.8	6.3	12.1	27.7	45.6	18.0	10.8	11.6	19.8	20.6	55.9	11.7	16.2	26.0	15.5	15.3	9.6	13.5	7.1	13.1	10.5	10.6	17.3	42.4	9.3	4.8	7.1	10.5	14.9	51.9	28.5	6.2	5.4	6.2	13.8	6.7	15.9	18.6	21.9	16.9	16.3	9.4	8.2	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 75.2;Hep G2: 20.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favourable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.7	2.1	2.8	3.7	75.2	2.7	3.7	2.6	3.0	1.9	1.5	4.9	1.6	1.9	1.4	1.8	3.5	4.5	2.2	3.6	1.4	2.4	1.8	2.3	20.2	2.3	3.1	1.0	13.1	3.8	3.4	7.0	1.6	2.3	1.7	2.2	1.5	2.6	2.4	2.3	2.9	2.7	7.4	1.4	1.2	1.9	1.2	3.6	3.6	1.7	4.1	1.8	1.1	1.2	2.2	1.3	2.7	4.2	1.8	2.0	4.1	2.6	2.7	1.6	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 56.8;skeletal muscle: 27.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 4.7;Karpas-707: 5.6;U-266/70: 6.0"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.3;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.9"	"Low region specificity"	"Detected in all"							"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					15000000	15000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	9.0	0.8	1.7	8.7	2.2	1.1	3.9	1.5	2.3	0.2	17.4	2.0	4.6	10.9	0.2	1.7	0.9	0.5	19.8	16.9	1.7	0.9	8.7	56.8	0.2	0.2	1.3	2.2	0.4	3.6	0.5	1.1	0.1	2.0	0.7	3.5	1.6	17.0	2.7	27.0	6.1	19.2	0.2	0.7	0.4	8.6	0.8	1.6	0.0	0.6	13.9	3.3	0.3	0.5	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.5	1.5	0.4	1.1	0.9	0.0	1.3	0.8	0.0	0.0	0.0	0.4	1.9	0.8	0.7	0.0	4.3	0.0	0.0	0.0	1.5	2.7	0.7	2.5	4.7	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.5	5.6	0.0	2.6	0.9	0.9	0.6	1.0	0.9	0.3	3.0	0.0	1.8	1.2	1.7	0.5	1.4	0.2	3.8	0.2	0.4	0.3	1.3	1.3	0.2	6.0	0.4	0.4	0.8	1.9	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.7	2.2	1.5	2.3	1.7	0.9	1.3	2.2	2.0	1.6
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 126.9;liver: 195.2"	"Group enriched"	"Detected in some"	20	"A549: 120.7;HaCaT: 33.4;Hep G2: 112.0;RT4: 79.8;SCLC-21H: 36.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Low region specificity"	"Detected in single"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	0.1	0.0	0.1	23.8	0.2	0.0	0.8	0.2	0.1	5.5	50.4	0.5	2.0	14.4	0.3	1.0	53.0	0.6	126.9	0.2	0.1	0.2	29.4	195.2	2.0	0.1	0.1	0.1	0.9	7.0	0.0	0.2	0.1	0.2	16.8	71.6	0.1	59.7	4.1	0.3	3.9	35.4	5.6	0.2	0.1	57.8	0.4	0.1	0.5	0.2	44.0	7.4	56.3	15.0	0.2	0.0	0.5	0.8	2.4	0.1	0.0	0.0	120.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.0	0.0	0.7	0.0	33.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	112.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	79.8	36.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1
GRAMD4	"DIP, KIAA0767"	ENSG00000075240	"GRAM domain containing 4"	Q6IC98	22	46576012-46679790	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell line enhanced"	"Detected in all"		"HL-60: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.67e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.19e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.69e-2)"	9.2	20.5	12.2	10.5	13.6	12.6	7.9	7.6	19.6	6.9	24.7	9.2	5.6	21.3	8.2	7.9	14.2	10.4	22.9	18.9	13.0	7.7	9.1	83.9	12.0	9.9	8.0	15.3	6.9	14.8	8.1	14.4	6.5	9.3	9.0	16.9	14.8	10.2	4.7	15.7	27.8	28.7	7.2	9.4	10.2	17.7	6.3	7.3	12.2	12.3	6.0	16.1	7.3	10.8	2.0	4.7	2.5	2.9	6.9	3.7	1.4	5.0	5.7	6.8	8.6	9.1	5.4	7.0	3.9	2.4	1.6	2.0	2.1	8.0	18.3	6.7	4.3	10.7	4.1	2.1	2.4	4.9	4.7	6.2	4.2	4.9	7.4	38.1	25.1	3.5	5.1	1.2	2.8	2.3	11.5	12.6	2.2	8.8	22.2	20.4	3.7	2.7	10.1	1.0	12.0	3.1	5.9	4.8	13.5	4.2	8.4	14.7	8.2	13.6	3.3	2.0	4.1	2.7	2.5	2.6	8.1	9.8	4.6	15.1	17.7	2.5	2.9	1.9	1.4	1.9	0.6	2.0	1.1	1.0	3.9	0.7	1.0	0.6	1.1	6.9	0.8	4.7	3.7	1.4	12.2	13.6	7.6	19.6	13.0	7.7	8.0	15.3	9.3	7.3
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492812-164621848	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 17.7"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;HUVEC TERT2: 10.5;RPTEC TERT1: 8.7;TIME: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	1.6	2.9	1.0	1.2	1.5	0.0	6.0	0.7	3.6	0.8	1.2	0.0	1.1	1.2	0.6	7.5	1.7	0.5	0.3	10.8	5.7	1.1	8.3	17.7	0.7	0.1	0.9	2.0	2.4	6.0	0.0	1.8	2.2	1.4	0.8	0.4	1.2	1.0	0.5	3.2	0.5	0.8	0.6	0.6	0.6	1.1	3.1	0.4	0.0	5.5	3.0	0.1	0.6	1.1	0.0	0.0	0.4	0.1	0.0	0.0	3.0	0.9	5.5	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	2.4	0.6	0.0	3.4	0.0	0.4	0.9	1.6	0.3	0.0	4.8	0.0	0.3	1.3	0.1	0.0	0.0	0.4	1.0	2.0	0.0	10.5	0.0	0.1	1.7	2.2	0.0	0.0	2.1	1.4	0.0	0.0	0.1	8.7	0.4	3.3	0.4	0.0	0.3	0.0	0.6	0.0	13.2	0.2	1.4	0.0	0.1	0.5	0.1	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.0	1.0	1.5	0.7	3.6	5.7	1.1	0.9	2.0	1.4	0.4
GRM8	"GLUR8, GPRC1H, mGlu8, MGLUR8"	ENSG00000179603	"Glutamate metabotropic receptor 8"	O00222	7	126438598-127253294	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;liver: 8.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;HEK 293: 2.8;NTERA-2: 7.1;RH-30: 4.2;SCLC-21H: 6.4;SH-SY5Y: 3.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051481	Uncertain									"HPA051481: AB_2681499"	"unprognostic (4.57e-3)"	"unprognostic (5.10e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.12e-2)"	0.2	1.5	2.0	2.0	4.6	0.1	0.2	1.1	6.4	0.3	4.5	4.0	0.0	0.3	0.3	0.3	0.2	0.5	3.5	5.5	2.6	4.0	1.9	8.0	0.7	0.2	2.9	2.6	2.3	1.4	0.2	0.7	0.2	14.5	0.4	5.0	3.5	0.2	0.2	0.1	0.3	0.2	0.5	1.2	0.2	0.8	3.8	1.5	0.0	2.4	0.0	0.3	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.1	0.1	0.0	4.2	0.1	0.2	0.0	6.4	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.6	1.1	5.4	2.6	4.0	2.9	2.6	14.5	1.5
GRTP1	"FLJ22474, TBC1D6"	ENSG00000139835	"Growth hormone regulated TBC protein 1"	Q5TC63	13	113324164-113364148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 39.2;liver: 37.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046201	Approved									"HPA046201: AB_2679584"	"unprognostic (5.31e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.07e-3)"	"prognostic favourable (1.50e-5)"	"unprognostic (4.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.50e-3)"	2.1	7.2	1.9	7.0	2.2	1.5	8.6	1.1	1.9	7.6	25.9	1.3	14.6	28.2	6.4	7.4	10.5	4.8	16.7	1.2	3.3	1.0	10.8	37.4	2.9	2.4	1.8	2.4	6.6	11.5	2.8	1.4	8.7	4.1	8.7	8.2	9.0	12.1	8.3	5.5	14.4	39.2	4.5	3.2	3.7	7.5	9.4	3.1	1.8	1.9	5.0	6.2	6.5	8.0	3.3	2.8	6.7	2.5	1.6	2.4	1.9	5.8	2.1	4.3	7.4	0.7	1.0	13.4	1.0	0.0	0.3	0.1	12.1	13.1	0.3	1.0	0.4	8.6	3.6	1.0	0.0	0.3	5.0	7.4	6.1	11.9	1.2	0.8	3.0	0.3	1.6	0.9	0.2	0.0	4.5	0.6	0.0	10.9	0.2	1.3	11.8	1.7	0.8	0.2	0.3	1.0	6.9	0.5	3.8	0.4	6.4	1.4	30.4	0.8	0.5	0.3	1.7	1.1	0.4	2.3	2.5	1.0	4.8	1.8	2.5	4.0	2.5	2.2	1.3	1.4	1.0	2.8	1.6	1.0	0.9	3.3	2.4	1.6	6.7	1.6	2.2	2.8	0.5	1.9	1.9	2.2	1.1	1.9	3.3	1.0	1.8	2.4	4.1	3.1
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Group enriched"	"Detected in some"	20	"CACO-2: 20.3;Hep G2: 15.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell line enhanced"	"Detected in some"		"HEL: 26.6;HeLa: 31.8;HHSteC: 25.4;hTEC/SVTERT24-B: 23.0;HUVEC TERT2: 19.5;MOLT-4: 34.3"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB022669: , CAB047357: , HPA048652: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.7	0.4	0.0	0.1	0.2	0.0	0.1	26.6	31.8	0.5	25.4	0.0	0.2	0.0	0.0	23.0	0.1	19.5	0.0	17.8	0.7	0.0	34.3	0.2	17.1	0.0	0.1	0.1	3.3	2.8	0.0	1.6	0.2	0.0	0.1	0.1	0.3	14.0	0.0	11.4	0.6	0.2	0.0	14.3	18.8	1.1	9.8	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol		200000000	200000000	Cytosol	Cytosol	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favourable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.0	21.3	16.5	28.2	23.2	44.3	7.2	40.6	72.1	26.9	29.4	26.7	33.2	27.7	17.6	26.9	17.9	10.8	36.0	28.4	13.8	25.9	20.4	15.2	58.3	41.5	26.1	34.3	33.6	15.4	39.1	47.3	51.5	41.9	17.3	56.4	16.9	20.3	36.8	15.2	14.9	14.9	10.8	11.7	40.0	20.0	8.2	10.3	13.1	9.4	121.1	10.3	21.1	47.5	32.0	16.8	49.7	36.1	0.3	0.4	0.2	59.9	45.5	12.6	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2
GUCD1	"C22orf13, LLN4, MGC1842"	ENSG00000138867	"Guanylyl cyclase domain containing 1"	Q96NT3	22	24540423-24555935	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022786			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA022786: AB_1845711"	"unprognostic (1.58e-1)"	"prognostic favourable (6.84e-4)"	"unprognostic (2.83e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.01e-2)"	16.7	12.8	7.6	13.6	7.2	25.8	19.0	5.1	7.5	9.0	37.4	8.7	9.7	23.3	7.8	9.8	14.3	7.4	19.7	35.7	7.0	5.6	29.3	73.3	12.2	11.9	8.0	5.3	10.2	30.0	7.0	6.7	11.3	6.8	11.7	12.8	9.0	8.7	8.7	28.9	8.8	59.9	13.5	8.0	14.9	15.8	9.1	5.7	13.4	10.6	14.5	13.8	14.3	8.0	23.3	6.5	23.7	7.0	3.3	4.4	5.5	14.0	13.2	11.8	14.5	24.8	23.3	9.4	14.0	22.6	24.6	24.1	20.1	11.0	26.7	9.1	19.1	18.8	13.5	16.4	13.2	25.6	16.4	11.4	13.1	18.3	20.0	29.6	22.6	23.5	13.1	24.5	11.3	26.0	11.4	26.8	18.5	16.6	17.0	12.7	11.1	11.4	19.7	19.2	26.3	19.2	15.6	12.3	12.1	16.9	23.0	12.0	18.2	21.1	17.3	53.1	21.9	16.4	11.8	26.2	17.9	18.8	21.8	16.6	17.8	7.8	7.0	23.7	3.8	7.0	4.4	18.6	3.6	3.9	6.5	23.3	3.5	3.9	7.4	3.3	6.6	4.7	3.4	5.5	7.6	7.2	5.1	7.5	7.0	5.6	8.0	5.3	6.8	5.7
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.6;ASC TERT1: 32.8;HSkMC: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	91000000	91000000	Cytosol	Cytosol	"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.8	3.1	2.7	10.2	28.6	32.8	2.6	3.9	9.6	2.9	4.5	0.6	7.9	4.2	4.5	6.0	4.0	0.7	1.9	4.2	12.6	0.9	0.0	1.0	2.6	16.0	1.3	1.6	32.2	3.7	6.9	4.5	13.1	1.1	7.3	5.6	2.2	1.5	3.2	1.5	1.8	0.4	0.3	3.5	3.7	1.6	0.9	4.9	5.1	4.0	4.8	3.0	6.8	13.0	9.9	1.6	2.5	1.0	9.8	2.9	1.0	16.6	6.1	6.2	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.8;Hep G2: 31.1;REH: 6.5;THP-1: 5.9"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 15.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.7;granulocytes: 12.6;monocytes: 11.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					150000	150000			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favourable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	2.9	1.8	1.6	6.8	1.2	0.7	3.5	0.4	1.1	5.8	11.9	1.9	3.5	5.8	3.6	6.2	2.7	3.2	2.7	2.2	0.9	0.8	10.9	78.7	1.8	2.1	1.4	1.6	5.0	8.6	1.7	1.6	3.8	1.4	6.5	2.9	12.1	1.4	3.1	0.9	1.6	24.5	6.5	1.5	1.8	2.4	1.7	0.9	1.6	2.0	1.3	1.9	4.3	3.2	2.8	15.7	12.6	11.8	0.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	3.0	8.8	0.1	0.0	0.1	0.3	0.0	3.1	0.0	0.5	0.0	1.0	3.5	0.0	31.1	0.3	1.2	0.1	1.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.0	6.5	0.7	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.7	11.8	12.6	0.0	7.0	0.0	2.2	0.0	0.0	15.7	2.8	0.0	0.0	3.7	0.5	1.8	5.1	0.0	3.5	1.6	1.2	0.4	1.1	0.9	0.8	1.4	1.6	1.4	0.9
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827194	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					3000000	3000000			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favourable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favourable (5.19e-4)"	14.8	36.9	24.9	7.8	26.7	26.2	16.4	26.8	35.3	9.7	12.9	13.6	19.6	17.6	6.8	13.0	11.7	11.8	9.9	50.9	28.0	24.5	38.8	91.4	14.5	8.5	23.2	24.5	6.3	24.6	17.1	19.7	9.2	18.5	12.4	9.5	11.9	12.5	16.2	67.1	11.0	17.1	11.7	20.7	10.1	13.1	33.8	13.7	7.4	14.1	18.3	7.2	9.7	18.2	13.7	28.9	27.7	36.5	10.9	18.3	12.5	11.4	17.4	15.8	17.8	13.8	5.5	14.2	14.4	13.4	22.3	18.0	8.9	10.0	2.4	29.7	12.3	12.6	14.9	14.4	6.7	23.8	24.0	4.4	17.8	25.5	19.9	5.8	24.2	6.7	31.1	11.1	7.6	19.1	5.8	21.6	7.0	18.9	14.9	12.5	6.0	16.1	12.6	9.9	27.0	28.6	5.2	21.2	18.3	15.8	20.3	31.0	14.9	19.4	14.5	6.8	8.4	14.2	16.5	24.5	23.1	7.1	11.6	5.4	10.8	14.4	15.3	27.7	12.6	25.8	9.2	13.7	16.2	12.9	13.7	12.4	15.8	13.2	13.5	10.9	36.5	28.9	18.3	12.5	24.9	26.7	26.8	35.3	28.0	24.5	23.2	24.5	18.5	13.7
HBE1	HBE	ENSG00000213931	"Hemoglobin subunit epsilon 1"	P02100	11	5268345-5505652	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.7;liver: 6.7"	"Cell line enriched"	"Detected in some"	15	"K-562: 461.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043234	Approved									"HPA043234: AB_2678378"	"unprognostic (7.59e-2)"			"unprognostic (6.70e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.25e-1)"		"unprognostic (1.64e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.02e-3)"		"unprognostic (2.14e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.34e-2)"	1.8	1.1	1.1	0.4	1.0	1.3	0.9	1.0	1.9	0.7	0.4	0.4	0.4	0.1	0.6	2.0	0.4	1.0	0.6	0.4	1.4	0.8	0.9	6.7	0.6	0.4	7.7	5.1	1.9	0.5	0.1	0.6	3.6	3.2	1.1	0.3	0.4	0.7	0.6	1.5	0.6	0.4	1.2	0.5	1.0	0.4	2.2	0.4	1.6	0.6	0.4	0.4	0.4	0.7	0.0	0.0	2.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.7	1.1	1.0	1.0	1.9	1.4	0.8	7.7	5.1	3.2	0.4
HFE2	"haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC"	ENSG00000168509	"Hemochromatosis type 2 (juvenile)"	Q6ZVN8	1	146017468-146036746	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 49.4;skeletal muscle: 128.9;tongue: 28.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;HSkMC: 4.9;K-562: 4.7;RH-30: 1.7"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 87.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"													42000	42000				"unprognostic (2.30e-1)"			"unprognostic (6.98e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-8)"	"unprognostic (6.61e-2)"	"unprognostic (2.72e-1)"		"unprognostic (1.76e-2)"	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	0.0	0.0	14.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	128.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.2	2.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	4.9	0.0	0.0	0.0	0.0	4.7	0.1	0.7	0.0	0.0	0.0	0.4	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLF	MGC33822	ENSG00000108924	"HLF, PAR bZIP transcription factor"	Q16534	17	55265012-55325065	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 78.8"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 58.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 2.4;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favourable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favourable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	9.5	15.2	13.3	2.0	26.2	1.0	10.8	15.2	38.0	10.5	10.6	6.4	2.4	1.7	10.3	8.5	18.1	9.3	6.1	15.9	12.6	6.9	9.2	78.8	9.5	2.1	6.6	24.5	34.6	2.7	2.8	8.0	1.5	12.3	9.9	3.1	23.7	15.9	9.5	5.3	11.6	3.0	14.3	5.5	5.7	4.7	3.4	6.3	0.0	23.4	7.1	5.6	9.2	5.2	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	9.7	0.2	0.0	0.0	58.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.9	0.0	0.1	0.1	4.8	0.0	4.1	0.2	0.0	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	1.9	1.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	13.3	26.2	15.2	38.0	12.6	6.9	6.6	24.5	12.3	6.3
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	120000	120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.7	6.2	7.0	5.2	28.5	21.8	2.7	8.5	15.0	9.3	11.3	3.9	20.9	5.6	17.6	13.3	8.7	8.3	13.8	10.1	11.5	6.3	7.5	5.5	8.8	36.9	2.9	5.0	25.2	20.6	12.2	23.4	12.6	7.6	8.0	16.9	11.0	4.5	5.8	1.8	8.6	6.5	5.7	10.4	21.8	5.6	5.9	5.2	11.1	4.2	18.8	13.3	7.3	9.3	7.7	4.7	14.0	3.6	11.4	5.6	5.0	19.1	10.9	8.9	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell line enhanced"	"Detected in all"		"AF22: 123.5;HBEC3-KT: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		310000	310000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favourable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	15.3	7.4	123.5	14.2	7.2	28.7	8.4	2.4	9.7	3.5	7.0	12.8	22.2	16.3	5.5	3.5	12.1	30.7	71.2	3.7	3.4	36.9	6.0	6.8	17.3	11.3	13.1	4.3	15.6	8.6	18.5	7.4	3.6	10.7	44.6	2.9	7.1	11.8	16.0	22.1	3.9	8.5	17.3	18.0	54.7	23.8	10.6	5.1	12.6	6.3	3.7	9.9	17.5	4.3	2.6	13.3	2.8	2.3	6.0	9.1	22.2	2.3	15.8	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"intestine: 24.2;kidney: 17.2;liver: 15.6"	"Group enriched"	"Detected in some"	7	"A549: 6.2;CACO-2: 20.6;Hep G2: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	17.3	0.1	0.1	13.7	0.1	1.5	0.1	0.8	5.1	0.1	0.1	0.0	17.2	15.6	0.1	0.1	0.1	0.1	0.2	6.3	0.0	0.1	0.1	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.0	24.2	0.5	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.5	1.8	0.3	0.3	0.4	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.2	0.2	0.3	0.2	0.3	0.4	0.4	0.1	0.5	0.4	0.4	1.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 65.5;kidney: 30.5;liver: 57.3"	"Group enriched"	"Detected in some"	9	"CACO-2: 51.6;Hep G2: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.2	0.2	13.4	0.2	0.0	0.2	0.2	0.3	0.2	54.0	0.2	0.1	33.0	0.2	6.2	0.2	0.4	15.7	0.2	0.2	0.2	30.5	57.3	0.3	0.1	0.2	0.1	0.3	22.7	0.0	0.2	0.1	0.2	0.2	14.4	0.2	0.2	0.1	0.2	0.2	65.5	0.3	0.2	0.2	7.1	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.4	0.4	0.6	1.2	0.8	0.8	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.6	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	0.4	0.4	0.7	0.8	0.8	0.6	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.1
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 39.8;liver: 31.0"	"Group enriched"	"Detected in some"	4	"AN3-CA: 6.0;EFO-21: 7.2;Hep G2: 18.5;RPTEC TERT1: 22.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039466	Approved					15000	15000			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favourable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	3.3	5.4	3.3	0.6	3.8	0.8	2.1	7.0	4.3	0.8	0.6	8.2	1.5	0.7	0.9	4.0	1.3	2.0	3.8	10.1	4.2	2.8	39.8	31.0	0.9	0.7	9.3	5.2	0.6	12.0	2.0	2.4	0.6	7.2	1.3	0.6	3.6	1.8	2.2	2.0	1.2	0.6	0.8	8.2	0.7	0.6	0.7	6.9	0.0	1.8	4.1	0.6	0.8	0.6	2.1	1.7	4.4	1.2	1.2	1.3	0.5	0.3	2.7	0.1	6.0	1.2	0.3	0.1	0.1	0.2	0.1	0.0	2.2	0.3	0.2	7.2	0.1	2.0	0.1	0.2	0.1	0.2	3.1	0.1	1.0	18.5	0.8	0.2	0.2	0.3	0.6	0.2	0.1	0.3	0.1	0.4	0.4	1.2	0.1	0.2	0.2	0.0	0.2	0.5	0.4	22.8	0.4	0.5	0.9	0.1	1.1	0.7	2.1	0.1	0.3	0.7	0.2	0.4	0.2	0.4	0.6	0.1	1.5	0.3	0.1	2.4	1.1	1.2	1.2	0.9	1.0	1.1	1.3	0.9	0.5	2.1	1.1	1.2	4.4	1.2	1.2	1.7	0.9	0.5	3.3	3.8	7.0	3.9	4.2	2.8	9.3	5.2	7.2	6.9
HOOK1	HK1	ENSG00000134709	"Hook microtubule tethering protein 1"	Q9UJC3	1	59814786-59876378	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 19.6;RPTEC TERT1: 18.1;SK-BR-3: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018537, HPA018820"	Enhanced									"HPA018537: AB_1850907, HPA018820: AB_1850910"	"unprognostic (9.82e-3)"	"unprognostic (4.29e-1)"	"prognostic favourable (4.53e-6)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-1)"	"prognostic favourable (4.42e-4)"	"unprognostic (1.79e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-1)"	1.0	4.5	3.6	3.6	8.3	1.9	7.6	11.6	8.0	3.3	9.9	0.6	7.5	7.7	2.0	6.0	12.8	4.5	2.4	2.4	6.8	2.9	20.9	35.9	3.8	3.2	1.3	5.5	1.4	16.7	24.6	18.4	2.3	3.6	4.1	9.0	8.4	18.1	7.6	0.4	9.3	13.0	0.2	0.7	1.9	6.6	10.4	1.4	2.7	9.2	4.0	3.2	1.9	4.9	3.5	0.0	1.5	0.0	2.1	9.9	1.1	8.7	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	7.7	0.0	19.6	0.0	5.1	1.9	3.9	0.0	0.3	8.6	0.1	2.5	9.3	0.0	0.0	2.0	0.0	8.7	0.0	0.0	0.0	5.0	0.0	0.0	3.7	0.0	0.0	7.4	3.6	0.0	0.0	9.7	18.1	9.1	7.4	3.0	0.1	17.5	0.2	10.2	0.1	0.0	0.0	0.0	0.0	0.0	11.9	8.8	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.4	0.0	2.5	1.7	2.7	0.6	0.0	3.5	9.9	2.9	0.1	2.1	0.0	0.0	0.4	1.1	3.6	8.3	11.6	8.0	6.8	2.9	1.3	5.5	3.6	1.4
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.7;Hep G2: 18.8;hTERT-HME1: 11.3;RT4: 38.9;TIME: 21.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	23.7	0.0	0.0	4.3	0.7	0.0	4.7	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.1	18.8	0.1	0.1	0.1	0.0	1.2	0.0	11.3	0.3	0.0	0.2	3.5	0.1	0.0	0.4	0.1	8.6	0.0	0.0	0.5	0.4	38.9	0.2	0.6	0.0	1.1	0.1	0.0	0.0	21.8	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
HSD17B7	"PRAP, SDR37C1"	ENSG00000132196	"Hydroxysteroid 17-beta dehydrogenase 7"	P56937	1	162790702-162812817	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.3;liver: 16.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047496	Approved									"HPA047496: AB_2680068"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (8.47e-5)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.17e-2)"	1.9	9.2	1.4	2.0	1.0	0.7	4.3	1.4	1.9	2.8	2.9			3.1	2.1	4.4	4.7	2.2	1.6	1.6	1.9	2.6	2.2	16.8	4.3	3.7	1.5		3.6	2.6	2.5	4.1	1.8		2.8	4.0		3.1	1.3	2.0	3.6	3.1	1.8	3.2	2.9	2.9	0.6			2.8		3.9	2.2	2.8	12.5	9.6	15.8	7.4	7.0	16.3	10.5	6.8	7.0	18.5	8.2	10.7	11.5	12.1	2.7	8.9	5.4	10.8	9.6	22.0	16.4	6.3	2.3	11.0	16.8	23.7	5.7	7.1	9.0	4.1	5.3	15.1	8.9	7.3	7.3	6.9	13.2	21.0	6.9	8.9	7.8	11.3	4.6	4.8	9.5	7.9	11.7	8.7	5.3	11.1	10.5	19.2	10.9	15.8	8.2	4.4	4.3	4.2	7.0	9.4	5.3	2.5	5.9	3.8	5.3	6.9	6.8	16.2	4.0	0.6	6.1	15.8	6.0	11.2	13.9	6.1	14.6	12.5	10.5	13.4	6.5	10.9	13.0	13.1	5.0	7.0	7.4	9.6	16.3	10.5										
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.0;Hep G2: 22.7;HMC-1: 35.2;U-2197: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	6.9	8.0	0.8	4.0	2.9	10.5	0.5	8.7	13.7	1.7	3.6	0.5	12.1	0.4	2.9	10.6	2.1	0.7	1.2	0.9	31.0	1.9	0.5	6.3	22.7	2.7	0.1	35.2	5.0	2.1	8.3	1.6	0.7	1.6	0.3	6.5	14.8	0.2	4.9	0.6	1.1	0.8	2.8	7.6	5.3	0.4	3.0	1.5	1.1	5.6	0.7	11.0	0.5	4.0	3.6	1.0	34.3	0.9	0.6	5.0	0.4	14.0	0.8	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favourable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.2	13.7	10.3	5.2	17.9	17.8	11.9	10.5	6.5	7.5	6.3	26.3	17.2	9.8	5.8	15.3	17.6	11.1	14.7	9.3	41.2	7.3	10.2	22.2	25.7	11.2	5.7	6.6	18.9	10.7	11.2	8.1	8.7	14.1	6.6	20.4	10.1	14.2	5.3	6.0	17.8	9.2	31.2	14.4	15.9	13.9	7.4	5.3	26.3	17.5	8.8	24.7	7.0	9.8	10.8	10.1	30.2	10.2	7.8	19.2	4.6	13.4	8.5	6.3	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	410000000	410000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB005224: AB_2119181, CAB078151: , HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	79.2	43.0	86.8	89.1	88.9	84.0	117.8	133.6	101.0	71.2	95.1	76.6	74.3	23.2	106.3	140.2	55.4	85.4	143.5	96.1	54.8	32.6	62.3	48.5	79.0	137.1	62.8	48.9	49.2	64.0	87.6	125.8	136.9	49.8	88.2	94.0	28.5	37.7	70.3	71.3	51.8	34.4	56.0	96.9	95.2	50.0	25.8	61.8	83.4	86.3	84.3	70.2	93.3	78.7	53.9	46.2	43.8	55.7	90.3	84.5	42.9	107.4	46.5	83.4	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9
HYAL1	"FUS2, HYAL-1, LUCA1, NAT6"	ENSG00000114378	"Hyaluronoglucosaminidase 1"	Q12794	3	50299889-50312381	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 105.8"	"Group enriched"	"Detected in some"	4	"Hep G2: 44.8;SK-BR-3: 13.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	15000	15000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	4.9	6.3	1.0	0.9	1.3	0.0	8.4	0.9	1.4	2.9	1.8	1.7	1.3	1.2	3.5	3.5	5.8	1.9	19.3	18.2	1.1	0.5	25.0	105.8	11.3	2.5	1.2	0.9	1.9	3.1	8.0	0.8	1.3	2.9	1.4	1.0	3.1	3.6	1.2	5.2	5.8	1.4	2.7	1.2	28.0	7.2	1.7	0.8	0.2	3.1	4.2	1.0	1.3	4.3	1.2	1.1	7.3	0.9	0.7	1.5	0.2	1.3	0.8	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.0	0.2	5.1	1.3	0.0	0.3	0.2	3.1	0.1	0.2	0.0	0.0	0.0	0.1	3.8	44.8	2.1	0.3	0.3	1.8	6.5	0.0	0.2	1.3	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.1	2.7	0.1	0.0	1.0	0.0	13.0	0.1	0.9	0.1	0.8	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.2	0.9	2.9	0.7	0.3	1.5	0.9	0.7	1.0	0.4	1.2	1.5	0.8	7.3	0.7	0.7	1.1	0.9	0.2	1.0	1.3	0.9	1.4	1.1	0.5	1.2	0.9	2.9	0.8
HYOU1	"Grp170, HSP12A, ORP150"	ENSG00000149428	"Hypoxia up-regulated 1"	Q9Y4L1	11	119044189-119057202	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 97.5"	"Cell line enhanced"	"Detected in all"		"EFO-21: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049296	Approved				"Intracellular and membrane"	140000000	140000000			"HPA049296: AB_2680702"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.46e-2)"	"prognostic favourable (2.58e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (5.10e-5)"	"unprognostic (3.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.38e-2)"	10.8	13.1	10.7	18.1	18.1	11.0	13.4	11.9	20.2	16.7	15.0	10.5	22.9	12.3	14.1	36.7	12.6	13.2	11.2	16.4	11.2	18.1	21.6	97.5	14.4	10.9	12.0	14.3	11.2	75.1	15.3	22.8	17.4	16.6	15.0	15.5	8.8	43.5	16.1	5.8	6.5	13.5	13.5	9.7	13.5	15.2	24.3	11.3	14.7	49.9	5.1	14.1	12.2	15.7	4.0	24.1	2.8	4.3	4.9	9.4	2.7	8.4	7.5	16.7	48.8	9.4	4.4	23.4	12.7	8.1	14.0	10.5	22.3	22.1	18.0	93.2	8.7	12.9	15.6	15.3	11.9	19.4	5.9	32.5	7.6	15.9	42.6	18.8	16.4	5.5	19.8	12.3	41.4	21.8	11.3	29.7	7.4	20.5	12.2	10.0	12.0	7.6	13.3	12.6	29.9	10.5	14.9	10.1	15.2	17.6	22.8	11.3	17.0	17.5	16.6	13.3	10.6	6.0	16.6	19.1	13.6	13.1	11.9	16.3	29.3	2.8	3.1	1.4	8.5	4.3	9.4	4.0	4.7	6.1	3.6	2.7	3.0	4.4	0.9	4.9	2.9	24.1	3.5	2.7	10.7	18.1	11.9	20.2	11.2	18.1	12.0	14.3	16.6	11.3
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10270835-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.3;lung: 91.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 31.1;Karpas-707: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002126, CAB002142, HPA004877"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		3100000000	3100000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favourable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	26.1	8.6	4.0	41.0	4.1	36.5	15.0	1.0	4.5	5.6	10.0	2.7	1.6	6.1	8.5	7.7	7.9	10.7	19.8	16.3	2.6	2.1	10.9	68.3	91.3	32.8	5.4	1.7	12.4	7.2	2.5	4.0	9.3	6.8	10.4	6.6	10.6	7.2	3.6	13.9	6.9	7.9	8.0	7.8	42.2	7.3	6.5	3.6	8.3	11.6	13.7	13.4	14.8	17.1	2.2	13.3	22.2	14.2	7.9	5.6	8.9	8.2	0.1	1.5	0.0	0.4	0.9	2.1	1.7	18.5	4.1	12.5	2.7	9.3	7.6	25.8	0.7	1.7	0.3	0.0	8.7	22.7	0.0	0.7	0.2	11.3	31.1	0.2	4.5	10.9	0.7	2.6	4.0	2.1	2.8	88.5	0.3	0.6	0.1	6.4	0.5	4.7	0.2	0.0	28.1	7.0	0.0	0.0	0.2	11.4	0.6	18.1	1.4	0.5	6.4	4.2	0.4	2.3	0.1	27.0	27.8	4.7	6.8	4.9	6.2	2.2	13.9	2.6	3.0	14.2	5.6	2.2	2.4	3.6	13.3	0.9	1.0	2.2	22.2	7.9	7.9	7.5	3.4	8.9	4.0	4.1	1.0	4.5	2.6	2.1	5.4	1.7	6.8	3.6
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK, gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9;liver: 39.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favourable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	4.3	6.1	9.4	2.9	20.3	2.2	4.5	12.3	8.3	2.3	11.3	7.0	3.1	14.2	2.5	7.4	4.1	6.8	4.5	2.8	7.6	8.6	27.2	39.1	3.7	4.7	7.3	6.3	3.2	6.6	3.6	5.2	1.8	6.2	4.2	4.7	5.2	4.6	5.0	1.2	3.3	20.2	3.5	7.0	4.2	4.3	2.0	6.8	14.5	7.0	1.2	4.3	2.8	2.1	17.5	9.6	35.9	20.5	15.0	23.0	11.4	3.4	8.4	1.1	1.3	3.8	5.5	6.1	2.4	7.0	2.6	2.1	2.2	3.1	4.4	4.1	3.7	5.9	0.9	1.6	2.8	9.6	1.0	1.6	3.3	9.6	16.7	1.0	2.0	3.7	2.2	5.8	5.5	6.0	1.3	4.6	3.9	19.3	2.7	1.1	1.0	3.8	3.3	3.2	2.5	7.0	4.0	5.4	6.9	5.6	4.4	5.9	4.4	5.9	6.1	1.2	0.8	10.9	4.5	6.8	7.8	0.6	6.0	1.8	2.1	35.9	6.1	8.6	14.7	10.6	12.3	17.5	12.7	12.1	8.5	11.4	10.2	13.8	1.1	15.0	20.5	9.6	23.0	11.4	9.4	20.3	12.3	8.3	7.6	8.6	7.3	6.3	6.2	6.8
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 138.4;HMC-1: 322.9;NB-4: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	1000000000	1000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.3	24.6	138.4	42.3	0.5	7.7	3.8	0.3	0.0	0.0	0.0	0.0	10.8	0.0	0.7	9.0	9.6	0.0	0.0	5.2	5.5	0.0	1.5	3.4	2.3	322.9	14.1	1.0	0.1	0.4	0.0	0.2	0.7	0.1	6.2	9.6	66.6	27.3	0.3	8.3	0.5	0.1	0.1	7.1	5.3	27.9	0.0	0.2	0.1	20.7	4.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.5	0.3	10.6	29.5	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0
IGSF9	"IGSF9A, KIAA1355, Nrt1"	ENSG00000085552	"Immunoglobulin superfamily member 9"	Q9P2J2	1	159927039-159945604	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 65.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.0;HaCaT: 21.9;NTERA-2: 11.1;SCLC-21H: 19.6;SH-SY5Y: 10.0;T-47d: 11.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA037753	Uncertain				"Intracellular and membrane"					"HPA037753: AB_10672915"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (3.30e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	2.7	0.0	0.3	4.5	0.5	0.0	2.2	0.4	0.3	2.3	6.7	0.4	3.4	6.6	1.3	5.9	6.8	4.2	1.4	0.7	0.4	0.1	0.4	65.3	0.7	0.3	0.3	0.3	2.4	1.0	0.9	0.3	1.5	0.6	4.0	3.8	21.2	4.0	6.2	0.3	20.2	13.7	0.9	0.5	0.3	11.8	3.0	0.4	1.1	1.1	7.0	2.7	2.1	3.9	0.9	1.4	1.6	0.1	0.0	0.2	0.0	4.9	0.0	2.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	7.0	2.5	0.0	0.2	0.0	21.9	1.1	3.1	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	9.6	0.1	0.3	0.0	0.2	0.0	0.0	9.2	0.1	0.0	11.1	2.3	0.0	0.0	0.9	0.0	6.7	19.6	10.0	0.6	8.6	0.0	11.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.2	1.4	0.9	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.3	0.5	0.4	0.3	0.4	0.1	0.3	0.3	0.6	0.4
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846580-53865800	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.0;liver: 26.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.9;Hep G2: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced				"Intracellular and membrane"					"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	1.1	2.1	13.4	2.2	12.2	0.9	9.2	15.1	14.7	17.1	5.8	6.8	0.0	5.1	5.0	1.3	1.9	3.2	2.4	2.5	17.1	7.4	63.0	26.6	3.5	2.3	11.9	6.4	1.8	5.3	1.4	3.9	1.2	11.2	2.5	6.1	1.9	4.1	1.0	1.4	2.3	5.1	1.2	11.3	1.4	3.4	2.5	15.2	0.0	2.9	0.0	1.0	1.7	1.0	0.9	1.1	4.1	0.6	0.5	3.1	0.5	0.9	1.8	2.7	2.0	0.0	0.0	4.3	1.8	0.0	0.0	0.0	11.9	0.8	2.7	0.6	0.6	0.5	7.3	0.0	0.0	0.9	2.1	3.5	3.6	34.5	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	2.4	0.5	1.3	7.3	1.5	1.0	1.1	3.1	0.8	3.1	3.9	2.2	6.0	1.4	1.1	5.6	1.2	1.4	1.8	2.0	1.6	2.2	2.8	3.2	1.7	1.6	1.9	1.0	4.1	0.6	0.2	1.0	0.6	0.6	0.5	2.1	0.6	0.2	0.9	0.8	0.9	0.3	0.5	0.2	1.1	3.1	0.5	13.4	12.2	15.1	14.7	17.1	7.4	11.9	6.4	11.2	15.2
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	14000000	14000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.6	6.2	3.5	1.3	1.9	7.0	3.3	1.9	3.2	4.5	13.0	2.5	1.2	2.6	1.6	5.0	3.7	2.7	2.6	2.9	4.3	5.2	7.0	3.7	1.4	3.0	12.4	2.9	3.1	3.0	1.6	6.3	8.8	2.2	1.8	3.4	3.8	6.4	4.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.7	4.2	4.9	4.2	2.7	13.7	5.3	4.1	6.1	2.1	3.6	2.1	2.5	2.3	10.9	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3
IL27	"IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28"	ENSG00000197272	"Interleukin 27"	Q8NEV9	16	28499362-28512051	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;brain: 6.5;liver: 21.2"	"Cell line enriched"	"Detected in some"	11	"BEWO: 19.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 4.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 6.5"	"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.2;intermediate monocyte: 6.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB024722	Approved				"Secreted to blood"					"CAB024722: "	"unprognostic (4.79e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-3)"	"prognostic favourable (1.30e-4)"	"unprognostic (3.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (6.07e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.41e-7)"	"unprognostic (6.44e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	0.8	0.2	0.1	1.4	0.9	0.9	0.1	0.1	1.0	0.2	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.1	6.5	0.1	0.1	21.2	0.6	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.8	2.2	0.2	0.0	0.4	0.1	0.0	0.6	0.1	0.1	0.2	1.4	2.9	0.1	0.5	1.2	1.9	0.4	0.0	0.0	0.2	0.0	0.3	1.1	3.5	6.3	2.7	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	6.2	1.3	0.1	6.3	0.2	0.3	0.0	0.1	1.1	0.0	0.0	0.0	3.5	2.7	0.2	0.0	0.4	1.5	0.1	0.9	0.1	1.0	6.5	0.1	0.2	0.0	2.2	1.2
IL32	"NK4, TAIF, TAIFb, TAIFd"	ENSG00000008517	"Interleukin 32"	P24001	16	3065297-3082192	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 216.2;liver: 316.2;pancreas: 196.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 66.4;CAPAN-2: 45.1;HDLM-2: 94.6;Hep G2: 64.4;Karpas-707: 56.6;RH-30: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 216.2"	"Lineage enriched"	"Detected in many"	9	"T-cells: 216.2"									"HPA029397, CAB030029"	Uncertain				"Secreted to blood"					"CAB030029: AB_1089175, HPA029397: AB_10612120"	"unprognostic (2.00e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.29e-3)"	18.8	6.1	2.7	45.3	3.3	3.9	16.7	1.4	1.9	4.5	46.5	2.2	4.7	36.3	6.3	10.9	7.7	3.1	18.3	21.5	2.4	2.5	78.1	316.2	42.8	43.3	3.5	1.9	6.7	196.4	0.0	3.3	8.3	3.1	9.5	15.6	4.0	23.5	4.1	51.4	3.5	149.0	8.7	3.9	73.8	8.1	4.6	1.5	48.8	21.3	113.6	40.3	10.5	11.2	0.4	0.6	2.3	0.5	24.7	216.2	88.7	33.8	1.4	0.1	0.0	0.0	3.9	2.7	1.6	4.2	2.1	3.4	66.4	45.1	0.0	8.3	0.9	1.4	0.1	4.0	2.5	94.6	0.3	0.1	6.8	64.4	7.8	0.1	2.9	4.7	0.4	1.8	7.5	8.1	0.0	56.6	2.6	0.2	42.1	1.0	0.9	0.9	0.1	48.3	4.4	32.1	2.1	0.0	0.5	14.9	1.0	0.2	0.9	0.5	21.9	8.0	9.3	0.4	4.8	0.6	1.4	0.2	0.1	41.9	4.1	1.1	0.5	0.5	134.0	0.4	132.1	0.4	122.1	126.9	0.4	0.4	47.6	89.8	2.3	24.7	0.4	0.6	216.2	88.7	2.7	3.3	1.4	1.9	2.4	2.5	3.5	1.9	3.1	1.5
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.4;liver: 143.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 152.5;RPMI-8226: 71.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 45.7;non-classical monocyte: 81.4"	"Lineage enriched"	"Detected in all"	6	"monocytes: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Approved	Vesicles				Vesicles	Vesicles	"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (9.62e-4)"	"unprognostic (4.97e-2)"	18.4	9.2	8.5	8.3	8.8	9.7	14.1	10.1	14.3	6.0	7.4	21.8	7.5	12.5	5.2	8.3	15.6	4.6	8.0	5.6	10.8	11.6	6.4	143.2	18.5	6.9	8.6	8.3	16.4	27.2	4.6	5.2	17.5	23.9	15.9	6.7	11.9	31.4	3.1	2.4	10.5	14.2	5.1	19.2	4.5	13.4	8.2	8.3	10.7	3.3	6.1	6.9	11.2	5.6	10.0	13.6	10.7	81.4	4.0	12.7	12.5	18.9	3.5	9.4	5.9	25.0	33.4	5.2	1.5	21.6	4.5	30.1	2.1	27.5	12.4	4.4	11.7	10.3	6.4	11.2	5.4	3.8	18.9	3.3	6.5	0.0	12.3	5.7	56.0	20.8	6.2	34.9	3.2	6.0	6.2	152.5	5.8	9.8	28.0	15.1	9.8	2.2	5.2	0.0	71.5	35.7	9.4	7.0	5.6	5.0	3.6	7.9	3.5	19.3	6.8	5.0	1.5	9.5	3.9	37.2	6.5	11.0	22.2	22.5	4.6	3.1	4.9	2.1	8.7	45.7	4.4	7.7	6.0	7.4	13.6	10.0	5.9	6.7	10.7	4.0	81.4	7.7	12.7	12.5	8.5	8.8	10.1	14.3	10.8	11.6	8.6	8.3	23.9	8.3
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403249-76708132	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.5;Hep G2: 17.8;HMC-1: 63.8;RPMI-8226: 23.3;U-937: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 34.4"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		8400000	8400000	"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: "	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	11.1	11.3	1.4	14.7	1.7	6.3	8.0	1.1	1.2	6.1	21.6	0.6	36.2	16.8	2.6	14.7	3.3	2.7	21.7	4.2	1.6	1.6	13.2	66.1	7.8	13.0	1.3	0.7	4.2	14.8	25.5	2.3	42.5	2.1	9.1	6.8	15.2	18.9	34.3	1.4	3.7	35.7	3.4	2.0	16.5	12.4	30.7	0.4	7.7	12.8	2.8	7.7	4.3	4.2	0.6	7.8	14.9	3.2	4.1	5.9	1.3	0.0	2.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.2	0.8	0.0	0.0	3.6	0.0	0.0	2.4	3.5	7.9	2.1	17.8	0.0	4.4	63.8	0.0	0.0	0.0	0.0	0.3	6.9	6.4	0.0	0.0	3.8	12.1	4.4	0.1	1.4	0.0	23.3	0.0	0.0	0.1	0.9	5.0	0.2	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	5.9	0.0	5.5	0.0	16.7	0.9	14.9	3.2	1.8	4.8	2.4	4.0	0.6	5.0	4.1	2.9	0.2	2.0	3.6	6.3	4.1	3.1	7.8	5.9	1.3	1.4	1.7	1.1	1.2	1.6	1.6	1.3	0.7	2.1	0.4
ISOC2	FLJ23469	ENSG00000063241	"Isochorismatase domain containing 2"	Q96AB3	19	55452985-55462343	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA043142	Enhanced		Approved	Mitochondria,Cytosol		230000	230000	Mitochondria	Mitochondria	"HPA043142: AB_10794653"	"unprognostic (2.74e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.90e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.09e-2)"	12.7	16.4	13.4	12.8	15.0	10.5	28.1	9.0	15.6	10.9	15.9	9.9	17.1	20.6	8.9	13.5	14.7	10.7	19.2	20.9	13.4	12.9	33.2	93.9	11.2	10.2	15.4	11.2	9.1	23.8	12.8	14.2	5.5	14.6	12.0	10.0	7.2	23.3	21.2	47.2	10.0	20.5	12.0	13.9	15.8	12.9	23.3	13.4	5.9	14.9	22.9	11.8	12.8	8.8	11.5	18.1	0.5	20.0	14.1	10.4	9.1	12.6	19.3	5.3	14.3	3.7	7.7	17.0	9.0	9.6	11.9	12.2	9.5	22.6	24.2	16.8	10.9	12.7	10.3	11.9	4.0	9.2	68.2	13.7	4.6	31.2	14.7	15.3	42.0	11.4	11.4	7.6	5.9	10.8	22.3	16.2	7.6	25.0	0.0	18.0	8.2	54.9	17.4	11.0	31.6	19.8	12.0	6.3	18.0	8.8	19.8	10.2	16.5	27.3	7.7	8.7	12.5	9.8	10.8	19.6	16.9	18.8	13.7	19.5	15.0	0.4	9.9	0.5	8.3	20.0	8.2	11.5	7.7	10.4	18.1	8.8	7.8	7.8	0.4	14.1	16.1	14.8	9.1	9.1	13.4	15.0	9.0	15.6	13.4	12.9	15.4	11.2	14.6	13.4
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26336515-26833198	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"TIME: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.8	20.6	12.8	14.5	13.8	6.1	18.5	9.3	15.0	7.9	9.9	7.8	3.7	6.0	7.2	7.8	12.0	7.3	8.0	7.1	14.2	6.0	14.4	47.1	6.5	8.1	12.8	4.6	8.0	9.2	17.4	9.9	11.9	13.0	6.6	7.8	4.8	17.6	3.8	4.7	13.3	8.9	5.4	20.3	12.5	5.9	3.4	15.3	35.3	5.3	6.6	10.7	5.5	8.1	4.3	9.0	17.3	5.2	3.6	3.1	0.7	2.6	1.1	1.6	2.6	4.9	5.0	1.7	2.5	3.4	1.7	1.8	0.1	1.4	9.2	1.6	3.3	2.9	8.6	5.2	2.3	2.2	2.8	7.4	2.4	14.8	4.5	6.6	3.3	4.7	0.7	3.7	6.8	16.3	3.2	2.9	2.2	2.2	4.6	8.8	7.1	0.8	1.5	3.8	5.8	4.0	4.2	0.5	2.6	11.2	2.0	6.2	4.2	3.3	35.6	3.5	1.3	3.4	3.1	2.7	2.1	17.2	3.2	3.0	2.2	17.3	5.2	7.1	2.4	2.2	2.0	4.2	2.1	1.9	1.0	4.3	2.5	2.2	13.5	3.6	3.0	9.0	3.1	0.7	12.8	13.8	9.3	15.0	14.2	6.0	12.8	4.6	13.0	15.3
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114360945-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.3;brain: 23.1;liver: 33.2"	"Group enriched"	"Detected in some"	5	"BJ: 14.7;NTERA-2: 5.6;SK-MEL-30: 10.4;THP-1: 18.3;U-937: 6.5"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.8	25.3	12.6	0.8	7.3	0.6	1.1	21.7	15.0	1.7	1.2	9.5	0.0	0.9	3.9	0.9	0.8	1.0	1.0	7.7	23.1	3.6	4.8	33.2	2.5	0.9	4.5	16.9	1.4	3.8	1.0	16.0	0.6	9.1	11.7	1.3	4.2	1.1	5.4	9.9	2.1	0.9	2.8	8.4	1.1	1.1	3.8	6.5	0.0	0.9	0.0	0.8	2.4	1.1	0.3	0.3	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	14.7	2.2	0.3	0.1	0.0	0.2	0.0	0.5	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	5.6	0.0	0.1	0.0	0.7	0.2	0.1	1.8	0.0	0.0	0.1	10.4	0.2	18.3	0.2	0.0	0.4	1.6	0.0	0.1	0.0	0.1	1.8	6.5	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.3	0.8	0.1	0.3	0.3	0.1	0.0	12.6	7.3	21.7	15.0	23.1	3.6	4.5	16.9	9.1	6.5
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203495-27221768	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA026545: "	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12.0	3.1	2.2	2.1	2.5	2.5	2.0	2.7	3.2	2.3	44.9	2.0	3.3	2.3	5.1	3.0	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4.0	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2.0	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.3	3.2	1.6	1.8	3.4	2.1	2.3	4.7	4.2	3.1	2.9	9.5	3.6	3.5	1.9	3.6	3.2	2.8	10.9	5.4	6.0	4.1	7.2	3.4	4.2	7.2	2.5	2.5	3.1	2.0	3.6	7.6	5.8	2.9	2.8	4.2	7.6	11.0	2.2	6.2	3.9	8.4	1.8	1.9	5.9	3.8	0.9	3.0	2.2	3.2	5.6	4.1	5.7	2.9	2.0	2.2	3.6	3.8	7.6	2.3	3.9	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6.0	3.0	5.6	6.0	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;liver: 58.6;placenta: 26.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;RPMI-8226: 7.6;RPTEC TERT1: 19.6;SK-BR-3: 10.1;U-698: 8.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	79	"classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	97	"B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7"	"Region enriched"	"Detected in single"	4	"thalamus: 1.3"	"Low region specificity"	"Detected in single"			"HPA031115, HPA056942"	Enhanced									"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	3.7	0.6	0.5	3.3	0.6	0.3	2.4	0.2	0.9	0.3	0.4	0.2	0.0	0.0	2.7	0.1	0.3	0.4	0.5	0.4	0.8	0.4	14.2	58.6	6.5	3.2	0.3	0.3	0.4	0.3	0.0	0.4	26.0	0.3	0.4	0.3	0.3	0.5	0.0	0.2	0.3	1.0	0.1	0.5	8.0	0.4	0.6	0.1	0.7	0.4	0.1	4.5	1.4	0.3	20.3	11.1	0.1	14.7	0.0	0.0	2.8	0.1	1.6	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.4	0.0	0.2	5.2	0.4	0.0	2.1	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.8	0.0	0.2	0.0	2.2	0.9	0.4	1.4	0.1	7.6	19.6	4.0	0.2	0.1	0.0	10.1	0.0	3.9	1.6	0.0	0.0	0.1	0.0	1.3	0.3	0.5	8.1	0.2	1.9	1.6	0.0	5.2	0.1	0.0	14.7	0.0	16.1	0.0	0.0	5.3	20.3	0.0	0.0	0.1	0.0	14.7	11.1	0.0	2.8	0.5	0.6	0.2	0.9	0.8	0.4	0.3	0.3	0.3	0.1
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		360000	360000	Cytosol	Cytosol	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	40.1	0.1	0.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.7	0.5	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	44.8	27.2	0.5	0.1	0.2	3.9	3.2	23.5	0.1	0.0	0.1	0.2	0.3	20.5	0.0	2.4	0.1	0.1	0.0	0.2	0.1	0.6	20.7	0.1	0.0	22.2	3.3	0.2	11.1	5.7	0.3	1.3	0.1	19.6	0.0	0.1	0.0	0.0	70.2	4.6	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669174	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.1;liver: 58.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		24000	24000	Cytosol	Cytosol	"HPA044391: AB_10965168, HPA053040: AB_2682022"	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	9.3	31.4	6.8	6.7	10.0	1.2	8.9	2.0	7.1	5.5	13.5	9.0	5.3	17.8	5.7	8.3	7.6	5.2	14.6	19.3	7.2	7.2	70.1	58.8	9.7	8.9	11.5	7.5	5.5	10.6	6.2	12.6	6.3	10.1	7.5	10.0	6.2	7.8	8.6	12.0	6.1	19.1	7.2	11.6	8.0	7.7	45.7	11.7	6.0	9.8	10.9	5.9	8.2	7.4	14.0	18.2	13.4	17.3	11.0	13.8	6.4	14.0	14.7	4.6	1.9	8.1	12.5	2.8	7.9	4.6	8.6	6.4	7.0	15.9	0.0	3.2	3.8	10.1	5.6	8.3	6.8	8.5	6.2	6.6	1.9	3.8	17.1	6.4	5.7	15.0	10.2	4.2	6.4	2.2	11.3	13.4	11.2	4.2	3.6	1.2	5.0	13.9	3.2	2.7	2.9	32.6	7.5	6.7	2.3	17.6	97.4	8.8	16.3	8.6	3.5	0.6	4.7	15.1	6.4	10.9	8.2	0.0	4.8	11.0	6.3	11.1	15.2	13.4	9.9	17.3	12.5	14.0	10.4	9.7	18.2	13.2	10.1	10.6	6.4	11.0	16.4	12.8	13.8	6.4	6.8	10.0	2.0	7.1	7.2	7.2	11.5	7.5	10.1	11.7
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 13.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 9.1;Hep G2: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;olfactory region: 0.9"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody				Nucleoplasm	Nucleoplasm	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	4.4	0.4	1.5	1.0	0.5	0.3	1.3	0.5	0.5	1.1	6.8	0.0	1.5	8.3	2.2	2.6	0.5	0.6	3.9	1.8	0.3	0.3	1.9	13.8	3.7	0.4	0.3	0.6	0.6	3.4	0.0	0.3	2.6	0.5	0.6	0.0	0.2	1.5	0.4	0.8	1.3	7.3	0.1	0.4	1.9	4.9	1.3	0.0	0.3	1.1	1.7	2.1	0.8	0.6	0.2	2.1	1.6	4.8	2.5	1.0	1.5	3.7	1.3	0.0	0.1	1.7	1.4	6.4	0.3	0.2	0.4	0.4	9.1	5.6	0.2	1.5	0.7	1.5	0.0	0.2	0.0	7.8	1.7	4.0	0.5	18.9	1.3	0.2	2.6	1.8	1.4	1.4	0.3	1.6	2.6	2.0	0.3	1.9	0.1	0.8	0.4	0.2	0.4	0.4	0.2	0.2	1.2	0.2	1.0	2.3	0.3	8.3	0.2	0.3	3.6	1.4	6.0	7.3	0.1	2.5	1.9	0.2	1.4	0.7	4.2	0.8	4.0	0.3	0.8	1.9	0.5	0.2	0.2	1.0	2.1	0.2	0.2	0.7	1.6	2.5	4.8	0.6	0.1	1.5	1.5	0.5	0.5	0.5	0.3	0.3	0.3	0.6	0.5	0.0
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		300000000	300000000	Cytosol	Cytosol	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavourable (3.26e-8)"	"prognostic unfavourable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	66.1	48.6	48.0	131.1	34.9	70.0	53.9	19.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116771	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3;skeletal muscle: 39.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;HMC-1: 11.8;T-47d: 22.9;U-266/70: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 8.9;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favourable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	15.3	5.5	6.8	1.6	6.7	0.8	3.7	4.9	11.7	4.1	12.5	7.6	4.5	6.1	1.5	3.0	3.8	2.1	3.6	25.3	6.6	5.8	21.5	44.3	2.8	0.9	8.1	9.7	7.9	7.7	8.5	4.4	2.1	9.9	4.4	6.8	5.1	14.2	4.5	39.7	1.8	2.5	1.2	4.5	0.7	11.2	1.0	4.0	0.0	4.3	14.4	2.7	1.1	1.2	0.0	0.2	8.9	5.7	0.1	0.1	0.9	0.5	1.6	0.0	0.3	1.3	1.1	5.0	0.1	0.1	0.1	0.2	2.1	2.1	0.0	1.7	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.5	2.1	0.0	11.8	1.6	0.2	0.0	0.0	0.1	0.6	1.9	0.0	3.9	0.0	0.6	1.1	1.0	0.0	0.0	5.9	1.1	0.1	0.0	0.0	0.0	4.0	0.2	22.9	2.5	0.0	0.0	0.2	0.0	0.0	9.1	0.5	0.0	1.5	0.0	0.0	8.9	2.7	0.8	0.0	4.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.9	6.8	6.7	4.9	11.7	6.6	5.8	8.1	9.7	9.9	4.0
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.8"	"Cell line enhanced"	"Detected in many"		"K-562: 46.1;RPTEC TERT1: 22.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA030899	Approved	Supported			"Secreted to blood"	8300000	8300000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	15.9	5.5	3.8	3.7	4.3	3.3	23.5	2.5	3.9	15.0	9.2	5.6	5.4	3.2	20.6	7.3	10.9	11.7	10.1	9.2	4.3	4.9	14.6	82.8	20.3	9.0	4.9	3.3	18.4	16.7	3.9	13.1	12.8	8.2	10.8	4.1	18.1	12.0	5.7	5.6	10.2	7.3	12.9	7.0	6.4	11.9	6.6	3.1	1.9	13.1	11.2	6.9	13.6	8.6	0.6	1.8	6.9	1.9	1.1	2.3	1.8	1.3	0.8	1.1	1.2	5.0	4.6	3.8	5.9	3.4	2.0	1.9	0.6	3.2	0.5	4.4	7.4	1.1	0.9	5.1	5.5	6.9	1.5	7.7	3.5	0.1	3.0	0.5	0.6	13.0	3.0	1.2	4.6	5.8	46.1	0.9	9.5	0.3	0.6	0.1	1.8	0.1	0.1	0.9	0.3	22.3	0.6	0.7	11.3	1.4	0.6	1.6	2.1	2.0	2.2	2.1	4.3	0.4	3.2	1.3	0.8	0.2	4.4	2.2	2.0	6.9	1.9	2.8	1.3	1.5	1.3	0.6	1.1	1.1	1.8	0.3	0.9	1.5	1.1	1.1	1.7	1.2	2.3	1.8	3.8	4.3	2.5	3.9	4.3	4.9	4.9	3.3	8.2	3.1
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell line enhanced"	"Detected in some"		"A549: 10.4;BEWO: 5.5;CACO-2: 3.3;HeLa: 3.8;Karpas-707: 2.6"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.4	0.1	0.1	0.0	0.0	5.5	0.1	0.1	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.1	0.4	0.1	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 30.7;HaCaT: 47.1;RPTEC TERT1: 31.3;TIME: 61.1"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in all"			HPA016966	Uncertain				"Secreted to blood"	170000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.5	30.7	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.3	4.8	0.0	7.5	0.0	47.1	2.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	10.8	4.8	9.4	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.7	31.3	3.6	0.2	0.0	0.2	0.3	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268250	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 29.1"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 58.7;CAPAN-2: 70.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"CAB033876: AB_2135101, HPA037609: AB_2675579"	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	6.3	1.8	1.1	1.1	4.2	0.1	10.7	1.0	1.7	20.7	7.3	4.6	1.4	1.4	8.0	4.6	2.3	7.4	4.6	1.8	1.6	0.3	4.4	29.1	3.1	0.6	1.1	1.2	6.1	14.5	1.7	1.4	5.1	8.2	5.1	1.5	3.2	15.7	10.7	14.7	3.1	2.5	7.1	3.0	1.8	2.3	10.8	1.0	1.4	5.7	1.9	1.7	3.1	6.0	0.8	1.2	0.1	0.2	2.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	7.2	0.2	7.4	58.7	0.6	6.4	1.2	70.5	0.0	6.8	5.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	3.0	1.6	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	13.3	0.7	0.2	0.0	0.0	0.0	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.3	0.0	1.2	0.0	0.0	1.1	4.2	1.0	1.7	1.6	0.3	1.1	1.2	8.2	1.0
LPCAT3	"C3F, MBOAT5, nessy, OACT5"	ENSG00000111684	"Lysophosphatidylcholine acyltransferase 3"	Q6P1A2	12	6976186-7018510	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.5;liver: 78.2"	"Cell line enhanced"	"Detected in all"		"RT4: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.74e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-2)"	"prognostic favourable (4.89e-5)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.23e-1)"	16.4	24.4	4.2	8.8	5.0	8.1	15.1	15.7	5.4	7.9	37.5	6.1	8.1	43.4	8.2	7.8	13.6	9.1	11.3	20.2	4.1	2.7	37.3	78.2	20.3	17.9	5.2	5.3	13.9	38.7	4.6	9.4	29.0	4.8	13.7	17.2	8.3	22.2	8.2	19.4	13.3	85.5	12.4	4.9	11.3	22.8	7.6	4.0	14.1	14.6	10.3	13.7	15.7	8.5	5.3	13.9	32.3	33.7	11.5	10.8	12.4	6.2	11.5	5.0	13.9	35.0	16.5	10.7	3.6	15.3	9.9	16.9	24.4	32.3	6.7	2.0	5.8	15.7	5.9	13.2	7.7	16.5	7.2	13.6	10.2	21.9	7.5	7.0	14.5	26.1	7.7	9.5	4.7	9.2	7.2	4.9	6.4	9.4	8.5	8.6	16.6	6.7	9.0	7.1	6.9	12.1	48.4	4.3	4.2	21.7	33.5	2.4	3.4	9.8	3.8	6.2	9.2	10.7	2.6	6.1	4.3	9.9	7.7	7.4	5.3	13.9	20.8	32.3	8.6	30.0	10.0	5.0	9.0	9.7	13.9	5.3	8.5	8.7	20.0	11.5	33.7	7.9	10.8	12.4	4.2	5.0	15.7	5.4	4.1	2.7	5.2	5.3	4.8	4.0
LPGAT1	"FAM34A, FAM34A1, KIAA0205, NET8"	ENSG00000123684	"Lysophosphatidylglycerol acyltransferase 1"	Q92604	1	211743457-211830772	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008304	Approved									"HPA008304: AB_1079272"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.70e-2)"	15.9	17.4	11.8	10.7	20.3	14.9	16.5	12.3	22.7	10.5	13.3	25.9	9.9	19.5	7.9	9.4	6.7	7.5	10.4	9.7	15.1	13.6	8.6	75.6	9.6	13.8	19.0	11.9	6.1	13.1	15.1	9.0	7.7	15.5	9.5	9.0	21.8	9.0	15.6	8.3	5.2	39.8	10.3	16.0	13.3	6.4	17.5	18.9	5.1	22.1	3.9	8.0	9.2	6.9	1.6	2.7	13.4	2.3	4.5	1.2	0.7	14.5	16.1	5.3	12.6	9.6	13.5	7.7	10.5	16.7	9.8	9.1	4.8	12.3	6.0	6.2	16.2	8.0	17.8	9.4	12.4	11.7	6.0	6.3	13.5	10.8	11.6	15.4	10.8	7.9	11.6	9.0	11.8	11.7	7.1	0.1	12.9	4.5	5.8	5.7	5.8	2.6	14.1	21.0	1.8	10.9	12.1	30.9	16.0	17.2	18.3	17.9	9.3	10.1	11.3	17.9	7.9	16.4	17.0	8.8	10.7	16.1	8.9	13.1	12.2	9.5	2.3	13.4	1.2	1.9	1.0	1.6	0.8	0.9	2.7	1.0	0.2	0.7	10.4	4.5	1.3	2.1	0.2	0.7	11.8	20.3	12.3	22.7	15.1	13.6	19.0	11.9	15.5	18.9
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				Cytosol	Cytosol	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	11.9	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.1	17.2	2.5	11.8	10.3	14.8	8.3	1.9	16.6	3.7	9.1	6.3	3.4	9.6	16.0	9.2	13.4	9.5	11.1	8.9	6.2	11.2	5.3	3.8	0.0	10.0	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6
LRRC3	C21orf102	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455486-44462196	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 35.3;liver: 19.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.1;U-2 OS: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017975	Uncertain									"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"	3.7	2.7	1.1	2.5	1.6	1.0	3.9	0.3	1.0	4.5	7.6	1.1	2.5	3.1	2.1	3.3	3.7	1.9	35.3	2.8	1.2	1.4	1.1	19.1	3.8	3.7	0.5	0.2	5.7	2.3	0.1	2.0	1.8	0.9	4.1	1.6	2.1	2.6	1.3	1.0	3.3	3.0	5.2	0.8	1.9	5.4	5.4	0.0	2.2	1.0	2.2	1.6	4.5	5.8	0.9	0.5	2.1	0.8	0.5	1.1	0.1	0.7	0.5	4.5	3.7	0.0	0.0	11.1	1.8	0.0	0.2	0.0	1.6	1.5	0.0	3.3	0.9	0.2	2.1	0.0	0.1	0.3	4.8	0.0	0.5	4.9	0.8	0.0	2.9	1.4	1.8	0.0	0.0	1.8	0.4	5.7	0.0	1.5	0.7	0.2	1.2	1.8	2.3	0.0	1.8	0.1	0.2	3.6	4.0	1.7	0.3	0.7	1.0	2.3	3.4	0.0	8.3	0.0	0.0	3.2	6.2	0.0	0.0	2.0	0.6	1.8	0.8	0.2	0.3	0.7	1.1	0.6	0.5	0.2	0.3	0.9	0.4	0.4	2.1	0.5	0.6	0.5	0.2	0.1	1.1	1.6	0.3	1.0	1.2	1.4	0.5	0.2	0.9	0.0
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.3;pancreas: 98.6"	"Cell line enhanced"	"Detected in many"		"A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007270	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		2100000	2100000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA007270: AB_1079253"	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favourable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	5.0	11.2	2.9	20.9	4.0	0.9	12.4	2.0	4.5	8.7	32.8	4.0	24.4	29.5	6.5	21.4	20.3	10.6	58.2	2.6	3.4	3.1	15.7	106.3	21.1	17.0	4.1	2.6	4.8	98.6	6.2	13.4	36.6	7.1	11.2	15.4	40.9	26.2	33.8	1.9	16.8	39.5	1.8	3.8	9.1	46.7	21.0	1.9	3.4	24.0	20.1	20.9	9.9	9.5	5.3	0.3	5.9	0.2	6.1	7.1	3.2	89.3	1.5	0.1	0.2	0.2	0.1	16.2	0.2	0.3	0.4	0.3	39.1	41.6	3.5	13.8	0.2	37.5	8.3	13.7	0.0	5.4	15.1	0.0	1.2	17.3	0.3	0.0	0.1	0.2	15.3	0.3	4.5	0.1	14.1	3.2	0.2	31.7	0.1	0.1	12.8	0.5	0.7	0.1	9.7	8.6	36.2	7.1	0.2	7.5	24.4	6.7	20.9	0.5	0.0	0.7	8.6	0.5	0.4	5.1	9.0	8.1	0.6	0.1	2.2	5.9	0.2	0.2	3.3	0.0	3.3	5.3	7.1	6.7	0.1	4.1	5.5	6.0	0.1	6.1	0.0	0.3	4.8	3.2	2.9	4.0	2.0	4.5	3.4	3.1	4.1	2.6	7.1	1.9
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775021-12822131	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 48.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 44.4;hTERT-HME1: 35.5;T-47d: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	10.6	7.2	2.9	7.9	9.2	0.1	13.0	23.4	5.5	11.5	13.7	7.1	2.9	4.0	5.0	7.9	8.5	4.1	14.7	3.5	3.5	3.3	4.1	48.7	17.8	5.3	7.7	4.0	4.5	19.9	0.2	7.3	21.0	5.9	8.0	9.6	4.7	21.6	7.3	2.4	8.8	6.6	13.2	8.1	11.0	9.9	3.7	7.9	0.9	8.6	2.8	5.3	10.3	9.4	0.0	0.1	1.2	0.0	0.0	0.0	1.6	0.9	3.1	0.0	1.0	4.8	6.7	0.0	1.6	8.9	2.2	2.4	0.0	1.1	0.0	0.6	8.5	1.3	0.0	0.1	1.6	0.0	0.3	0.4	2.9	1.6	44.4	0.0	0.0	2.6	4.2	7.9	35.5	1.4	0.0	11.6	1.2	0.7	0.0	0.0	0.0	3.4	0.0	0.6	0.0	8.7	0.5	6.8	0.6	1.9	1.2	1.5	51.0	0.1	0.5	1.9	0.3	4.9	1.2	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	9.2	23.4	5.5	3.5	3.3	7.7	4.0	5.9	7.9
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody				Nucleoplasm	Nucleoplasm	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favourable (9.50e-4)"	25.4	18.9	19.1	15.0	17.4	12.8	25.5	12.6	17.8	17.5	16.6	9.6	14.0	9.5	17.1	21.1	16.2	24.9	17.0	34.2	15.4	18.2	30.6	101.6	11.2	19.2	18.8	13.8	25.3	26.1	20.5	13.9	9.0	24.9	21.1	14.0	13.1	14.1	19.1	28.7	10.6	12.6	27.6	17.9	11.5	15.7	22.9	9.0	16.2	19.4	14.9	12.9	25.3	19.7	12.7	7.2	47.4	10.2	8.4	14.2	10.1	11.8	12.8	11.9	9.4	32.3	25.7	3.9	9.9	16.6	5.7	8.7	14.3	14.9	8.4	38.7	11.9	8.4	5.2	10.4	9.4	15.6	8.1	3.8	3.5	36.9	24.0	12.4	7.5	18.6	9.2	16.0	46.0	23.6	8.4	14.8	24.7	15.8	12.3	8.4	12.4	6.7	16.9	6.6	10.0	20.6	7.0	11.6	11.2	6.1	10.3	16.5	10.6	7.3	6.2	8.2	6.0	12.9	6.8	14.7	20.5	13.1	21.5	13.4	7.1	47.4	7.2	23.3	8.6	9.1	11.8	12.7	13.2	10.6	5.9	11.2	10.7	10.8	26.8	8.4	10.2	7.2	14.2	10.1	19.1	17.4	12.6	17.8	15.4	18.2	18.8	13.8	24.9	9.0
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177209-119349761	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 59.0;Hep G2: 41.4;Karpas-707: 46.2;U-266/70: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		390000000	390000000	"Golgi apparatus"	"Golgi apparatus"	"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: "	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	41.8	19.8	5.8	10.5	17.4	8.1	32.2	1.5	7.9	12.3	23.3	3.2	3.6	17.4	11.3	12.0	10.6	9.5	22.0	10.4	5.0	3.3	23.4	74.2	16.4	16.8	2.8	5.7	10.3	22.0	3.4	6.4	26.1	3.7	14.7	9.9	10.5	41.0	5.3	7.1	9.6	36.3	19.7	3.5	20.9	10.0	8.7	3.7	8.8	15.2	10.3	9.1	21.2	36.4	1.4	5.5	6.0	1.1	1.9	4.7	0.6	0.0	0.0	0.7	0.0	59.0	26.1	1.4	1.4	8.6	1.0	2.6	4.0	0.5	8.8	0.0	5.4	0.1	1.5	0.0	1.3	13.0	4.0	7.3	0.8	41.4	5.9	0.0	3.7	17.8	1.1	8.8	5.4	0.7	25.5	46.2	8.3	1.2	0.3	0.0	0.4	2.1	2.4	0.9	13.3	2.8	7.3	3.0	4.4	0.0	0.1	0.0	2.1	0.9	5.1	3.6	3.3	6.7	3.2	62.4	8.8	17.4	10.7	0.1	2.1	6.0	0.6	2.0	2.4	1.1	4.7	1.4	1.3	1.3	0.6	0.9	0.8	1.9	3.8	1.9	0.9	5.5	1.4	0.6	5.8	17.4	1.5	7.9	5.0	3.3	2.8	5.7	3.7	3.7
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577543-95609457	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		87000	87000	"Golgi apparatus"	"Golgi apparatus"	"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favourable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	18.0	8.1	6.0	6.7	6.9	2.4	14.4	8.3	6.0	9.6	9.5	5.0	5.8	7.7	7.5	8.2	11.5	7.2	7.1	9.3	6.5	6.2	14.6	44.9	9.8	12.3	8.9	6.7	10.4	8.0	10.9	13.5	7.4	7.8	9.2	8.0	4.5	8.1	7.6	3.8	5.9	9.5	6.0	11.6	13.2	10.7	7.1	6.9	17.9	11.7	5.9	9.7	11.2	7.5	6.6	3.4	8.5	5.7	3.8	10.4	3.3	3.7	3.2	12.2	9.9	20.3	23.9	4.7	10.6	9.7	6.2	9.3	3.6	9.5	7.2	13.2	6.8	6.2	8.4	7.0	14.2	12.4	7.6	9.8	3.0	5.9	7.1	12.7	8.7	23.6	8.2	7.3	5.1	14.4	15.0	16.8	13.1	2.6	7.4	5.4	1.8	3.2	8.9	12.2	10.7	9.4	6.6	9.8	5.3	5.9	4.3	3.7	6.8	12.0	13.0	6.2	4.4	11.1	10.3	12.6	7.4	8.9	11.0	11.2	14.0	8.5	3.3	1.9	4.8	5.7	6.8	6.6	5.9	5.5	3.4	3.3	6.9	4.6	0.7	3.8	4.9	1.3	10.4	3.3	6.0	6.9	8.3	6.0	6.5	6.2	8.9	6.7	7.8	6.9
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766611-43882447	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 104.9"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.2;SiHa: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					3600000	3600000			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	25.0	18.2	24.8	3.9	34.8	0.5	16.5	5.5	24.5	12.0	18.9	20.3	15.6	24.9	38.0	20.0	11.4	34.9	15.4	32.4	21.2	46.9	41.8	104.9	10.9	2.3	24.4	19.9	56.0	4.1	15.6	8.9	9.4	26.8	30.1	6.3	3.0	38.0	55.9	34.8	3.0	30.5	35.9	39.1	1.3	8.4	5.2	21.3	0.2	1.8	8.2	2.8	12.1	8.5	0.0	0.0	0.0	0.1	0.0	1.0	1.2	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.6	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	20.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.8	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	39.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	24.8	34.8	5.5	24.5	21.2	46.9	24.4	19.9	26.8	21.3
MARC2	"FLJ20605, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.3;parathyroid gland: 63.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 21.6;TIME: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced									"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favourable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"	8.1	8.2	5.5	4.6	5.9	0.1	9.5	2.7	5.6	4.4	19.4	3.7	5.0	16.7	4.8	6.6	6.7	3.8	10.3	10.2	5.0	3.7	38.2	73.3	12.5	2.2	4.0	5.7	9.2	12.7	63.3	4.3	3.5	8.0	6.4	5.9	6.9	24.3	3.9	8.8	2.0	36.4	8.1	1.9	4.5	9.1	7.4	2.7	0.4	19.6	6.2	2.9	5.5	9.0	2.2	0.0	14.1	0.1	0.0	0.0	0.1	5.5	4.6	2.5	3.2	6.2	2.9	1.9	4.0	7.0	4.9	4.9	3.1	7.0	0.0	2.8	3.8	0.7	0.0	5.5	4.6	0.0	9.5	0.0	9.0	6.4	5.8	2.6	0.0	4.9	8.6	1.8	0.0	13.2	3.5	0.0	3.0	1.3	0.0	9.1	4.0	4.7	0.0	7.8	0.1	17.1	6.0	1.4	3.7	6.3	0.0	8.6	21.6	3.4	20.0	0.0	3.0	6.4	7.0	1.2	0.0	0.0	1.0	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	5.9	2.7	5.6	5.0	3.7	4.0	5.7	8.0	2.7
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942166-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.3;lung: 65.6;lymphoid tissue: 58.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 15.8;intermediate monocyte: 26.7"	"Lineage enriched"	"Detected in many"	5	"monocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		24000000	24000000	"Golgi apparatus"	"Golgi apparatus"	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	22.8	11.7	0.8	29.6	1.1	0.9	3.3	2.3	1.3	0.3	2.8	0.9	0.0	0.6	0.3	12.9	5.2	13.8	0.8	10.8	0.6	0.4	1.6	66.3	65.6	29.3	1.3	3.1	4.7	0.4	0.2	0.8	2.3	2.7	4.5	0.7	1.0	2.9	0.8	6.8	1.1	1.3	9.6	1.7	58.7	2.2	2.8	0.6	0.0	3.0	0.5	0.4	8.8	1.1	0.0	5.0	0.3	26.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.6	0.0	0.0	6.0	0.9	0.0	3.6	0.0	0.2	0.0	1.3	0.0	0.0	15.8	0.0	0.0	26.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	3.2	0.4	0.0	3.4	0.8	1.1	2.3	1.3	0.6	0.4	1.3	3.1	2.7	0.6
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Group enriched"	"Detected in some"	8	"BJ: 26.5;BJ hTERT+: 101.0"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	1800000000	1800000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA001617: AB_1079314, HPA009641: "	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favourable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	26.5	101.0	0.3	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932517	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.5;thyroid gland: 120.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.5;Karpas-707: 75.4;RPMI-8226: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1"	"Low lineage specificity"	"Detected in all"											HPA017434			Supported	"Lipid droplets"		140000	140000	"Lipid droplets"	"Lipid droplets"	"HPA017434: "	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	38.3	35.2	25.3	10.3	32.1	4.4	44.8	22.7	21.5	21.4	36.6	17.8	15.6	18.3	16.1	13.0	19.9	29.1	25.2	12.8	27.1	12.6	43.0	126.5	26.4	24.5	29.3	22.2	29.0	35.6	11.9	10.5	7.9	26.5	13.6	20.0	13.0	19.0	14.2	16.1	10.9	22.3	19.4	32.2	16.0	28.1	17.3	25.9	3.6	120.3	9.4	16.0	29.1	15.8	14.7	11.5	29.7	20.2	3.8	3.7	5.4	0.2	0.0	1.8	10.9	75.5	21.7	23.8	0.2	1.8	0.1	0.3	0.9	1.0	12.8	0.9	0.8	1.5	1.1	1.2	0.0	1.3	2.8	3.1	2.3	7.3	16.4	0.7	6.6	22.6	0.1	0.1	0.0	5.0	1.8	75.4	0.7	0.0	0.6	3.3	8.9	0.0	0.7	0.1	41.6	3.5	13.5	4.2	6.9	0.2	7.4	0.2	21.6	0.7	2.9	0.1	0.2	0.9	0.0	3.8	0.6	5.7	1.4	1.5	0.0	29.7	12.7	25.8	1.0	14.2	0.6	13.6	0.4	0.8	11.5	14.7	0.1	0.7	0.8	3.8	20.2	10.1	3.7	5.4	25.3	32.1	22.7	20.0	27.1	12.6	29.3	22.2	26.5	25.9
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.5;THP-1: 58.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	Cytosol	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.4	6.6	3.1	0.6	0.0	2.0	3.9	4.5	5.4	0.2	1.1	13.0	1.2	1.0	5.2	4.3	7.5	3.5	1.6	2.1	1.5	0.0	0.0	10.5	2.3	7.7	3.5	4.7	18.5	7.6	1.1	0.0	3.3	2.0	0.2	3.5	3.5	3.5	1.6	2.5	6.5	3.0	0.7	6.1	1.6	2.4	1.5	11.1	1.1	0.5	58.2	0.7	1.0	1.9	3.3	8.5	0.6	1.1	2.9	10.4	8.8	3.2	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3
MGAT4B	GnT-Ivb	ENSG00000161013	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B"	Q9UQ53	5	179797597-179806952	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 125.6;liver: 100.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"eosinophil: 8.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052134	Uncertain				"Intracellular and membrane"					"HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favourable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	13.2	22.8	9.1	19.5	8.2	9.5	18.7	15.3	13.5	8.7	77.3	5.9	10.1	61.7	9.2	10.4	16.8	10.7	26.0	20.6	9.5	5.4	31.9	100.0	17.1	15.6	6.3	5.2	9.1	13.4	10.3	8.3	14.4	6.3	8.8	30.9	10.1	19.2	8.2	8.4	12.1	125.6	7.5	4.9	12.5	22.3	11.2	5.6	7.0	16.6	14.6	10.0	9.5	13.7	0.9	0.6	8.5	0.7	0.0	0.6	0.2	21.9	22.2	10.9	25.3	33.6	18.0	19.0	13.0	26.2	11.9	9.4	24.3	61.1	3.7	33.5	30.0	16.6	16.0	29.3	9.0	30.6	8.5	11.2	20.1	21.2	23.7	14.2	3.5	19.5	20.6	12.0	15.0	24.4	7.3	10.1	20.0	24.4	2.1	11.8	6.7	8.9	5.5	8.7	10.4	35.6	42.6	18.0	10.6	19.5	20.2	35.1	13.8	14.4	29.7	30.0	13.3	16.8	20.8	8.6	9.9	9.3	36.0	17.8	21.6	0.0	0.7	8.5	0.3	0.1	0.1	0.0	0.5	0.2	0.6	0.9	0.4	0.6	0.3	0.0	0.5	0.5	0.0	0.2	9.1	8.2	15.3	13.5	9.5	5.4	6.3	5.2	6.3	5.6
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 335.0;ASC TERT1: 129.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"				Mitochondria	Mitochondria	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.0	7.1	8.3	335.0	129.3	0.0	24.6	25.2	13.4	20.9	11.3	50.2	0.0	3.0	31.4	0.1	18.6	39.3	12.2	0.0	2.5	10.2	16.6	39.9	78.3	19.8	0.0	83.9	43.9	40.9	43.2	23.5	7.2	0.0	28.8	6.1	0.0	8.0	59.7	23.8	0.0	4.2	13.5	30.2	59.3	1.3	1.0	38.4	24.6	1.0	26.6	11.2	14.8	13.8	1.8	27.1	31.7	0.0	0.0	0.0	45.5	31.6	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0
MIP	"AQP0, LIM1, MP26"	ENSG00000135517	"Major intrinsic protein of lens fiber"	P30301	12	56449502-56469166	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 2.9;retina: 2.1;testis: 3.3"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SK-BR-3: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014940	Supported									"HPA014940: AB_2669122"	"unprognostic (6.48e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.14e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.51e-5)"	"unprognostic (4.56e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.82e-2)"	0.2	0.4	0.4	0.2	0.5	0.1	0.2	0.3	0.7	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.4	0.5	0.8	0.2	2.9	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	2.1	0.2	0.2	0.2	0.1	0.2	0.2	0.6	0.2	0.0	3.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.1	1.3	1.0	1.4	0.3	0.6	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.3	0.8	0.0	0.2	0.9	0.1	0.1	0.2	0.2	0.0	0.0	0.6	0.3	2.7	0.2	0.0	0.1	0.8	1.8	0.1	0.0	0.3	0.1	0.0	0.3	1.7	0.4	0.4	0.0	0.9	0.6	0.6	0.0	0.1	0.7	0.3	0.4	1.5	0.5	0.9	2.5	0.7	0.5	1.8	0.2	0.4	0.3	0.0	0.0	0.1	0.2	0.9	0.0	0.8	0.3	1.0	1.4	0.1	0.6	0.8	0.3	0.7	0.6	0.2	0.0	1.1	0.2	0.4	0.6	0.3	0.3	1.3	0.5	0.0	0.4	0.5	0.3	0.5	0.5	0.8	0.4	0.2	0.2	0.2
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 29.5;K-562: 8.8;SCLC-21H: 15.9;T-47d: 7.1"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Region enhanced"	"Detected in many"		"cerebellum: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	30.0	18.0	4.2	0.8	3.9	0.5	10.9	20.4	6.8	1.1	16.5	0.4	2.6	33.2	0.4	22.1	1.0	3.5	5.5	1.8	3.2	1.7	11.6	103.6	0.9	0.4	1.2	4.0	2.0	6.5	4.0	3.9	0.4	5.0	0.9	1.3	1.1	2.7	0.9	24.7	1.2	27.1	0.7	1.2	0.4	3.5	5.7	0.0	0.0	2.0	7.7	0.4	0.8	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	4.5	0.0	2.4	29.5	0.8	0.1	1.0	0.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	3.4	0.0	0.0	0.4	0.6	0.0	0.0	0.7	0.0	0.0	15.9	0.4	0.5	2.5	0.0	7.1	3.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	20.4	6.8	3.2	1.7	1.2	4.0	5.0	0.0
MMAA	cblA	ENSG00000151611	"Methylmalonic aciduria (cobalamin deficiency) cblA type"	Q8IVH4	4	145618263-145660035	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037361	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA037361: AB_10672107"	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favourable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (3.21e-4)"	1.7	3.3	1.4	1.4	1.7	0.5	2.6	2.3	1.5	1.5	3.1			4.2	1.4	2.6	2.3	1.5	2.0	1.8	1.2	1.5	4.3	14.7	1.7	1.3	1.4		1.3	2.5	1.4	0.9	1.1		1.3	3.5		2.0	1.3	5.2	2.3	3.4	1.2	1.2	1.6	1.9	2.0			2.2		1.7	1.6	1.6	4.2	4.2	4.1	10.0	5.8	7.8	2.9	2.3	1.3	4.3	2.2	10.4	10.4	0.9	5.9	4.7	2.4	1.4	1.8	4.7	7.9	2.0	3.9	1.9	2.1	4.5	1.6	5.6	1.0	3.5	0.9	1.4	7.5	4.2	3.2	6.5	6.4	2.5	6.6	7.4	1.0	5.4	5.1	2.9	7.6	1.6	1.6	2.2	3.6	1.5	1.5	14.2	1.8	2.1	1.7	3.4	7.2	3.2	3.7	2.0	6.1	3.8	1.6	4.6	1.5	3.0	1.9	3.6	4.0	4.2	3.4	4.1	3.8	3.2	6.3	8.4	5.8	4.2	7.8	6.4	3.6	3.3	5.9	7.8	0.0	5.8	10.0	4.2	6.1	2.9										
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria"	Q9Y4U1	1	45500053-45513382	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	3.5	7.4	5.8	3.3	10.2	2.2	6.1	3.6	12.2	5.4	6.3	11.8	3.2	5.6	4.1	5.6	4.0	6.2	2.9	11.1	6.2	5.1	7.6	30.1	2.7	3.1	7.3	6.9	6.4	9.8	9.5	5.4	2.9	8.5	3.9	7.6	4.0	11.9	7.5	14.7	3.8	4.1	4.2	6.7	3.6	4.5	7.3	5.7	4.1	4.4	3.7	3.6	3.9	3.1	2.1	3.6	5.0	6.1	2.6	3.9	1.1	6.8	3.6	6.1	9.3	5.8	3.5	7.6	5.3	3.6	9.7	8.8	7.3	4.3	10.7	7.0	4.4	5.7	11.2	12.7	8.9	2.9	10.3	8.3	5.9	8.2	5.5	11.8	3.0	5.0	7.2	10.7	11.8	4.6	9.4	6.1	7.4	7.3	7.9	3.8	10.0	8.3	9.8	2.5	11.9	5.7	5.4	9.8	5.0	8.0	13.3	17.4	7.7	4.3	2.1	6.9	9.4	7.7	2.9	9.2	7.4	6.3	5.0	5.7	6.3	5.0	1.6	1.6	1.7	2.4	2.8	2.0	2.0	1.4	1.7	2.1	3.9	2.0	3.5	2.6	6.1	3.6	1.4	1.1	5.8	10.2	3.6	12.2	6.2	5.1	7.3	6.9	8.5	5.7
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;hTERT-HME1: 25.1;SiHa: 26.9;SK-MEL-30: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.8	2.3	0.1	0.0	2.2	2.8	1.4	4.0	2.2	1.9	5.0	1.5	2.1	0.0	1.2	6.5	4.2	1.4	6.3	2.7	1.1	1.1	0.1	6.8	5.6	7.5	0.0	1.9	4.4	20.4	7.6	25.1	0.3	2.3	0.0	3.1	1.7	0.0	0.0	0.4	2.0	0.0	0.0	0.0	2.7	9.0	0.0	0.6	26.9	1.7	18.7	1.2	0.1	1.3	1.5	1.9	3.3	0.6	0.0	0.0	0.0	3.9	0.0	0.6	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favourable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	28.1	23.8	13.7	12.1	7.6	12.3	11.9	11.6	10.0	4.6	13.8	13.7	11.7	6.3	12.2	9.5	8.4	9.3	20.9	6.8	10.1	33.1	9.9	26.4	9.0	10.9	13.5	9.7	7.0	9.6	23.8	22.0	7.3	10.4	18.3	48.9	4.2	9.3	10.1	13.6	34.5	22.1	5.2	25.6	22.8	8.7	38.2	8.7	9.0	39.6	6.6	6.9	7.2	24.4	7.7	15.1	10.3	11.5	6.3	32.6	11.0	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8
MPDU1	"CDGIf, Lec35, PQLC5, SL15"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	15.4	24.6	12.6	10.3	16.5	16.6	16.7	9.1	26.2	16.0	27.3	22.8	4.6	18.5	8.2	15.3	20.5	14.2	16.4	9.1	11.6	10.3	36.0	80.1	15.4	12.3	12.9	8.4	10.8	24.3	21.0	9.3	27.4	15.7	15.1	30.0	17.3	17.2	9.6	11.0	14.7	39.0	11.8	13.3	23.8	20.3	9.1	10.9	17.6	21.4	12.5	17.5	15.5	11.3	7.5	19.7	5.5	26.8	6.4	10.0	8.7	12.3	25.8	18.8	12.4	23.9	21.9	11.4	20.4	30.0	38.7	28.5	13.4	20.8	7.3	14.8	35.3	23.9	28.5	35.0	33.0	15.3	26.1	13.4	17.1	22.9	29.8	11.1	20.8	22.3	28.9	36.1	21.4	29.3	21.8	9.5	41.9	17.6	7.3	6.9	20.3	12.2	16.9	14.6	12.5	38.8	12.1	11.8	21.5	26.6	18.5	7.0	21.6	9.0	19.7	16.0	8.2	9.3	25.4	4.8	8.8	6.1	22.9	14.4	22.7	5.5	16.2	4.8	6.7	26.8	5.5	7.5	6.5	9.0	19.7	7.5	6.7	7.6	2.6	6.4	24.2	18.5	10.0	8.7	12.6	16.5	9.1	26.2	11.6	10.3	12.9	8.4	15.7	10.9
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105704-13279590	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell line enhanced"	"Detected in many"		"AF22: 26.4;HUVEC TERT2: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Uncertain									"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	17.6	9.2	16.7	5.1	14.4	1.0	18.7	20.4	18.8	13.4	12.5	12.8	8.0	3.1	15.1	13.3	6.9	15.4	10.2	23.6	14.7	12.8	16.0	68.7	9.5	3.5	14.5	12.4	22.3	4.5	11.4	21.7	20.0	14.8	16.9	5.2	9.6	5.4	20.3	14.7	3.2	5.3	21.0	18.6	9.2	7.3	9.5	17.0	0.0	10.2	6.5	2.3	12.1	24.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	6.9	9.4	26.4	11.6	18.1	16.7	5.4	7.1	7.3	6.3	6.0	0.0	0.0	0.0	2.1	17.4	0.1	7.7	3.8	10.3	0.0	4.5	4.6	9.6	1.6	9.4	0.0	2.5	12.1	1.6	4.4	2.9	24.0	0.1	0.0	5.4	1.8	0.0	0.1	11.3	3.9	0.0	6.4	0.0	6.3	3.9	3.3	12.2	5.5	1.2	6.8	3.5	0.0	19.1	6.4	1.2	2.1	5.4	0.0	0.0	0.0	3.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	16.7	14.4	20.4	15.1	14.7	12.8	14.5	12.4	14.8	17.0
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		2800000	2800000	Mitochondria	Mitochondria	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.1	16.7	8.2	16.9	9.6	6.0	13.0	7.7	6.9	8.4	11.4	15.9	6.3	22.3	11.2	5.5	9.9	7.1	11.2	1.2	13.4	39.7	8.6	7.3	37.4	30.6	9.2	12.1	10.5	21.9	5.5	5.1	17.0	15.3	6.5	2.3	11.0	0.8	31.5	15.4	17.4	23.9	9.7	16.6	8.5	4.6	4.2	31.6	5.1	8.1	14.7	8.7	15.0	13.1	7.3	20.7	8.0	5.2	11.4	5.3	6.7	2.6	11.3	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 1.8;testis: 5.0;thyroid gland: 5.1"	"Cell line enriched"	"Detected in some"	7	"RT4: 11.4"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	5.0			5.1		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327623-165343160	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 171.6"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 61.6;HBEC3-KT: 61.1;Karpas-707: 69.6;RPTEC TERT1: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056127	Enhanced									"HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favourable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	5.0	26.5	17.1	6.7	23.7	3.5	21.5	7.7	29.6	15.6	12.6	22.8	4.0	22.6	6.1	31.5	44.9	7.1	7.4	5.8	18.8	20.8	16.3	171.6	30.0	6.4	13.1	18.6	18.0	7.5	10.9	7.0	7.4	41.1	19.1	10.8	12.1	10.6	4.7	2.2	22.5	20.7	5.7	33.5	4.3	10.3	15.8	12.5	4.3	7.5	17.6	12.9	8.6	17.7	21.2	10.1	6.2	9.8	12.1	20.8	15.8	14.3	3.5	33.8	6.1	16.8	53.8	6.3	5.8	26.4	7.5	20.9	6.7	61.6	7.1	3.5	7.0	11.8	16.9	61.1	8.4	6.0	10.4	3.2	3.6	20.7	33.7	5.8	4.5	33.3	40.2	27.7	17.2	9.7	5.6	69.6	12.4	7.4	5.1	9.4	19.4	3.5	2.7	3.7	21.4	67.1	16.8	6.7	5.0	9.0	13.0	5.4	6.0	7.2	11.1	3.5	6.2	3.1	3.9	12.8	13.5	9.4	7.4	5.9	4.7	6.2	4.6	4.5	19.0	5.9	14.2	21.2	18.3	17.6	7.8	18.9	20.0	20.8	3.4	12.1	9.8	10.1	15.8	15.8	17.1	23.7	7.7	29.6	18.8	20.8	13.1	18.6	41.1	12.5
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 108.5;liver: 146.5;skeletal muscle: 111.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 13.7;HHSteC: 9.5;HMC-1: 14.1;hTEC/SVTERT24-B: 38.1;NTERA-2: 18.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 33.3"	"Group enriched"	"Detected in many"	7	"basal ganglia: 35.4;cerebral cortex: 14.5;hippocampal formation: 15.3;pons and medulla: 37.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB002161, CAB013056"	Approved									"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	108.5	14.2	2.7	8.0	35.4	1.0	35.2	0.6	14.5	11.3	10.2	0.7	0.2	4.8	1.8	4.1	17.4	11.0	16.1	16.2	15.3	1.8	20.7	146.5	16.1	14.2	3.6	0.0	7.1	46.1	1.2	11.0	1.4	37.2	4.4	7.8	3.8	3.0	2.6	111.3	4.4	12.4	9.2	16.9	4.6	6.1	2.0	2.1	0.0	18.6	4.1	1.7	10.7	7.1	0.4	0.6	0.0	0.1	0.3	1.1	0.2	0.0	2.9	0.0	0.0	8.9	13.7	0.1	0.9	3.7	0.6	0.7	1.0	2.2	0.0	1.1	0.5	0.2	0.0	0.1	1.4	0.0	0.0	0.0	1.3	4.5	9.5	0.1	14.1	4.0	0.0	38.1	0.0	3.6	0.3	0.0	2.6	0.0	0.0	0.0	18.9	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.8	1.1	0.6	0.0	0.5	0.9	0.0	0.3	0.0	0.3	1.0	0.2	2.7	35.4	0.6	14.5	15.3	1.8	3.6	0.0	37.2	2.1
MT1E	"MT1, MTD"	ENSG00000169715	"Metallothionein 1E"	P04732	16	56625475-56627112	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 248.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 122.6;LHCN-M2: 93.4;RPTEC TERT1: 105.8;U-2 OS: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.9;T-cells: 14.2"									HPA041152	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041152: AB_2732490"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (5.06e-5)"	"unprognostic (1.86e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.78e-2)"	68.4	71.5	38.0	18.4	104.6	2.5	47.7	13.8	42.3	10.1	75.3	20.0	10.7	36.2	7.3	18.4	27.1	33.1	44.2	19.6	40.0	27.0	66.1	248.5	21.1	13.7	66.0	27.4	13.4	145.0	4.5	5.1	7.8	94.3	22.6	64.3	13.9	9.1	9.1	28.0	16.4	114.5	29.8	58.6	5.4	47.0	4.1	24.5	0.0	110.7	21.3	4.9	9.4	11.8	0.3	3.9	0.0	2.0	0.1	14.2	1.9	11.1	0.0	0.0	0.0	18.0	20.8	0.1	29.5	31.6	8.1	9.5	0.1	14.9	0.0	2.3	10.1	24.2	27.2	122.6	11.2	11.2	0.0	0.4	16.2	1.9	8.1	0.0	0.0	14.3	41.6	21.2	24.4	4.9	0.0	0.0	93.4	0.0	0.0	7.3	10.7	0.1	0.0	0.0	0.3	105.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	13.6	12.1	0.0	59.7	9.4	5.6	0.0	0.2	0.2	34.3	18.6	0.1	0.0	2.0	0.0	10.5	1.4	3.7	0.3	5.9	14.2	3.9	0.0	2.7	10.7	0.0	0.1	1.2	0.2	13.7	1.9	38.0	104.6	13.8	42.3	40.0	27.0	66.0	27.4	94.3	24.5
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657694-56660698	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 84.1;liver: 98.0;thyroid gland: 152.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.0;NB-4: 29.2;NTERA-2: 18.7;RPTEC TERT1: 80.9;THP-1: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 14.7;classical monocyte: 10.2;gdTCR: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9"	"Low lineage specificity"	"Detected in all"																						"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	6.4	12.1	14.8	5.8	22.9	2.4	3.1	5.9	18.6	2.2	24.6	9.7	4.9	15.9	2.3	13.5	2.2	3.7	10.6	1.9	16.0	13.7	84.1	98.0	2.5	6.5	27.5	15.7	1.3	55.7	1.4	4.5	1.5	37.0	11.6	17.6	8.3	3.9	4.3	1.1	2.0	37.9	3.3	23.8	3.9	15.1	1.6	9.2	0.0	152.5	0.0	2.8	3.3	1.1	7.4	2.5	14.7	10.2	2.3	25.4	14.4	1.2	0.8	0.0	0.0	0.0	0.0	1.6	0.9	1.8	0.6	1.0	0.3	4.8	0.0	3.2	0.1	4.5	5.7	0.9	0.7	18.0	0.8	1.3	0.2	0.5	0.4	0.0	14.9	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	29.2	18.7	1.8	0.0	0.0	0.7	80.9	0.8	9.4	1.1	1.1	0.3	0.5	0.6	17.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	13.6	15.7	0.1	14.7	10.2	2.8	14.0	0.9	12.7	7.4	15.3	23.9	2.5	3.0	15.2	25.4	1.5	2.3	0.4	0.8	23.9	14.4	14.8	22.9	5.9	18.6	16.0	13.7	27.5	15.7	37.0	9.2
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;EFO-21: 8.3;NB-4: 2.9;SCLC-21H: 2.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Low lineage specificity"	"Detected in single"																						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	0.6	0.0	1.4	1.1	20.1	0.0	0.2	0.2	4.7	0.3	21.7	0.6	0.2	9.4	0.8	3.1	4.1	0.2	2.8	0.2	7.4	0.9	88.1	134.0	0.3	1.3	4.4	1.6	0.3	50.2	0.0	0.2	0.3	8.3	2.3	11.0	1.6	0.5	0.2	0.3	0.7	53.9	1.4	1.9	0.2	6.7	0.4	1.5	0.2	60.3	0.9	0.4	1.0	0.2	0.2	0.1	0.0	1.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	2.9	0.4	0.0	0.3	0.0	1.6	0.6	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	20.1	0.2	4.7	7.4	0.9	4.4	1.6	8.3	1.5
MT1HL1	MT1P2	ENSG00000244020	"Metallothionein 1H like 1"	P0DM35	1	237004103-237004418	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 10.5;liver: 4.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;U-2 OS: 1.6;U-266/84: 3.4;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																										"unprognostic (5.79e-2)"					"unprognostic (2.78e-1)"				"unprognostic (2.65e-1)"		"unprognostic (3.77e-2)"		0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	10.5	0.1	0.0	1.7	4.3	0.1	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.7	0.1	0.2	0.6	0.8	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.0	3.4	0.0	1.2	0.0	0.0	0.8	0.2	0.2	0.2	0.2	0.4	0.1	0.8	0.9	0.6	0.2	0.8	0.5	0.0	0.1	0.2	0.0	1.6	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MT1M	"MT1, MT1K"	ENSG00000205364	"Metallothionein 1M"	Q8N339	16	56632233-56633986	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 78.0;brain: 80.1;liver: 85.1"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"																				"unprognostic (1.83e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.19e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (4.67e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.71e-2)"	78.0	10.3	16.5	12.7	80.1	1.6	25.5	4.7	31.0	5.1	33.7	6.1	0.4	8.1	2.8	4.9	20.5	16.9	12.4	9.5	39.3	13.6	38.9	85.1	17.5	15.7	28.7	9.6	4.4	40.8	2.5	1.4	2.2	54.5	11.6	35.3	3.5	5.0	3.7	16.6	7.4	35.6	12.6	37.1	3.5	13.1	2.0	13.1	0.0	12.2	3.2	2.2	5.4	5.1	0.1	0.0	2.3	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.5	4.8	0.1	0.3	1.7	0.4	0.4	0.0	0.2	0.0	1.9	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	32.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.2	0.0	0.4	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.0	0.2	2.3	0.0	0.1	0.0	0.4	0.0	16.5	80.1	4.7	31.0	39.3	13.6	28.7	9.6	54.5	13.1
MT1X	"MT-1l, MT1"	ENSG00000187193	"Metallothionein 1X"	P80297	16	56682424-56684196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 351.9;skeletal muscle: 474.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 94.7;HBEC3-KT: 166.8;NTERA-2: 60.5;U-87 MG: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (8.15e-2)"	"unprognostic (9.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.18e-3)"	"unprognostic (7.05e-3)"	"unprognostic (7.26e-3)"	"unprognostic (9.49e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.85e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavourable (1.82e-10)"	"unprognostic (1.56e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.37e-3)"	130.2	18.6	18.1	15.0	86.0	4.3	59.8	14.5	55.7	23.3	39.0	7.3	7.1	15.9	5.4	30.6	120.9	18.3	18.8	72.4	42.3	13.0	98.8	351.9	23.5	43.3	34.6	18.6	10.2	216.6	2.5	20.4	3.2	70.7	20.6	28.2	8.2	49.7	8.3	474.1	78.4	29.3	17.5	78.1	3.2	29.9	4.7	16.8	1.3	130.3	82.5	15.4	10.9	34.1	4.8	17.0	17.0	17.1	6.6	30.3	13.4	4.0	4.0	0.1	8.5	94.7	20.8	3.4	12.6	7.7	3.3	3.7	0.7	3.6	3.0	3.4	2.9	35.4	11.2	166.8	3.9	12.1	6.9	4.0	2.5	1.3	13.5	25.7	9.6	21.1	31.8	8.2	8.6	0.7	0.6	1.1	11.3	10.2	5.2	27.8	60.5	27.0	5.4	0.5	7.8	33.3	0.4	8.7	3.1	38.2	9.7	2.7	1.1	6.7	1.8	7.3	8.9	7.4	8.8	1.3	0.9	1.2	65.6	41.4	4.2	17.0	17.1	5.4	23.2	7.7	26.4	4.8	26.1	28.8	17.0	3.0	24.8	30.3	0.8	6.6	3.1	5.9	25.7	13.4	18.1	86.0	14.5	55.7	42.3	13.0	34.6	18.6	70.7	16.8
MT2A	MT2	ENSG00000125148	"Metallothionein 2A"	P02795	16	56608199-56609497	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 626.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 424.2;LHCN-M2: 170.7;U-87 MG: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.14e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (5.74e-5)"	"unprognostic (5.69e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (2.92e-9)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.03e-2)"	177.1	215.4	27.7	49.6	66.6	16.3	58.2	10.3	41.7	23.1	48.1	20.8	12.4	26.0	10.7	37.5	35.8	33.6	48.0	30.8	31.6	23.4	74.6	626.9	53.0	38.7	51.0	13.9	23.3	129.1	2.9	11.4	21.8	95.2	30.4	20.2	15.9	19.5	10.8	184.6	29.6	62.8	21.2	63.4	29.7	30.6	7.6	26.5	0.6	69.6	29.8	15.6	24.6	20.5	3.8	13.1	25.3	26.3	10.5	33.6	18.0	13.9	5.8	0.1	4.9	40.4	59.2	0.8	117.3	60.8	23.0	21.0	0.0	24.7	2.1	16.4	9.4	15.1	5.2	424.2	9.5	22.6	3.5	2.6	5.9	2.1	19.2	17.0	1.7	36.8	19.8	53.3	20.8	28.9	0.1	0.2	170.7	10.0	1.8	22.5	11.2	55.3	2.0	6.9	0.1	108.8	0.1	2.7	0.6	28.8	10.2	7.8	1.6	2.1	36.9	119.2	46.3	19.5	33.5	0.1	0.2	0.1	140.4	20.9	7.2	25.3	16.3	21.3	31.9	24.8	21.2	3.8	18.7	33.6	13.1	2.2	13.0	25.8	9.6	10.5	26.3	2.1	30.4	18.0	27.7	66.6	10.3	41.7	31.6	23.4	51.0	13.9	95.2	26.5
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642623	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038390	Approved		Supported	Mitochondria		55000	55000	Mitochondria	Mitochondria	"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	13.6	19.6	15.6	12.8	20.3	8.3	12.5	14.1	21.3	10.4	22.3	19.3	8.7	28.3	12.6	15.1	21.6	9.9	11.6	15.0	14.0	13.8	40.8	74.8	9.1	13.9	15.2	12.2	9.3	14.4	16.8	9.3	9.5	15.4	11.8	24.7	13.6	13.4	10.0	31.4	12.1	33.9	16.1	11.4	11.4	10.1	44.2	10.2	15.1	15.5	24.9	16.4	11.6	10.7	13.7	25.7	7.9	21.3	12.1	13.6	17.5	19.0	20.9	17.9	24.1	21.2	19.6	13.2	20.6	18.9	27.9	26.5	16.5	19.4	26.3	11.2	25.3	24.0	32.1	27.2	34.1	13.1	29.9	15.0	29.8	33.0	29.2	31.3	15.2	22.2	21.5	18.5	27.8	25.2	27.8	15.8	34.0	27.7	23.9	23.5	19.3	31.7	22.4	27.2	18.9	32.3	24.7	21.3	15.0	28.3	28.6	14.6	41.1	14.7	20.9	25.8	22.5	42.6	26.5	16.9	19.1	29.7	21.3	27.3	23.0	5.9	19.8	7.9	12.7	21.3	12.0	13.7	11.1	11.7	25.7	10.9	9.7	11.2	1.9	12.1	17.0	16.9	13.6	17.5	15.6	20.3	14.1	21.3	14.0	13.8	15.2	12.2	15.4	10.2
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.7;liver: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 88.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 88.7;monocytes: 25.4"									"HPA008067, HPA054177"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favourable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	10.0	6.6	4.5	7.6	4.4	2.5	5.7	3.9	2.8	4.4	12.4	3.7	6.8	8.3	4.3	6.2	4.5	4.0	7.9	5.2	4.1	5.0	27.9	120.9	6.4	5.4	5.5	1.7	3.3	18.8	11.4	9.4	13.9	3.9	8.6	3.7	6.5	10.6	7.6	6.0	1.9	18.3	4.4	6.1	7.6	6.3	5.9	3.3	5.3	12.0	3.1	5.7	4.0	9.9	9.7	9.3	88.7	25.4	12.4	12.6	13.8	11.0	27.9	2.5	1.4	9.9	8.3	11.2	7.7	10.2	13.6	10.4	21.7	21.7	13.8	23.5	9.6	17.8	23.8	7.6	10.4	14.4	15.8	11.9	16.2	25.7	17.1	5.6	0.4	12.6	22.3	5.6	14.2	5.1	26.3	11.4	10.7	23.7	8.6	23.1	11.9	10.5	9.4	13.7	21.0	24.8	20.7	6.8	3.3	21.5	12.9	28.4	16.5	10.3	3.3	5.2	11.1	2.4	5.1	5.7	18.5	14.0	2.6	22.0	4.0	9.8	16.6	43.5	7.7	19.0	9.9	9.7	10.8	9.0	9.3	8.7	12.6	9.7	88.7	12.4	25.4	7.0	11.2	13.8	4.5	4.4	3.9	2.8	4.1	5.0	5.5	1.7	3.9	3.3
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		110000	110000	Cytosol	Cytosol	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.2	4.7	14.3	16.6	28.5	27.1	7.9	11.9	15.7	12.6	18.7	5.4	6.9	12.3	9.5	12.7	7.6	15.9	8.4	17.8	10.5	11.5	6.5	10.8	14.2	20.8	8.3	6.3	16.4	12.6	12.8	15.0	12.1	11.9	14.8	14.8	8.3	9.7	8.3	6.1	3.5	8.8	17.9	17.0	14.6	12.8	13.3	9.2	13.1	9.4	19.7	8.2	13.4	8.7	11.8	8.7	15.9	16.0	5.9	6.6	10.6	16.6	9.9	10.2	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 2.7;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	18.8	2.5	3.3	5.9	4.3	0.2	21.8	1.4	4.7	8.2	8.0	2.1	21.6	4.2	11.8	8.2	9.0	4.9	8.9	11.6	3.6	3.1	12.2	92.7	34.5	6.6	3.6	2.3	7.8	34.3	15.0	3.1	15.7	4.4	8.5	7.4	5.8	7.5	18.6	9.3	7.5	5.4	6.7	2.7	6.6	5.0	3.6	2.0	3.6	9.3	10.4	4.8	10.3	9.9	2.7	0.4	0.0	0.0	0.0	1.2	0.0	19.9	10.3	16.8	5.0	4.6	20.0	15.2	38.1	18.9	26.4	26.3	12.6	1.8	0.0	6.3	43.7	44.3	5.5	32.8	33.3	0.0	4.8	0.0	4.8	16.1	10.9	0.4	0.1	8.0	22.7	27.5	74.3	4.8	0.0	0.0	24.3	8.4	7.6	2.4	10.9	16.4	9.8	10.7	1.5	10.3	8.5	8.5	22.4	12.9	2.2	11.5	2.0	0.6	5.8	25.3	12.7	15.2	4.4	0.1	0.0	0.2	15.3	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	4.3	1.4	4.7	3.6	3.1	3.6	2.3	4.4	2.0
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HHSteC: 6.4;TIME: 7.9;U-87 MG: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.3	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.3	0.0	1.4	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.6	6.4	0.0	0.0	2.7	0.1	0.2	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.2	0.1	7.9	3.0	0.8	0.2	0.7	0.2	0.2	0.2	11.9	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581337	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059227	Uncertain									"HPA059227: AB_2683951"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	3.5	17.1	14.3	7.8	21.3	4.6	10.7	16.3	22.2	7.7	12.2	7.4	12.8	21.9	6.7	8.8	9.1	9.2	8.9	8.6	14.0	16.4	38.0	94.5	6.0	12.7	13.6	13.8	11.3	9.8	20.1	13.5	5.9	16.7	8.4	13.0	10.5	8.5	16.4	1.5	6.8	15.7	6.2	8.1	6.4	9.5	5.4	5.6	9.7	11.2	6.1	9.0	8.5	6.3	14.9	10.3	7.2	8.4	17.6	21.1	10.0	15.5	18.8	39.1	48.5	7.0	14.4	7.3	9.1	16.5	12.7	16.4	12.6	21.1	11.1	18.3	13.1	15.8	20.4	23.2	15.4	22.3	21.5	3.8	9.0	39.1	10.6	8.1	5.5	14.4	12.0	10.3	13.0	17.1	7.0	18.6	11.4	35.2	13.2	11.2	33.0	15.9	26.5	12.2	32.0	30.2	13.7	48.4	42.7	10.6	19.6	21.0	32.2	13.2	8.0	5.5	19.5	6.8	7.2	25.4	12.4	10.4	14.8	13.1	9.2	5.2	4.6	7.2	17.8	8.4	21.1	14.9	17.7	18.4	10.3	14.1	17.2	20.6	6.7	17.6	5.0	5.3	20.8	10.0	14.3	21.3	16.3	22.2	14.0	16.4	13.6	13.8	16.7	5.6
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036999	Approved		Supported	Centrosome,Cytosol		960000	960000	Cytosol	Cytosol	"HPA036999: AB_10672105"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.1	8.9	12.1	6.2	4.1	6.0	9.7	9.2	8.4	11.2	9.9	6.2	5.8	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.8	4.7	4.9	7.6	16.7	5.1	8.5	6.1	3.3	8.0	11.8	9.4	3.1	4.3	4.4	15.0	3.5	4.2	9.7	16.0	6.2	6.9	3.2	5.6	9.6	6.1	7.1	4.4	4.4	6.1	2.5	2.9	3.5	4.9	5.4	8.5	9.6	7.9	7.6	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;RPMI-8226: 21.5;U-266/70: 38.0;U-266/84: 16.4;U-698: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA046402: AB_10962951, HPA078027: AB_2732369"	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	4.0	0.1	0.3	0.2	0.1	0.1	0.0	0.7	3.3	0.1	0.6	0.1	0.1	0.9	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.3	0.5	3.6	0.1	0.1	0.1	0.1	4.5	0.1	0.1	1.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	38.0	16.4	27.6	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLRP14	"CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8"	ENSG00000158077	"NLR family pyrin domain containing 14"	Q86W24	11	7020446-7071308	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 2.5;testis: 3.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HEK 293: 1.7;HUVEC TERT2: 4.1;U-698: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039477	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"HPA039477: AB_10794748"	"unprognostic (6.46e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.20e-4)"	"unprognostic (5.57e-2)"	"unprognostic (8.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.8	0.1	0.2			0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.3	1.6	2.5	0.4	0.2	0.4		1.3	0.0	1.7	0.1	0.0		0.1	0.2		0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.3	0.0	3.4			0.3		0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.9	0.5	0.6	0.0	0.4	1.6	0.0	0.1	0.0	0.0	0.1	0.6	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.1	4.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	2.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313285	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.7"	"Cell line enhanced"	"Detected in many"		"HSkMC: 67.4;LHCN-M2: 40.0;RPTEC TERT1: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		15000	15000	"Golgi apparatus"	"Golgi apparatus"	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.02e-6)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12.0	8.3	15.3	8.2	1.6	0.0	4.7	97.7	10.0	3.4	1.1	0.6	11.2	2.0	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0.0	0.9	0.0	0.0	4.7	0.0	4.2	24.3	31.6	0.0	6.0	15.9	9.6	19.1	0.0	6.5	0.0	21.4	12.2	0.0	0.0	2.1	9.7	0.0	0.0	0.0	7.4	0.0	33.1	0.0	0.0	67.4	23.3	6.8	10.1	13.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.1	0.0	26.8	0.0	103.7	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	9.3	5.5	22.1	8.5	1.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.9	0.2	0.0	0.2	0.1	0.6	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.6	1.7	1.6	0.0	1.1	0.6	3.3	0.6
NPBWR1	GPR7	ENSG00000183729	"Neuropeptides B and W receptor 1"	P48145	8	52938431-52941117	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;brain: 2.8;liver: 2.6"	"Group enriched"	"Detected in some"	5	"A549: 2.2;HaCaT: 2.9;SiHa: 4.5"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	9	"classical monocyte: 1.6;eosinophil: 3.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.1;monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.5"												"unprognostic (2.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.84e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.8	0.8	0.0			0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.1	0.0	2.6	0.0	0.0	0.0		0.0	0.0	0.0	1.5	0.0		0.1	0.0		0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.0	1.3	0.1	0.0	0.0	3.1	1.6	0.0	0.2	0.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	4.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.8										
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913966	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 47.2;liver: 49.4;pancreas: 52.8"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 40.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 52.3;stomach cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	6	"cerebellum: 1.9"	"Low region specificity"	"Detected in all"														"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.1	7.5	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	11.8	0.3	0.1	32.6	0.1	0.8	0.1	0.0	18.5	16.6	0.1	0.0	9.3	49.4	2.4	0.1	0.1	0.1	0.1	52.8	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	3.5	0.0	47.2	0.1	0.1	5.3	8.5	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.6	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	40.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
NSUN6	"ARL5B-AS1, FLJ23743, NOPD1"	ENSG00000241058	"NOP2/Sun RNA methyltransferase family member 6"	Q8TEA1	10	18545561-18659285	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045902	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA045902: AB_10962354"	"unprognostic (7.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-3)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.63e-2)"	"prognostic favourable (8.42e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (5.55e-5)"	"unprognostic (2.23e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.00e-3)"	5.2	9.8	9.4	8.0	10.3	9.1	8.1	17.8	12.1	8.7	8.2	5.9	13.4	7.2	8.2	10.7	5.7	6.5	5.3	6.3	9.2	8.9	6.0	48.7	4.7	8.7	9.5	6.6	10.2	8.9	8.5	17.7	5.5	7.2	9.3	7.3	3.8	7.0	8.3	3.3	7.6	11.1	9.1	10.8	7.5	7.1	12.3	8.7	10.7	9.3	3.7	8.9	8.0	12.5	9.3	4.5	3.1	8.4	5.5	11.6	2.8	5.7	4.9	13.3	9.8	6.6	9.1	5.8	8.1	2.0	6.7	9.2	9.3	8.8	13.1	3.5	3.1	8.6	13.4	8.4	8.7	12.7	11.0	13.7	6.4	11.1	6.8	6.1	9.3	7.0	8.3	6.4	4.5	3.1	18.9	12.8	6.4	3.3	14.0	7.1	6.8	3.8	10.0	6.8	13.5	5.0	7.1	7.1	8.9	6.8	7.2	5.5	4.6	4.9	5.2	5.7	6.6	10.2	5.8	7.9	8.2	14.7	4.0	11.2	3.3	1.4	4.2	3.1	5.4	5.3	8.5	9.3	7.8	6.7	3.3	7.9	9.6	8.1	1.9	5.5	8.4	4.5	11.6	2.8	9.4	10.3	17.8	12.1	9.2	8.9	9.5	6.6	7.2	8.7
NUDT7		ENSG00000140876	"Nudix hydrolase 7"	P0C024	16	77722492-77742260	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.7;THP-1: 27.5;U-698: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042042	Supported		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA042042: AB_10806232"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.84e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.52e-1)"	"prognostic favourable (5.36e-11)"	"unprognostic (1.19e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.42e-2)"	8.7	19.0	5.4	4.8	8.3	1.4	6.2	4.2	8.6	4.6	8.4	5.7	5.9	7.1	6.2	12.4	8.6	7.1	5.7	24.8	4.8	7.3	14.8	45.1	5.0	6.8	6.3	6.2	5.2	8.5	9.1	4.7	4.2	7.8	6.4	8.3	11.6	5.9	5.3	5.0	6.0	9.4	7.1	7.2	5.5	5.4	6.7	3.5	6.1	19.7	6.5	5.9	6.3	6.0	13.6	7.9	2.5	11.0	2.3	20.6	6.0	1.1	3.9	3.5	2.0	16.7	4.2	3.3	1.0	5.2	1.6	2.0	1.1	4.9	5.7	3.8	3.8	3.9	2.7	4.2	0.9	1.8	3.6	0.0	0.2	5.2	1.8	3.9	0.8	7.2	5.4	0.8	3.1	2.7	4.1	2.5	0.6	10.5	2.0	9.1	3.7	0.9	4.3	0.4	1.7	7.9	0.0	2.9	2.9	3.6	1.5	3.0	10.6	27.5	2.1	1.8	0.2	0.8	0.2	0.0	0.0	22.1	7.0	4.9	0.0	2.5	8.5	1.0	9.1	11.0	10.1	8.8	10.8	10.8	6.8	13.6	14.3	9.9	1.4	2.3	10.6	7.9	20.6	6.0	5.4	8.3	4.2	8.6	4.8	7.3	6.3	6.2	7.8	3.5
NUGGC	"C8orf80, HMFN0672, SLIP-GC"	ENSG00000189233	"Nuclear GTPase, germinal center associated"	Q68CJ6	8	28021964-28083871	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 21.1;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	5	"Daudi: 44.6;Karpas-707: 15.3;U-698: 32.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.23e-2)"	"unprognostic (2.17e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.83e-4)"	"unprognostic (2.08e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.14e-2)"	0.8	0.3	0.3	32.2	0.4	0.5	0.4	0.3	0.3	0.3	4.9	0.1	0.4	1.1	0.3	0.4	1.6	0.5	0.4	0.5	0.3	0.3	4.1	21.1	1.1	12.9	0.3	0.0	0.9	0.3	0.0	0.3	0.0	0.0	0.5	0.8	0.3	3.6	2.7	0.3	0.3	4.6	0.0	0.3	5.2	1.6	0.5	0.0	0.1	2.3	1.4	23.2	1.8	0.4	3.3	1.2	2.5	1.1	1.2	7.8	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	44.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	15.3	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	6.0	0.5	32.9	0.1	0.1	0.0	1.8	1.1	0.5	7.8	0.7	1.0	3.3	3.4	4.9	0.3	1.9	0.7	2.1	2.5	1.2	0.4	1.2	0.2	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120210767-120230332	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;Hep G2: 53.7;NB-4: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.6;monocytes: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	65000000	65000000	Nucleoplasm	Nucleoplasm	"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	16.2	22.5	8.6	6.9	15.4	3.5	24.9	1.2	10.3	18.7	16.8	4.0	8.0	19.4	14.3	17.2	10.7	13.4	20.6	13.7	8.7	1.4	21.5	93.4	5.6	8.1	5.4	6.4	26.2	43.7	2.4	7.4	4.6	3.2	10.3	13.5	18.2	26.5	5.8	3.7	3.0	22.1	11.7	3.3	15.3	9.9	5.5	5.5	1.2	6.8	8.6	3.6	11.2	10.9	0.1	4.6	0.3	6.2	0.0	0.4	1.3	6.9	2.1	8.2	4.1	12.9	14.5	0.4	13.5	14.0	5.5	8.0	2.1	10.8	0.0	34.3	9.1	7.3	2.3	3.4	2.1	5.0	5.6	5.7	1.3	53.7	11.5	12.6	2.3	18.0	2.1	5.2	14.6	15.7	3.7	6.5	1.3	2.5	0.0	36.0	3.3	11.0	3.2	0.2	6.7	8.2	3.8	0.4	2.9	3.9	4.4	11.2	1.4	20.9	9.5	11.8	4.4	12.0	1.3	0.2	0.1	0.1	9.1	21.0	4.0	0.0	6.2	0.0	0.2	2.9	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.4	0.3	0.0	0.6	0.9	0.3	1.3	8.6	15.4	1.2	10.3	8.7	1.4	5.4	6.4	3.2	5.5
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase like"	Q9ULD0	10	49734643-49762379	"Citric acid cycle related proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.9;liver: 48.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.4;RPTEC TERT1: 27.6;SH-SY5Y: 10.4;SK-BR-3: 10.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favourable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.9	8.1	8.3	1.0	15.3	0.8	0.8	16.2	23.6	1.3	1.3	4.9	2.7	1.4	2.2	1.7	0.9	1.5	1.1	4.1	8.7	13.7	74.9	48.8	0.8	0.9	12.1	11.0	1.9	3.4	23.1	11.7	0.9	23.6	1.8	1.0	8.2	10.3	5.0	0.9	0.8	1.4	1.2	2.9	1.0	1.4	1.9	3.2	0.0	13.0	0.0	1.1	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.9	13.4	0.0	0.0	1.7	0.0	0.0	0.7	0.1	6.4	1.4	0.0	7.2	0.0	0.2	4.6	0.1	0.2	0.0	0.3	0.0	0.1	3.2	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	4.9	4.4	1.2	0.6	0.0	0.0	0.0	27.6	0.4	7.6	10.4	0.1	10.2	0.7	2.8	1.8	0.0	0.0	7.0	0.0	0.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	15.3	16.2	23.6	8.7	13.7	12.1	11.0	23.6	3.2
OMP		ENSG00000254550	"Olfactory marker protein"	P47874	11	77102840-77103331	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.4;liver: 3.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;BJ hTERT+ SV40 Large T+: 2.9;CACO-2: 3.6;hTEC/SVTERT24-B: 2.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	63	"olfactory region: 119.4"																	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.53e-2)"	"unprognostic (3.54e-1)"		"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.17e-2)"	0.0	0.8	0.1	0.2	0.2	1.9	0.0	0.1	0.1	0.4	3.0			5.4	0.0	0.0	1.3	0.2	2.3	0.2	0.0	0.1	0.6	3.9	0.2	0.0	0.0		0.3	0.5	0.0	0.2	0.0		0.5	3.8		0.3	0.1	0.0	0.0	5.0	0.1	0.1	0.1	1.9	0.7			0.2		0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	1.2	0.0	2.9	0.5	3.6	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.8	0.0	0.0	1.6	0.3	1.2	1.2	0.0	1.5	0.5	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2B2	"hs6M1-10, OR2B2Q, OR2B9, OR6-1"	ENSG00000168131	"Olfactory receptor family 2 subfamily B member 2"	Q9GZK3	6	27911185-27912396	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"liver: 1.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;U-266/84: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"																											"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7			0.1		0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1										
OR2T12		ENSG00000177201	"Olfactory receptor family 2 subfamily T member 12"	Q8NG77	1	248290139-248303424	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;epididymis: 2.9;liver: 4.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.6;U-2197: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.1	0.1	0.1	0.2	0.3	0.9	0.2	0.1	0.4	0.4	0.2			0.1	0.3	2.9	0.1	0.3	0.0	0.1	0.4	0.4	0.1	4.7	0.2	0.2	0.4		0.2	0.1	0.0	0.2	0.0		0.1	0.4		0.1	0.0	0.2	0.7	0.3	0.0	0.2	0.2	0.2	0.7			0.6		0.2	0.2	0.2	1.3	0.6	2.4	0.4	1.0	0.8	0.1	1.0	0.3	0.4	0.8	0.1	0.2	0.8	0.1	0.1	0.1	0.2	0.7	0.5	1.1	0.5	0.1	0.3	0.2	0.3	0.2	0.8	0.3	0.9	4.6	0.7	0.1	0.9	1.2	0.2	0.2	0.3	0.0	0.1	0.4	2.0	0.1	0.8	1.3	0.8	1.2	0.3	0.5	0.6	0.7	0.2	1.1	0.7	0.8	0.6	0.9	0.3	0.7	0.9	1.2	1.0	0.9	3.5	0.6	0.9	0.9	0.4	0.6	0.5	0.8	2.4	0.4	0.3	0.8	0.3	0.6	0.8	0.6	0.6	0.2	1.3	0.8	0.8	1.1	1.0	0.4	0.6	0.3	0.1										
OR2V1	"OR2V1P, OST265"	ENSG00000185372	"Olfactory receptor family 2 subfamily V member 1"	Q8NHB1	5	181123122-181131169	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;liver: 5.0"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA049953	Uncertain									"HPA049953: AB_2680971"																		0.2	0.1	0.1	0.2	0.1	0.6	1.2	0.1	0.2	0.4	0.1			0.0	0.3	0.7	0.2	3.5	0.0	0.1	0.5	0.1	0.2	5.0	0.1	0.5	0.1		0.2	0.1	0.0	0.1	0.0		0.2	0.0		0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.2	0.2			1.3		0.2	0.1	0.1	1.7	0.7	1.0	0.5	0.2	0.7	0.2	1.3	0.9	2.1	1.9	0.6	0.5	0.6	0.6	0.2	0.9	0.2	1.1	1.0	0.9	0.8	0.1	1.3	0.2	0.8	0.7	0.3	0.1	0.8	0.8	0.9	0.6	0.7	1.3	0.8	0.2	0.9	1.0	0.3	0.6	1.4	1.1	1.1	1.3	0.8	1.4	0.3	0.7	0.5	0.4	0.2	2.4	1.8	1.4	0.8	0.1	0.4	0.8	0.7	1.1	0.7	1.0	0.3	1.2	1.1	0.9	1.2	0.4	0.5	0.2	0.7	0.5	1.0	0.7	0.2	0.6	1.7	0.7	0.3	0.1	1.0	0.4	0.4	0.7	0.2	0.3	0.7	0.6	0.2										
OR4K17		ENSG00000176230	"Olfactory receptor family 4 subfamily K member 17"	Q8NGC6	14	20110739-20122199	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;liver: 7.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																																							0.2	0.2	0.2	0.4	0.2	3.5	0.2	0.2	0.3	1.0	0.3			0.7	0.4	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.4	7.7	0.2	0.5	0.3		0.2	0.3	0.0	0.2	0.0		0.3	0.0		0.4	0.0	1.3	0.9	0.2	0.0	0.2	0.3	0.3	0.4			0.3		0.0	0.4	0.3	1.3	1.2	3.0	1.3	1.4	1.3	0.5	1.3	1.3	1.5	1.5	0.2	0.2	1.8	0.4	0.0	0.1	0.2	1.3	1.8	2.1	1.1	0.2	1.2	0.2	0.6	0.2	1.9	1.1	2.5	2.0	0.8	0.3	2.5	1.9	0.4	0.4	0.5	0.4	0.3	2.3	2.3	0.1	1.9	1.1	2.8	1.9	1.0	1.0	1.5	1.4	0.2	2.0	1.3	1.5	2.0	1.4	0.6	1.4	1.2	1.0	1.4	0.8	1.2	1.0	2.5	1.2	2.4	1.4	1.4	0.6	3.0	1.0	1.4	0.8	1.0	0.9	1.0	1.0	0.9	0.6	1.3	1.3	1.2	2.7	1.4	1.3	1.2	0.9	0.5										
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83948282-83966332	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 25.2;Hep G2: 37.9;T-47d: 28.2;WM-115: 23.6"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.5;monocytes: 12.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019239			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA019239: "	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favourable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	4.0	9.8	1.7	3.0	6.5	0.8	28.2	0.6	3.7	1.7	17.4	2.1	0.7	18.1	1.3	1.7	5.6	1.8	5.1	6.9	1.3	1.4	13.8	63.5	8.2	1.6	13.4	0.0	3.2	5.2	2.5	1.4	1.2	6.6	2.1	1.8	5.1	2.0	1.7	7.8	1.6	21.3	5.5	13.7	5.4	5.0	5.6	1.9	0.0	5.2	13.5	2.9	6.0	10.6	0.0	1.0	4.5	12.3	0.0	0.0	0.8	1.7	25.2	0.2	1.1	1.6	2.3	1.9	2.9	2.7	2.6	0.9	6.2	9.2	0.0	6.8	2.4	4.6	1.0	1.8	1.0	0.3	0.3	0.4	5.6	37.9	5.5	0.8	9.9	1.4	1.5	6.9	1.6	2.5	2.2	2.5	3.4	11.7	0.3	0.3	0.2	5.8	0.8	2.6	1.2	1.8	2.1	0.1	0.6	6.1	1.9	12.3	28.2	1.0	8.7	4.1	6.2	6.0	1.9	1.1	0.4	0.0	13.7	1.3	23.6	0.1	2.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	0.0	12.3	0.0	0.0	0.8	1.7	6.5	0.6	3.7	1.3	1.4	13.4	0.0	6.6	1.9
OXER1	"GPCR, GPR170, TG1019"	ENSG00000162881	"Oxoeicosanoid receptor 1"	Q8TDS5	2	42762481-42764261	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.9;liver: 26.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.8;Hep G2: 9.8;HMC-1: 8.4;REH: 4.2;THP-1: 3.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 17.4;eosinophil: 42.9"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 42.9"									HPA051433	Uncertain									"HPA051433: AB_2681485"	"unprognostic (6.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.46e-2)"	8.2	0.7	0.7	1.2	0.7	2.0	0.9	0.7	1.5	1.9	2.1	0.7	0.7	4.9	1.7	2.9	1.1	1.4	1.1	2.0	1.5	0.3	4.1	26.9	9.1	4.1	0.7	0.7	5.4	3.8	0.4	2.0	2.7	1.3	3.4	1.6	3.3	3.4	1.7	2.1	2.9	8.3	0.7	0.7	6.4	1.6	1.1	2.7	3.8	1.6	2.2	1.6	2.5	4.8	0.0	0.4	42.9	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	8.8	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.2	0.0	0.5	2.9	0.0	9.8	0.1	0.2	8.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.9	0.0	4.2	1.4	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	17.4	0.5	42.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.7	1.5	1.5	0.3	0.7	0.7	1.3	2.7
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	140000000	140000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	57.7	50.3	18.6	60.0	50.4	59.3	44.2	112.8	72.8	49.2	66.6	36.9	50.6	23.3	49.6	72.5	41.0	20.5	44.1	28.5	15.0	34.7	34.9	52.9	150.1	66.3	110.1	57.7	44.7	30.0	39.3	41.7	81.0	24.7	100.7	35.0	52.7	31.5	87.5	14.6	45.8	25.8	33.3	46.2	38.2	69.8	22.4	24.8	56.2	162.4	58.5	73.4	129.7	62.9	92.4	46.3	52.4	55.0	72.4	52.4	22.0	121.4	42.4	70.4	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2
PALM2		ENSG00000243444	"Paralemmin 2"	Q8IXS6	9	109640788-109946703	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;liver: 19.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 5.8;RH-30: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA074153, HPA076866"			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.74e-6)"	"unprognostic (8.39e-2)"	14.8	6.1	8.1	2.0	11.1	1.2	6.7	1.7	17.9	4.3	2.4	9.1	0.0	1.8	4.9	1.7	2.4	3.8	3.0	7.6	6.3	1.8	2.7	19.7	4.8	1.5	5.0	9.7	2.3	2.2	1.4	1.6	3.1	8.4	2.4	2.4	0.0	3.2	1.4	2.5	3.1	2.0	2.2	4.9	1.5	2.2	2.7	8.7	0.0	4.3	0.0	1.4	2.8	2.6	0.5	0.1	1.1	0.2	0.3	0.1	0.0	0.1	0.5	0.5	0.0	0.4	0.9	0.2	0.4	1.2	0.7	1.7	0.3	0.7	0.1	0.1	1.8	1.7	0.0	0.6	1.2	0.1	0.9	0.0	2.4	0.2	0.0	0.0	0.1	2.0	0.8	5.8	0.9	0.0	0.0	0.0	2.4	0.5	0.0	0.0	3.4	1.3	0.0	20.4	0.4	2.8	0.4	3.8	0.0	5.0	0.2	1.6	2.0	0.4	0.2	2.0	2.9	0.1	1.6	0.1	0.7	0.1	1.6	0.0	2.4	0.3	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.1	0.0	1.1	0.3	0.1	0.1	0.0	0.0	8.1	11.1	1.7	12.7	6.3	1.8	5.0	9.7	8.4	8.7
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053365-14059159	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.5;testis: 19.7"	"Group enriched"	"Detected in some"	4	"AN3-CA: 21.7;CACO-2: 23.2;HAP1: 19.4;NTERA-2: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA052794: AB_2681952, HPA056119: AB_2683042"	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.2	0.2	4.3	0.9	1.9	0.0	2.1	3.7	3.6	2.9	0.5	3.2	0.2	2.7	0.4	11.1	0.2	1.5	1.6	0.2	4.2	2.8	12.9	26.5	2.4	0.2	1.7	4.3	0.4	11.7	1.8	0.2	0.7	10.1	1.8	0.2	1.1	6.9	8.0	0.2	0.2	0.8	0.9	2.7	0.2	13.0	19.7	4.9	0.2	6.8	0.2	1.0	3.9	1.9	0.9	0.2	0.0	0.3	0.0	1.8	0.0	1.6	1.5	3.6	21.7	0.3	0.1	4.4	0.4	0.1	1.2	0.6	23.2	0.5	0.0	0.2	0.4	0.1	19.4	0.0	0.3	0.0	1.3	0.1	0.5	2.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.1	4.5	0.0	0.0	3.6	0.2	0.1	14.0	1.3	0.0	0.0	0.0	0.0	1.8	2.7	3.6	0.1	0.0	0.0	1.3	0.0	0.2	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.9	0.8	0.3	0.0	0.1	0.9	1.8	1.8	0.0	0.0	0.1	0.2	0.5	0.0	4.3	1.9	3.7	3.6	4.2	2.8	1.7	4.3	10.1	4.9
PANK1	"MGC24596, PANK, PANK1a, PANK1b"	ENSG00000152782	"Pantothenate kinase 1"	Q8TE04	10	89579497-89645572	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.1;liver: 63.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.00e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.55e-4)"	"unprognostic (4.61e-2)"	"prognostic favourable (1.55e-10)"	"unprognostic (3.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	"unprognostic (6.64e-2)"	1.1	2.5	2.3	1.2	1.9	0.0	1.0	13.4	4.1	2.4	6.1	1.3	0.5	9.0	0.9	1.9	2.9	1.2	1.5	3.9	1.9	2.6	20.1	63.8	2.1	0.6	2.1	2.7	1.1	1.2	2.6	2.2	1.0	3.1	1.5	7.8	1.8	1.4	1.0	5.7	5.5	9.2	1.0	1.7	0.9	2.0	1.5	1.0	2.6	4.7	2.4	1.0	1.1	5.5	1.0	2.3	0.9	0.6	0.1	1.6	0.7	5.6	3.7	20.8	14.2	11.3	8.2	10.5	3.3	3.6	3.2	4.3	5.8	5.9	4.1	2.2	2.5	5.7	9.4	2.1	3.5	1.4	4.2	2.7	4.1	11.5	3.3	8.6	1.6	5.0	9.4	4.8	3.8	3.7	4.7	0.5	4.6	4.4	9.5	8.8	16.3	2.3	8.4	4.1	2.7	9.9	2.7	6.5	7.8	4.2	5.1	3.3	5.5	6.3	1.6	1.9	1.8	3.8	4.0	4.8	8.8	5.1	2.6	6.9	1.3	0.9	0.3	0.1	0.7	0.1	1.4	1.0	0.8	1.6	1.0	0.1	1.0	0.2	0.7	0.1	0.6	2.3	1.1	0.7	2.3	1.9	13.4	4.1	1.9	2.6	2.1	2.7	3.1	1.0
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell line enhanced"	"Detected in many"		"BJ: 34.9;fHDF/TERT166: 88.3;HHSteC: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favourable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.6	1.1	0.0	25.3	32.3	0.0	34.9	29.9	21.2	15.4	0.1	0.7	0.0	1.8	88.3	1.5	2.6	2.4	24.3	0.0	1.9	1.6	2.6	0.0	38.3	0.0	0.7	11.4	0.0	12.2	1.0	17.7	0.0	16.5	14.9	13.3	0.0	0.1	1.3	4.5	0.0	0.0	0.0	22.1	1.5	0.1	0.3	17.0	0.6	0.2	2.5	0.9	22.0	7.2	4.2	24.4	2.5	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3
PAQR9	FLJ41938	ENSG00000188582	"Progestin and adipoQ receptor family member 9"	Q6ZVX9	3	142949164-142963682	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"A549: 5.3;AF22: 3.3;HEL: 3.6;NTERA-2: 4.0;U-266/70: 9.9;U-266/84: 5.4"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052798	Uncertain									"HPA052798: AB_2681955"		"unprognostic (4.13e-2)"		"unprognostic (2.54e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.12e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.91e-2)"	0.4	0.6	2.5	0.3	7.0	7.0	0.3	0.5	10.1	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.4	12.1	3.3	1.7	0.3	18.6	0.3	0.3	0.7	3.1	0.3	0.5	0.3	1.4	0.8	6.0	0.4	0.3	2.7	0.3	0.3	5.9	0.3	0.3	0.3	1.0	0.3	0.3	20.8	0.3	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.3	3.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.4	9.9	5.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.0	0.5	10.1	3.3	1.7	0.7	3.1	6.0	0.3
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.3;kidney: 74.5;liver: 91.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		420000	420000	Vesicles	Vesicles	"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	5.0	5.9	3.6	2.4	6.4	2.5	2.9	2.3	8.0	4.1	9.4	11.8	6.8	47.3	4.5	5.1	1.5	2.3	2.9	3.3	3.9	3.1	74.5	91.4	2.3	2.8	6.7	5.6	2.3	17.9	2.4	2.4	7.0	8.4	2.6	8.0	9.4	2.2	6.2	2.3	1.8	39.3	6.5	4.9	1.6	15.0	2.1	6.2	2.5	1.9	4.3	1.6	4.1	1.6	1.7	5.6	6.4	5.8	3.3	2.3	2.5	3.4	6.9	6.7	4.6	6.1	3.5	3.1	13.9	8.8	5.3	5.5	6.2	8.8	3.9	5.4	9.6	5.3	3.1	3.6	4.6	1.8	5.0	3.1	7.5	5.6	3.0	4.5	3.1	6.2	4.3	3.2	4.0	3.2	2.7	8.6	8.3	5.3	4.1	7.9	1.9	3.0	7.2	8.8	6.3	10.6	5.0	3.9	5.2	9.3	5.4	6.3	18.7	5.4	10.0	5.3	3.8	2.5	2.2	5.2	3.7	5.7	6.3	2.5	1.3	4.2	5.8	2.9	0.9	2.9	1.8	1.7	1.4	0.9	5.6	1.6	2.3	1.6	6.4	3.3	1.7	2.4	2.3	2.5	3.6	6.4	2.3	8.0	3.9	3.1	6.7	5.6	8.4	6.2
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		96000	96000	Mitochondria	Mitochondria	"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	8.9	3.3	8.1	13.7	5.4	3.5	1.8	7.8	3.5	3.4	4.4	3.2	0.0	3.7	2.9	3.8	3.7	20.6	1.0	1.7	5.2	4.4	27.7	17.0	10.7	0.0	5.7	20.6	5.3	2.8	6.4	2.9	8.4	0.0	1.2	19.0	5.0	2.4	6.3	7.4	3.7	6.9	1.8	3.2	0.9	7.2	10.2	17.3	9.2	7.0	7.5	1.2	3.2	3.9	3.6	4.6	2.0	1.9	2.2	0.0	4.0	2.8	3.3	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 67.5;Hep G2: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Approved		Enhanced	Nucleoplasm,Cytosol		210000	210000	Nucleoplasm	Nucleoplasm	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.4	48.5	2.9	30.1	11.0	10.3	3.9	6.6	11.0	10.3	8.2	67.5	36.2	4.2	19.2	7.2	13.6	18.3	10.6	7.0	10.9	33.1	3.7	7.7	66.3	11.6	3.6	13.6	10.0	11.6	10.2	4.8	27.6	7.2	0.3	7.1	34.1	0.4	12.2	4.1	45.4	2.0	4.0	13.4	43.2	21.1	12.7	21.5	5.5	37.6	14.3	10.9	7.1	11.4	1.7	14.4	2.5	16.2	0.1	0.8	0.1	9.4	11.9	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase beta subunit"	P05166	3	136250306-136337896	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	79000	79000			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	13.0	46.0	14.3	7.7	16.3	12.7	11.8	7.8	19.2	8.1	17.5	21.0	11.6	15.3	7.1	6.4	11.8	8.1	12.5	36.7	14.1	12.6	36.0	80.2	7.7	8.7	18.9	16.4	6.8	20.8	16.2	9.6	10.0	22.3	10.2	17.6	10.0	10.9	10.6	30.5	8.0	11.1	14.1	18.6	7.9	11.5	17.6	15.5	6.3	15.7	12.4	8.1	9.6	6.6	12.4	24.6	3.9	16.6	12.8	14.9	11.5	20.2	14.5	13.9	20.8	10.6	11.7	24.6	10.7	11.6	16.2	23.0	21.5	14.3	25.3	29.9	15.0	11.3	16.3	14.4	24.7	15.0	13.8	44.3	17.1	32.4	22.6	34.0	19.7	13.8	13.8	10.3	23.6	18.2	32.2	13.6	12.4	38.6	33.6	20.0	11.7	13.1	9.3	11.5	36.1	29.8	22.2	27.8	20.7	27.0	16.0	24.5	31.9	20.2	13.6	8.2	8.7	22.9	9.4	25.9	21.3	21.1	11.6	13.2	9.5	2.8	16.2	3.9	13.2	16.6	14.9	12.4	8.8	13.6	24.6	10.2	9.0	11.1	1.4	12.8	14.6	21.2	7.9	11.5	14.3	16.3	7.8	19.2	14.1	12.6	18.9	16.4	22.3	15.5
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101297142-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.3;liver: 76.0;lymphoid tissue: 37.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 26.1;CACO-2: 18.3;HEK 293: 27.5;Hep G2: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	38000	38000			"HPA004774: AB_1079583"	"prognostic favourable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	3.0	1.5	5.1	1.5	25.1	0.9	6.1	4.5	11.5	1.5	8.4	41.9	0.0	3.6	1.4	2.5	4.8	1.9	1.9	10.1	8.9	5.7	1.7	76.0	2.3	4.6	38.8	8.4	4.0	1.7	0.5	3.1	16.5	29.0	1.9	8.2	0.7	1.5	0.7	3.5	4.0	4.8	1.9	69.3	37.4	5.3	6.6	24.5	3.7	1.4	3.5	1.3	1.6	1.6	2.6	0.7	1.9	2.4	7.5	1.4	2.5	8.6	7.0	1.3	0.9	0.1	0.1	26.1	0.5	1.3	0.0	0.1	18.3	4.0	0.2	1.2	0.2	5.9	7.0	0.7	0.1	1.2	27.5	15.0	3.6	24.6	0.8	2.1	0.3	0.4	4.8	0.1	0.2	0.0	11.5	0.2	0.0	4.2	0.1	1.9	3.7	3.0	0.2	0.2	1.9	2.3	12.2	3.5	3.8	12.1	0.9	3.9	1.0	9.5	0.1	0.1	0.7	0.2	0.0	0.3	0.3	0.3	0.1	0.3	3.4	1.3	0.6	1.9	0.6	0.8	0.7	1.1	1.0	0.5	0.2	2.6	1.4	1.3	1.1	7.5	2.4	0.7	0.2	2.5	5.1	25.1	4.5	10.4	8.9	5.7	38.8	8.4	29.0	24.5
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell line enhanced"	"Detected in some"		"A-431: 28.4;HaCaT: 38.1;HeLa: 33.2;RPTEC TERT1: 18.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	300000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	6.3	0.9	0.0	2.1	1.4	0.0	0.0	0.0	0.0	0.0	13.2	4.5	0.0	5.2	2.5	38.1	1.1	11.6	0.0	0.0	0.0	0.0	33.2	9.2	0.7	0.0	0.0	2.2	8.6	8.4	6.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.4	0.6	0.0	0.0	0.3	18.8	0.0	0.5	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55750979-55842830	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.4;liver: 53.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 56.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA022979	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	8.2	5.6	4.9	8.2	8.2	5.1	8.4	3.1	5.3	6.2	11.9	3.0	29.8	9.3	5.2	15.8	6.6	4.9	10.1	12.1	5.1	4.7	17.0	53.2	11.6	7.8	6.2	4.9	5.2	7.5	4.2	5.3	19.4	5.5	7.5	12.7	5.3	7.1	32.1	10.8	4.1	9.8	8.3	5.0	10.0	12.5	8.0	3.9	3.0	5.7	5.8	5.2	8.1	9.9	2.0	12.1	56.4	15.3	6.2	2.7	6.5	8.6	7.9	6.0	2.2	8.1	7.9	15.5	3.4	4.5	5.4	5.3	8.9	11.2	2.4	26.5	5.3	4.8	3.5	5.7	4.9	38.3	8.0	21.4	2.4	16.7	7.2	8.1	17.0	6.5	7.6	3.2	5.9	10.5	15.3	8.6	5.9	7.5	6.4	6.6	6.5	7.1	3.3	8.7	1.9	5.7	6.4	3.0	6.8	1.7	3.7	14.3	10.0	14.1	7.6	6.2	4.4	6.9	4.4	24.6	7.7	1.5	5.7	13.5	10.7	15.1	15.3	56.4	2.5	12.6	1.5	2.0	1.6	2.5	12.1	1.4	0.9	2.2	15.9	6.2	13.2	0.9	2.7	6.5	4.9	8.2	3.1	5.3	5.1	4.7	6.2	4.9	5.5	3.9
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69328621-69330595	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	6.6	7.9	4.8	7.8	4.5	5.3	4.8	3.1	6.9	3.6	7.6	3.8	3.3	7.1	5.3	5.6	8.4	4.4	6.5	3.8	4.6	3.3	14.9	30.2	3.7	7.0	3.0	5.2	5.0	14.2	8.2	3.9	4.9	4.4	5.3	4.1	4.3	12.8	4.6	10.4	6.0	5.2	3.4	2.3	5.0	8.3	3.7	2.0	10.2	7.3	9.2	6.2	3.7	4.0	10.3	3.2	2.5	2.8	1.7	6.9	1.5	8.9	6.0	1.2	2.9	1.8	1.3	10.6	7.5	2.0	5.4	4.7	14.9	6.4	16.6	10.0	2.6	12.9	3.7	4.0	2.2	4.0	30.8	8.4	5.7	21.3	3.7	11.7	6.7	2.8	7.1	4.8	2.3	3.1	20.2	1.9	2.9	11.5	9.1	12.3	7.7	11.1	21.6	1.9	15.4	4.3	5.6	10.3	8.2	13.0	2.2	6.3	12.8	3.8	4.6	4.6	8.8	5.4	8.7	15.7	10.4	19.6	3.1	8.7	6.0	0.0	2.8	2.5	1.2	1.6	3.1	4.3	3.9	3.9	3.0	10.3	6.9	2.5	0.0	1.7	1.5	3.2	3.0	1.5	4.8	4.5	3.1	6.9	4.6	3.3	3.0	5.2	4.4	2.0
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	12000000	12000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavourable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.6	31.1	33.8	94.5	30.9	22.1	49.0	46.0	30.8	26.4	43.1	25.8	88.4	23.5	103.3	37.8	21.4	22.8	43.6	23.2	16.7	13.4	11.3	9.0	56.5	41.5	25.7	31.9	21.7	19.6	28.9	23.2	53.5	18.4	64.2	23.1	35.7	24.4	29.3	50.4	18.1	16.1	26.2	57.0	30.8	25.7	10.8	28.4	41.7	30.1	16.0	17.1	19.8	29.2	20.8	11.8	50.5	32.3	48.9	22.0	16.6	48.6	30.4	70.8	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067062-123225227	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	2900000	2900000	"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favourable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavourable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	11.6	17.1	2.6	11.2	3.1	6.3	9.3	1.0	4.0	10.0	11.0	2.4	10.9	5.6	12.2	17.1	6.7	9.1	22.2	7.2	2.5	1.2	11.0	66.0	14.4	7.1	2.2	1.8	11.4	18.3	5.2	12.1	29.1	1.9	14.3	10.8	12.7	10.8	7.6	8.1	6.1	8.2	9.5	2.3	8.6	17.6	18.0	2.5	3.2	18.2	5.5	7.9	7.8	6.9	3.2	12.8	0.3	9.0	0.5	2.4	2.3	8.1	5.0	6.3	7.6	28.9	26.2	33.6	15.5	26.0	8.7	24.0	16.0	7.5	0.0	20.3	24.0	4.3	2.7	9.4	9.2	0.2	3.1	3.6	1.5	19.1	12.0	8.9	0.5	22.5	14.2	5.9	12.4	29.4	4.5	21.3	5.9	9.9	2.4	10.5	4.6	5.2	2.3	4.5	22.5	7.3	4.8	6.8	4.1	7.5	8.5	13.3	7.4	11.0	16.3	2.2	7.1	10.5	4.2	6.3	1.6	3.6	7.2	7.1	7.5	0.0	9.0	0.3	1.4	2.2	2.4	3.2	1.0	0.9	5.4	0.8	0.6	0.6	0.2	0.5	0.4	12.8	0.0	2.3	2.6	3.1	1.0	4.0	2.5	1.2	2.2	1.8	1.9	2.5
PDXP	"CIN, dJ37E16.5, FLJ32703"	ENSG00000241360	"Pyridoxal phosphatase"	Q96GD0	22	37658727-37666934	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.4;liver: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 12.9"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000531	Approved					17000	17000			"HPA000531: AB_2666018"	"unprognostic (6.29e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	2.4	14.8	43.5	1.7	32.0	3.0	2.5	24.9	55.4	1.7	8.3	5.3	0.8	15.4	3.7	4.1	1.0	3.4	2.7	12.9	38.1	27.7	10.2	34.7	1.3	3.9	16.4	15.8	3.5	8.4	6.1	7.9	1.0	13.6	3.3	7.6	3.8	7.1	4.2	5.7	0.9	15.8	4.8	9.1	2.6	3.3	10.4	4.6	4.2	3.4	1.0	5.4	2.2	0.7	1.5	12.9	0.5	0.4	0.8	0.9	0.1	2.8	6.7	14.0	12.2	4.4	1.1	1.7	6.6	3.1	12.0	9.4	2.5	0.2	18.2	6.8	3.2	1.4	18.9	0.1	10.3	5.5	37.5	3.1	9.6	13.6	2.8	12.4	15.3	0.4	1.2	5.8	8.6	5.5	11.1	11.0	10.7	2.3	25.4	20.8	7.1	16.5	19.8	10.1	13.4	5.2	0.3	32.6	20.6	6.3	5.3	11.6	1.3	9.9	3.2	10.4	13.0	11.0	13.2	11.4	14.5	19.4	9.8	4.0	13.1	0.0	0.3	0.5	0.9	0.4	0.1	1.5	0.3	0.6	0.6	1.4	0.3	0.1	0.4	0.8	0.2	12.9	0.3	0.1	43.5	32.0	24.9	50.6	38.1	27.7	16.4	15.8	13.6	4.6
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118135858-118145584	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 260.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA008819, CAB013493, HPA063904"	Enhanced		Supported	"Plasma membrane"		62000000	62000000	"Plasma membrane"	"Plasma membrane"	"CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favourable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	26.8	207.3	83.0	15.2	82.3	13.5	32.3	63.3	102.7	35.5	50.4	58.0	18.9	75.3	22.9	52.8	24.3	28.5	22.6	57.6	77.6	69.7	132.7	260.7	22.1	16.0	77.8	71.5	43.5	46.2	139.2	30.8	16.5	59.1	35.4	25.4	41.2	43.6	33.1	65.1	20.9	75.4	23.4	79.1	15.3	20.6	22.7	43.5	8.7	94.9	26.1	19.7	20.2	17.8	45.2	37.3	3.0	12.1	20.9	45.3	36.4	31.7	27.1	38.5	40.0	60.7	29.8	59.9	25.3	29.6	40.0	20.6	16.2	11.0	51.2	25.5	37.9	22.9	56.9	23.5	31.3	12.8	54.4	25.7	30.6	112.6	35.1	46.5	11.3	29.4	39.1	23.6	16.5	18.6	42.6	19.1	40.0	37.6	25.3	94.2	37.3	32.9	50.1	28.7	93.4	49.0	31.0	46.1	35.8	52.6	36.6	49.5	52.5	31.7	20.1	30.8	17.5	30.0	25.4	18.7	33.2	26.4	36.1	34.8	33.2	0.7	11.0	3.0	26.9	12.1	42.4	45.2	45.3	33.3	33.3	32.5	43.9	35.3	1.2	20.9	10.3	37.3	41.2	36.4	83.0	82.3	63.3	102.7	77.6	69.7	77.8	71.5	59.1	43.5
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.2;RPTEC TERT1: 23.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes				Peroxisomes	Peroxisomes	"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favourable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	14.2	4.4	3.2	6.5	3.3	3.5	7.0	6.7	3.7	2.8	11.5	4.4	2.7	13.2	2.0	6.6	2.4	4.5	7.2	2.7	3.3	3.1	17.4	78.4	3.6	3.8	4.4	2.9	3.2	3.1	3.8	5.4	0.9	3.5	3.1	4.2	6.2	3.5	3.5	3.4	3.3	20.9	3.2	5.1	2.8	2.6	0.9	3.6	2.4	8.5	2.0	3.5	2.2	4.1	5.1	1.4	4.1	3.9	8.8	14.7	4.1	3.8	4.2	1.7	0.1	10.4	3.9	2.1	0.9	2.1	2.5	4.1	4.8	11.0	0.1	7.9	2.2	0.9	4.7	5.6	4.3	6.0	5.0	4.9	2.4	24.2	10.5	1.3	3.4	3.3	3.9	2.5	3.6	2.4	2.0	5.6	5.3	2.7	1.5	1.3	3.1	3.2	3.3	3.3	0.5	23.3	0.6	2.4	3.4	2.3	4.8	9.5	5.7	4.1	0.0	1.6	1.7	4.0	2.7	6.5	5.5	1.9	3.5	1.8	3.6	0.8	3.9	1.3	6.4	1.5	7.3	4.2	8.6	7.3	1.4	5.1	9.2	6.0	4.1	8.8	2.0	0.2	14.7	4.1	3.2	3.3	6.7	3.7	3.3	3.1	4.4	2.9	3.5	3.6
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042375	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA042375: AB_10796905"	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.3	27.5	7.2	19.0	15.5	10.9	10.9	9.2	8.2	12.6	10.0	16.0	9.8	12.6	16.8	9.4	17.1	10.7	5.5	3.2	9.3	37.3	6.2	15.1	23.0	17.1	5.6	9.4	11.1	11.6	8.4	12.8	6.7	6.0	5.3	5.6	27.5	9.9	10.0	10.2	22.6	9.3	11.7	11.5	10.4	5.3	7.3	17.3	6.5	4.4	16.4	6.8	2.1	5.9	12.4	12.5	20.7	8.0	7.4	4.9	2.3	11.5	7.8	10.2	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 13.6;Hep G2: 5.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.6	0.3	1.0	0.0	0.1	0.2	0.0	0.8	0.2	0.6	0.2	0.1	0.5	0.1	0.3	0.4	0.4	1.1	0.4	0.1	5.4	0.0	0.1	0.5	0.2	0.6	0.1	0.4	0.0	0.1	2.1	0.2	0.7	0.6	0.3	0.3	0.3	0.5	0.2	0.1	0.0	0.4	0.4	0.2	0.5	1.5	0.2	0.4	0.0	0.1	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Enhanced	"Nucleoli,Endoplasmic reticulum"		6000000	6000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	26.8	17.0	33.4	38.4	72.2	34.7	21.7	40.6	47.3	21.6	26.9	20.5	33.0	7.7	44.5	42.1	21.5	36.4	17.0	29.1	8.2	41.8	8.7	16.3	23.0	12.0	14.3	4.7	35.7	9.6	26.2	13.6	13.9	9.2	4.8	25.3	28.7	10.7	10.5	87.5	28.7	12.8	20.9	11.2	28.5	20.5	31.2	13.9	29.7	49.4	15.9	11.4	9.2	10.7	15.1	22.2	53.2	38.2	5.1	9.3	8.4	41.1	22.8	28.6	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 128.3;skeletal muscle: 83.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced									"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favourable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	10.5	16.8	5.3	5.3	6.2	1.4	7.7	5.1	8.7	6.0	10.7	5.4	5.7	11.4	5.4	5.6	6.8	3.6	8.5	38.0	4.0	4.9	36.4	128.3	6.4	3.2	6.5	3.7	7.6	9.9	6.8	6.7	4.5	5.3	6.2	7.4	7.1	6.3	5.4	83.8	3.8	15.5	10.2	4.4	3.0	8.5	4.1	4.1	1.9	13.0	29.5	3.6	7.6	9.4	9.2	13.3	10.7	16.0	3.3	15.4	10.2	6.1	12.8	5.8	8.3	42.1	26.9	4.6	6.3	8.8	7.2	7.2	3.3	11.2	0.3	4.9	10.5	2.9	7.5	7.4	4.5	14.8	4.0	5.3	3.6	13.0	20.9	0.9	10.0	19.1	10.7	7.8	3.1	6.9	3.0	11.9	16.7	5.7	3.2	4.2	5.3	4.7	5.7	9.0	2.0	15.0	7.9	2.0	6.3	23.6	0.5	11.5	24.0	15.9	2.3	11.1	4.1	13.6	4.2	13.7	9.2	1.2	14.4	6.8	4.3	10.7	16.0	6.5	7.2	11.7	15.4	9.2	9.1	9.2	13.3	4.9	11.5	11.7	0.6	3.3	9.0	12.2	8.6	10.2	5.3	6.2	5.1	8.7	4.0	4.9	6.5	3.7	5.3	4.1
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.1	2.5	0.0	0.0	5.1	0.0	0.2	13.4	0.8	3.7	0.0	0.4	0.0	10.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	17.4	0.2	0.3	51.7	1.2	5.6	0.0	0.0	1.0	0.6	0.0	0.0	0.3	0.0	26.4	0.0	0.0	0.8	0.0	0.2	0.2	0.0	32.9	0.0	27.1	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell line enriched"	"Detected in some"	9	"K-562: 47.4"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Low region specificity"	"Detected in some"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		2900000	2900000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 377.9"	"Group enriched"	"Detected in some"	14	"Hep G2: 34.2;RT4: 31.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	290000	290000			"HPA015236: "	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favourable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	25.2	1.0	0.0	13.1	0.0	0.6	14.0	0.0	0.6	1.4	63.9	0.0	0.1	35.0	0.7	22.7	31.5	11.7	2.4	105.4	0.0	0.0	1.6	377.9	3.0	6.5	0.0	0.0	35.6	2.4	0.6	0.5	15.5	0.0	27.1	68.2	6.1	9.5	1.0	30.6	5.0	99.0	39.7	0.0	0.6	4.0	9.8	0.0	0.0	16.0	8.9	19.3	39.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	31.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.8;HHSteC: 171.3"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.2	2.3	197.8	27.0	35.9	9.1	7.1	5.5	6.3	4.3	0.6	0.0	0.1	18.6	0.3	3.1	0.0	9.6	11.5	0.0	15.1	0.4	16.1	171.3	1.8	27.8	28.5	3.2	13.6	0.0	6.8	2.7	3.3	21.6	0.7	4.1	6.2	4.3	5.6	10.0	1.5	0.1	0.0	10.6	0.2	5.3	4.2	1.0	9.0	2.2	4.0	10.7	0.0	1.7	8.6	0.0	2.0	2.0	6.1	0.0	3.1	0.8	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 14.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077050			Supported	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"	"Vesicles, Lipid droplets"	"HPA077050: "	"prognostic favourable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favourable (2.16e-4)"	20.9	1.7	8.0	2.9	5.2	3.9	6.5	4.2	5.8	1.8	3.3	2.0	10.5	1.6	1.6	5.5	1.9	3.1	1.9	12.0	7.8	1.4	5.8	44.6	2.8	1.5	3.4	2.6	25.8	30.1	0.5	6.2	0.6	3.7	4.5	0.9	3.4	40.3	4.6	40.8	1.7	1.3	1.5	1.7	1.8	11.5	1.4	4.2	0.0	2.2	6.0	1.1	3.7	5.7	0.6	0.4	14.7	0.5	0.8	0.4	0.1	0.5	0.3	1.1	3.8	2.8	0.1	5.5	0.2	0.2	0.2	0.1	0.4	1.0	0.3	1.2	0.2	0.4	0.0	0.0	0.0	0.5	0.4	0.3	1.4	1.7	0.6	0.4	0.9	0.7	0.0	0.0	0.1	0.3	1.2	0.5	0.3	0.9	0.3	0.9	0.7	0.5	0.3	0.2	3.4	0.3	5.0	0.7	4.7	0.5	0.8	0.0	10.4	0.7	1.0	0.6	0.5	0.5	0.3	0.6	0.2	0.2	0.5	1.1	0.2	1.5	0.5	0.8	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.4	14.7	0.8	0.3	0.4	0.2	0.1	8.0	5.2	4.2	5.8	7.8	1.4	3.4	2.6	3.7	4.2
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 85.3;U-87 MG: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"			"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavourable (7.64e-10)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.99e-11)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	17.0	12.2	3.8	1.2	13.9	15.0	9.7	60.4	18.5	32.9	62.1	0.9	1.7	0.0	11.8	10.2	3.6	4.4	51.9	85.3	0.0	7.0	4.2	11.9	8.4	35.8	0.0	0.0	26.2	7.5	28.5	13.9	45.4	5.6	0.2	58.1	6.2	0.0	0.0	2.4	5.2	0.0	2.5	0.0	13.8	0.8	1.9	0.0	48.1	5.2	5.1	14.1	0.5	57.0	40.8	12.4	12.9	36.0	18.5	2.6	0.0	76.0	0.0	7.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Enhanced	Nucleoplasm,Cytosol		150000	150000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.5	14.5	1.1	2.7	7.4	5.7	0.0	5.9	3.9	6.7	5.8	23.8	13.0	16.7	28.5	5.9	10.6	9.1	16.2	9.7	20.3	7.8	11.8	6.8	24.7	8.0	10.4	8.1	7.6	12.7	12.4	15.4	8.7	11.1	5.8	7.8	13.1	10.5	3.4	2.1	18.0	8.9	5.1	12.2	18.5	9.1	5.9	4.9	5.4	8.8	5.0	15.6	3.8	9.1	10.8	6.3	10.7	12.4	13.8	15.2	8.8	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404863-95435329	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"myeloid DC: 22.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	350000000	350000000			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	17.0	42.2	54.1	7.5	59.1	3.3	23.1	25.4	52.2	16.5	24.0	29.7	7.4	28.2	16.6	22.7	10.2	15.0	18.9	13.1	57.2	31.4	23.9	81.0	33.1	4.5	41.4	31.0	10.6	7.2	10.9	15.0	34.3	34.8	14.7	31.1	9.9	8.5	17.2	4.3	19.4	19.1	18.4	44.2	7.3	8.8	9.6	40.1	1.8	13.6	5.1	11.2	13.7	8.1	0.9	22.1	0.5	5.2	5.0	3.5	3.0	9.6	60.4	49.1	26.6	6.9	15.2	13.8	19.7	23.1	15.4	16.8	13.6	22.0	0.0	27.6	19.4	6.5	8.9	15.1	17.5	0.1	11.7	4.9	36.3	45.0	10.9	0.0	6.8	22.0	17.5	8.2	11.3	31.7	3.1	0.2	45.2	8.8	0.0	5.4	9.6	14.0	0.0	23.2	2.3	47.5	7.5	3.4	10.6	28.1	31.4	18.9	9.2	3.1	34.5	23.1	16.8	7.7	18.9	5.2	6.0	0.0	21.6	4.5	30.1	0.0	5.2	0.5	3.5	2.6	3.1	0.9	1.3	3.2	22.1	0.4	1.9	2.4	0.0	5.0	1.2	5.3	0.6	3.0	54.1	59.1	25.4	34.3	57.2	31.4	41.4	31.0	34.8	40.1
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.7	27.9	12.8	23.7	48.5	18.4	21.4	5.3	17.5	10.1	14.1	20.9	56.7	12.2	4.9	11.6	6.2	16.8	8.4	4.3	10.4	12.4	5.6	8.2	38.7	33.7	5.6	10.1	37.8	10.6	13.3	9.7	9.4	16.9	5.3	9.1	18.7	6.1	10.1	15.9	15.8	8.7	8.4	13.1	11.4	15.4	13.4	12.8	14.4	73.3	19.3	21.0	9.6	8.4	9.5	10.5	14.3	10.5	5.2	8.0	8.3	13.4	8.6	12.2	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.5;liver: 49.7;skeletal muscle: 55.6"	"Cell line enriched"	"Detected in some"	7	"A-431: 42.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favourable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (3.07e-3)"	5.7	2.4	3.1	2.4	4.2	0.3	1.3	4.7	5.5	2.6	9.4	4.2	1.8	5.7	0.9	4.8	3.0	1.2	2.2	24.6	3.3	3.1	49.5	49.7	2.5	0.4	3.1	1.8	1.3	2.8	14.6	7.6	0.3	7.8	2.6	6.6	14.0	30.4	3.0	55.6	5.5	14.2	1.6	3.2	0.8	3.1	3.4	3.4	0.3	17.4	18.2	1.5	1.7	1.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	42.9	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.1	4.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	6.2	0.0	2.0	0.1	1.4	0.0	1.7	0.2	0.7	0.0	0.4	0.3	0.0	0.8	3.8	0.0	0.0	0.8	0.7	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	4.2	4.7	5.5	3.3	3.1	3.1	1.8	7.8	3.4
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Cell line enhanced"	"Detected in all"		"U-698: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				Cytosol	Cytosol	"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favourable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	12.8	8.6	12.4	8.4	12.5	6.8	12.5	12.7	8.9	9.5	8.7	29.2	13.5	16.3	9.6	8.2	12.2	18.4	10.4	12.2	11.2	5.7	15.9	5.1	12.7	6.2	18.5	12.7	7.7	6.3	10.7	7.9	11.7	19.2	21.7	10.4	4.2	20.0	7.5	15.3	9.4	15.4	8.3	19.9	14.1	14.2	4.1	11.0	11.4	10.5	2.1	12.1	6.9	12.6	11.1	13.4	5.5	8.1	2.3	5.7	59.6	3.9	21.7	14.0	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9
PRAMEF4	RP5-845O24.6	ENSG00000243073	"PRAME family member 4"	O60810	1	12879224-12886201	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"liver: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"liver cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (5.41e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314562	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.9;liver: 76.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 79.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.0"	"Low region specificity"	"Detected in many"							HPA028523	Uncertain				"Secreted to extracellular matrix"	4300000000	4300000000			"HPA028523: AB_10669642"	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	20.9	0.7	0.1	1.0	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11.0	0.1	0.3	0.2	76.0	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1.0	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	79.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	4.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.5;ASC TERT1: 31.6;HSkMC: 28.6;SK-MEL-30: 45.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007724, HPA023974"	Approved				"Secreted to blood"	3400000000	3400000000			"HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.2	42.5	31.6	0.8	1.5	3.5	0.8	3.1	6.0	0.9	0.2	9.3	2.3	0.1	0.8	0.6	1.1	0.1	2.7	16.5	1.1	16.9	3.6	0.6	0.8	28.6	0.6	1.8	0.6	3.5	11.4	0.2	16.5	0.2	0.1	0.0	2.0	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	45.8	0.1	8.0	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.0	10.5	9.8	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2
PROSER2	"C10orf47, MGC35403"	ENSG00000148426	"Proline and serine rich 2"	Q86WR7	10	11823339-11872277	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.8"	"Cell line enhanced"	"Detected in many"		"A-431: 32.3;CAPAN-2: 38.7;HBEC3-KT: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.0"	HPA041337	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041337: AB_10794663"	"unprognostic (2.36e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.60e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.69e-2)"	2.7	1.1	0.7	1.8	1.4	9.5	9.8	1.0	1.3	3.7	2.5	0.4	2.4	1.2	2.5	1.7	6.2	3.0	2.2	1.4	1.5	0.7	8.6	40.8	10.2	0.2	1.4	0.3	1.7	21.7	0.0	1.5	9.2	1.2	7.3	2.0	9.9	4.5	2.7	1.7	3.2	1.1	1.3	1.0	8.2	7.1	7.5	0.5	4.3	12.0	3.6	5.6	6.5	9.9	0.0	1.9	0.0	1.0	0.0	0.7	0.9	32.3	4.6	0.2	0.1	1.0	1.2	1.9	1.4	0.7	1.1	0.6	10.7	38.7	0.0	6.0	0.1	8.5	3.3	24.7	0.6	0.0	7.9	3.7	2.0	6.8	5.8	0.0	2.3	1.4	5.4	7.0	8.0	3.6	5.5	0.0	1.6	4.4	0.0	1.2	2.0	2.6	5.2	4.2	0.0	2.6	1.6	0.0	0.4	2.4	9.8	4.1	5.1	2.0	2.4	0.0	7.9	12.9	0.1	0.0	0.0	0.0	0.0	1.3	1.8	0.0	1.0	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.9	0.7	1.4	1.0	1.3	1.5	0.7	1.4	0.3	1.2	0.5
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 10.9"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034955, HPA034956"	Uncertain				"Secreted - unknown location"					"HPA034955: AB_2674380, HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.3	0.0	0.0	0.5	0.3	0.0	0.1	2.9	0.4	0.2	0.3			1.4	1.0	0.0	0.1	0.3	0.6	0.2	0.1	0.3	0.6	10.9	0.5	0.9	0.1		0.3	2.2	0.0	0.8	0.2		1.2	0.0		0.0	0.8	0.0	3.9	0.5	0.4	0.2	1.0	1.3	0.0			0.3		0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.0	0.0	0.0	1.0	0.5	1.1	1.0	0.0	0.2	0.0	0.3	0.7	0.0	1.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.3	0.1	1.3	0.3	1.6	0.8	1.9	1.6	0.0	0.0	0.0	0.0	9.8	0.8	0.9	0.0	1.0	0.7	0.1	0.7	1.0	0.7	2.5	0.2	1.4	0.1	0.3	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8										
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 148.4;SK-MEL-30: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		1700000	1700000	Cytosol	Cytosol	"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.8	18.1	15.2	27.0	4.5	5.3	36.0	22.8	16.3	11.6	21.8	4.6	5.2	17.4	10.1	51.3	26.7	26.0	25.2	17.4	17.0	9.2	5.9	8.3	35.5	41.8	33.2	10.7	16.9	148.4	15.4	41.3	10.6	6.4	45.0	9.6	10.0	11.3	5.3	34.9	19.8	5.6	9.9	20.5	15.8	6.2	6.9	16.1	6.3	11.0	90.8	5.2	41.9	2.4	2.9	9.5	10.8	18.5	30.6	28.2	0.1	34.3	26.3	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599855	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;liver: 113.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					940000	940000			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	9.9	23.7	6.7	3.4	8.1	0.4	8.0	9.7	10.0	8.0	116.3	2.2	3.0	45.2	8.0	7.8	27.4	14.3	15.2	7.7	7.0	4.2	47.3	113.8	5.2	2.6	3.3	6.6	5.9	4.3	6.2	9.0	3.2	6.4	12.3	6.7	6.8	11.4	6.4	3.3	6.7	117.6	8.7	2.5	2.2	21.2	3.3	3.4	1.1	9.0	36.4	12.5	21.9	23.6	0.3	8.9	0.2	0.9	0.0	0.2	0.5	10.1	43.1	12.6	0.1	46.2	46.7	9.8	16.5	25.1	15.8	16.5	11.7	13.8	0.0	4.7	15.7	12.5	10.2	17.4	19.6	0.0	3.0	2.5	26.8	56.7	10.6	1.4	5.3	33.2	26.3	21.6	11.1	39.8	1.7	0.0	30.5	3.1	0.0	0.3	5.2	10.6	0.0	3.6	0.2	18.4	33.2	14.2	0.6	20.3	6.1	6.0	19.0	6.9	32.1	3.1	6.5	35.2	2.9	0.0	0.0	0.0	15.0	0.0	3.9	0.0	0.9	0.0	0.0	0.1	0.2	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	8.9	0.0	0.5	6.7	8.1	9.7	10.0	7.0	4.2	3.3	6.6	6.4	3.4
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase type IVA, member 1"	Q93096	6	63521748-63583587	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 135.1;skeletal muscle: 111.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Approved									"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavourable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	13.9	42.3	11.3	10.5	14.0	54.3	10.8	7.1	17.0	17.5	30.2	18.9	8.0	17.9	13.1	13.5	16.1	12.3	16.7	10.0	12.0	14.8	14.2	135.1	25.0	9.0	16.1	13.8	24.1	87.4	5.0	12.8	19.8	16.3	17.7	31.2	13.6	20.1	10.0	111.2	17.2	18.3	35.7	24.2	7.1	15.5	19.8	13.3	6.4	11.4	19.9	9.3	31.0	12.6	14.6	18.2	46.9	20.6	15.8	20.1	14.4	18.9	23.6	29.7	28.7	20.3	18.9	59.5	33.4	22.3	12.2	17.0	19.8	11.2	16.2	14.5	19.7	9.4	20.2	42.0	19.6	17.4	13.6	10.1	65.9	89.9	40.2	31.0	16.5	22.9	81.5	26.3	70.5	18.8	23.1	31.5	33.8	25.7	14.8	13.9	12.3	12.8	19.9	12.3	12.8	27.2	22.5	11.2	20.6	73.0	16.0	32.9	15.4	27.6	18.7	30.7	33.7	24.2	32.9	26.3	22.5	29.9	16.4	16.6	36.0	34.6	19.8	15.2	13.7	20.6	20.1	14.6	15.0	14.6	18.2	12.4	14.8	14.2	46.9	15.8	14.2	9.1	18.1	14.4	11.3	14.0	7.1	17.0	12.0	14.8	16.1	13.8	16.3	13.3
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell line enhanced"	"Detected in many"		"TIME: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"									HPA012568	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	940000000	940000000	"Nucleoplasm, Vesicles, Plasma membrane"	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA012568: AB_1846248"	"unprognostic (2.90e-3)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.5	15.1	1.5	6.1	1.8	2.2	2.6	36.4	10.2	12.0	13.7	8.8	9.2	0.0	21.0	10.5	14.2	5.1	13.8	8.0	2.6	9.9	3.8	9.5	5.9	12.7	1.4	8.3	2.9	6.8	10.5	20.7	13.0	1.8	0.0	5.5	1.9	1.3	1.3	3.4	11.2	0.0	6.9	2.0	25.7	6.6	6.5	7.6	23.1	14.5	5.1	8.2	3.7	52.7	14.5	17.9	10.7	28.4	0.0	2.1	0.0	11.6	7.4	8.2	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3752026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 79.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA019246: AB_2670113"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (3.64e-4)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	26.3	5.5	5.9	5.9	6.5	0.4	30.6	3.2	6.6	11.1	10.3	6.4	5.3	10.7	10.1	14.4	13.9	8.3	18.5	10.8	6.5	4.4	13.4	79.6	14.2	5.8	7.5	3.1	6.2	10.0	3.4	4.3	32.9	6.2	9.1	3.1	7.5	12.3	8.1	11.9	11.7	16.9	20.6	7.0	6.1	8.9	3.9	6.9	1.0	16.8	11.5	5.8	14.9	21.0	4.2	0.3	0.5	0.0	0.0	0.9	0.3	11.5	4.9	8.1	5.4	25.6	19.3	26.0	21.0	16.2	18.0	13.9	8.1	2.3	0.0	13.7	34.4	8.7	1.6	5.8	8.6	11.7	1.6	0.0	3.5	7.2	42.8	0.0	0.0	17.5	19.0	11.1	24.0	19.6	0.0	1.5	14.0	0.7	0.0	0.1	0.3	5.9	0.6	4.3	0.4	6.8	9.7	0.9	0.4	14.0	14.4	28.3	1.1	0.7	20.5	15.3	6.5	5.9	14.3	0.0	0.0	0.0	3.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.3	4.2	0.1	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.3	5.9	6.5	3.2	6.6	6.5	4.4	7.5	3.1	6.2	6.9
PXMP2	PMP22	ENSG00000176894	"Peroxisomal membrane protein 2"	Q9NR77	12	132687606-132704991	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (1.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (9.84e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.04e-1)"	5.7	4.1	6.5	6.5	5.3	6.7	10.3	3.4	7.6	3.4	18.1	3.8	7.4	17.4	4.3	7.9	5.3	5.0	14.1	16.3	5.3	3.7	18.4	78.9	3.6	5.0	4.4	6.1	6.8	32.3	2.5	2.4	2.7	4.4	5.4	13.3	4.6	9.0	3.6	12.8	4.3	25.9	3.9	3.2	3.5	22.9	4.2	4.6	13.8	7.9	5.8	4.4	4.6	4.1	3.3	9.9	4.3	1.9	2.2	4.4	1.9	24.1	10.2	15.3	14.2	9.2	7.2	9.0	8.6	8.1	18.9	16.8	12.3	9.3	15.1	10.5	12.3	17.3	20.3	11.0	10.3	8.5	32.2	13.4	18.3	13.5	18.1	9.9	6.0	9.3	9.1	7.8	6.2	5.0	23.0	11.9	9.9	21.9	31.1	15.6	14.9	14.0	32.2	16.4	12.4	13.8	10.2	29.1	9.4	18.7	9.9	11.8	26.4	22.8	5.9	9.3	21.8	8.0	14.4	10.8	10.4	24.1	10.4	14.1	7.3	0.0	1.9	4.3	3.8	0.8	3.7	3.3	3.1	3.9	3.3	3.3	3.0	2.5	0.9	2.2	0.9	9.9	4.4	1.9	6.5	5.3	3.4	7.6	5.3	3.7	4.4	6.1	4.4	4.6
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		1800000	1800000	Mitochondria	Mitochondria	"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favourable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.3	22.3	8.8	12.3	21.4	10.9	15.6	16.3	6.9	15.2	13.4	17.8	15.1	4.2	10.5	9.0	6.5	12.5	18.4	9.5	12.9	2.5	11.5	11.6	42.1	12.9	15.0	1.0	13.5	11.7	9.6	13.1	7.6	12.4	9.7	16.3	5.9	22.3	24.1	15.0	15.1	9.3	6.8	16.9	15.7	6.3	16.7	21.4	10.8	1.8	46.3	4.9	5.8	13.2	8.8	15.8	8.7	12.9	15.1	23.5	29.6	17.6	13.3	14.6	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29679008-29698699	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 96.7;Hep G2: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.6;monocytes: 7.7"									HPA011887	Approved				"Intracellular and membrane"	230000	230000			"HPA011887: AB_2668555"	"prognostic unfavourable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	3.2	36.4	6.1	3.0	5.2	1.1	2.4	1.6	5.8	17.9	10.8	4.4	43.3	20.0	12.7	44.3	1.3	14.9	4.9	11.3	4.9	7.5	40.1	61.2	4.7	2.9	7.9	7.5	15.3	22.9	6.1	2.6	24.3	10.0	4.4	5.2	12.6	15.0	19.4	1.5	1.6	24.1	4.7	6.4	5.3	2.7	3.1	2.6	3.7	2.2	0.3	2.1	5.9	5.1	0.1	4.6	1.2	7.7	0.5	1.4	2.2	0.1	0.2	9.2	10.1	1.5	3.8	22.6	0.9	0.9	1.5	1.8	23.1	16.5	0.4	96.7	1.8	0.1	3.1	0.1	0.8	0.1	2.1	4.7	0.3	40.3	8.8	0.6	1.9	12.0	0.2	0.8	0.0	0.0	11.8	0.5	0.0	22.5	3.0	16.4	28.1	0.0	13.0	2.8	9.1	8.4	0.7	7.4	15.1	0.0	26.3	19.3	19.6	21.1	0.1	0.4	3.8	0.1	0.0	0.3	0.7	3.0	0.7	1.7	1.5	0.0	3.7	0.4	1.3	4.7	1.4	0.1	0.9	1.0	4.6	0.1	0.1	0.7	1.2	0.5	7.7	2.6	0.8	2.2	6.1	5.2	1.6	5.8	4.9	7.5	7.9	7.5	10.0	2.6
RAB17		ENSG00000124839	"RAB17, member RAS oncogene family"	Q9H0T7	2	237574322-237601614	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.8;liver: 37.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.2;MCF7: 17.7;SK-BR-3: 19.2;SK-MEL-30: 46.1;T-47d: 12.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035176	Approved									"HPA035176: AB_10696368"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.68e-2)"	"prognostic favourable (4.14e-4)"	"unprognostic (5.87e-2)"	"prognostic favourable (3.33e-13)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-1)"	"prognostic favourable (2.51e-4)"	0.8	1.0	0.5	1.4	0.5	0.0	4.7	0.4	0.8	1.2	21.4	1.2	10.3	19.2	0.8	9.5	1.8	2.9	5.2	1.0	1.1	0.5	20.6	37.0	7.9	0.4	0.5	0.4	0.8	25.4	9.8	6.1	6.5	5.3	2.9	4.2	1.9	13.5	15.2	0.7	0.9	57.8	0.6	0.4	0.5	10.0	0.9	0.4	0.6	22.9	0.9	1.2	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	4.0	0.1	0.0	7.9	0.0	0.1	16.2	0.0	0.0	0.0	0.0	10.7	9.8	0.0	2.7	0.0	0.2	0.0	4.8	0.1	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.3	17.7	0.0	0.2	0.2	0.0	0.4	0.0	1.0	4.4	8.8	4.2	0.0	0.0	19.2	46.1	12.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	0.4	0.8	1.1	0.5	0.5	0.4	5.3	0.4
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7"	"Cell line enhanced"	"Detected in many"		"A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.6	1.0	13.6	0.4	19.9	0.5	0.9	30.5	13.5	2.0	4.1	0.5	1.5	5.7	0.4	2.3	1.2	0.9	1.1	1.2	18.0	6.2	0.7	21.9	0.6	0.6	5.6	9.1	0.6	24.6	3.1	9.2	0.3	2.5	2.2	5.4	0.7	17.7	1.6	1.1	1.2	6.0	0.4	1.9	0.6	5.3	0.6	3.2	0.0	1.2	0.0	1.1	0.9	0.0	0.8	0.2	0.0	0.1	0.0	1.1	0.7	1.1	13.6	0.0	3.5	0.2	0.1	0.1	0.6	1.1	0.5	0.9	0.4	2.7	0.2	0.9	0.8	2.2	0.7	0.2	0.0	1.5	1.4	0.5	14.9	1.2	0.6	0.0	0.4	0.5	0.1	0.1	0.2	0.3	0.3	0.0	1.6	8.9	0.0	0.6	0.8	1.2	1.1	1.1	2.3	5.2	0.9	18.9	3.7	0.3	17.1	0.6	5.6	0.2	0.6	0.0	2.5	0.2	0.2	2.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	13.6	19.9	30.5	13.5	18.0	6.2	5.6	9.1	2.5	3.2
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535410	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.8;non-classical monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"				"Nuclear bodies, Plasma membrane"	"Nuclear bodies, Plasma membrane"	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.0	6.1	7.3	6.3	7.6	2.7	17.6	8.4	12.7	9.8	7.9	3.7	6.8	6.9	6.8	8.4	9.2	6.3	12.5	8.3	5.2	5.0	8.2	51.1	17.2	6.8	4.2	8.4	3.6	5.8	4.0	9.9	11.1	6.0	7.2	6.7	8.5	11.2	4.4	8.3	10.2	10.2	7.1	4.8	26.7	7.8	7.9	3.1	1.7	25.8	7.9	5.6	9.6	8.7	0.0	1.1	0.0	2.8	1.1	0.6	0.3	5.4	3.8	8.0	4.6	6.3	8.2	7.0	7.6	5.6	7.9	10.0	17.5	5.8	0.0	1.8	11.5	2.7	4.1	6.5	16.5	1.1	2.3	0.0	9.1	3.0	15.8	0.0	0.1	11.3	5.5	14.5	15.3	12.3	0.4	4.2	15.7	3.0	0.0	0.0	4.7	4.8	0.1	11.3	3.0	5.7	17.6	2.8	3.8	5.2	5.0	6.3	2.8	0.2	14.5	19.5	6.3	9.3	8.0	2.0	3.4	0.0	16.1	0.1	4.3	0.0	0.8	0.0	0.2	2.8	0.6	0.0	0.5	0.1	1.1	0.0	0.4	0.1	0.0	1.1	2.6	0.1	0.5	0.3	7.3	7.6	8.4	12.7	5.2	5.0	4.2	8.4	6.0	3.1
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341674	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 145.8;liver: 184.8;pancreas: 145.4"	"Group enriched"	"Detected in some"	6	"AF22: 27.1;Hep G2: 39.3;HHSteC: 35.5;NTERA-2: 82.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 8.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	550000000	550000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	46.5	145.8	4.6	20.5	5.0	0.0	28.0	2.6	4.4	51.2	31.0	10.7	10.9	5.0	23.8	21.0	18.3	21.9	30.5	12.9	5.3	3.6	21.9	184.8	33.2	10.7	7.6	3.0	40.2	145.4	66.7	6.3	5.6	12.0	35.5	8.0	23.5	6.1	12.2	7.4	3.2	10.3	27.5	7.7	11.0	10.9	11.1	5.4	1.0	7.8	5.2	10.5	26.3	39.7	0.1	8.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.3	2.1	5.1	0.8	3.5	0.2	1.6	0.2	3.1	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.1	4.4	39.3	35.5	0.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.5	82.8	0.0	0.0	3.6	0.0	0.6	0.2	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	8.2	0.0	0.0	4.6	5.0	2.6	4.4	5.3	3.6	7.6	3.0	12.0	5.4
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1490747-1497927	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.8;liver: 119.0;testis: 71.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.8;Hep G2: 15.0;K-562: 41.8;T-47d: 34.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		26000	26000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6.0	1.4	41.7	2.8	4.4	60.2	1.0	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119.0	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1.0	4.2	0.1	4.8	5.8	7.1	2.3	2.0	2.5	0.8	10.3	1.6	0.5	11.5	0.5	0.1	0.5	0.5	15.8	6.4	1.1	3.6	0.3	2.1	2.7	0.1	0.2	0.5	1.1	6.0	0.3	15.0	1.2	0.4	2.0	1.3	1.1	0.0	0.3	0.3	41.8	1.5	0.1	7.9	0.5	1.3	3.8	5.6	1.5	0.3	2.6	3.0	0.9	0.2	5.6	2.8	4.0	1.7	34.9	1.6	0.9	0.8	1.6	2.4	0.4	5.0	1.4	0.1	3.5	2.6	2.3	0.0	1.5	0.0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1.0	2.8	3.2	0.1	5.8	4.8	4.2	2.0	2.3	4.1	5.9	3.1	6.0	4.5	1.9	2.6	2.1	2.1	1.1
RHOD	"ARHD, Rho, RhoD, RhoHP1"	ENSG00000173156	"Ras homolog family member D"	O00212	11	67056818-67072013	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 76.5"	"Cell line enhanced"	"Detected in many"		"A-431: 35.4;CAPAN-2: 25.7;HaCaT: 31.7;HBEC3-KT: 42.0;hTCEpi: 49.7;T-47d: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.9;naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	16	"B-cells: 1.1;T-cells: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 16.8"	"Not detected"	"Not detected"														"unprognostic (2.12e-2)"	"prognostic unfavourable (9.17e-4)"	"unprognostic (3.89e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (3.10e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.38e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	4.7	0.7	1.3	1.7	1.4	0.0	7.3	1.5	1.0	9.9	5.0	0.8	7.6	6.0	4.0	4.6	51.5	3.2	11.0	30.4	1.8	0.4	10.2	76.5	3.1	3.3	1.0	0.7	6.7	19.2	11.6	5.1	34.3	4.3	6.4	0.7	6.4	14.9	10.5	10.5	16.8	6.6	3.0	0.7	0.8	7.2	2.8	0.7	0.9	14.0	45.9	22.4	4.3	16.8	1.1	0.0	0.0	0.0	0.0	2.0	0.3	35.4	2.8	0.2	3.7	0.5	0.4	5.5	3.2	5.3	1.9	1.9	2.6	25.7	0.0	5.9	3.7	31.7	0.3	42.0	0.3	0.0	0.1	0.0	15.4	0.2	5.3	0.0	0.0	5.2	49.7	0.6	13.1	1.9	0.0	2.5	0.6	22.9	0.0	0.0	4.2	14.7	0.0	0.0	0.0	17.9	2.6	0.2	0.0	16.6	0.9	1.3	35.3	0.1	1.2	0.0	0.1	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.9	0.2	0.2	0.0	0.0	1.1	2.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.3	1.4	1.5	1.0	1.8	0.4	1.0	0.7	4.3	0.7
RIPPLY1		ENSG00000147223	"Ripply transcriptional repressor 1"	Q0D2K3	X	106900063-106903335	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.4;liver: 11.5"	"Cell line enriched"	"Detected in some"	8	"RH-30: 12.0"	"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA052284	Uncertain				"Intracellular and membrane"					"HPA052284: AB_2681785"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.52e-3)"	"unprognostic (7.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.31e-1)"	0.2	0.9	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.0	6.4	11.5	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.0	2.4	0.2	1.8	0.4	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
RND1	"ARHS, Rho6, RHOS"	ENSG00000172602	"Rho family GTPase 1"	Q92730	12	48857145-48865898	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;liver: 50.6"	"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077800			Supported	"Vesicles,Plasma membrane,Actin filaments"				"Vesicles, Plasma membrane, Actin filaments"	"Vesicles, Plasma membrane, Actin filaments"	"HPA077800: AB_2686854"	"unprognostic (5.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (8.38e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.35e-3)"	2.9	1.3	9.9	2.6	15.0	2.0	2.8	2.6	21.8	1.4	2.8	1.4	0.2	2.6	4.4	1.5	1.8	1.1	13.3	2.5	7.4	7.6	1.8	50.6	12.3	1.4	7.1	8.6	0.9	2.0	3.2	3.2	1.6	8.6	3.7	2.3	1.0	4.0	1.5	0.6	0.6	2.3	2.6	5.6	0.9	6.1	0.8	2.3	0.0	5.5	2.1	2.4	6.9	2.0	1.7	1.7	0.0	0.0	0.5	1.6	0.2	0.6	4.2	2.1	1.1	0.4	0.0	0.3	0.0	0.2	0.6	0.7	2.6	0.9	3.2	0.8	0.0	0.0	1.7	0.1	0.4	1.0	1.0	0.4	0.0	1.6	0.2	0.9	0.6	0.0	0.1	0.3	0.4	1.1	0.1	3.3	0.0	5.4	0.4	0.2	5.0	0.2	1.0	0.2	1.5	0.6	0.8	0.0	0.5	0.1	38.6	0.1	3.8	0.1	0.2	0.0	0.4	0.0	0.5	1.7	2.8	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.7	0.2	0.1	1.7	1.1	0.7	0.1	0.0	0.5	0.0	0.0	0.4	0.2	9.9	15.0	2.6	20.4	7.4	7.6	7.1	8.6	8.6	2.3
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.9;CAPAN-2: 14.8;Hep G2: 12.6;RPTEC TERT1: 13.0;RT4: 37.2;WM-115: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain									"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.5	0.0	0.0	0.0	1.5	0.8	17.9	0.0	0.1	0.0	0.0	7.8	14.8	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	8.7	0.0	0.1	12.6	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	13.0	37.2	0.0	0.0	0.0	0.9	0.9	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0
SAA2-SAA4		ENSG00000255071	"SAA2-SAA4 readthrough"		11	18231423-18248635	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 15.9;cervix, uterine: 10.6;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"A-431: 6.7;CAPAN-2: 1.5;EFO-21: 3.9;HaCaT: 2.7;RPTEC TERT1: 1.5;SiHa: 1.5"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 39.9"					"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"									HPA060139	Uncertain									"HPA060139: AB_2684210"	"prognostic favourable (4.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.96e-1)"		"unprognostic (8.27e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (2.92e-8)"	"unprognostic (1.92e-1)"			"unprognostic (2.72e-1)"	15.9	0.6	0.0	0.7	0.0	0.0	2.7	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	44.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	1.5	0.0	3.9	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favourable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	14.8	0.1	0.4	0.3	0.0	4.9	12.7	0.3	0.7	0.0	0.0	0.0	5.7	6.9	0.0	9.2	0.0	0.4	0.0	5.6	0.0	0.0	8.9	0.3	0.0	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	1.8	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	23.5	0.0	4.9	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4
SAT2	SSAT2	ENSG00000141504	"Spermidine/spermine N1-acetyltransferase family member 2"	Q96F10	17	7626234-7627876	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022136, HPA057096"	Enhanced									"HPA022136: AB_1856592, HPA057096: AB_2683334"	"unprognostic (2.61e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.23e-2)"	"prognostic favourable (8.76e-6)"	"unprognostic (2.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.75e-1)"	"prognostic favourable (6.05e-5)"	"unprognostic (1.83e-1)"	"unprognostic (6.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	11.3	43.9	14.8	6.3	16.7	6.4	11.0	11.3	17.4	12.5	33.4	9.2	10.8	51.5	11.7	14.9	8.9	10.2	11.3	14.5	13.4	9.8	49.6	73.2	9.1	8.9	18.3	17.1	19.9	20.0	11.3	13.7	5.5	15.2	11.5	9.2	13.9	16.2	13.6	12.0	7.9	47.9	10.1	10.5	12.5	13.3	11.7	16.8	2.7	18.5	11.9	7.3	9.9	13.3	8.6	18.4	5.5	25.6	6.6	11.8	12.9	7.5	11.6	10.1	19.2	15.0	18.6	1.3	5.3	18.4	11.6	15.1	3.7	3.9	1.5	3.0	5.0	6.7	6.3	5.1	7.5	2.2	19.3	1.6	6.2	19.2	19.5	0.0	5.5	24.3	12.3	6.8	4.7	17.0	1.0	2.4	12.3	0.6	0.1	1.6	4.0	8.0	2.9	5.0	1.8	17.4	8.6	1.1	10.0	5.2	10.2	9.6	6.4	1.6	8.3	5.5	4.0	0.1	7.7	5.0	4.2	0.2	19.9	2.2	8.5	4.6	25.6	5.5	8.9	17.1	10.5	8.6	7.7	9.1	18.4	8.3	11.8	8.4	1.6	6.6	8.8	8.3	11.2	12.9	14.8	16.7	11.3	17.4	13.4	9.8	18.3	17.1	15.2	16.8
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell line enhanced"	"Detected in all"		"AF22: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	"Nucleoplasm, Endoplasmic reticulum"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	7.1	3.6	53.9	11.5	21.0	18.2	7.6	8.0	15.1	5.4	9.6	22.5	26.6	6.7	25.4	8.7	26.7	16.8	20.3	5.3	3.3	22.9	10.0	23.5	17.9	17.1	6.3	3.4	14.9	16.7	17.1	17.6	8.2	6.5	9.8	24.9	7.4	2.5	8.2	16.8	11.4	3.5	13.6	5.7	38.0	32.0	14.2	8.0	18.4	4.2	10.5	16.8	10.9	15.5	5.2	8.4	9.2	3.7	1.8	3.1	9.0	2.0	13.9	9.0	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 173.1;liver: 93.7;placenta: 65.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.9;monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: "	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavourable (1.83e-5)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	21.2	173.1	7.9	3.5	21.4	1.8	25.0	4.3	10.1	4.7	28.6	13.4	1.1	8.8	4.3	3.5	2.8	4.7	8.0	3.2	7.4	5.1	2.2	93.7	5.8	5.3	6.3	5.1	14.3	2.9	3.3	4.4	65.9	9.4	4.3	4.9	10.7	8.6	2.3	3.0	6.3	21.3	4.4	5.7	5.0	2.7	7.7	11.4	0.5	4.0	1.1	5.6	3.6	10.0	3.1	24.9	1.2	6.5	0.2	0.4	2.5	9.1	22.2	7.2	28.5	4.8	10.3	0.0	6.4	7.4	8.0	5.1	26.5	29.3	26.5	18.7	4.4	14.0	18.4	43.4	3.8	12.6	18.6	7.4	21.9	42.7	16.3	12.7	6.5	17.6	8.8	15.3	10.9	21.9	14.1	11.4	1.4	18.2	3.9	17.1	6.6	23.0	16.6	5.8	53.0	0.7	12.8	13.6	5.3	35.2	47.5	32.9	26.6	14.5	2.1	1.3	8.7	6.5	10.0	2.7	1.1	4.4	5.2	15.5	12.5	0.0	6.5	0.0	0.2	3.7	0.2	3.1	0.1	0.4	8.2	1.7	0.1	0.1	1.2	0.2	0.5	24.9	0.0	2.5	7.9	21.4	4.3	10.1	7.4	5.1	6.3	5.1	9.4	11.4
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Peroxisomes		370000	370000	Peroxisomes	Peroxisomes	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favourable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favourable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.9	14.3	19.3	35.3	63.3	54.1	20.9	31.0	46.6	20.4	29.6	12.8	28.2	24.7	33.6	45.4	18.3	13.2	29.0	31.2	36.0	19.2	26.6	20.5	26.3	42.2	38.3	44.9	43.9	39.6	24.2	12.1	57.7	23.6	12.9	41.2	15.0	42.5	33.3	21.1	28.1	22.4	33.9	33.8	56.5	44.2	16.0	19.2	27.1	55.0	25.9	28.1	43.8	44.6	27.8	14.4	48.4	24.7	21.6	27.4	28.9	36.0	38.1	25.7	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.9;hTCEpi: 56.3;U-251 MG: 58.0;U-266/70: 60.1;U-266/84: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Supported	"Focal adhesion sites"	"Secreted to blood"	1600000	1600000	"Focal adhesion sites"	"Focal adhesion sites"	"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavourable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	30.8	17.3	5.5	13.8	1.5	0.2	17.3	8.6	8.3	8.1	6.8	3.6	18.8	0.0	3.2	6.1	30.4	2.4	60.9	5.4	0.1	1.6	0.0	1.6	18.5	1.3	1.3	0.1	0.8	56.3	7.2	17.3	0.8	0.7	12.1	4.3	18.4	0.0	0.3	4.9	33.5	0.6	2.0	23.3	10.3	46.3	1.6	12.8	6.5	43.9	1.9	4.3	0.3	1.3	32.1	10.3	1.1	58.0	60.1	126.7	0.1	9.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493351-96611780	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.1;thyroid gland: 111.2"	"Cell line enhanced"	"Detected in many"		"AF22: 101.9;EFO-21: 47.8;fHDF/TERT166: 44.1;RPTEC TERT1: 53.2;U-138 MG: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	43.2	9.9	13.9	9.1	16.9	2.5	17.0	12.7	8.4	43.4	18.7	7.3	21.2	5.8	21.9	15.3	13.3	21.0	15.0	19.1	12.0	12.6	23.9	115.1	14.4	4.4	9.7	9.3	45.9	16.8	1.6	24.0	31.3	10.7	25.9	10.7	51.4	6.3	28.1	9.4	6.5	9.6	34.3	9.5	7.5	11.9	8.7	9.3	0.5	111.2	13.8	3.5	35.9	26.3	0.0	1.3	13.9	1.9	0.0	0.2	0.5	0.0	0.0	101.9	0.0	36.8	34.4	0.1	14.7	17.5	8.6	9.5	3.0	0.0	0.0	47.8	44.1	0.0	17.6	0.2	7.4	0.0	6.9	0.0	9.8	37.4	1.1	0.2	0.4	13.3	0.4	19.4	0.5	0.3	9.6	0.0	3.5	0.8	0.0	2.5	10.8	0.1	0.1	16.0	0.3	53.2	8.7	3.0	7.9	0.0	0.0	0.7	4.3	11.4	8.0	49.4	15.1	0.2	8.2	0.9	0.0	0.1	15.7	0.0	15.4	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.9	0.0	0.1	0.0	0.0	0.5	13.9	16.9	12.7	8.4	12.0	12.6	9.7	9.3	10.7	9.3
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favourable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	22.6	2.9	1.6	0.1	40.4	24.9	69.8	29.0	39.6	32.8	23.6	34.5	57.9	0.0	13.0	36.4	29.4	1.1	73.7	40.0	6.5	1.0	0.7	2.4	13.4	44.1	0.1	1.2	33.5	49.4	13.5	33.1	4.3	1.1	0.0	18.9	22.5	0.0	2.0	2.9	9.1	0.0	14.6	0.0	54.0	30.2	0.6	2.3	39.8	24.7	7.1	17.9	1.3	8.1	25.1	20.9	2.5	18.6	1.2	0.9	0.1	39.5	2.3	14.9	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422237-113438276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.2;MCF7: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 13.2;monocytes: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favourable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favourable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	3.1	15.3	4.2	3.8	5.1	1.4	2.8	1.5	7.1	2.6	7.1	5.5	6.2	10.0	2.5	9.7	1.3	4.6	5.2	7.2	3.6	6.1	15.5	53.2	2.8	2.8	9.5	4.2	4.6	15.3	5.0	7.6	3.1	7.8	4.2	5.0	4.6	4.9	4.5	2.1	0.7	7.8	2.9	8.8	3.0	5.2	7.0	2.6	1.5	20.3	1.3	1.6	4.0	1.5	1.1	13.2	0.3	7.1	1.3	0.2	1.7	3.5	14.0	1.9	5.8	0.4	0.8	1.4	2.0	0.5	2.2	1.8	5.9	3.8	0.1	10.5	3.3	3.6	0.9	4.7	0.7	8.4	3.5	9.0	3.4	2.5	11.8	1.1	22.2	1.9	6.7	5.4	8.0	3.2	6.9	2.7	2.6	38.0	0.0	4.5	2.0	6.0	0.0	2.9	6.7	5.7	4.4	0.6	0.2	8.6	9.8	8.3	12.0	10.2	2.9	2.7	5.2	11.9	1.8	0.6	0.5	0.1	11.4	3.7	3.3	0.1	6.5	0.0	0.0	7.1	0.0	1.1	0.0	0.0	13.2	0.1	0.0	0.0	0.3	1.3	0.9	12.8	0.2	1.7	4.2	5.1	1.5	7.1	3.6	6.1	9.5	4.2	7.8	2.6
SEBOX	"OG9, OG9X"	ENSG00000274529	"SEBOX homeobox"		17	28364268-28365244	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"liver: 2.6;pancreas: 1.1;testis: 1.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;CACO-2: 3.3;HL-60: 1.0;T-47d: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 40.5"	"Not detected"	"Not detected"			HPA045689	Uncertain									"HPA045689: AB_2679419"							"unprognostic (8.66e-2)"							"unprognostic (3.10e-3)"				0.0	0.0		0.0		0.1	0.0		0.1	0.0	0.0			0.9	0.0	0.0	0.1	0.0	0.0	0.0			0.0	2.6	0.0	0.1			0.0	1.1	0.0		0.0		0.0	0.0		0.0	0.0	0.4	0.1	0.0	0.0		0.1	0.0	1.5			0.0		0.0	0.0		0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.5	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396857-30425317	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 43.0;liver: 112.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3;hTCEpi: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"									HPA064466	Approved		Supported	Nucleoplasm,Cytosol		190000	190000	Nucleoplasm	Nucleoplasm	"HPA064466: AB_2685270"	"prognostic favourable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	1.9	1.2	13.6	1.9	14.2	2.4	22.7	7.3	15.0	2.2	5.7	12.6	7.3	10.1	2.4	43.0	8.0	2.3	4.3	1.1	10.8	10.4	3.6	112.3	1.8	2.1	16.1	10.4	1.3	1.9	3.7	5.0	1.5	10.6	25.7	1.4	24.2	4.0	7.8	1.0	2.9	13.5	2.4	8.9	1.0	3.4	1.2	10.4	1.1	4.3	0.6	2.7	1.8	2.9	0.8	0.9	0.5	0.2	0.1	7.1	1.5	9.9	2.4	2.0	2.7	3.0	7.5	0.1	8.1	6.5	4.8	5.0	0.6	6.7	0.2	2.4	9.8	7.7	1.2	38.3	5.3	0.9	1.9	0.2	2.4	3.6	4.1	0.0	2.6	5.2	20.9	4.4	7.9	12.0	0.0	0.2	9.6	1.7	1.0	0.2	0.0	3.4	0.4	3.5	0.2	8.5	3.3	1.2	1.4	5.0	1.1	4.5	6.5	0.1	18.2	6.7	4.3	2.7	4.9	0.1	0.0	0.3	14.7	0.0	5.3	0.1	0.2	0.4	0.9	0.2	0.4	0.8	2.6	0.6	0.1	0.6	7.1	4.7	0.5	0.1	0.1	0.9	1.1	1.5	13.6	14.2	7.3	13.4	10.8	10.4	16.1	10.4	10.6	10.4
SEC14L3	TAP2	ENSG00000100012	"SEC14 like lipid binding 3"	Q9UDX4	22	30447959-30472049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 6.8;liver: 6.0;thyroid gland: 3.5"	"Cell line enhanced"	"Detected in some"		"WM-115: 3.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059450	Uncertain									"HPA059450: AB_2684024"		"unprognostic (2.42e-1)"		"unprognostic (2.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.00e-4)"	"unprognostic (3.62e-3)"		"unprognostic (6.68e-2)"	"unprognostic (3.19e-1)"		"unprognostic (2.41e-10)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.10e-1)"		0.0	0.1	0.0	0.0	0.3	6.8	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.4			3.5		0.0	0.0	0.0	0.5	0.3	1.3	0.1	0.1	0.3	0.0	0.2	0.2	0.1	1.0	0.6	0.0	0.9	0.3	0.0	0.1	0.2	0.0	0.8	0.2	0.3	0.0	0.6	0.3	0.0	0.2	0.3	1.5	0.1	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.4	0.6	0.1	0.3	0.3	0.2	0.3	0.3	0.4	0.4	0.3	0.6	1.0	0.1	0.3	0.0	0.3	0.7	0.0	0.9	0.4	0.7	0.1	0.2	0.2	0.3	0.0	0.9	3.1	1.3	0.1	0.1	0.2	0.0	0.1	0.2	0.3	0.1	0.0	0.5	0.1	0.1	0.7	0.1	0.1	0.3	0.2	0.0										
SEC14L4	"dJ130H16.5, TAP3"	ENSG00000133488	"SEC14 like lipid binding 4"	Q9UDX3	22	30488913-30505711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 35.8;testis: 13.4"	"Cell line enriched"	"Detected in some"	4	"BEWO: 28.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 3.1;neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 3.0"	HPA069748			Approved	Centrosome		44000	44000	Centrosome	Centrosome	"HPA069748: AB_2686187"	"unprognostic (6.98e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.06e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.98e-2)"	0.1	1.1	0.1	0.1	0.1	6.7	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.0	0.1	1.0	0.3	0.2	0.4	0.1	0.1	0.1	0.3	35.8	8.5	0.1	0.1	0.1	0.2	0.2	6.7	0.2	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.5	0.4	13.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.7	0.5	3.1	0.4	0.4	0.4	0.1	1.7	5.4	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.4	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.1	0.4	0.4	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.4	2.6	0.4	0.3	0.5	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Group enriched"	"Detected in many"	4	"Hep G2: 90.8;HSkMC: 79.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	2300000000	2300000000	"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.3	0.1	7.5	2.1	1.3	0.6	1.9	0.0	0.0	2.0	10.7	0.3	6.7	0.2	0.3	0.0	0.0	0.0	0.4	8.7	0.5	0.0	90.8	4.6	0.5	0.0	79.4	0.1	0.0	0.0	0.0	1.0	2.2	3.9	0.2	0.1	1.1	5.2	0.1	0.2	0.3	15.6	2.1	1.2	0.3	0.5	0.4	2.7	0.2	21.2	0.1	0.1	0.5	0.3	0.9	0.1	1.4	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;liver: 33.9"	"Group enriched"	"Detected in many"	4	"A549: 13.7;CACO-2: 13.1;Hep G2: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	840000	840000	"Vesicles, Lipid droplets"	"Vesicles, Lipid droplets"	"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	1.2	5.0	8.2	9.2	5.6	0.2	1.9	17.8	9.0	2.5	34.3	4.9	3.2	25.9	2.1	16.6	1.8	3.1	25.9	1.6	4.9	5.0	9.5	33.9	2.9	1.2	4.2	4.6	9.2	21.3	3.7	4.4	2.2	7.8	8.6	42.3	4.8	4.3	6.1	1.2	7.1	44.0	2.5	2.5	1.8	10.4	2.5	3.7	0.1	9.8	0.5	0.5	2.3	2.4	2.4	1.0	0.4	0.4	0.0	1.3	0.0	0.0	13.7	3.5	1.5	2.2	0.7	3.0	0.5	1.5	0.7	0.7	13.1	2.2	0.2	1.8	0.6	0.9	3.4	0.6	0.6	0.3	2.1	0.7	1.1	47.9	5.7	0.5	0.4	3.7	0.8	0.7	0.4	1.9	1.3	0.1	1.1	0.8	0.2	0.5	0.5	0.8	1.3	0.3	0.6	3.2	0.4	1.1	5.5	0.5	0.9	1.4	3.8	0.6	1.3	0.4	1.6	0.4	0.1	0.4	0.2	0.2	0.4	0.4	0.4	0.0	0.4	0.4	0.3	0.0	0.2	2.4	0.4	1.3	1.0	0.6	0.4	0.2	0.0	0.0	0.2	0.3	0.1	0.0	8.2	5.6	17.8	9.0	4.9	5.0	4.2	4.6	7.8	3.7
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30446181	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.8;liver: 111.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 94.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favourable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	9.0	9.0	4.9	6.9	6.4	4.0	6.7	6.3	8.4	5.3	25.6	5.2	5.5	26.6	7.6	6.1	6.0	6.1	12.6	5.3	5.2	5.1	32.8	111.2	5.8	7.6	5.5	3.8	5.2	10.0	7.3	6.4	7.5	7.7	6.6	13.1	6.2	10.6	4.7	11.1	5.5	52.8	4.9	4.4	10.5	12.1	3.0	4.6	14.1	11.9	6.4	9.5	8.1	4.4	14.6	15.3	20.5	13.7	23.2	18.9	8.9	14.5	13.2	4.7	16.2	14.4	9.2	12.3	10.1	12.5	9.9	12.3	8.1	11.1	20.9	15.6	10.6	8.1	8.6	9.2	10.1	13.3	26.6	20.9	7.1	38.2	18.2	11.6	94.5	11.7	19.7	9.3	17.4	9.1	16.8	13.6	8.8	21.5	17.4	23.9	11.6	9.9	17.0	8.2	16.0	12.2	13.1	9.9	8.5	8.6	25.3	32.7	22.2	38.7	7.6	10.4	7.4	10.0	6.0	11.8	18.8	10.9	9.0	21.6	11.5	6.1	12.9	20.5	11.2	11.2	17.1	12.4	15.9	16.1	15.3	14.6	18.9	12.9	12.9	23.2	13.7	10.9	15.1	8.9	4.9	6.4	6.3	8.4	5.2	5.1	5.5	3.8	7.7	4.6
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160442	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles				Vesicles	Vesicles	"HPA070409: AB_2686265"	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	7.0	6.1	3.8	8.5	6.4	11.8	7.4	5.4	6.0	5.3	13.5	7.8	8.9	11.8	6.7	9.6	5.3	6.5	8.9	5.6	4.8	3.6	10.5	34.2	9.4	9.7	7.2	4.9	8.5	11.3	7.3	5.1	4.4	5.4	4.7	7.8	5.2	6.2	9.2	5.5	10.9	15.3	3.7	7.0	7.5	7.4	8.9	6.8	12.3	7.7	4.8	8.0	6.8	5.5	5.7	5.9	3.2	4.0	3.4	5.5	2.2	2.9	1.6	6.3	3.3	5.7	8.0	5.5	3.1	4.1	3.4	3.4	1.3	7.3	5.4	3.0	3.5	3.6	4.9	3.6	3.8	2.7	1.6	6.7	5.6	2.6	6.4	5.9	8.8	7.5	5.8	2.5	5.7	3.6	10.5	5.5	2.7	1.7	9.4	16.5	2.9	6.2	4.8	7.4	4.8	4.7	3.1	4.7	4.4	2.8	2.2	5.2	4.2	5.7	3.7	5.2	2.7	1.7	2.9	8.7	9.7	6.0	3.2	9.7	3.2	2.4	4.0	2.2	3.6	3.4	3.5	3.4	4.5	4.9	3.4	5.7	4.6	5.5	3.2	3.4	2.4	5.9	2.6	2.2	3.8	6.4	5.4	6.0	4.8	3.6	7.2	4.9	5.4	6.8
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.5;HaCaT: 53.0;HBEC3-KT: 83.7;hTCEpi: 47.6;RT4: 57.3;SK-BR-3: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 12.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favourable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (2.11e-4)"	"prognostic unfavourable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	2.0	6.6	0.6	13.5	1.2	1.1	12.1	0.8	0.8	17.3	32.9	0.8	52.1	27.4	3.7	26.5	32.5	4.3	34.4	2.0	1.0	0.6	57.5	113.9	10.3	7.1	1.8	0.5	1.7	12.9	5.7	5.1	33.9	1.4	17.0	12.8	5.0	58.6	74.4	20.2	14.2	73.0	6.7	1.2	1.7	20.7	3.5	0.8	5.7	13.1	12.7	19.1	31.1	19.9	0.2	12.0	2.3	2.7	0.0	0.0	0.5	12.8	3.0	2.7	8.7	5.9	8.0	7.4	24.7	18.4	1.6	2.0	4.6	46.5	8.5	32.6	23.2	53.0	0.3	83.7	0.3	0.8	2.0	0.0	2.7	2.4	6.6	0.0	9.9	7.3	47.6	10.2	22.5	1.0	0.3	0.0	2.7	2.1	0.3	0.3	2.8	6.5	0.0	5.3	2.8	8.8	57.3	1.1	6.6	6.3	47.9	1.0	28.0	1.4	6.1	0.4	2.0	0.2	0.5	0.4	0.3	0.4	0.2	0.2	2.0	0.0	2.7	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.5	0.6	1.2	0.8	0.8	1.0	0.6	1.8	0.5	1.4	0.8
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561091-94569913	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 24.8;liver: 118.6;pancreas: 36.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 22.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 94.8;pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA003607	Approved				"Secreted to blood"	22000000000	22000000000			"HPA003607: AB_1079914"	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favourable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	3.2	0.3	0.1	7.9	0.1	0.1	24.8	0.1	0.0	0.0	1.4	118.6	0.0	0.0	0.0	0.0	0.1	36.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593120	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 74.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056919			Approved	Mitochondria	"Secreted to blood"	2300000000	2300000000	Mitochondria	Mitochondria	"HPA056919: AB_2797257"	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	1.1	100.4	0.4	1.8	1.8	0.0	7.7	0.2	0.5	4.0	1.0	1.6	126.6	0.6	4.8	5.0	0.5	3.6	34.3	5.6	0.6	0.4	33.6	112.4	0.3	1.9	3.1	0.3	6.4	33.8	0.0	0.8	0.2	1.9	1.9	0.0	0.9	10.9	106.7	6.6	0.7	0.7	0.4	1.5	36.1	2.0	146.5	0.6	0.1	0.9	1.5	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.1	5.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.2	0.5	0.6	0.4	3.1	0.3	1.9	0.6
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 34.2;T-cells: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Uncertain		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	5.6	14.0	15.2	12.0	20.9	12.9	8.1	20.7	24.5	6.5	18.8	7.9	5.3	13.2	6.5	6.0	12.6	6.6	7.1	9.4	14.5	18.3	28.3	66.8	5.3	17.0	15.3	17.0	13.6	9.7	7.4	11.8	10.4	15.1	7.6	12.5	5.7	7.7	8.0	11.7	6.3	13.4	8.1	15.0	8.2	10.1	5.0	11.0	13.9	7.7	7.3	17.8	11.3	9.1	4.5	3.0	34.2	2.6	4.8	16.0	5.6	10.0	32.0	16.4	17.7	5.6	12.2	26.4	25.8	10.9	21.8	21.2	40.1	20.4	21.1	20.1	13.5	13.0	31.4	45.0	23.7	51.6	26.3	15.5	28.9	17.5	8.3	30.2	19.6	9.9	8.8	24.1	10.6	16.7	22.2	16.8	15.8	35.3	35.3	2.4	12.9	10.6	29.7	16.8	22.6	8.2	39.7	28.0	17.9	24.9	23.6	12.6	11.4	10.0	16.2	17.3	27.4	12.6	33.6	21.4	25.2	48.2	28.3	27.3	17.9	34.2	2.1	10.4	11.3	2.6	9.4	4.5	16.0	12.6	3.0	3.8	12.7	12.9	0.6	4.8	1.7	1.4	12.7	5.6	15.2	20.9	20.7	24.5	14.5	18.3	15.3	17.0	15.1	11.0
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.3;liver: 31.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favourable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	4.0	10.1	26.1	4.9	24.6	12.8	3.1	10.1	28.3	3.4	6.6	12.9	3.7	7.6	3.2	18.4	2.7	5.2	4.4	3.6	25.3	12.7	12.7	31.4	3.7	3.6	16.0	18.6	2.9	2.7	3.4	3.1	4.5	14.9	5.2	6.8	2.6	2.1	5.4	6.3	3.2	7.3	4.5	9.6	5.2	5.1	2.9	13.3	1.6	4.3	1.7	3.7	5.0	2.1	3.0	4.2	6.4	8.9	5.8	1.3	2.1	3.4	7.3	11.6	8.9	2.8	1.8	4.2	6.9	3.9	11.0	5.8	11.2	8.7	2.0	7.2	7.2	3.0	9.0	9.9	5.2	8.3	5.8	8.4	7.2	14.7	3.5	4.3	9.2	4.8	2.7	7.7	0.9	6.4	7.3	1.7	2.9	6.6	1.2	6.5	14.3	4.7	8.0	9.6	2.5	6.4	8.0	7.5	2.1	6.4	3.3	2.6	1.7	2.2	4.6	3.3	11.0	4.7	7.9	3.0	2.9	2.4	11.5	7.9	4.0	4.8	8.9	4.2	0.9	3.9	1.3	1.6	0.5	1.0	4.2	3.0	0.6	0.8	6.4	5.8	4.3	2.9	1.0	2.1	26.1	24.6	10.1	26.3	25.3	12.7	16.0	18.6	14.9	13.3
SGK2		ENSG00000101049	"SGK2, serine/threonine kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.1;kidney: 39.1;liver: 32.9"	"Group enriched"	"Detected in some"	5	"A549: 13.5;CAPAN-2: 10.6;EFO-21: 5.4;Hep G2: 13.7;RPTEC TERT1: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favourable (5.65e-4)"	11.4	0.7	2.8	4.3	9.9	0.2	3.1	1.0	10.2	1.4	21.3	33.1	0.9	17.8	1.0	19.7	0.7	1.6	7.9	0.7	4.3	2.5	39.1	32.9	0.6	0.5	6.9	5.1	3.2	14.1	0.5	1.7	0.5	13.7	1.4	23.4	0.0	0.9	1.8	0.4	3.2	20.7	1.0	14.2	0.7	11.9	1.0	6.0	0.0	1.0	0.2	0.2	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	10.6	0.0	5.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	13.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	19.4	2.2	0.1	0.5	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	9.9	1.0	10.2	4.3	2.5	6.9	5.1	13.7	6.0
SHH	"HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS"	ENSG00000164690	"Sonic hedgehog"	Q15465	7	155799986-155812273	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;liver: 18.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.7;EFO-21: 8.1;Hep G2: 3.3;PC-3: 3.6;RT4: 23.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	3600000	3600000				"unprognostic (7.17e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.70e-2)"	"prognostic favourable (8.62e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.66e-2)"	0.3	11.9	1.1	1.0	2.4	0.2	0.2	0.6	2.5	6.1	1.7	0.4	4.7	1.9	0.9	9.5	0.3	0.3	27.7	0.2	0.9	3.0	3.8	18.4	2.9	0.1	1.9	0.9	0.2	0.4	0.1	0.4	0.1	5.7	6.0	1.5	0.0	0.2	2.7	0.2	0.4	1.8	5.2	1.7	0.2	13.6	0.3	0.6	0.0	0.2	0.0	0.1	14.1	3.1	0.2	0.8	1.5	0.4	0.4	0.4	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.7	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.6	0.0	0.0	0.0	1.8	23.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.4	0.1	0.2	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.3	1.5	0.4	0.4	0.8	0.2	0.3	1.1	2.4	0.6	2.5	0.9	3.0	1.9	0.9	5.7	0.6
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023314	Enhanced		Supported	Nucleoplasm,Cytosol		240000	240000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA023314: AB_1856830"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favourable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	23.7	24.1	7.6	12.0	19.5	12.2	28.3	5.0	6.2	16.9	18.7	23.9	10.6	18.5	15.0	4.3	23.5	16.0	20.2	9.6	11.0	23.3	8.3	18.9	18.0	4.9	5.5	9.0	10.1	8.0	13.1	5.9	11.6	7.0	4.2	6.0	17.5	27.4	7.6	9.6	7.9	22.5	30.3	15.7	26.9	16.2	10.5	5.5	34.2	6.5	8.6	26.6	7.8	2.7	3.3	9.8	29.9	15.8	8.6	8.2	7.4	6.4	13.0	7.8	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell line enhanced"	"Detected in all"		"RH-30: 208.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Enhanced	Microtubules,Mitochondria		160000	160000	Mitochondria	Mitochondria	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavourable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	24.6	11.4	11.6	30.6	9.1	14.0	23.0	13.4	21.8	17.9	16.5	16.4	11.9	45.7	22.2	16.5	15.8	20.9	21.7	9.7	25.5	18.6	18.8	7.0	11.6	67.4	31.1	16.7	17.9	31.6	14.4	48.2	17.8	19.7	43.5	13.6	16.2	24.7	17.0	9.9	18.6	16.7	208.3	42.3	9.0	11.4	24.9	11.9	7.0	16.5	48.4	22.4	38.3	11.2	7.3	14.8	9.4	18.1	58.3	31.9	38.8	15.7	29.0	13.0	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3
SHROOM1	"APXL2, KIAA1960"	ENSG00000164403	"Shroom family member 1"	Q2M3G4	5	132822141-132830898	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7;urinary bladder: 37.8"	"Cell line enhanced"	"Detected in many"		"RT4: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037690, HPA037691"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA037690: AB_2675613, HPA037691: AB_2675614"	"unprognostic (2.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.72e-6)"	"unprognostic (8.22e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.26e-3)"	5.5	2.4	8.2	2.9	13.5	0.7	3.5	8.3	9.6	4.2	12.0	26.3	23.8	6.5	6.4	2.7	2.2	3.8	7.2	2.4	9.5	5.3	3.2	42.7	4.6	1.0	23.8	7.9	2.6	6.7	7.6	3.1	12.4	12.3	35.9	11.9	8.8	6.3	17.0	1.8	1.5	10.0	4.9	13.8	1.3	10.5	1.3	20.5	0.0	3.0	0.6	1.0	37.8	11.6	0.1	0.2	0.7	3.7	0.3	0.1	0.6	6.7	4.1	0.7	0.6	1.2	3.4	7.3	6.8	6.3	5.8	6.5	8.9	4.7	1.2	9.9	4.0	0.7	2.5	4.6	3.6	6.8	7.9	0.2	6.4	8.1	3.5	0.5	2.4	1.5	2.5	4.1	2.5	3.8	5.4	6.6	4.9	3.5	0.1	3.0	1.1	5.7	0.4	0.0	0.6	1.0	19.3	4.7	1.2	6.7	0.6	3.7	4.2	2.3	3.7	6.7	9.0	0.9	8.8	7.1	5.0	0.1	6.6	0.0	2.1	0.5	3.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.6	8.2	13.5	8.3	9.6	9.5	5.3	23.8	7.9	12.3	20.5
SIGIRR	"IL-1R8, TIR8"	ENSG00000185187	"Single Ig and TIR domain containing"	Q6IA17	11	405716-417455	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 67.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023188	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"	"Nucleoli fibrillar center, Cytosol"	"HPA023188: "	"unprognostic (6.21e-3)"	"prognostic favourable (7.44e-5)"	"unprognostic (7.30e-2)"	"prognostic favourable (1.34e-5)"	"unprognostic (6.85e-2)"	"prognostic favourable (9.08e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (7.61e-6)"	"unprognostic (1.00e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.63e-2)"	"prognostic favourable (1.54e-5)"	11.0	3.2	11.8	19.3	12.3	18.1	17.7	2.4	12.3	10.7	16.9	11.2	16.2	18.6	11.0	14.5	13.7	16.3	12.8	12.9	11.1	10.1	29.4	67.0	14.9	25.6	11.7	8.5	9.6	22.7	10.0	7.3	6.2	15.6	14.2	9.2	15.2	22.1	13.4	6.4	4.5	20.4	11.2	17.7	28.7	17.7	7.4	10.2	12.4	15.4	8.8	18.0	11.3	13.3	11.4	12.9	17.4	16.7	27.8	38.9	22.8	7.8	21.5	1.3	7.5	1.2	6.4	15.7	1.2	1.8	3.6	3.2	9.9	49.4	2.2	5.8	6.8	11.3	3.5	4.0	0.6	6.7	13.1	4.3	4.3	0.2	4.0	3.5	7.5	3.4	0.8	0.6	0.5	10.5	4.4	0.1	1.0	26.4	10.4	12.2	7.8	11.8	13.4	0.0	7.7	2.6	5.3	13.3	6.5	0.1	7.3	9.4	9.3	2.9	12.1	1.2	1.5	1.8	0.0	2.7	4.5	5.4	4.9	8.3	4.2	17.4	13.0	11.2	38.9	13.9	30.9	11.4	32.5	33.7	12.9	8.6	29.8	28.9	7.0	27.8	16.7	4.9	29.9	22.8	11.8	12.3	2.4	12.3	11.1	10.1	11.7	8.5	15.6	10.2
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637809	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Approved									"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavourable (3.42e-4)"	15.3	19.7	9.2	9.8	14.5	8.5	13.0	9.4	16.1	17.0	18.2	13.4	13.3	23.0	18.6	13.4	18.6	17.4	17.1	12.1	9.4	12.0	14.2	89.1	9.6	14.5	10.7	10.7	20.1	22.9	15.0	8.3	17.8	14.0	18.9	13.2	15.7	12.0	19.6	7.7	16.8	24.9	15.1	9.2	9.8	14.6	9.4	9.3	9.6	11.8	15.0	15.8	16.4	15.2	14.0	23.8	12.4	19.3	13.1	32.6	20.1	40.7	36.2	12.5	41.0	46.5	32.3	16.2	29.7	20.1	26.2	24.3	22.6	17.8	20.0	17.7	32.2	25.5	16.0	33.7	5.7	34.8	43.3	19.1	53.9	24.7	30.6	32.8	16.6	32.6	36.1	28.9	35.9	19.8	7.1	37.1	28.1	0.2	19.9	47.6	15.8	47.0	23.3	14.0	56.2	23.9	8.1	14.8	16.6	29.5	21.1	15.6	25.0	22.4	16.7	21.8	17.5	22.9	4.4	10.3	16.2	0.5	22.5	28.6	45.0	10.5	19.1	12.4	22.2	18.4	24.2	14.0	32.6	26.7	23.8	10.8	27.8	22.6	5.4	13.1	19.3	17.5	29.9	20.1	9.2	14.5	9.4	16.1	9.4	12.0	10.7	10.7	14.0	9.3
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693607-81696174	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;liver: 10.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025966	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.0	0.3	0.9	0.1	2.3	0.0	0.2	5.1	1.8	0.3	2.5			2.9	0.3	0.9	0.2	0.3	1.4	0.1	0.9	2.1	1.8	10.3	0.3	0.0	0.8		0.4	1.0	0.3	1.9	0.0		0.5	3.5		0.3	0.2	0.1	0.4	3.5	0.2	0.3	0.3	3.4	0.0			0.8		0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.9	0.4	1.0	1.1	0.9	1.7	0.9	1.1	0.5	0.4	0.7	0.4	0.6	1.1	1.6	0.3	1.1	1.3	0.9	1.6	0.8	2.9	2.2	3.0	1.7	0.5	0.1	0.3	0.4	2.6	0.8	2.0	0.5	1.9	1.4	1.6	0.8	0.6	1.4	0.5	0.6	0.4	0.4	0.7	1.4	3.7	2.6	1.1	0.8	0.8	0.4	1.9	0.7	1.1	1.3	1.8	1.7	1.7	1.8	2.6	0.2	1.3	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.0										
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell line enhanced"	"Detected in many"		"BJ: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA072719: AB_2686552"	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavourable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.3	4.1	3.0	16.9	8.1	4.2	0.0	35.2	10.9	14.3	8.2	0.0	0.3	0.0	0.5	13.6	0.6	0.4	14.9	8.4	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.3	3.6	7.4	8.7	0.0	0.0	0.0	3.3	0.0	0.2	1.0	11.2	3.1	6.7	8.1	0.0	7.0	0.0	0.7	5.3	3.9	19.7	0.1	0.2	0.4	0.0	13.9	3.7	15.2	17.4	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952647-62969585	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell line enhanced"	"Detected in many"		"BJ: 15.7;CACO-2: 14.5;Hep G2: 30.1;NB-4: 16.2;RPMI-8226: 15.6;U-937: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047470			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	4.2	1.3	1.6	11.4	3.4	11.9	2.2	0.4	1.4	1.9	4.8	0.6	0.1	6.4	1.7	1.2	1.5	2.1	7.3	1.5	1.5	0.7	1.5	42.7	5.7	6.6	4.8	0.0	1.9	3.4	0.0	2.5	1.9	3.4	1.6	3.8	1.1	3.6	1.2	3.4	0.9	3.9	1.4	3.9	10.5	10.7	0.8	2.9	0.5	1.4	0.5	11.8	5.6	2.4	4.0	4.2	0.0	2.7	7.3	1.3	1.2	0.0	0.0	0.0	0.1	0.1	1.3	0.0	15.7	4.5	5.2	8.3	14.5	0.0	11.3	0.0	12.5	0.0	2.3	0.0	1.1	0.0	0.0	4.9	0.3	30.1	3.6	8.8	0.0	1.1	0.0	6.2	0.0	3.4	0.0	6.6	0.0	0.0	0.3	16.2	0.0	0.0	11.6	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.5	0.0	2.2	0.1	6.1	0.0	19.0	0.0	0.0	1.6	0.0	1.3	2.7	0.9	4.0	0.0	0.6	4.2	3.2	0.0	0.6	0.0	7.3	0.6	0.0	0.1	1.2	1.6	3.4	0.4	1.4	1.5	0.7	4.8	0.0	3.4	2.9
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 71.4;liver: 44.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.3;Karpas-707: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced									"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	3.5	1.6	0.5	11.4	1.2	1.4	3.2	0.1	2.0	2.6	36.6	0.8	2.9	36.7	3.1	15.2	6.1	4.7	21.9	8.5	0.9	1.1	18.2	44.3	8.7	8.3	1.0	1.7	2.9	3.0	4.1	1.5	4.9	1.3	4.0	3.7	4.2	8.6	4.3	1.0	6.5	71.4	3.7	1.2	4.7	8.1	2.8	0.8	3.1	8.1	7.6	5.4	4.5	4.4	2.1	8.9	21.7	15.0	2.7	4.6	6.0	1.4	8.5	0.0	4.8	0.9	1.4	3.5	2.9	5.1	1.7	2.9	5.1	21.3	0.6	9.0	3.8	4.6	0.2	0.4	0.4	4.2	0.7	0.1	2.1	4.6	9.4	0.0	4.0	3.9	0.9	1.4	0.3	0.0	0.1	19.7	0.9	4.3	0.1	0.6	0.5	1.9	1.5	0.0	2.6	0.8	2.9	0.1	1.6	1.1	12.4	10.3	2.4	2.5	0.2	1.3	2.7	3.9	0.1	3.5	0.8	0.2	5.2	2.7	4.9	15.3	15.0	12.6	3.5	14.3	2.0	2.1	2.8	2.5	8.9	1.3	1.5	2.2	21.7	2.7	10.8	6.4	4.6	6.0	0.5	1.2	0.1	2.0	0.9	1.1	1.0	1.7	1.3	0.8
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887780-2903740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.1;kidney: 13.4;liver: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;CAPAN-2: 6.9;MCF7: 13.0;SK-MEL-30: 24.1;WM-115: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1"									HPA068288	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	1.4	0.3	0.2	6.0	0.7	0.0	0.6	0.2	2.2	0.5	13.7	0.6	0.2	12.8	0.8	1.2	1.1	0.4	4.9	0.3	0.2	0.3	13.4	13.6	0.6	0.2	1.3	1.5	0.4	0.2	0.0	0.3	2.0	1.6	0.7	9.8	0.2	4.2	0.2	0.4	1.0	20.1	0.6	1.6	0.8	1.4	0.6	0.4	0.2	0.3	1.6	0.3	0.5	0.9	0.0	4.9	5.2	9.1	0.5	0.6	2.7	0.8	7.0	0.1	0.3	0.0	0.0	0.6	0.4	0.3	0.0	0.2	1.6	6.9	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.6	4.0	0.5	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	13.0	0.0	0.3	0.1	0.3	0.2	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.3	24.1	0.0	0.6	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.2	1.9	10.8	5.2	9.1	1.6	0.3	5.1	0.1	0.0	0.1	0.3	4.9	0.0	0.0	0.1	2.2	0.5	3.5	0.0	0.6	2.7	0.2	0.7	0.2	2.2	0.2	0.3	1.3	1.5	1.6	0.4
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 24.8;intestine: 94.3;liver: 25.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;HDLM-2: 6.9;Hep G2: 11.4;Karpas-707: 9.5;RPMI-8226: 9.2;U-266/70: 14.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA047612	Enhanced									"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.3	0.0	0.3	0.5	0.5	0.8	0.3	0.3	0.3	2.3	22.1	0.3	0.8	11.6	0.3	1.6	0.3	24.8	1.8	0.3	0.3	0.3	18.0	25.4	0.6	0.4	0.3	0.3	0.4	0.9	0.0	0.3	0.3	0.4	2.7	0.3	0.3	1.0	0.6	0.3	1.0	94.3	0.3	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.2	4.4	0.7	0.1	0.0	0.3	0.0	0.3	1.8	0.3	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.0	1.1	4.9	2.6	0.0	0.2	0.0	0.0	0.1	6.9	0.1	0.1	0.6	11.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.2	4.7	0.9	0.1	0.1	5.7	0.2	9.2	0.4	0.3	0.2	0.3	0.2	1.7	0.0	4.4	0.1	0.3	0.3	0.2	0.1	0.0	14.6	1.7	6.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.0	0.7	0.0	0.1	4.4	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.6;SK-BR-3: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"											HPA023048	Supported		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favourable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favourable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.0	26.0	2.5	12.4	0.9	0.7	5.0	6.0	1.9	7.7	5.8	15.7	6.0	6.3	4.7	1.4	9.0	3.5	6.2	1.4	4.6	20.1	5.1	15.8	49.6	1.1	11.5	6.3	0.5	3.2	5.4	1.0	4.4	8.6	7.9	2.6	26.4	16.8	12.2	2.5	19.6	12.8	5.3	19.9	6.8	12.7	16.4	11.1	5.6	38.2	1.3	16.3	6.4	1.9	5.9	19.5	8.6	10.8	4.9	2.5	3.6	2.6	12.2	5.1	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favourable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.4	14.6	16.8	5.8	2.9	2.3	23.6	4.2	3.2	10.1	10.3	26.1	15.5	7.4	19.9	2.6	9.8	18.8	6.0	12.0	2.9	12.4	8.4	13.7	20.3	6.8	10.7	6.7	6.2	6.4	8.7	7.8	11.6	23.7	2.8	4.9	18.1	0.0	10.0	29.6	9.0	4.2	10.0	17.1	24.3	15.6	8.1	26.5	14.5	30.7	24.8	9.1	8.2	6.8	7.6	16.9	17.8	12.7	5.8	14.5	4.7	9.3	10.3	12.4	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.6;RPMI-8226: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Supported	Mitochondria,Cytosol		13000	13000	"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.4	3.5	4.9	11.3	4.3	0.7	7.8	4.2	5.5	5.7	5.5	6.8	6.5	5.5	12.3	1.4	8.7	3.5	4.1	16.4	4.1	9.0	6.9	6.9	5.1	9.4	17.4	5.5	4.0	7.4	1.2	7.0	8.0	34.6	7.2	3.7	10.3	4.7	1.8	9.9	3.7	2.1	47.7	5.9	3.4	1.4	5.0	7.2	0.0	4.0	11.0	4.4	5.7	6.2	1.1	9.1	5.7	12.9	8.9	7.5	9.0	6.7	8.2	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063999-19112888	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.3"	"Cell line enhanced"	"Detected in many"		"K-562: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	6	"B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1"	"Low region specificity"	"Detected in all"							HPA049449	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favourable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favourable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	4.8	5.7	13.8	4.5	12.2	7.5	4.9	22.5	15.4	7.0	4.8	5.9	4.5	5.7	6.8	4.4	4.5	7.4	4.7	8.9	9.7	7.8	26.7	42.3	5.4	8.5	5.9	7.8	13.8	7.4	6.5	9.6	3.2	7.9	7.6	3.0	12.2	11.0	6.3	26.7	5.2	5.6	5.7	6.1	7.3	4.6	4.5	8.1	6.6	17.1	7.3	12.2	5.5	5.4	6.2	0.7	0.2	0.6	2.8	5.1	1.5	6.3	0.8	1.6	2.9	6.3	5.2	2.6	3.1	4.7	4.8	5.5	1.2	12.8	4.6	7.3	2.9	1.2	3.3	2.6	2.8	1.1	6.3	1.6	1.7	10.2	5.0	0.7	3.2	5.2	1.8	3.6	2.2	2.1	17.8	8.3	2.5	5.7	7.6	7.3	0.9	6.6	5.9	2.9	8.8	1.9	1.2	1.8	1.3	3.3	0.1	1.4	5.8	3.6	1.9	3.6	2.0	7.4	3.0	9.6	5.2	3.6	3.8	9.8	1.8	0.0	0.2	0.2	5.1	0.5	2.8	6.2	2.9	4.3	0.3	5.1	1.9	2.8	0.0	2.8	0.6	0.7	2.9	1.5	13.8	12.2	22.5	15.4	9.7	7.8	5.9	7.8	7.9	8.1
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.0;HMC-1: 8.9;T-47d: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041654	Uncertain		Approved	Microtubules				Microtubules	Microtubules	"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.2	0.0	1.7	0.2	0.4	4.1	1.9	0.1	0.0	0.0	4.4	2.5	0.7	2.2	0.0	1.3	0.1	0.0	0.0	2.5	0.9	3.3	3.0	13.0	0.2	2.1	8.9	0.6	0.2	0.1	0.0	0.3	3.4	0.0	0.3	2.8	1.3	3.5	1.0	7.0	7.1	0.0	0.3	0.7	5.0	0.2	1.3	0.5	0.2	1.2	9.0	1.4	2.1	4.7	0.9	4.7	1.3	6.8	3.1	1.2	1.6	4.3	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709487-46736347	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;HSkMC: 24.2;SK-MEL-30: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041015	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA041015: AB_2677252"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	4.7	4.6	2.6	4.3	3.3	0.1	8.7	2.1	3.1	11.4	6.7	2.7	6.7	2.6	5.4	6.6	4.8	5.6	10.2	6.7	3.3	1.4	2.6	51.5	4.8	3.4	2.2	2.0	7.1	22.9	15.0	4.2	8.3	3.8	18.0	8.8	9.8	11.5	11.0	2.1	2.4	3.0	9.7	2.3	1.9	12.4	3.4	1.0	0.8	18.1	4.5	4.6	7.1	5.7	0.0	0.0	13.8	0.0	0.3	0.0	0.0	0.0	0.0	4.7	4.8	19.6	16.7	14.4	9.1	12.5	4.3	5.1	0.3	16.0	0.0	6.9	16.5	0.1	0.0	0.4	2.0	0.0	0.1	1.3	0.0	7.6	13.8	0.0	0.0	24.2	0.4	2.6	0.0	1.7	0.1	0.0	7.2	16.6	0.0	0.4	1.8	1.2	0.0	0.7	0.0	0.0	4.3	0.0	0.7	1.8	3.0	24.8	2.3	3.7	1.0	9.2	4.0	7.2	1.1	0.1	0.0	0.0	0.0	0.0	1.9	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.6	3.3	2.1	3.1	3.3	1.4	2.2	2.0	3.8	1.0
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.6	6.8	3.7	4.8	16.3	7.6	33.1	12.8	9.4	6.8	6.7	2.9	22.2	2.6	11.2	11.7	8.0	5.6	7.4	8.2	6.6	4.2	2.1	13.8	6.8	9.2	7.3	4.7	11.3	18.7	8.7	14.2	4.2	8.2	12.3	8.4	4.2	1.4	4.6	11.5	5.4	4.4	1.8	9.5	21.2	12.5	3.8	6.6	12.5	6.5	28.6	3.3	9.5	6.7	5.1	11.9	17.0	10.1	5.4	8.2	2.1	4.8	7.4	4.4	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221562-113264492	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.7;salivary gland: 57.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0"	"Low region specificity"	"Detected in all"							HPA013810	Approved									"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.51e-2)"	7.8	12.1	5.0	4.9	6.1	4.6	6.0	3.7	6.7	10.6	16.2	6.7	21.2	20.7	4.9	7.8	9.8	4.8	5.7	5.8	5.0	4.9	15.4	55.7	8.8	3.5	5.6	4.0	6.3	11.4	5.8	9.4	7.9	7.4	10.3	8.1	8.5	57.9	21.7	3.0	14.3	41.8	4.6	5.8	8.6	9.3	4.7	5.0	2.6	6.3	6.8	9.8	5.8	5.2	1.0	9.9	5.0	17.0	2.5	2.0	4.3	8.2	8.9	7.3	16.1	16.8	12.0	27.1	14.7	22.4	10.2	11.9	12.7	7.3	6.5	6.0	12.6	20.6	13.9	8.4	11.5	5.7	7.7	5.3	8.0	14.2	41.2	9.7	8.1	14.5	19.0	13.2	21.7	9.3	12.1	12.1	9.6	8.8	6.6	4.9	11.9	10.1	6.8	19.3	6.4	9.3	10.4	6.9	9.1	14.2	28.5	38.5	14.5	8.3	8.5	7.7	4.7	15.3	8.8	7.3	14.8	9.0	12.7	9.2	8.9	1.3	13.0	1.5	1.5	16.2	2.0	1.0	1.0	1.5	9.9	0.9	1.2	1.1	5.0	2.5	17.0	1.4	1.1	4.3	5.0	6.1	3.7	6.7	5.0	4.9	5.6	4.0	7.4	5.0
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813015	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (2.30e-2)"	14.9	4.8	5.1	7.2	4.5	1.5	14.3	4.4	7.3	7.0	13.8	4.4	4.9	17.4	7.1	3.2	22.5	6.1	8.8	5.3	5.4	3.9	6.0	74.7	7.1	7.1	3.9	3.6	4.9	11.4	4.9	7.8	10.5	5.6	6.0	9.8	3.6	15.5	7.0	8.5	3.4	17.4	6.8	5.0	6.5	13.4	7.4	4.8	5.6	5.2	7.0	10.9	9.4	8.6	4.7	8.3	9.9	10.5	4.3	16.7	8.6	5.3	13.8	3.1	8.0	10.2	10.4	10.6	11.6	10.1	6.8	7.5	6.2	8.7	5.0	5.5	13.2	14.1	6.6	6.8	3.2	13.0	7.9	2.8	11.0	11.2	22.5	5.5	8.8	12.3	8.3	5.2	5.6	8.8	6.4	7.5	7.1	11.5	2.8	4.3	14.0	19.5	3.8	5.3	11.8	7.6	13.3	3.1	4.5	8.6	8.3	4.8	7.4	2.9	13.4	14.2	8.3	24.9	8.3	5.5	12.9	2.5	10.2	7.3	7.7	5.0	10.2	9.9	10.2	10.5	11.1	4.7	16.7	13.4	8.3	3.6	8.5	7.4	1.6	4.3	6.9	7.2	10.8	8.6	5.1	4.5	4.4	7.3	5.4	3.9	3.9	3.6	5.6	4.8
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999332-67054099	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.0	6.3	5.1	7.5	7.0	4.7	4.7	6.6	5.5	6.2	16.2	7.5	4.8	9.9	5.4	3.8	5.3	4.4	4.4	3.8	4.7	3.8	8.1	50.4	3.8	5.7	7.4	4.0	6.4	7.2	6.4	8.7	6.0	5.4	5.6	17.3	7.1	3.9	4.0	6.9	6.2	14.3	5.4	4.0	4.0	8.0	4.1	5.6	11.1	5.1	4.0	6.4	5.8	6.5	2.3	1.8	9.7	2.4	5.1	4.3	1.4	4.9	2.8	8.8	7.4	9.2	10.7	10.5	11.2	14.8	8.1	5.7	6.1	1.2	15.4	4.9	8.8	7.7	6.1	7.1	10.3	15.3	2.8	11.4	6.0	12.1	7.7	13.0	7.6	10.3	15.9	9.6	6.9	3.1	6.9	8.2	19.7	1.6	8.0	4.0	3.7	3.9	6.2	18.2	1.7	3.7	9.5	1.1	3.9	16.9	5.2	7.1	4.3	9.7	3.4	15.2	3.6	9.3	10.7	17.2	8.9	8.6	10.8	2.0	6.4	9.7	1.5	4.0	3.4	1.1	4.2	2.3	2.6	2.7	1.8	1.7	3.7	3.3	0.3	5.1	2.4	1.0	4.3	1.4	5.1	7.0	6.6	5.5	4.7	3.8	7.4	4.0	5.4	5.6
SLC37A4	"G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d"	ENSG00000137700	"Solute carrier family 37 member 4"		11	119024114-119030906	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"liver: 42.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 16.0;HEK 293: 17.0;Hep G2: 21.1;MCF7: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038939, HPA038940"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA038939: AB_2676279, HPA038940: AB_2676280"	"unprognostic (4.77e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.34e-2)"	"unprognostic (5.39e-2)"	2.1	3.7	4.8	4.8	3.7	1.4	3.7	7.8	5.9	1.7	5.0	2.7	13.6	26.0	2.6	15.9	2.5	4.0	6.9	4.6	3.7	4.9	29.6	42.2	3.3	4.7	3.7	3.1	3.3	15.5	5.9	2.2	3.3	2.3	4.3	5.3	3.0	4.6	13.6	27.7	2.0	6.7	1.9	3.1	3.4	1.8	4.5	1.4	2.9	3.3	3.3	2.4	1.7	2.3	1.2	0.7	2.7	3.7	2.0	4.1	1.2	0.4	7.0	2.5	1.9	4.6	1.9	1.5	0.2	5.8	1.6	4.0	16.0	1.2	1.8	3.9	2.3	0.4	1.1	8.0	2.5	2.1	17.0	5.3	1.5	21.1	1.7	3.0	0.9	0.0	2.2	0.8	4.3	5.3	2.1	4.7	2.7	14.8	0.1	6.8	0.1	8.4	4.3	0.0	8.4	1.8	7.4	3.3	3.3	0.0	0.4	2.6	3.2	2.3	0.0	0.0	2.5	0.1	2.8	0.8	1.3	0.5	0.7	7.7	0.7	0.0	1.9	2.7	3.3	3.7	2.8	1.2	1.9	4.1	0.7	1.1	1.6	2.3	0.0	2.0	1.5	0.2	2.1	1.2	4.8	3.7	7.8	5.9	3.7	4.9	3.7	3.1	2.3	1.4
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042636	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.1;liver: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;HMC-1: 2.1;SCLC-21H: 8.5;SK-MEL-30: 1.3"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Group enriched"	"Detected in some"	5	"amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.2	0.1	6.1	0.2	0.6	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.2	0.0	0.2	1.4	0.6	2.5	0.2	4.5	0.2	0.2	0.7	0.2	0.2	1.3	0.5	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	2.3	2.4	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.6	0.2	2.6	0.6	2.5	0.7	0.2	0.2	0.2
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367249-22434129	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 135.5;pancreas: 77.2"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA016508	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		950000	950000	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"	"HPA016508: AB_1857148"	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favourable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	15.0	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3.0	6.4	4.0	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19.0	5.0	1.8	2.5	0.5	2.9	8.7	3.9	10.6	14.3	4.0	8.0	14.3	12.1	8.7	15.4	68.2	24.1	38.0	47.3	10.1	10.7	8.7	18.0	11.8	19.7	19.2	39.7	11.1	11.2	8.5	11.4	47.7	34.1	5.8	9.4	12.9	15.6	42.7	29.8	10.7	7.4	10.9	12.2	4.9	8.8	3.7	24.3	11.0	12.6	7.5	22.8	8.8	4.6	6.8	10.6	15.7	6.7	31.8	5.4	8.5	5.9	30.0	15.2	18.8	15.7	6.3	5.7	14.0	42.4	7.8	17.4	0.0	0.5	2.5	8.3	0.1	8.7	5.0	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in some"	60	"CACO-2: 22.2;Hep G2: 32.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Low region specificity"	"Detected in many"			HPA018423			Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favourable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	22.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
SLC41A2	DKFZP434K0427	ENSG00000136052	"Solute carrier family 41 member 2"	Q96JW4	12	104802553-104958744	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.1;liver: 54.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.3;SK-BR-3: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 4.4;plasmacytoid DC: 13.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038658	Approved									"HPA038658: AB_10671747"	"unprognostic (7.19e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.06e-3)"	"unprognostic (3.05e-2)"	"prognostic favourable (9.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.30e-2)"	6.1	7.0	3.8	5.2	3.9	0.5	7.1	9.2	5.4	4.9	19.9	2.3	15.9	14.5	3.0	7.9	1.6	2.1	6.8	3.0	2.9	5.5	4.6	54.1	4.5	2.0	2.8	4.0	4.2	12.0	5.7	21.5	16.1	3.4	2.2	7.2	2.0	5.9	14.9	0.9	1.6	37.1	4.0	2.4	1.9	16.8	4.3	2.1	1.0	5.8	0.3	2.7	2.2	2.7	0.6	13.0	0.3	0.2	0.3	0.9	0.3	5.9	13.6	0.5	2.9	11.7	8.5	5.4	4.2	6.9	2.9	5.0	8.5	5.8	2.4	4.6	8.3	0.6	3.1	1.4	5.6	29.3	7.7	0.2	5.5	3.8	2.6	0.9	3.4	2.9	1.2	3.1	0.9	3.7	0.2	6.4	0.5	2.7	1.2	0.0	1.3	4.4	0.5	6.0	5.8	11.8	0.1	5.5	1.4	7.2	24.1	1.1	9.4	0.0	1.1	4.5	3.2	4.7	4.7	7.7	9.5	3.2	7.1	0.5	3.1	0.2	0.2	0.0	0.2	0.1	0.9	0.6	0.2	0.1	4.4	0.3	0.4	0.2	0.3	0.3	0.1	13.0	0.1	0.3	3.8	3.9	9.2	5.4	2.9	5.5	2.8	4.0	3.4	2.1
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 149.9;thyroid gland: 69.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 69.9;HMC-1: 61.7;RPMI-8226: 78.8;WM-115: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	32.3	6.3	2.5	12.4	4.3	18.8	16.8	2.2	3.0	11.9	9.6	3.6	2.4	2.7	10.1	6.5	12.6	8.9	11.4	12.5	3.1	1.5	4.2	149.9	16.5	8.8	4.0	1.8	16.0	7.2	1.2	1.8	5.1	3.4	11.6	4.2	9.4	12.2	3.1	15.4	11.0	6.2	10.3	4.7	11.6	6.9	6.8	2.3	10.4	69.0	11.5	13.8	20.3	15.4	2.7	23.6	6.1	36.8	1.1	7.8	14.0	39.3	0.0	2.3	0.0	7.7	11.3	0.1	3.0	13.1	4.5	7.8	0.0	8.6	22.8	1.4	7.2	22.7	6.6	4.0	9.1	0.1	0.0	35.4	13.5	0.0	15.6	69.9	61.7	33.9	0.1	43.9	0.5	12.6	40.4	22.0	17.5	0.0	14.6	44.9	3.4	0.7	30.4	0.4	78.8	10.8	0.0	5.4	0.0	8.7	0.2	36.7	3.4	10.6	6.7	0.2	11.8	29.9	8.6	0.0	0.1	5.7	27.1	25.4	75.2	3.2	28.8	6.1	5.7	34.5	6.5	2.7	4.0	7.8	23.6	2.0	3.1	3.2	2.5	1.1	36.8	23.6	6.9	14.0	2.5	4.3	2.2	3.0	3.1	1.5	4.0	1.8	3.4	2.3
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.4;T-47d: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favourable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	4.0	2.7	0.0	10.5	2.0	6.2	0.4	0.2	1.7	2.6	9.9	0.1	20.4	0.6	0.9	0.3	0.0	10.1	4.0	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.6;kidney: 51.1;liver: 44.9"	"Cell line enhanced"	"Detected in many"		"A549: 13.0;AN3-CA: 10.3;Hep G2: 24.9;U-266/70: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 11.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 12.2;plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.9;granulocytes: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced									"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favourable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	2.2	45.6	0.8	0.4	2.2	1.1	0.6	1.0	3.1	13.2	1.2	3.7	1.3	0.7	7.6	12.2	0.9	2.4	1.7	3.5	4.7	0.5	51.1	44.9	3.0	3.5	0.9	2.5	5.0	0.2	0.2	7.2	0.3	11.4	2.6	0.5	4.3	1.1	5.5	12.1	10.4	0.6	3.5	2.3	1.9	0.5	15.5	0.6	0.9	4.7	5.7	1.2	0.6	4.5	0.1	6.9	12.2	1.3	0.0	0.7	0.4	0.0	13.0	0.3	10.3	0.3	0.0	0.0	0.3	0.3	1.6	1.4	0.0	0.4	0.1	2.5	1.8	0.0	4.6	0.3	0.4	0.0	6.1	0.1	6.9	24.9	0.1	0.1	0.3	0.2	2.3	1.2	0.2	3.6	0.0	0.0	0.0	1.8	0.0	0.2	1.4	0.5	0.1	0.1	0.1	0.0	0.8	2.5	2.1	4.3	0.0	1.1	4.4	1.1	0.0	0.1	0.5	0.2	1.2	19.4	7.6	0.0	0.5	0.1	2.2	0.2	1.3	12.2	0.3	1.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.7	0.3	0.0	0.2	6.9	0.0	0.4	0.8	2.2	1.0	3.1	4.7	0.5	0.9	2.5	11.4	0.6
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nuclear speckles, Plasma membrane"	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.6	51.8	10.2	21.0	10.2	6.0	23.3	19.0	10.3	15.6	13.5	29.5	25.1	9.4	41.8	9.0	15.4	10.4	9.2	2.9	27.1	15.5	12.3	25.2	15.0	16.7	6.3	39.8	8.7	8.1	17.7	4.5	8.7	38.2	8.0	12.0	30.1	18.2	11.0	24.3	19.3	14.4	5.6	11.0	12.7	11.9	8.4	30.6	17.4	32.9	16.2	13.6	12.6	18.6	21.0	10.7	20.6	28.0	8.6	11.6	5.3	32.1	16.0	42.1	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 68.0;SK-BR-3: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.4	17.0	10.9	14.3	10.1	3.7	68.0	6.0	4.1	9.1	6.3	25.1	5.9	11.4	9.1	3.2	9.2	23.3	6.9	6.4	8.8	13.7	20.2	7.3	38.4	12.0	25.9	10.6	12.7	5.9	11.2	8.7	8.2	29.5	4.7	5.8	33.8	8.8	12.6	31.4	6.2	14.8	12.8	16.5	5.2	15.8	9.2	13.6	6.5	73.1	8.6	16.2	5.6	3.7	10.1	13.8	6.1	16.0	7.9	18.0	18.1	5.5	18.2	14.1	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.1;liver: 59.3"	"Group enriched"	"Detected in some"	12	"Hep G2: 8.3;RPTEC TERT1: 16.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6"	"Group enriched"	"Detected in many"	51	"dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favourable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.6	0.8	6.3	1.3	12.9	0.6	0.8	6.6	14.7	0.9	1.0	4.3	0.0	3.7	1.3	5.6	0.5	3.0	1.2	0.7	7.2	4.6	22.1	59.3	2.2	0.8	8.1	4.9	0.7	1.3	0.6	0.3	0.9	9.4	0.6	1.8	0.2	0.6	0.5	0.5	0.7	1.1	1.2	3.1	0.8	2.3	1.6	8.8	0.0	4.5	0.0	0.7	0.9	0.2	0.0	2.9	3.7	8.6	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.7	0.1	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.7	0.0	8.6	0.0	0.0	1.9	6.3	12.9	6.6	14.7	7.2	4.6	8.1	4.9	9.4	8.8
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 66.3;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (2.65e-7)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.1	11.1	0.0	6.8	0.5	0.6	3.3	0.0	0.0	2.3	0.0	0.0	7.3	1.7	2.3	0.0	3.8	0.0	8.0	7.0	66.3	3.0	0.0	8.9	1.4	8.6	8.2	3.1	0.0	0.0	7.7	10.7	0.3	3.5	3.7	0.9	0.0	5.1	5.3	0.8	17.0	0.1	1.3	0.5	0.2	3.1	0.0	0.3	7.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.4	15.5	13.0	0.0	11.9	4.7	2.0	1.8	1.3	1.7	16.8	2.1	13.8	0.8	7.0	5.0	2.8	14.7	4.9	16.8	4.2	12.1	8.3	11.7	5.3	11.4	6.7	4.2	14.5	8.5	5.6	12.3	6.2	1.0	9.4	7.2	2.3	3.8	0.0	3.4	7.3	5.7	1.0	10.7	9.7	5.4	1.4	3.5	1.4	7.8	10.5	4.4	2.7	6.9	4.1	10.5	7.6	12.2	5.3	10.3	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.1	0.5	0.8	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.0	1.7	0.1	2.1	0.1	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.5	1.1	0.0	0.3	0.2	0.0	1.4	0.1	0.1	0.1	3.5	1.4	0.0	2.1	0.3	0.1	13.7	0.1	0.1	0.2	9.5	0.0	2.1	1.9	2.3	0.0	0.2	0.2	2.7	0.7	0.0	0.0	1.4	0.7	0.3	20.5	8.2	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.9;HEL: 7.0;Hep G2: 9.7;HMC-1: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain									"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	21.4	15.2	15.0	13.4	23.1	1.4	7.8	4.8	15.8	8.6	12.9	22.8	0.8	18.0	5.8	7.7	8.8	8.3	12.3	7.1	15.6	11.9	9.6	98.1	24.9	21.4	23.9	7.4	4.9	9.6	3.7	4.0	18.3	17.7	4.9	10.4	9.1	6.3	4.7	2.6	3.0	21.2	10.9	24.1	23.6	6.5	4.4	21.3	4.0	6.8	3.6	11.8	12.5	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	7.0	0.3	9.7	0.0	0.5	13.0	0.0	0.0	0.2	0.0	0.0	3.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.8	0.8	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	23.1	4.8	15.8	15.6	11.9	23.9	7.4	17.7	21.3
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;liver: 12.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.5;HAP1: 5.4;Karpas-707: 1.5;SCLC-21H: 3.5"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria		1400000	1400000	Mitochondria	Mitochondria	"HPA017636: , HPA048042: AB_2732542"	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.6	0.6	7.4	2.0	12.0	0.4	0.5	10.6	17.4	9.9	3.0	1.5	0.3	1.1	12.1	2.0	7.6	12.6	0.8	1.0	13.2	5.5	0.6	12.8	0.9	0.5	3.7	6.5	2.5	0.4	0.4	0.3	0.4	4.2	3.3	3.1	0.3	0.8	9.6	0.9	0.5	1.5	6.2	2.3	0.4	0.8	1.0	2.4	0.0	0.6	0.0	0.5	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	12.0	10.6	15.7	13.2	5.5	3.7	6.5	4.2	2.4
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;liver: 48.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.4;HeLa: 53.3;HSkMC: 15.6;SiHa: 31.4;SK-BR-3: 13.8;U-266/70: 19.9;U-87 MG: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	27000	27000	"Plasma membrane"	"Plasma membrane"	"CAB034427: AB_2193382, HPA004153: "	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	7.4	10.7	23.0	1.4	10.8	1.1	2.9	5.2	62.2	8.6	2.2	32.0	19.4	3.0	2.2	10.3	1.3	7.1	1.5	4.7	22.6	16.2	2.1	48.0	1.4	1.8	23.8	8.5	1.8	26.4	1.1	2.4	9.0	21.7	42.9	2.0	14.7	3.6	35.8	8.7	1.2	2.3	1.9	15.0	19.5	3.5	24.7	16.9	0.0	2.9	0.6	1.5	1.7	3.6	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	19.4	0.0	3.9	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	7.5	0.0	53.3	7.8	0.0	0.0	0.0	15.6	4.5	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.1	31.4	13.8	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	19.9	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.0	10.8	5.2	11.2	22.6	16.2	23.8	8.5	21.7	16.9
SNTB1	"59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43"	ENSG00000172164	"Syntrophin beta 1"	Q13884	8	120535745-120813273	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 43.7;liver: 53.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.1;U-266/70: 34.7;U-937: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024659	Uncertain				"Intracellular and membrane"	200000	200000			"HPA024659: AB_1857713"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	6.9	43.7	4.7	4.9	5.1	8.1	12.4	2.1	3.0	4.9	4.1	5.0	1.1	2.8	2.8	2.1	7.7	2.9	5.4	2.2	5.9	3.8	6.2	53.4	14.5	5.0	4.5	2.9	2.4	22.4	0.2	2.3	3.8	6.8	3.3	3.1	6.9	27.4	1.7	12.7	5.9	3.2	4.3	3.3	10.8	11.3	4.2	4.9	3.6	33.8	7.8	4.6	4.8	4.9	1.5	1.6	6.8	1.6	3.1	5.4	1.5	0.0	0.8	0.2	0.0	4.3	8.9	0.0	2.5	14.0	0.7	1.2	5.6	0.6	0.0	5.0	2.7	0.0	0.8	0.0	0.5	2.7	2.8	0.0	0.3	33.1	0.4	6.2	0.0	4.4	0.0	4.5	0.0	0.1	0.0	12.8	2.1	1.5	0.0	4.9	0.9	3.8	0.0	17.3	0.0	13.0	0.9	0.0	0.2	1.0	4.6	11.3	0.5	11.2	0.0	9.7	0.7	0.0	0.8	34.7	13.6	14.3	7.6	18.9	11.1	4.3	1.6	6.8	5.4	0.8	1.3	1.5	1.1	2.8	1.6	0.7	3.0	3.0	0.5	3.1	0.6	0.1	0.0	1.5	4.7	5.1	2.1	3.0	5.9	3.8	4.5	2.9	6.8	4.9
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291895-26374329	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;brain: 39.0;liver: 37.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 67.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	17.7	8.7	20.2	18.6	17.9	20.9	6.7	13.2	39.0	2.9	3.3	2.1	0.1	2.5	5.4	0.8	1.8	1.9	5.2	1.3	22.2	32.7	21.3	37.4	22.4	18.0	27.8	20.8	1.0	5.0	0.6	3.0	8.9	36.2	2.2	3.9	1.8	1.4	1.5	0.9	1.0	3.6	5.4	15.4	22.1	2.3	3.0	2.1	3.8	1.9	0.1	13.6	6.3	1.8	16.3	20.1	67.6	30.9	9.0	5.6	11.6	13.6	1.2	0.0	2.6	0.0	0.0	14.9	0.0	1.0	0.0	0.0	0.1	4.6	6.0	10.7	0.0	0.4	3.4	0.9	0.0	8.2	3.2	0.6	0.1	9.0	0.0	12.7	2.3	0.1	1.4	0.0	1.1	0.2	0.3	0.0	0.0	2.4	5.3	13.4	3.9	1.3	0.0	0.0	0.3	26.6	2.9	5.8	1.8	2.9	2.2	15.5	3.9	18.2	0.0	0.0	3.2	0.0	3.4	4.6	3.7	4.0	0.1	21.8	75.8	8.2	29.2	0.7	4.0	30.9	3.8	16.3	2.8	3.4	20.1	14.5	1.5	2.6	67.6	9.0	30.1	7.4	5.6	11.6	20.2	17.9	13.2	39.0	22.2	32.7	27.8	20.8	36.2	2.1
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254405-11256200	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.3;lymphoid tissue: 58.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 47.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 15.2"	"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	Nucleoplasm	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.9	2.8	0.7	19.2	1.5	13.9	37.9	15.2	1.1	15.8	6.3	0.3	2.2	3.3	4.9	7.6	5.6	4.2	11.0	3.6	0.6	1.0	11.1	42.3	9.6	25.8	0.8	0.0	9.3	3.8	0.7	16.8	9.3	2.4	5.3	1.8	3.2	3.7	3.9	2.3	6.0	11.0	6.5	1.1	14.7	6.6	7.1	0.4	58.3	5.1	4.8	14.7	5.4	8.3	4.4	1.3	12.9	0.1	5.5	2.7	0.4	1.2	0.2	0.5	0.1	1.6	0.2	1.8	1.0	7.3	0.4	0.6	0.3	0.2	2.8	2.2	0.4	0.5	0.2	0.1	0.1	47.2	0.3	0.7	0.0	3.8	0.6	0.0	8.7	0.6	0.1	1.0	0.0	0.1	6.3	0.8	0.0	1.1	3.1	1.8	5.3	0.8	0.3	0.3	0.3	0.5	0.2	0.7	0.1	0.2	1.7	0.5	0.0	0.4	0.0	0.6	3.1	0.4	0.6	0.2	0.2	4.4	1.2	0.3	0.6	12.9	0.1	8.8	2.2	0.0	2.0	1.4	2.5	2.7	0.0	4.4	2.7	2.5	0.3	5.5	0.0	1.3	2.6	0.4	0.7	1.5	15.2	0.6	0.6	1.0	0.8	0.0	2.4	0.4
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		91000000	91000000	"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	55.6	48.7	34.2	34.2	45.8	31.9	28.4	47.0	28.1	32.0	24.2	63.1	35.4	66.7	49.5	43.3	20.2	49.0	34.6	26.4	49.2	60.9	107.6	63.9	90.2	30.3	47.5	40.3	33.1	26.4	44.8	24.9	35.9	74.2	85.3	38.5	90.4	51.0	47.9	51.4	52.0	43.9	69.0	103.7	62.5	34.2	37.4	31.4	87.1	46.1	45.2	53.0	42.0	42.0	24.9	55.1	33.6	34.6	65.2	141.0	79.0	50.8	69.3	33.0	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		430000	430000	Cytosol	Cytosol	"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favourable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.8	13.9	3.5	11.4	3.1	5.4	3.7	4.4	3.0	10.0	8.5	11.5	8.6	2.0	9.9	5.4	23.8	18.2	16.6	8.0	34.3	11.3	15.9	18.2	25.5	2.3	27.5	26.6	6.9	12.6	5.7	9.2	9.3	17.7	5.6	9.4	6.3	16.6	14.9	13.6	14.8	0.0	23.0	7.7	7.3	15.4	25.0	13.1	8.9	14.1	6.7	20.3	11.3	8.3	8.0	7.0	17.8	10.5	1.0	6.9	2.0	12.9	24.4	20.7	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894928-76898147	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.3"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.8;CACO-2: 4.2;RT4: 18.8;T-47d: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.3	0.6	1.2	2.1	1.1	0.0	0.9	0.5	7.9	1.7	6.9	0.2	7.4	5.1	0.3	0.7	9.7	0.9	4.3	0.2	1.0	1.1	6.9	16.3	1.6	0.0	0.7	2.0	0.2	7.3	5.6	0.9	0.6	1.4	2.2	5.8	0.3	11.1	2.7	0.2	2.2	12.6	0.0	0.4	0.2	4.2	0.2	0.2	0.0	3.9	2.3	4.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	4.2	2.6	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	18.8	0.1	0.0	0.0	1.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.5	7.9	1.0	1.1	0.7	2.0	1.4	0.2
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor, Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"breast: 2.7;intestine: 3.6;liver: 3.5"	"Cell line enriched"	"Detected in single"	6	"SK-BR-3: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"						"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.5	1.4			0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.5	0.0	0.0		0.0	0.1	0.0	0.0	0.5		0.3	3.6		1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SRD5A1		ENSG00000145545	"Steroid 5 alpha-reductase 1"	P18405	5	6633343-6674386	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051402	Approved									"HPA051402: AB_2681470"	"unprognostic (1.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavourable (8.73e-6)"	"unprognostic (9.38e-3)"	"unprognostic (8.90e-2)"	"unprognostic (3.78e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.47e-2)"	2.4	3.3	7.7	2.9	8.2	3.2	14.8	9.2	11.8	5.6	5.2	5.3	0.7	5.7	3.1	4.6	24.2	2.9	4.0	1.9	9.3	7.5	6.4	42.4	3.0	3.5	6.2	5.5	4.1	4.3	3.0	1.9	2.1	13.4	2.6	3.6	2.4	5.0	2.1	2.2	17.5	10.4	2.6	3.1	2.9	3.9	2.7	2.9	3.3	2.4	15.3	12.1	2.6	10.1	1.9	3.7	7.0	3.3	1.3	1.3	1.3	5.5	5.5	7.3	6.2	7.0	6.9	3.4	5.4	4.1	5.3	3.3	5.5	4.9	6.7	8.9	7.8	9.0	5.9	3.6	5.7	4.1	2.5	2.1	13.7	3.3	3.2	3.0	1.8	5.0	10.2	3.8	3.0	2.6	3.6	6.2	6.8	6.5	1.4	3.4	4.6	4.4	4.6	5.6	2.0	7.1	5.2	13.8	6.3	16.4	7.3	5.0	3.0	0.8	5.4	8.1	4.0	13.1	6.7	3.3	4.4	2.4	6.7	3.5	7.4	7.0	3.3	1.4	1.0	2.4	0.7	1.7	1.0	1.3	3.7	1.9	0.9	1.0	2.0	1.3	2.6	1.8	1.1	1.3	7.7	8.2	9.2	11.8	9.3	7.5	6.2	5.5	13.4	2.9
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31581067	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;liver: 30.9;prostate: 28.4"	"Group enriched"	"Detected in some"	7	"BJ hTERT+: 2.8;RT4: 5.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	10.1	0.0	0.2	17.9	0.0	10.4	0.0	0.0	0.0		0.0	30.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0										
ST3GAL6	"SIAT10, ST3GALVI"	ENSG00000064225	"ST3 beta-galactoside alpha-2,3-sialyltransferase 6"	Q9Y274	3	98732236-98821201	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.7"	"Group enriched"	"Detected in many"	4	"RPMI-8226: 35.7;SK-MEL-30: 42.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 17.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 20.7;neutrophil: 25.8"	"Group enriched"	"Detected in many"	144	"dendritic cells: 10.6;granulocytes: 25.8;monocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018792	Approved					3000000	3000000			"HPA018792: AB_10964349"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (9.47e-3)"	"unprognostic (6.79e-4)"	11.5	7.5	5.9	3.6	8.3	2.4	6.0	14.4	8.2	4.9	3.6	6.7	1.9	2.2	2.4	11.3	2.4	6.0	2.4	21.8	7.1	5.9	12.2	46.7	7.1	3.5	9.5	4.3	1.7	4.7	1.1	4.6	20.1	10.1	3.5	3.0	6.3	15.9	2.3	6.5	14.4	2.2	2.3	17.4	3.0	4.6	1.8	7.4	14.3	3.1	2.2	2.8	1.6	1.9	0.0	10.6	25.8	7.7	0.0	0.1	1.8	0.1	0.5	0.7	1.0	1.3	0.4	4.9	0.1	0.6	0.5	0.9	3.3	0.2	2.3	1.3	0.0	0.8	1.5	0.7	0.4	0.0	1.0	0.1	0.2	5.8	5.7	4.9	9.3	0.6	0.0	1.4	2.6	5.5	0.0	2.4	0.5	0.0	0.8	8.4	1.3	1.3	0.4	0.5	35.7	1.3	0.0	1.5	7.6	1.9	0.2	42.2	0.1	8.8	4.2	1.1	0.9	0.3	0.4	9.5	0.7	0.0	1.8	7.0	4.0	7.4	7.7	20.7	0.0	4.1	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	25.8	0.0	2.0	2.4	0.0	1.8	5.9	8.3	14.4	8.2	7.1	5.9	9.5	4.3	10.1	7.4
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930485-187078553	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.9;U-266/70: 101.7;U-266/84: 130.0;U-698: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	580000	580000			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	10.6	6.5	11.8	16.7	15.4	4.0	10.5	2.8	11.8	19.1	11.4	22.7	4.2	4.3	8.6	4.3	4.4	8.6	5.7	10.6	10.7	7.6	19.1	161.4	10.9	27.6	18.2	7.6	4.5	4.1	20.5	5.7	5.5	13.7	19.5	14.2	5.4	17.7	4.6	5.7	4.5	12.6	5.8	22.3	27.0	8.5	2.4	15.1	19.4	19.4	4.0	41.6	13.2	14.3	33.6	4.6	6.9	8.9	8.5	29.3	16.9	0.7	0.7	3.0	2.2	0.2	0.0	4.7	0.2	0.4	0.1	0.3	0.2	0.2	31.9	2.6	0.0	1.4	18.8	1.9	0.2	1.5	0.8	1.2	0.1	15.5	0.1	3.0	10.0	0.2	4.1	0.0	1.7	11.0	6.4	3.0	0.9	1.3	2.2	2.1	6.7	0.9	5.1	0.0	1.0	1.4	0.0	4.9	0.5	0.1	3.6	8.3	5.3	2.1	4.2	0.0	0.4	0.0	0.3	101.7	130.0	47.4	0.1	6.0	11.0	6.9	2.7	1.1	16.5	5.2	15.0	32.7	18.2	13.8	4.6	33.6	29.3	20.2	1.3	8.5	8.9	4.2	14.2	16.9	11.8	15.4	2.8	11.8	10.7	7.6	18.2	7.6	13.7	15.1
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794168	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.5;Hep G2: 35.2;MCF7: 100.1;SK-BR-3: 71.7;T-47d: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA026661: AB_1857538"	"prognostic favourable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	4.5	34.0	11.3	6.8	16.0	2.0	16.0	17.6	15.9	18.6	42.8	5.5	16.6	11.5	6.5	26.2	10.9	6.2	28.7	15.5	10.3	6.8	11.1	130.6	10.0	3.1	10.6	5.4	8.2	47.3	16.4	9.5	22.6	10.1	17.6	46.0	9.1	21.7	12.1	15.0	12.7	15.0	6.7	4.4	4.6	47.4	40.0	14.8	3.3	21.3	12.0	9.3	7.8	10.2	2.9	2.0	15.8	1.8	5.6	1.3	0.6	8.2	2.5	1.3	4.8	1.6	1.6	16.6	0.9	4.3	2.9	2.9	34.5	6.1	0.7	2.8	3.1	5.2	3.9	7.7	3.4	4.5	1.5	0.9	1.8	35.2	6.1	0.2	1.5	1.1	21.5	3.2	4.5	2.9	1.9	3.6	0.6	100.1	0.7	1.8	0.5	3.4	0.7	2.2	0.5	3.9	10.1	2.2	1.6	1.4	71.7	10.2	39.5	1.0	2.1	2.9	1.9	1.0	1.6	3.6	3.0	1.2	0.7	0.9	0.9	7.9	1.8	11.4	1.2	0.9	1.0	2.9	1.1	1.3	0.8	2.3	1.1	1.3	15.8	5.6	0.4	2.0	1.2	0.6	11.3	16.0	17.6	15.9	10.3	6.8	10.6	5.4	10.1	14.8
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 7.6;RPMI-8226: 7.6;U-266/70: 9.3;U-937: 8.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 20.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	2.8	1.0	1.2	8.6	1.5	5.9	2.7	20.8	3.4	14.3	7.7	1.5	6.6	3.5	7.3	22.3	9.2	4.3	4.4	1.9	1.0	1.1	1.4	59.6	4.3	11.1	1.1	1.0	3.2	1.1	0.6	1.0	9.3	1.2	6.1	5.9	1.5	3.2	6.6	0.9	12.4	7.7	3.6	1.9	10.8	3.3	4.4	1.4	1.7	2.5	10.6	9.8	6.1	7.9	2.1	4.8	6.9	4.6	4.8	7.6	5.6	0.4	0.1	0.1	1.2	2.9	3.1	0.2	0.4	0.4	1.0	1.6	0.1	0.1	6.0	0.0	1.8	5.1	1.4	1.2	0.8	0.1	0.5	2.3	0.3	0.5	0.6	3.4	7.6	2.5	2.5	0.3	0.8	0.1	0.7	1.7	0.6	0.2	0.6	4.9	0.4	0.0	0.1	0.9	7.6	0.4	1.7	0.4	0.1	0.2	0.7	0.7	0.7	0.8	0.2	1.7	0.9	1.7	0.1	9.3	1.9	2.4	1.2	8.6	0.5	6.9	3.0	4.2	5.8	4.6	5.0	2.1	5.4	6.1	4.8	1.6	7.6	7.5	2.4	4.8	4.0	2.5	6.3	5.6	1.2	1.5	20.8	3.4	1.0	1.1	1.1	1.0	1.2	1.4
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;Karpas-707: 30.9;U-266/70: 19.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.7	1.8	0.2	2.4	5.2	1.4	3.3	4.1	2.5	1.6	1.9	1.7	4.4	0.0	3.3	2.7	2.3	0.7	0.9	0.6	14.7	1.0	0.2	2.2	2.2	0.7	2.1	2.7	0.8	2.6	1.3	0.6	0.0	0.1	30.9	2.8	2.4	0.2	1.7	0.4	2.0	0.0	0.8	2.5	0.9	1.8	0.8	4.3	3.2	4.1	0.0	1.1	0.7	0.7	3.1	2.0	7.3	2.3	19.9	3.6	0.0	4.3	1.3	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4										
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Supported	"Plasma membrane,Mitochondria"		290000	290000	"Plasma membrane, Mitochondria"	"Plasma membrane, Mitochondria"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favourable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	13.8	12.1	12.0	14.6	20.2	35.1	14.7	16.6	24.4	19.6	21.9	13.4	31.0	17.7	5.4	23.4	7.1	9.3	23.0	25.5	7.5	6.4	16.1	11.0	20.8	26.1	21.1	11.3	26.2	20.0	15.3	35.3	20.8	12.2	16.3	42.6	9.7	7.9	6.7	11.2	7.5	5.5	18.6	26.5	33.2	21.6	2.3	8.2	26.4	30.6	22.0	23.5	13.6	18.1	19.5	12.8	21.4	19.7	11.1	16.2	12.5	28.6	16.5	22.9	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40134977-40860763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.1;liver: 27.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 27.5;LHCN-M2: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced									"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favourable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavourable (2.53e-4)"	2.7	13.5	3.2	5.1	4.6	0.7	4.0	1.1	3.1	4.4	5.0	1.1	0.7	1.4	9.6	2.9	3.2	2.7	4.5	6.9	4.3	2.4	42.1	27.6	1.2	3.9	2.8	2.4	5.7	3.8	3.8	3.5	1.2	4.8	3.4	2.9	5.4	2.4	4.3	11.3	1.6	5.6	13.9	5.0	1.3	1.8	4.1	4.1	0.0	2.4	6.3	1.5	2.9	3.5	1.4	0.2	1.1	0.2	0.0	4.6	0.7	0.5	0.0	3.0	2.3	3.3	7.6	1.2	1.5	2.9	2.2	2.5	1.2	0.6	2.0	0.7	2.2	0.1	1.0	27.5	3.4	0.0	1.3	1.7	0.2	4.4	4.1	0.2	0.2	9.6	6.2	2.3	1.4	0.6	2.3	0.3	16.5	0.0	0.1	0.3	5.2	2.3	1.9	0.3	0.0	4.7	0.0	0.2	1.7	2.5	1.1	3.5	0.1	0.4	2.3	9.4	2.7	0.1	0.6	0.2	0.0	0.1	1.8	0.8	2.1	0.0	0.1	0.3	0.7	0.0	1.2	1.4	2.0	1.0	0.1	1.2	4.6	2.7	1.1	0.0	0.2	0.2	0.0	0.7	3.2	4.6	1.1	3.1	4.3	2.4	2.8	2.4	4.8	4.1
SULT1A1	"P-PST, STP, STP1"	ENSG00000196502	"Sulfotransferase family 1A member 1"	P50225	16	28605196-28623625	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.1"	"Group enriched"	"Detected in many"	4	"EFO-21: 41.4;Hep G2: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 50.6;intermediate monocyte: 39.2;myeloid DC: 22.9;neutrophil: 47.7;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 22.9;granulocytes: 47.7;monocytes: 50.6"									"HPA049500, HPA051051"	Supported					3700000	3700000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.17e-2)"	"prognostic favourable (7.02e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.89e-2)"	10.2	36.1	12.0	7.2	15.4	9.3	5.7	15.8	19.8	4.6	21.4	4.5	15.5	54.2	3.7	14.4	3.1	6.6	5.4	9.7	14.7	10.4	11.0	98.1	26.7	8.4	9.2	14.9	3.5	9.6	6.7	10.0	5.6	10.3	3.7	17.5	12.2	11.5	22.5	4.9	1.4	41.1	5.2	6.3	23.2	7.2	5.1	4.6	4.0	13.4	2.6	3.7	6.3	2.2	0.3	22.9	47.7	50.6	0.9	1.5	19.3	1.5	0.6	0.8	2.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	10.3	0.2	41.4	0.0	0.6	0.8	2.8	0.0	0.3	7.3	2.8	3.1	82.0	4.9	0.0	3.2	0.2	0.2	0.0	0.0	0.7	1.1	1.3	0.8	9.7	0.2	2.2	0.7	0.0	3.0	0.3	5.4	0.7	0.8	2.5	0.2	0.7	13.4	0.3	8.0	7.9	5.4	0.2	2.0	0.2	0.1	3.2	1.9	0.4	0.7	15.1	0.0	4.9	50.6	0.9	0.6	39.2	0.7	0.3	0.6	0.5	22.9	0.1	0.9	0.6	47.7	0.9	22.3	1.7	1.5	19.3	12.0	15.4	15.8	19.8	14.7	10.4	9.2	14.9	10.3	4.6
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597109	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.5;liver: 26.2;seminal vesicle: 24.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.7;EFO-21: 8.6;Hep G2: 31.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2"									"HPA049500, HPA051051"	Supported									"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	1.0	1.9	0.6	2.5	1.0	0.5	1.2	1.6	0.7	0.3	9.8	0.6	5.9	25.7	0.5	1.1	0.9	0.6	1.6	2.1	0.8	0.5	2.3	26.2	11.9	0.3	0.6	0.6	0.9	1.4	1.0	1.2	2.7	0.7	0.3	6.8	4.6	0.9	24.2	0.2	0.2	37.5	0.2	0.6	2.7	0.7	0.3	0.2	0.5	4.5	0.5	0.2	1.9	1.1	0.2	3.5	12.6	10.2	0.4	0.5	3.9	1.3	0.6	0.6	0.5	0.1	0.3	6.7	0.7	0.0	0.1	0.0	1.3	2.9	0.2	8.6	0.2	1.1	0.3	0.4	0.2	0.4	0.3	1.2	1.6	31.9	0.5	1.0	1.3	0.2	0.5	0.5	0.1	0.2	0.7	1.4	0.1	1.5	0.2	2.0	1.0	0.3	1.2	0.2	0.6	0.1	1.3	0.4	0.9	0.2	4.5	0.0	3.1	0.6	0.4	1.6	1.0	1.3	0.5	2.4	1.3	0.3	0.4	0.5	0.5	1.1	10.2	0.1	0.3	7.0	0.5	0.1	0.2	0.2	3.5	0.2	0.3	0.3	12.6	0.4	3.6	0.8	0.4	3.9	0.6	1.0	1.6	0.7	0.8	0.5	0.6	0.6	0.7	0.2
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Group enriched"	"Detected in some"	19	"HHSteC: 37.1;HSkMC: 16.8;hTCEpi: 14.0;HUVEC TERT2: 10.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"											"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.1	0.0	0.0	16.8	14.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1
TAC4	"HK-1, PPT-C, Pptc"	ENSG00000176358	"Tachykinin 4"	Q86UU9	17	49838309-49848017	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 4.7;pituitary gland: 10.4"	"Cell line enhanced"	"Detected in some"		"A549: 4.4;BEWO: 10.5;CACO-2: 6.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.19e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	0.4	0.6	0.4	0.5	0.4	1.2	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	1.4	0.2	0.4	2.2	0.4	0.1	0.4	4.7	0.5	0.7	0.4	0.4	0.4	0.4	0.0	10.4	0.4	0.4	0.4	0.0	0.4	1.0	0.4	0.4	4.0	0.4	0.4	0.4	1.3	0.7	0.5	0.4	0.4	1.1	0.4	0.4	0.9	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	4.4	0.1	0.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	6.0	0.4	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.7	1.2	0.2	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.9	0.4	0.5	0.0	0.4	0.0	0.4	0.3	0.0	0.1	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.6	0.5	0.0	0.8	0.4	0.2	0.2	0.3	0.9	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
TAS2R60	T2R60	ENSG00000185899	"Taste 2 receptor member 60"	P59551	7	143443453-143444409	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;liver: 1.4;pancreas: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.3;U-937: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030416	Uncertain									"HPA030416: AB_10603344"						"unprognostic (1.78e-2)"								"unprognostic (7.98e-2)"				0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.2	0.3			0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.2	0.0		0.0	1.3	0.5	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.5	0.1	0.0			0.0		0.2	0.1	0.2	0.0	0.0	1.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.5	1.0	0.0	0.9	0.0	0.0	0.3										
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	27.7	11.7	0.0	2.4	3.2	6.3	10.6	0.0	0.0	0.0	1.3	14.1	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	19.9	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.1	1.2	0.1	0.0	14.9	0.2	1.5	0.7	0.3	0.0	0.8	0.0	0.3	0.0	0.3	0.0	3.4	2.1	14.0	0.1	0.2	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4
TCTEX1D1	FLJ40873	ENSG00000152760	"Tctex1 domain containing 1"	Q8N7M0	1	66752459-66778787	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;fallopian tube: 18.2;liver: 13.5"	"Group enriched"	"Detected in some"	6	"HEL: 13.8;HUVEC TERT2: 13.9;THP-1: 15.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028420	Uncertain									"HPA028420: AB_10603995"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.72e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-6)"	"unprognostic (9.28e-4)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.65e-2)"	1.8	1.1	5.3	1.2	7.2	7.4	1.1	2.1	3.7	1.5	1.0	9.5	0.0	0.8	0.8	7.5	0.8	18.2	1.1	1.9	8.2	10.4	0.7	13.5	4.0	0.4	3.3	2.4	3.4	0.8	0.7	0.9	11.5	28.4	0.8	1.1	0.7	0.5	1.7	1.9	1.3	1.1	1.3	2.6	0.4	0.8	0.5	2.2	0.0	0.6	0.2	0.6	1.5	0.8	0.0	0.1	0.9	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	2.5	0.0	0.3	0.7	0.3	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	13.9	0.0	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.6	5.3	7.2	2.1	3.7	8.2	10.4	3.3	2.4	28.4	2.2
TENM1	"ODZ1, ODZ3, TEN-M1, TNM"	ENSG00000009694	"Teneurin transmembrane protein 1"	Q9UKZ4	X	124375903-124963817	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;liver: 10.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.7;MOLT-4: 9.9;RPTEC TERT1: 3.5;SCLC-21H: 3.5;U-138 MG: 5.9"	"Group enriched"	"Detected in many"	5	"glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 17.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002848	Uncertain									"HPA002848: AB_1079523"	"unprognostic (1.71e-3)"	"unprognostic (8.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.68e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.68e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.44e-2)"	1.9	3.0	1.4	0.4	2.4	3.5	1.0	17.0	4.4	0.4	1.1	0.9	0.4	0.1	1.4	2.3	0.4	1.5	2.0	0.4	2.3	2.7	1.8	10.5	0.9	0.9	1.0	4.2	0.4	0.4	0.0	3.5	0.4	3.3	4.8	0.3	1.5	0.9	3.8	0.5	1.6	0.7	1.1	2.6	0.6	0.5	2.3	0.4	0.4	3.1	0.4	0.7	0.4	0.4	0.0	0.0	2.4	0.1	0.6	1.6	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.0	0.0	1.2	0.0	0.0	9.9	0.0	0.5	1.5	0.0	0.0	0.1	3.5	0.0	3.5	0.0	0.0	0.7	0.0	0.8	0.0	0.0	5.9	0.2	0.0	0.4	0.3	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.9	0.0	0.9	1.0	0.0	0.0	1.6	1.1	2.4	0.6	0.0	0.0	0.2	0.1	1.4	2.4	17.0	3.9	2.3	2.7	1.0	4.2	3.3	0.4
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.2;placenta: 192.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.5;plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005575, CAB020842"	Supported		Approved	"Intermediate filaments,Cytosol"	"Secreted to blood"	95000000	95000000	Cytosol	Cytosol	"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	52.8	5.0	1.3	5.2	2.2	1.6	18.5	1.9	2.4	22.8	32.1	0.3	7.2	12.8	13.3	14.8	25.9	12.5	15.0	14.0	1.2	1.1	35.6	98.2	89.7	40.2	2.4	1.0	17.3	7.7	0.9	4.9	192.3	2.3	18.2	6.9	3.8	6.0	3.8	15.8	6.6	37.0	13.6	5.4	16.5	7.7	13.7	1.6	3.4	22.6	10.4	4.0	30.0	14.7	1.5	5.1	5.5	0.6	1.0	0.6	4.9	5.0	3.5	4.1	0.1	32.1	38.5	0.0	9.1	21.7	5.9	9.2	3.2	27.0	0.0	3.6	7.1	0.3	1.2	0.4	15.5	0.2	1.0	1.6	10.9	27.4	55.2	0.1	0.0	17.6	0.7	32.1	8.6	103.8	4.0	0.1	63.6	4.7	0.6	0.1	2.5	8.8	0.0	5.7	0.0	10.1	0.2	0.0	0.0	7.4	0.2	0.4	0.1	0.0	62.1	4.3	4.0	8.5	1.7	0.0	0.1	0.0	34.6	0.0	4.9	5.5	0.6	0.5	0.5	0.3	0.2	0.9	0.4	0.2	0.5	1.5	0.5	0.6	2.6	1.0	0.3	5.1	0.2	4.9	1.3	2.2	1.9	2.4	1.2	1.1	2.4	1.0	2.3	1.6
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 160.1;EFO-21: 53.8;HUVEC TERT2: 72.7;TIME: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"		1700000	1700000	Cytosol	Cytosol	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.5	4.9	0.0	0.1	5.1	0.5	2.5	9.9	4.8	0.0	0.1	8.0	160.1	0.0	53.8	0.1	0.1	0.0	23.2	0.3	0.0	0.0	1.0	0.2	3.5	20.9	0.0	0.0	0.5	0.0	4.2	0.0	72.7	2.1	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.0	0.0	0.1	23.2	0.0	0.8	0.2	0.0	94.8	0.1	6.0	0.7	4.7	0.0	0.0	0.0	6.5	0.0	1.9	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016658-25026664	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"				"Nuclear bodies"	"Nuclear bodies"	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	2.2	8.0	8.6	2.4	10.1	0.8	4.7	4.6	10.4	5.5	3.5	5.4	3.6	3.3	4.7	6.5	2.6	7.2	2.7	4.6	8.9	6.6	12.3	26.0	2.1	5.5	9.5	5.5	9.6	8.7	7.9	13.0	2.3	8.5	3.8	4.0	2.8	4.4	3.7	5.2	2.9	3.0	3.0	9.1	3.2	3.5	7.0	7.7	5.1	10.5	2.1	3.3	2.9	3.9	5.2	3.8	0.6	0.7	11.5	10.4	3.3	5.3	6.1	3.9	7.8	4.0	5.0	1.0	2.6	1.0	2.9	1.9	4.0	6.8	24.6	8.4	1.2	3.0	5.6	4.9	3.0	3.3	3.1	9.0	1.7	2.5	4.5	0.0	1.5	3.1	9.1	2.1	4.5	2.0	7.7	2.9	6.2	8.3	4.9	1.7	7.2	3.0	2.6	1.0	10.5	8.3	1.2	6.5	3.7	5.2	4.7	9.3	4.6	0.5	1.9	3.5	3.1	4.6	2.4	2.1	2.8	0.0	5.8	5.0	2.7	0.1	0.4	0.0	3.0	0.5	5.4	5.2	4.4	4.0	2.2	4.0	10.4	6.8	0.6	11.5	0.7	3.8	2.0	3.3	8.6	10.1	4.6	10.4	8.9	6.6	9.5	5.5	8.5	7.7
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6"	"Cell line enriched"	"Detected in some"	13	"ASC diff: 41.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Cell type enhanced"	"Detected in some"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040642	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.69e-3)"	62.0	1.6	0.0	18.3	0.0	0.0	22.7	1.0	0.0	0.0	12.2	0.0	2.8	0.0	0.1	1.2	0.1	0.3	16.5	11.7	0.0	0.0	2.1	92.5	0.0	2.9	0.1	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	45.6	2.0	9.3	7.2	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.5	0.1	0.5	0.2	1.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TIGD2		ENSG00000180346	"Tigger transposable element derived 2"	Q4W5G0	4	89111500-89114899	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054844, HPA071168"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA054844: AB_2682623, HPA071168: AB_2686353"	"unprognostic (7.11e-2)"	"unprognostic (8.02e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.47e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.94e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.02e-4)"	4.0	3.7	3.3	3.5	4.0	2.5	11.2	7.2	5.3	4.8	5.7	3.5	2.3	7.4	3.4	4.8	4.7	2.9	5.4	3.2	3.2	3.6	6.3	34.1	4.2	8.5	3.9	2.7	2.6	5.8	12.9	14.1	27.2	4.0	5.0	4.7	8.1	14.4	4.3	3.3	4.1	7.9	2.8	3.4	4.9	4.8	4.6	4.0	11.3	6.3	2.1	4.9	6.0	4.3	1.8	2.2	11.1	2.6	3.2	2.8	1.2	9.6	4.5	5.0	6.0	5.5	4.2	2.2	5.9	7.2	5.6	4.8	9.1	9.4	4.7	3.2	2.3	3.1	5.5	9.0	7.7	7.9	1.7	5.5	4.9	4.3	16.4	2.5	4.0	10.5	9.0	2.3	8.3	2.1	6.9	8.3	7.0	3.7	4.7	2.9	6.0	1.5	7.3	8.7	6.3	5.0	18.6	23.9	4.8	5.6	18.5	7.2	6.5	5.2	1.6	7.3	6.8	2.3	4.4	13.1	4.0	3.6	6.4	4.5	6.2	11.1	1.8	0.2	2.8	2.6	1.4	1.8	1.5	2.2	2.2	1.6	1.4	2.2	0.0	3.2	1.4	0.3	1.5	1.2	3.3	4.0	7.2	5.3	3.2	3.6	3.9	2.7	4.0	4.0
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333210-61353295	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.2;liver: 42.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 39.8;RPMI-8226: 42.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		4800000	4800000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	3.1	34.7	3.6	6.1	5.3	5.3	4.6	3.7	7.3	3.4	43.4	7.6	8.0	69.5	4.6	7.8	6.2	5.9	8.8	2.8	3.1	2.6	17.4	42.8	3.5	5.2	3.3	5.3	4.5	9.8	3.0	5.5	3.9	4.4	5.0	2.3	7.3	7.2	7.1	4.6	6.1	90.2	2.6	3.1	5.4	5.7	17.1	3.4	5.5	6.4	6.3	6.7	5.4	3.9	9.7	18.4	5.4	11.4	5.3	10.9	7.8	6.0	15.3	2.7	9.3	3.4	3.7	7.6	3.5	3.8	3.3	2.1	6.9	14.6	7.5	12.4	2.5	8.5	5.0	6.6	1.1	12.9	6.7	4.6	8.1	39.8	5.8	3.9	7.8	5.8	4.5	3.1	11.0	3.3	8.1	14.5	2.4	27.4	3.4	3.6	7.4	10.5	6.1	4.2	42.0	5.3	10.7	10.4	9.3	6.5	11.4	5.9	42.0	2.8	3.9	6.6	6.9	5.2	2.1	26.9	22.2	6.7	6.8	3.6	6.0	2.3	11.4	5.4	6.7	6.8	8.6	9.7	7.8	6.5	18.4	9.7	5.6	5.9	0.9	5.3	5.3	9.0	10.9	7.8	3.6	5.3	3.7	7.3	3.1	2.6	3.3	5.3	4.4	3.4
TMEM105	FLJ38792	ENSG00000185332	"Transmembrane protein 105"	Q8N8V8	17	81311270-81330674	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 7.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.3;MCF7: 3.3;T-47d: 2.1;THP-1: 2.7;U-937: 5.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (4.99e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.81e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.04e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.38e-1)"	0.1	0.8	0.1	0.1	0.1	0.6	0.7	0.0	0.1	0.5	1.7	0.0	0.0	0.5	0.1	0.2	2.4	0.7	5.0	0.0	0.1	0.0	2.4	7.5	4.7	0.1	0.1	0.0	0.2	0.1	0.0	0.1	1.0	0.5	0.8	0.4	0.7	4.0	0.0	0.5	1.1	2.0	1.3	0.2	1.3	0.3	0.2	0.0	0.0	2.4	3.3	2.4	3.3	1.0	0.5	1.0	1.9	0.4	0.8	0.4	0.1	0.5	1.1	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.3	0.2	0.0	0.1	0.0	2.1	2.7	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.6	0.4	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	0.5	0.2	0.4	1.9	0.8	0.1	1.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805120	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 76.8;liver: 234.5"	"Cell line enriched"	"Detected in some"	30	"HSkMC: 124.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 38.4;intermediate monocyte: 27.1"	"Lineage enriched"	"Detected in many"	4	"monocytes: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	10.5	4.9	5.8	17.1	6.0	0.7	7.8	1.2	4.3	6.2	32.2	4.8	2.0	16.1	3.6	12.8	7.5	6.3	34.2	15.0	5.2	4.5	76.8	234.5	8.8	23.5	6.9	3.4	19.0	5.0	0.4	2.2	8.9	6.6	6.3	22.3	22.8	3.9	2.0	3.1	3.3	51.2	6.5	6.9	17.3	7.1	3.7	5.4	2.1	4.8	4.8	9.2	13.5	9.1	0.4	9.3	3.3	38.4	0.0	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	3.3	0.1	27.1	0.1	0.4	0.0	0.1	9.3	0.0	0.0	0.0	0.5	0.0	12.9	0.6	0.1	10.7	5.8	6.0	1.2	4.3	5.2	4.5	6.9	3.4	6.6	5.4
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.3;liver: 247.9"	"Group enriched"	"Detected in some"	17	"HSkMC: 117.6;THP-1: 37.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 92.3;intermediate monocyte: 68.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Golgi apparatus"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	13.9	5.5	7.8	19.8	10.7	1.1	11.7	2.1	6.3	8.6	27.6	5.7	2.0	18.3	3.8	15.2	9.6	9.0	50.2	26.8	7.6	5.2	62.9	247.9	11.2	22.9	10.5	3.3	20.3	6.8	0.3	3.2	12.5	8.4	6.1	27.9	22.0	5.1	3.2	2.5	4.2	53.1	10.7	13.2	23.5	10.6	5.2	8.7	4.3	4.9	7.0	10.5	14.7	11.6	0.2	20.0	5.7	92.3	0.0	0.4	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	117.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	37.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	92.3	5.7	0.2	68.0	0.4	0.2	0.0	0.0	20.0	0.0	0.0	0.0	1.1	0.0	36.2	0.9	0.0	42.0	7.8	10.7	2.1	6.3	7.6	5.2	10.5	3.3	8.4	8.7
TMEM220		ENSG00000187824	"Transmembrane protein 220"	Q6QAJ8	17	10699015-10730316	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 58.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047680			Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047680: "	"unprognostic (1.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.84e-4)"	"prognostic favourable (2.23e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.97e-2)"	6.5	7.4	4.5	2.4	4.6	3.3	7.8	1.3	2.8	4.7	6.1	3.8	14.3	8.1	4.9	11.1	3.3	3.9	10.1	6.3	3.8	2.4	6.4	58.2	4.6	3.1	2.9	1.2	4.8	6.0	2.4	2.4	1.7	4.9	12.0	2.8	6.6	3.5	18.5	4.1	3.7	15.4	5.4	2.5	4.7	7.1	17.2	3.5	0.6	9.4	2.6	2.4	4.1	3.4	11.6	2.9	2.3	2.5	4.5	9.0	1.9	0.5	3.5	1.3	8.1	5.1	5.1	1.0	6.8	7.2	4.7	6.7	0.0	0.3	1.2	0.5	4.2	0.4	3.3	0.6	3.4	0.4	1.5	0.5	0.2	2.8	7.4	0.9	0.8	3.4	0.4	1.5	0.3	2.1	0.4	0.3	2.9	0.4	1.1	1.4	4.9	0.0	4.7	0.2	0.6	10.9	0.2	0.5	5.8	0.3	0.1	0.7	0.4	1.8	4.7	0.4	1.3	2.6	0.4	0.8	0.3	0.3	4.9	1.4	0.6	1.4	2.5	2.3	0.9	1.8	1.1	4.2	2.2	1.3	2.9	11.6	9.0	6.1	2.1	4.5	0.8	2.3	0.4	1.9	4.5	4.6	1.3	2.8	3.8	2.4	2.9	1.2	4.9	3.5
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674555	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7;liver: 44.7"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 38.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"				"Golgi apparatus"	"Golgi apparatus"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favourable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	8.3	9.0	6.0	4.4	8.7	6.0	7.0	2.4	11.8	4.9	11.0	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8.0	5.2	7.2	13.9	6.0	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4.0	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8.0	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.1	2.4	7.3	2.1	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.2	9.3	7.3	8.8	1.9	2.4	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.2	4.0	1.1	23.5	13.1	8.0	5.6	5.4	2.4	9.6	12.4	2.9	5.8	1.0	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3.0	8.6	2.6	5.3	3.1	2.5	2.6	5.0	1.5	2.0	0.5	2.8	6.0	38.7	3.0	2.8	6.0	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8.0	4.4
TMEM56	FLJ31842	ENSG00000152078	"Transmembrane protein 56"	Q96MV1	1	95117338-95197607	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell line enhanced"	"Detected in many"		"A-431: 13.9;RH-30: 23.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;granulocytes: 1.0"									HPA046762			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	3.3	6.6	6.1	1.6	6.5	10.4	2.0	10.9	10.6	2.0	8.2	3.8	2.8	3.6	2.5	2.1	1.9	2.2	4.5	15.1	4.2	3.2	3.9	74.2	2.6	0.7	3.5	5.7	1.5	6.5	5.4	6.8	3.1	4.7	3.8	6.6	28.1	4.8	2.7	7.2	1.7	6.6	8.1	4.1	1.0	3.9	3.2	3.2	0.0	4.8	1.7	0.8	4.8	3.1	3.3	0.1	1.0	0.1	0.0	0.3	0.1	13.9	8.0	1.1	1.7	0.5	0.0	1.9	0.5	0.3	1.8	4.3	5.8	6.7	0.0	7.0	0.2	0.1	4.7	0.7	3.2	9.7	2.6	0.3	6.8	1.2	0.5	0.2	0.4	0.8	0.2	1.4	0.0	0.0	12.2	0.7	0.4	1.1	0.8	0.0	1.1	4.4	0.0	23.2	0.3	7.8	9.1	2.9	2.3	9.9	7.0	4.1	7.6	0.2	0.1	0.2	6.0	0.7	4.9	2.5	4.8	0.0	1.0	0.0	1.4	0.3	0.1	0.1	0.1	0.0	0.0	3.3	0.2	0.2	0.0	1.6	0.3	0.1	1.0	0.0	0.0	0.1	0.1	0.1	6.1	6.5	10.9	10.6	4.2	3.2	3.5	5.7	4.7	3.2
TMEM56-RWDD3		ENSG00000271092	"TMEM56-RWDD3 readthrough"		1	95117923-95247225	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 42.6;retina: 25.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 15.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.42e-2)"	3.1	3.9	4.6	1.8	5.8	2.8	3.9	7.5	9.2	2.9	3.6	3.3	2.3	4.1	3.2	4.9	2.1	3.1	3.7	14.2	3.8	2.4	2.8	42.6	2.7	3.3	2.5	4.9	3.5	6.2	4.1	6.1	4.5	4.1	3.7	3.9	25.5	3.9	2.2	4.7	4.6	5.8	7.0	2.9	2.3	3.9	3.4	2.8	0.0	4.5	1.6	2.6	3.6	2.9	2.7	1.3	1.1	0.8	0.7	2.4	1.0	7.1	4.3	4.0	5.3	1.7	3.1	4.5	1.4	0.9	2.8	3.2	6.6	3.0	2.6	5.0	1.6	1.8	3.8	1.9	3.0	1.9	2.4	3.2	4.2	1.6	1.5	0.9	1.0	1.9	2.1	2.5	0.7	1.2	5.3	1.7	1.5	2.0	2.2	2.5	2.0	2.2	1.9	15.1	0.4	3.8	7.4	3.9	4.5	5.3	4.2	5.2	3.0	2.4	2.6	3.0	4.1	2.8	3.9	2.4	1.6	1.6	1.4	0.6	2.1	0.6	0.7	1.1	1.3	0.8	0.7	2.7	2.0	0.8	1.3	2.6	2.4	0.9	0.0	0.7	0.7	0.6	1.6	1.0	4.6	5.8	7.5	9.2	3.8	2.4	2.5	4.9	4.1	2.8
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome				Centrosome	Centrosome	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.4	0.7	1.3	1.8	6.3	2.2	4.7	1.2	1.1	1.7	0.9	1.0	0.6	0.9	11.1	8.8	2.5	5.9	1.2	3.9	3.7	0.8	1.7	2.1	1.3	0.5	6.0	3.5	0.8	2.4	6.4	10.0	0.9	2.4	5.9	2.8	12.5	1.1	5.1	2.1	3.9	1.8	0.8	4.9	2.2	8.3	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4
TMPRSS9		ENSG00000178297	"Transmembrane serine protease 9"	Q7Z410	19	2389771-2426239	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 6.3;lymphoid tissue: 4.6;testis: 5.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.1;SK-BR-3: 3.1;U-266/70: 5.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Low region specificity"	"Detected in all"			HPA051483	Uncertain									"HPA051483: AB_2681501"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.44e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.73e-2)"	0.1	1.1	0.9	0.4	0.2	2.0	1.3	0.0	0.2	0.0	0.4			0.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	6.3	0.0	0.1	0.0		0.2	1.2	0.0	0.2	0.1		0.1	0.0		0.5	0.0	1.5	1.8	0.4	0.0	0.0	4.6	0.1	5.9			0.0		0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	0.1	1.7	0.3	0.2	0.6	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.6	0.5	0.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.2	2.1	2.3	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	1.0	6.1	0.0	1.2	0.1	0.4	0.5	0.8	1.1	0.0	0.8	0.0	0.3	0.1	0.2	0.2	3.1	0.1	0.4	1.6	0.4	1.1	0.8	1.1	0.7	5.4	1.3	1.5	0.2	0.9	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1										
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;liver: 50.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.1;NB-4: 4.7;THP-1: 3.3;U-937: 12.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 50.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 50.8;T-cells: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012700	Approved				"Secreted to blood"					"HPA012700: AB_1852870"	"unprognostic (2.78e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.82e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (6.07e-13)"	"unprognostic (1.09e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.62e-2)"	11.2	0.9	0.6	4.6	0.6	2.5	1.3	1.2	1.5	0.8	2.4	0.4	0.2	2.8	2.7	2.3	1.8	3.6	2.0	2.1	0.6	0.1	1.0	50.6	4.3	8.3	3.8	0.2	2.9	2.5	0.0	0.9	1.8	1.4	1.2	1.8	1.9	1.4	1.5	0.2	0.7	3.8	1.6	0.3	8.2	1.8	1.6	0.2	1.5	1.4	0.9	5.9	2.1	14.1	0.3	1.7	50.8	4.5	7.2	16.6	2.9	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	0.0	21.1	0.0	0.1	0.2	1.1	0.0	0.6	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	12.0	0.0	28.3	4.5	27.4	11.4	1.0	16.6	0.1	4.9	9.2	1.7	0.3	0.8	4.2	50.8	7.2	0.1	0.1	3.9	2.9	0.6	0.6	1.2	1.5	0.6	0.1	3.8	0.2	1.4	0.2
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.0;salivary gland: 47.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 87.0;hTCEpi: 53.9;hTERT-HME1: 62.7;SK-MEL-30: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015272: , HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (1.70e-4)"	"prognostic unfavourable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	4.8	8.7	1.6	2.8	1.5	9.7	6.0	3.8	4.2	2.5	1.8	1.2	3.6	1.0	2.1	3.1	9.8	1.1	2.7	3.0	1.4	2.0	3.3	39.0	8.2	7.3	1.0	2.4	4.4	13.8	2.0	10.5	6.2	1.6	3.9	1.6	3.7	47.5	5.3	1.5	6.5	2.5	1.3	0.7	7.9	4.4	2.7	0.6	6.7	27.2	4.1	7.0	2.7	5.3	15.5	4.7	3.3	4.4	6.6	11.4	5.1	10.9	5.5	0.7	1.6	1.9	2.5	4.7	3.2	8.7	3.1	6.5	11.5	5.4	4.7	3.2	2.9	8.8	3.0	14.6	2.9	1.7	2.1	3.6	1.2	18.7	87.0	9.2	1.8	10.1	53.9	5.8	62.7	6.0	12.6	21.3	0.3	10.1	0.5	11.2	1.6	18.1	2.1	0.9	10.1	3.6	4.4	2.0	3.2	0.7	26.5	79.1	7.7	24.5	3.4	1.7	2.9	0.0	5.0	7.4	9.5	8.4	1.4	8.1	6.0	2.5	4.4	1.0	10.0	3.4	7.1	15.5	9.3	11.4	4.7	10.2	10.7	7.6	3.3	6.6	1.7	2.1	6.4	5.1	1.6	1.5	3.8	4.2	1.4	2.0	1.0	2.4	1.6	0.6
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151945-30160934	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8"	"Cell line enriched"	"Detected in single"	11	"EFO-21: 1.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hippocampal formation: 4.0"	HPA043325	Uncertain									"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	3.0	0.0	0.0	1.4	0.1	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 11.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 12.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"														"unprognostic (3.96e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.21e-4)"	"unprognostic (9.90e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.43e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.97e-4)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.12e-3)"	1.4	1.2	3.5	0.7	2.9	0.3	1.7	2.7	2.1	2.1	1.4			6.5	2.3	1.5	0.8	2.8	1.1	1.9	3.2	3.6	2.5	11.7	0.7	1.3	4.7		5.1	2.5	1.0	2.0	1.2		1.5	1.7		2.1	1.0	2.8	4.7	5.1	0.9	2.3	1.2	2.2	1.2			1.3		0.8	1.2	1.1	1.1	1.4	1.5	0.8	0.5	2.2	0.3	2.9	5.5	4.5	4.9	4.8	4.6	4.0	1.6	2.4	2.6	2.3	1.3	1.6	1.2	2.2	1.8	12.9	2.7	0.9	1.8	7.1	6.6	0.7	2.9	5.5	2.1	0.3	5.6	5.5	3.0	3.7	1.5	0.5	0.3	2.2	1.5	3.7	2.1	1.0	3.0	2.7	6.1	2.9	0.9	2.1	2.6	1.9	4.1	2.3	4.4	2.2	8.2	2.3	1.6	1.1	2.6	4.4	2.2	1.9	1.3	0.5	1.9	2.3	2.3	0.9	0.8	1.5	0.7	0.2	0.9	0.4	0.6	0.2	0.1	1.1	0.8	2.2	1.5	0.5	0.3	1.4	0.2	0.3										
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell line enhanced"	"Detected in many"		"A549: 42.5;ASC diff: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	2100000	2100000	Nucleoplasm	Nucleoplasm	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (2.87e-4)"	"prognostic favourable (1.66e-4)"	"prognostic unfavourable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	42.5	4.7	4.6	72.7	9.3	8.7	1.4	8.0	3.1	3.0	5.5	11.7	0.1	8.3	5.3	17.0	2.7	10.4	1.0	8.7	1.4	2.0	11.0	15.2	13.7	0.7	3.2	9.5	11.5	5.6	4.6	3.9	4.6	0.3	2.9	19.6	0.1	1.5	6.2	1.8	1.4	4.5	6.7	7.4	7.4	4.3	7.1	8.1	6.4	3.8	8.5	0.6	1.2	8.9	7.1	21.7	3.4	0.3	0.1	0.3	4.2	2.2	1.6	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 16.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		2800000	2800000	Mitochondria	Mitochondria	"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.04e-4)"	8.5	29.7	6.0	13.5	7.6	5.7	6.1	5.0	10.5	9.5	38.4	12.9	10.9	37.4	5.9	4.0	16.6	6.8	38.4	14.1	5.1	4.9	19.7	102.1	6.2	3.2	8.2	7.0	7.2	23.9	1.8	2.3	5.0	5.9	8.1	21.6	6.2	13.6	6.9	8.3	5.4	39.5	3.8	4.7	3.5	22.8	3.3	6.7	1.8	8.5	12.8	10.5	7.2	9.2	1.6	16.0	14.3	11.5	2.2	1.2	5.2	15.1	33.7	4.3	14.4	10.4	4.1	8.0	8.4	7.2	4.9	7.4	9.8	10.0	4.0	7.1	6.6	13.1	3.1	8.4	1.1	11.7	18.9	4.2	6.4	19.0	26.1	5.8	10.0	8.0	9.6	3.6	3.1	12.0	5.0	7.0	2.3	34.7	0.2	18.8	7.3	14.8	13.6	4.6	7.0	13.8	14.2	2.5	6.5	8.9	16.0	11.4	16.5	14.8	9.0	5.6	10.5	9.3	2.6	5.3	5.3	1.2	2.0	16.9	3.3	5.3	11.5	4.9	0.6	3.0	1.1	1.6	0.5	0.4	16.0	0.8	0.3	0.2	14.3	2.2	0.8	1.1	1.2	5.2	6.0	7.6	5.0	10.5	5.1	4.9	8.2	7.0	5.9	6.7
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 59.8;liver: 92.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdTCR: 36.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029302	Approved		Approved	Cytosol		19000	19000	Cytosol	Cytosol	"HPA029302: AB_10601704"	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favourable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	10.5	8.1	3.8	8.8	5.0	16.1	14.0	3.9	4.4	5.5	31.6	5.5	6.2	31.2	6.6	5.0	6.7	5.9	15.0	10.9	3.8	3.3	47.2	92.8	5.3	5.0	6.0	2.2	10.0	19.8	3.0	5.9	3.1	5.3	8.7	12.9	7.5	10.4	6.9	8.6	3.9	59.8	5.2	3.9	8.4	9.1	2.5	5.5	1.0	8.2	4.7	4.2	5.3	5.8	0.9	4.0	10.1	4.3	13.5	36.0	13.4	5.6	6.2	7.9	16.5	7.5	6.5	8.0	8.3	5.4	9.0	7.1	10.1	4.1	0.0	5.3	8.4	5.1	7.9	6.6	3.3	12.6	17.8	7.4	14.0	34.9	10.4	4.1	29.1	11.1	3.5	4.1	4.7	7.5	5.4	9.3	5.7	5.5	0.1	12.9	6.0	6.2	0.0	3.8	3.7	6.1	6.5	1.4	11.2	11.4	7.8	6.1	12.5	8.3	8.8	6.5	7.1	4.9	5.2	7.3	4.3	0.8	4.3	6.4	6.6	10.1	4.3	8.0	36.0	4.1	3.9	0.9	3.5	16.0	4.0	0.7	1.5	15.4	2.9	13.5	3.0	1.6	1.6	13.4	3.8	5.0	3.9	4.4	3.8	3.3	6.0	2.2	5.3	5.5
TTC39C	"C18orf17, FLJ33761, HsT2697"	ENSG00000168234	"Tetratricopeptide repeat domain 39C"	Q8N584	18	23992773-24135610	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 92.2"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065705, HPA065713"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065705: AB_2685538, HPA065713: AB_2685542"	"prognostic favourable (1.48e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (2.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.48e-3)"	9.0	14.2	6.2	12.0	4.9	17.7	10.9	5.1	12.2	8.7	6.3	2.4	1.5	5.1	9.8	6.5	9.4	9.0	17.2	3.9	5.3	2.7	3.3	92.2	7.1	14.1	2.2	6.7	5.9	9.8	1.3	13.4	1.5	6.2	9.7	4.6	20.8	11.8	3.9	4.7	24.2	6.2	5.3	2.2	6.7	6.1	14.3	1.0	12.0	3.7	5.7	20.9	8.3	9.3	5.2	8.8	0.5	1.9	5.7	35.5	4.2	6.5	4.9	3.3	2.2	20.8	22.0	11.9	9.4	21.5	7.5	7.7	0.6	3.6	10.8	9.3	16.4	8.2	6.4	8.2	6.0	16.0	6.6	3.1	23.5	12.1	4.0	16.9	8.3	17.7	11.1	4.3	6.1	0.5	0.1	0.1	4.8	5.1	2.7	5.1	8.1	12.6	15.5	5.0	4.1	7.8	10.0	8.7	6.9	18.1	6.1	5.7	4.8	6.2	4.2	6.6	4.9	5.0	4.7	0.2	0.0	15.7	8.8	17.7	4.5	0.5	1.9	0.0	11.2	1.9	28.8	5.2	24.9	14.0	2.5	3.3	10.7	9.0	0.5	5.7	1.5	8.8	35.5	4.2	6.2	4.9	5.1	12.2	5.3	2.7	2.2	6.7	6.2	1.0
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		12000000	12000000	"Centrosome, Mitochondria"	"Centrosome, Mitochondria"	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.3	14.4	13.8	9.3	47.2	61.2	58.0	35.4	29.0	19.1	22.8	36.9	23.3	28.7	10.7	38.0	12.0	16.7	22.2	31.0	19.2	7.1	18.2	10.2	25.2	22.5	16.0	16.1	40.1	40.7	17.9	18.5	26.5	9.1	11.7	79.6	10.8	21.7	15.1	33.1	10.1	17.8	27.4	16.6	33.8	16.0	7.3	6.0	28.3	36.4	13.4	10.4	11.4	36.1	20.0	31.6	29.7	18.6	20.9	9.4	36.4	24.0	25.1	61.0	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.5;RPMI-8226: 5.1;SH-SY5Y: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"									HPA045108	Supported									"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	5.1	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026911-41039217	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 52.2;kidney: 60.9;liver: 29.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.2;Hep G2: 4.4;RPTEC TERT1: 15.8;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015725	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	0.4	0.2	0.4	0.6	0.4	0.3	0.5	0.4	0.4	0.4	9.9	0.5	0.4	23.7	0.8	0.8	0.5	0.7	10.2	0.4	0.4	0.1	60.9	29.9	0.9	0.4	0.4	0.4	0.5	17.7	0.1	0.6	0.8	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.6	52.2	0.4	0.4	1.2	15.9	0.6	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.3	1.0	0.7	0.3	0.0	2.4	0.2	0.6	0.3	0.8	1.1	0.2	0.1	0.7	0.0	0.1	0.0	0.0	8.2	0.1	0.1	3.1	0.0	0.2	0.2	0.3	0.1	1.2	1.6	0.8	0.0	4.4	0.1	0.4	0.3	0.2	0.7	0.0	0.5	0.0	0.6	0.5	0.0	0.2	1.0	2.6	0.3	0.2	1.0	0.1	0.6	15.8	0.0	0.7	0.7	0.0	0.1	1.5	0.2	0.2	0.2	0.0	0.5	0.4	0.1	5.2	2.6	0.7	0.0	1.8	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.2	0.7	0.2	0.1	0.3	0.4	0.0	0.0	0.0	0.3	1.0	2.4	0.2	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316019	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.8;liver: 17.4;skin 1: 18.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.7;Hep G2: 4.8;SCLC-21H: 5.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA035729	Uncertain									"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.5	1.4	0.1	0.1	9.2	0.1	0.5	5.9	1.0	1.6	0.1	0.1	0.0	2.5	17.4	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.5	0.1	0.1	18.8	9.8	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.1	3.9	2.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.3"	"Cell line enhanced"	"Detected in all"		"ASC diff: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	21.3	23.0	9.3	11.5	11.0	12.9	28.1	9.4	14.5	24.3	19.3	17.1	16.5	12.6	24.0	27.4	18.5	17.8	22.6	20.1	9.8	10.2	29.9	173.3	16.4	17.5	13.7	9.1	25.5	55.5	14.0	25.0	22.5	13.3	22.3	12.6	20.8	34.8	21.4	11.4	15.9	26.8	27.7	12.5	15.4	17.5	18.2	10.6	15.8	25.6	13.8	14.6	28.4	18.7	32.3	49.9	59.6	40.6	24.7	43.7	33.6	10.4	26.9	8.9	25.3	98.2	58.5	9.9	38.9	33.8	19.1	32.6	11.2	12.1	8.2	21.0	48.6	9.7	12.2	15.2	21.8	11.6	29.7	7.5	37.3	53.6	15.5	14.5	11.3	33.8	8.2	26.4	22.7	20.7	9.8	19.6	37.4	37.9	10.6	29.8	16.0	25.9	19.3	23.5	40.9	18.9	9.2	18.1	21.9	17.0	12.4	18.8	20.4	17.7	18.0	25.7	9.2	23.6	14.6	11.9	11.0	7.2	66.9	25.1	13.2	21.5	40.6	59.6	40.3	28.1	39.7	29.9	40.5	40.7	39.6	32.3	36.4	35.4	34.2	24.7	28.3	49.9	43.7	33.6	9.3	11.0	9.4	14.5	9.8	10.2	13.7	9.1	13.3	10.6
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	1300000	1300000	Nucleoplasm	Nucleoplasm	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.7	0.0	0.2	5.6	0.0	0.3	0.0	0.4	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	18.9	1.0	0.0	0.1	11.1	0.5	0.5	0.0	1.7	0.2	0.3	0.3	0.0	4.1	0.0	1.6	0.0	10.6	0.1	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.5	0.7	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5
WNT3	"INT4, MGC131950, MGC138321, MGC138323"	ENSG00000108379	"Wnt family member 3"	P56703	17	46762506-46833154	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 7.8;skin 1: 17.2"	"Cell line enhanced"	"Detected in many"		"AF22: 10.1;U-698: 11.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 13.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA066281: AB_2685647"	"unprognostic (1.84e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.41e-4)"	"unprognostic (4.73e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.10e-8)"	"unprognostic (1.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	0.5	0.6	1.0	0.6	3.9	0.4	0.4	1.4	4.7	0.2	0.2	3.8	0.1	4.7	0.3	0.4	0.6	0.4	0.4	0.6	1.4	2.9	0.6	7.8	0.3	2.9	2.1	3.5	0.6	0.3	6.0	0.9	0.7	4.1	0.8	0.6	0.1	1.2	0.3	0.5	17.2	1.4	0.5	1.6	0.5	0.4	2.4	2.3	0.1	0.6	1.4	0.5	0.2	0.3	1.0	1.4	0.2	0.3	0.0	1.2	0.1	2.5	0.0	10.1	0.0	0.0	0.0	0.9	0.8	0.6	1.8	0.0	2.6	2.0	1.9	1.1	0.4	1.2	0.4	0.0	2.2	0.0	0.2	0.0	0.5	2.2	0.0	0.0	0.3	0.0	1.4	0.3	0.6	0.5	1.6	0.0	0.3	0.4	0.0	1.6	0.1	1.1	1.0	1.9	0.1	0.1	0.0	0.2	0.7	1.4	0.0	0.5	0.0	2.4	0.0	3.1	1.3	0.5	0.7	0.3	0.2	11.1	0.5	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.3	1.4	1.2	0.1	1.0	3.9	1.4	4.7	1.4	2.9	2.1	3.5	4.1	2.3
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;HBEC3-KT: 15.0;hTERT-HME1: 23.9;U-251 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.1	3.5	0.7	1.1	0.2	1.7	0.0	1.2	0.2	3.2	0.0	15.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.9	23.9	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.0	1.1	3.3	4.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	1.9	0.1	6.5	1.9	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA037863: AB_10672729, HPA038415: "	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	2.3	3.2	2.7	1.9	3.4	2.5	3.0	10.3	4.7	2.7	5.9	2.3	1.6	5.8	3.7	3.6	3.1	1.9	2.5	1.5	1.8	1.8	11.3	34.0	1.8	1.3	1.9	3.3	2.8	6.1	1.2	3.1	1.4	4.1	2.1	5.1	3.0	7.1	1.8	1.3	1.9	9.8	3.6	2.0	1.6	3.7	2.1	1.6	2.3	1.5	1.8	1.3	2.7	2.9	0.4	6.4	1.1	3.6	0.9	3.9	1.1	3.0	5.7	2.1	4.6	2.9	3.2	5.1	4.3	1.6	3.9	3.8	7.7	3.2	2.7	1.1	5.4	2.1	6.2	2.5	4.2	3.8	4.8	5.3	4.4	21.0	1.8	7.5	5.7	2.1	4.3	5.2	2.1	3.5	14.3	5.2	3.7	1.6	6.4	1.0	3.0	6.9	3.2	4.2	3.8	0.4	4.7	2.6	2.4	2.5	11.5	9.3	5.5	4.3	1.3	7.3	5.7	11.1	1.8	2.8	4.5	7.3	3.9	6.3	5.3	0.5	2.2	0.7	1.5	3.6	1.0	0.3	1.2	0.8	6.4	0.4	1.5	1.5	1.1	0.9	2.9	1.3	3.9	1.1	2.7	3.4	10.3	4.7	1.8	1.8	1.9	3.3	4.1	1.6
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289170	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014840	Approved		Supported	"Golgi apparatus,Vesicles,Centriolar satellite"				Vesicles	Vesicles	"HPA014840: AB_2217189"	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (8.70e-4)"	16.0	19.7	11.3	12.4	11.7	6.4	18.9	8.0	16.5	17.3	21.4	19.3	18.5	26.1	19.4	24.8	18.5	16.4	24.6	20.1	9.8	9.2	26.2	138.8	16.5	16.0	12.8	9.4	21.2	55.2	18.9	26.8	24.7	12.3	16.8	17.9	16.5	24.4	19.2	32.3	14.3	32.1	19.1	15.2	12.8	19.4	16.9	10.7	16.4	28.2	26.4	17.7	18.2	13.7	27.4	40.4	5.5	38.9	13.3	23.6	26.1	20.6	34.2	10.7	19.5	36.2	39.0	19.6	30.4	32.7	26.0	25.8	32.4	25.4	17.6	29.9	42.7	31.5	16.3	28.6	20.8	20.0	18.7	10.9	26.6	40.1	40.4	15.3	16.6	26.9	38.9	26.8	43.7	24.3	20.3	31.0	22.6	50.2	18.3	16.2	10.8	35.8	14.1	16.4	52.5	22.0	18.8	15.7	15.4	16.4	28.5	26.9	41.9	11.3	21.4	22.0	18.6	44.2	14.0	20.8	21.5	15.8	34.5	14.5	24.2	4.9	28.0	5.5	21.8	38.9	23.6	27.4	18.8	20.3	33.2	22.6	15.1	17.2	2.8	13.3	37.2	40.4	15.2	26.1	11.3	11.7	8.0	16.5	9.8	9.2	12.8	9.4	12.3	10.7
Z82190.2		ENSG00000285404			22	31754899-31956243	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.9;brain: 1.3;liver: 1.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;REH: 1.1;U-2197: 2.5;U-251 MG: 1.4;U-698: 1.0"									"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.1;monocytes: 1.9"									"HPA054969, HPA055619"	Uncertain									"HPA054969: AB_2682655, HPA055619: AB_2682864"																		0.0	0.5		0.0		0.0	0.0		1.3	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.4	1.7	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.9		0.4	0.0	0.0	0.0	0.0	0.9		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.2	1.1	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.2	1.0	0.0	0.0	0.0	0.3	0.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.0	0.1										
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056705			Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favourable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	9.3	9.8	9.6	13.6	14.5	14.5	8.0	20.2	13.2	7.6	8.9	12.0	10.8	11.1	12.9	6.1	9.1	8.1	11.2	8.8	10.3	7.1	11.7	56.1	7.2	11.0	16.9	10.7	7.3	12.6	8.3	10.8	9.0	14.2	8.3	3.9	8.0	14.0	8.8	9.2	10.5	10.8	9.4	8.5	11.7	10.3	14.9	15.0	11.3	8.0	5.8	13.5	8.3	9.2	15.6	21.7	19.2	16.4	20.2	23.8	13.0	8.5	11.1	4.3	7.0	3.6	2.5	10.1	8.9	5.9	14.2	5.9	23.7	11.8	8.9	17.1	5.0	15.8	2.9	10.6	1.8	6.0	7.7	8.4	9.6	24.2	7.1	5.2	14.9	6.4	9.0	5.8	2.3	7.7	9.1	8.4	4.6	8.6	12.8	12.4	7.1	13.9	13.6	3.3	9.1	7.9	8.0	8.3	10.3	12.7	14.4	7.9	9.9	14.8	8.7	22.2	7.9	8.4	11.4	8.3	13.1	12.3	14.0	5.2	9.9	6.6	16.0	19.2	23.8	16.4	23.1	15.6	20.4	21.5	15.1	14.5	20.3	20.5	17.0	20.2	13.2	21.7	19.8	13.0	9.6	14.5	20.2	13.2	10.3	7.1	16.9	10.7	14.2	15.0
ZNF511-PRAP1		ENSG00000283496	"ZNF511-PRAP1 readthrough"		10	133309410-133352529	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"intestine: 31.6;liver: 23.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.9;CACO-2: 7.0;Hep G2: 16.6"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA035360, HPA038713, HPA052451"	Supported									"HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839"																		2.1	1.6	1.1	5.0	1.7	1.2	6.2	3.0	2.7	3.1	11.9	1.9	4.9	31.6	3.9	3.5	3.5	1.3	3.0	4.8	1.8		13.7	23.8	2.1	4.7	2.2	1.9	4.9	9.7	0.9	2.1	1.5	1.7	5.1	7.6	2.9	5.0	3.0	5.8	1.3	28.1	4.4	0.8	3.0	3.4	6.5	2.7	3.2	4.6	7.1	3.0	2.0	4.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	3.3	5.2	0.0	0.0	6.9	0.0	1.4	0.0	0.0	7.0	2.2	0.0	3.3	1.7	0.1	0.8	0.0	2.1	0.3	0.0	0.9	0.0	16.6	0.0	1.3	1.8	0.0	0.0	1.5	5.0	0.0	0.3	6.3	0.0	0.0	3.4	5.3	0.3	0.0	0.9	1.2	3.0	0.2	0.3	0.5	5.6	0.3	2.8	2.4	0.0	0.5	0.0	0.0	3.1	2.6	0.1	1.5	0.0	0.8	0.4	1.1	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF648	FLJ46813	ENSG00000179930	"Zinc finger protein 648"	Q5T619	1	182054570-182061712	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;liver: 1.7;ovary: 3.0;testis: 2.2"	"Cell line enriched"	"Detected in single"	80	"HMC-1: 28.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053897	Uncertain									"HPA053897: AB_2682297"	"unprognostic (3.52e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.30e-1)"		"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.16e-6)"	"unprognostic (4.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.83e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.3	0.2	0.0			0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0		3.0	0.4	0.0	1.0	0.0		0.0	0.0		0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
